
<html lang="en"     class="pb-page"  data-request-id="4eda34bc-944d-4a1e-91cb-00cf47f1655f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.9b00162;issue:issue:10.1021/jmcmar.2019.62.issue-7;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Topographical Mapping of Isoform-Selectivity Determinants for J-Channel-Binding Inhibitors of Sphingosine Kinases 1 and 2" /></meta><meta name="dc.Creator" content="David&#xA;R.  Adams" /></meta><meta name="dc.Creator" content="Salha  Tawati" /></meta><meta name="dc.Creator" content="Giacomo  Berretta" /></meta><meta name="dc.Creator" content="Paula Lopez  Rivas" /></meta><meta name="dc.Creator" content="Jessica  Baiget" /></meta><meta name="dc.Creator" content="Zhong  Jiang" /></meta><meta name="dc.Creator" content="Aisha  Alsfouk" /></meta><meta name="dc.Creator" content="Simon P.  Mackay" /></meta><meta name="dc.Creator" content="Nigel J.  Pyne" /></meta><meta name="dc.Creator" content="Susan  Pyne" /></meta><meta name="dc.Description" content="Sphingosine kinase enzymes (SK1 and SK2) catalyze the conversion of sphingosine into sphingosine 1-phosphate and play a key role in lipid signaling and cellular responses. Mapping of isoform amino ..." /></meta><meta name="Description" content="Sphingosine kinase enzymes (SK1 and SK2) catalyze the conversion of sphingosine into sphingosine 1-phosphate and play a key role in lipid signaling and cellular responses. Mapping of isoform amino ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 19, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00162" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00162" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00162" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00162" /></link>
        
    
    

<title>Topographical Mapping of Isoform-Selectivity Determinants for J-Channel-Binding Inhibitors of Sphingosine Kinases 1 and 2 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00162" /></meta><meta property="og:title" content="Topographical Mapping of Isoform-Selectivity Determinants for J-Channel-Binding Inhibitors of Sphingosine Kinases 1 and 2" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0014.jpeg" /></meta><meta property="og:description" content="Sphingosine kinase enzymes (SK1 and SK2) catalyze the conversion of sphingosine into sphingosine 1-phosphate and play a key role in lipid signaling and cellular responses. Mapping of isoform amino acid sequence differences for SK2 onto the recently available crystal structures of SK1 suggests that subtle structural differences exist in the foot of the lipid-binding “J-channel” in SK2, the structure of which has yet to be defined by structural biology techniques. We have probed these isoform differences with a ligand series derived from the potent SK1-selective inhibitor, PF-543. Here we show how it is possible, even with relatively conservative changes in compound structure, to systematically tune the activity profile of a ligand from ca. 100-fold SK1-selective inhibition, through equipotent SK1/SK2 inhibition, to reversed 100-fold SK2 selectivity, with retention of nanomolar potency." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00162"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00162">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00162&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00162&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00162&amp;href=/doi/10.1021/acs.jmedchem.9b00162" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 3658-3676</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00157" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00164" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Topographical Mapping of Isoform-Selectivity Determinants for J-Channel-Binding Inhibitors of Sphingosine Kinases 1 and 2</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">David R. Adams</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David R. Adams</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Engineering & Physical Sciences, Heriot-Watt University, Edinburgh EH14 4AS, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David%0AR.++Adams">David R. Adams</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7154-7332" title="Orcid link">http://orcid.org/0000-0002-7154-7332</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Salha Tawati</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Salha Tawati</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Salha++Tawati">Salha Tawati</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Giacomo Berretta</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Giacomo Berretta</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Giacomo++Berretta">Giacomo Berretta</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Paula Lopez Rivas</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paula Lopez Rivas</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paula+Lopez++Rivas">Paula Lopez Rivas</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jessica Baiget</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jessica Baiget</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jessica++Baiget">Jessica Baiget</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhong Jiang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhong Jiang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Engineering & Physical Sciences, Heriot-Watt University, Edinburgh EH14 4AS, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhong++Jiang">Zhong Jiang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Aisha Alsfouk</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Aisha Alsfouk</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Aisha++Alsfouk">Aisha Alsfouk</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Simon P. Mackay</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Simon P. Mackay</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Simon+P.++Mackay">Simon P. Mackay</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8000-6557" title="Orcid link">http://orcid.org/0000-0001-8000-6557</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nigel J. Pyne</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nigel J. Pyne</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nigel+J.++Pyne">Nigel J. Pyne</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Susan Pyne</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Susan Pyne</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, U.K.</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +44(0)141 548 2012. E-mail: <a href="/cdn-cgi/l/email-protection#3d4e484e5c53134d4453587d4e494f5c4955135c5e134856"><span class="__cf_email__" data-cfemail="75060006141b5b050c1b103506010714011d5b14165b001e">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Susan++Pyne">Susan Pyne</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6608-9584" title="Orcid link">http://orcid.org/0000-0002-6608-9584</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00162&amp;href=/doi/10.1021%2Facs.jmedchem.9b00162" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 3658–3676</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 19, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>26 January 2019</li><li><span class="item_label"><b>Published</b> online</span>19 March 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 April 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00162" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00162</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3658%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDavid%250AR.%2BAdams%252C%2BSalha%2BTawati%252C%2BGiacomo%2BBerretta%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D7%26contentID%3Dacs.jmedchem.9b00162%26title%3DTopographical%2BMapping%2Bof%2BIsoform-Selectivity%2BDeterminants%2Bfor%2BJ-Channel-Binding%2BInhibitors%2Bof%2BSphingosine%2BKinases%2B1%2Band%2B2%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3676%26publicationDate%3DApril%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00162"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">861</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">12</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00162" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Topographical Mapping of Isoform-Selectivity Determinants for J-Channel-Binding Inhibitors of Sphingosine Kinases 1 and 2&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;David\nR.&quot;,&quot;last_name&quot;:&quot;Adams&quot;},{&quot;first_name&quot;:&quot;Salha&quot;,&quot;last_name&quot;:&quot;Tawati&quot;},{&quot;first_name&quot;:&quot;Giacomo&quot;,&quot;last_name&quot;:&quot;Berretta&quot;},{&quot;first_name&quot;:&quot;Paula&quot;,&quot;last_name&quot;:&quot;Lopez Rivas&quot;},{&quot;first_name&quot;:&quot;Jessica&quot;,&quot;last_name&quot;:&quot;Baiget&quot;},{&quot;first_name&quot;:&quot;Zhong&quot;,&quot;last_name&quot;:&quot;Jiang&quot;},{&quot;first_name&quot;:&quot;Aisha&quot;,&quot;last_name&quot;:&quot;Alsfouk&quot;},{&quot;first_name&quot;:&quot;Simon&quot;,&quot;last_name&quot;:&quot;P. Mackay&quot;},{&quot;first_name&quot;:&quot;Nigel&quot;,&quot;last_name&quot;:&quot;J. Pyne&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;Pyne&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;19&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;3658-3676&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00162&quot;},&quot;abstract&quot;:&quot;Sphingosine kinase enzymes (SK1 and SK2) catalyze the conversion of sphingosine into sphingosine 1-phosphate and play a key role in lipid signaling and cellular responses. Mapping of isoform amino acid sequence differences for SK2 onto the recently available crystal structures of SK1 suggests that subtle structural differences exist in the foot of the lipid-binding “J-channel” in SK2, the structure of which has yet to be defined by structural biology techniques. We have probed these isoform differences with a ligand series derived from the potent SK1-selective inhibitor, PF-543. Here we show how it is possible, even with relatively conservative changes in compound structure, to systematically tune the activity profile of a ligand from ca. 100-fold SK1-selective inhibition, through equipotent SK1/SK2 inhibition, to reversed 100-fold SK2 selectivity, with retention of nanomolar potency.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00162&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00162" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00162&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00162" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00162&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00162" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00162&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00162&amp;href=/doi/10.1021/acs.jmedchem.9b00162" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00162" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00162" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00162%26sid%3Dliteratum%253Aachs%26pmid%3D30889352%26genre%3Darticle%26aulast%3DAdams%26date%3D2019%26atitle%3DTopographical%2BMapping%2Bof%2BIsoform-Selectivity%2BDeterminants%2Bfor%2BJ-Channel-Binding%2BInhibitors%2Bof%2BSphingosine%2BKinases%2B1%2Band%2B2%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D7%26spage%3D3658%26epage%3D3676%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (8)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291445" title="Chemical structure">Chemical structure</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/jmcmar.2019.62.issue-7/20190411/jmcmar.2019.62.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/medium/jm-2019-00162z_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00162&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Sphingosine kinase enzymes (SK1 and SK2) catalyze the conversion of sphingosine into sphingosine 1-phosphate and play a key role in lipid signaling and cellular responses. Mapping of isoform amino acid sequence differences for SK2 onto the recently available crystal structures of SK1 suggests that subtle structural differences exist in the foot of the lipid-binding “J-channel” in SK2, the structure of which has yet to be defined by structural biology techniques. We have probed these isoform differences with a ligand series derived from the potent SK1-selective inhibitor, PF-543. Here we show how it is possible, even with relatively conservative changes in compound structure, to systematically tune the activity profile of a ligand from ca. 100-fold SK1-selective inhibition, through equipotent SK1/SK2 inhibition, to reversed 100-fold SK2 selectivity, with retention of nanomolar potency.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56640" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56640" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Sphingosine 1-phosphate (S1P) is a key signaling lipid derived from sphingosine (Sph) by the action of sphingosine kinases (SK1 and SK2). S1P is transported to the extracellular environment, where it functions as a ligand for a family of five S1P-specific G protein coupled receptors (S1P<sub>1–5</sub>), but it also acts on specific intracellular target proteins such as histone deacetylases 1/2 (HDAC1/2).<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Irreversible cleavage of S1P is catalyzed by S1P lyase, producing (<i>E</i>)-2-hexadecenal and phosphoethanolamine,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> but S1P is also reversibly dephosphorylated by S1P phosphatase to regenerate Sph,<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4−6)</a> levels of which are additionally influenced by flux through the ceramide (Cer) synthesis pathway.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The effects of S1P on cell function favor proliferation, migration, differentiation, and survival and are generally opposed by Cer, which induces apoptosis, senescence, and growth arrest.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> As a consequence, the concept of the “sphingolipid rheostat” was proposed,<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a> in which the interconversion of Cer via Sph to S1P controls cellular fate (recently reviewed<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12,13)</a>). Altered S1P signaling has been associated with numerous pathophysiologies, including cancer, cardiovascular disease, neurodegenerative conditions, diabetes, and inflammatory disease.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The possibility of manipulating the sphingolipid rheostat for therapeutic purposes has therefore provided a rationale for exploring the development of SK inhibitors and their potential to reduce S1P formation and signaling and to raise pro-apoptotic Cer levels.</div><div class="NLM_p">The SK1 and SK2 enzymes are encoded by distinct genes and differ in their subcellular localization, biochemical properties, and functions; there are three N-terminal variants of SK1 and two N-terminal variants of SK2.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> A number of classes of SK inhibitors have emerged in the last two decades, including the recent discovery of an ATP-competitive SK inhibitor chemotype that decreases cellular S1P levels, elevates Sph/Cer, induces apoptosis, and inhibits cell proliferation and colony formation.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Most work to date, however, has focused on the development of Sph-competitive inhibitors. This includes the development of inhibitors selective for SK1 that exhibit nanomolar potency, such as PF-543 (<b>1</b>),<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Genzyme-51 (<b>2</b>),<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and Amgen-23 (<b>3</b>),<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a><a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>. PF-543 reduces sickling of red blood cells<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> in vitro and in vivo and attenuates postinfarction cardiac remodeling.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> We have also demonstrated<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> that PF-543 protects against cardiomyocyte apoptosis and reduces cardiac maladaptive hypertrophy in a mouse model of pulmonary hypertension.</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/medium/jm-2019-00162z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Lipid Substrate (Sph), Product (S1P), and Established Inhibitors for SK1 and SK2</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00162&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label"><sup>a</sup></span>For references see text.</p><p><span class="fn-label"><sup>b</sup></span>This study.</p><p><span class="fn-label"><sup>c</sup></span>No data.</p><p class="last"><span class="fn-label"><sup>d</sup></span>Co-crystal structure available with SK1.</p></p></figure><div class="NLM_p">Early prototype Sph-competitive SK2-selective inhibitors include ABC294640 (<b>4</b>),<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> K145 (<b>5</b>),<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> SLR080811 (<b>6</b>),<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and (<i>R</i>)-FTY720 methyl ether (ROMe; <b>7</b>),<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a><a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>. Of these compounds, ABC294640, which induces cell death via apoptotic and autophagic pathways,<a onclick="showRef(event, 'ref24 ref28'); return false;" href="javascript:void(0);" class="ref ref24 ref28">(24,28)</a> has been tested in several disease models for cancer,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> rheumatoid arthritis,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and ulcerative colitis.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The compound has proceeded to phase I/II clinical studies targeting multiple oncology and inflammatory indications. However, ABC294640 also indirectly targets dihydroceramide desaturase and induces the proteasomal degradation of SK1 in prostate cancer cells and in HEK293T cells.<a onclick="showRef(event, 'ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33">(31−33)</a> ROMe, an SK2-selective inhibitor (<i>K</i><sub>i</sub> 16 μM), with no activity against SK1 at 100 μM, inhibits DNA synthesis in breast cancer cells, and induces autophagic death of T-cell acute lymphoblastic leukemic cells.<a onclick="showRef(event, 'ref27 ref34'); return false;" href="javascript:void(0);" class="ref ref27 ref34">(27,34)</a> Very recently, two reports have disclosed examples of more potent SK inhibitors, Pfizer-27c (<b>8</b>)<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and VT-20dd (<b>9</b>),<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> with selectivity for SK2. Despite these developments and a growing interest in the (patho)physiological roles of SK2, a clear structural rationale for the development of high potency SK2-specific inhibitors has yet to emerge.</div><div class="NLM_p">No SK2 crystal structures are available as yet to support structure-based design of SK2-selective inhibitors, but amino acid sequence alignment suggests a high degree of homology to SK1, the structure of which has recently been solved by X-ray crystallography.<a onclick="showRef(event, 'ref20 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref20 ref37 ref38">(20,37,38)</a> SK1 exhibits a bidomain architecture comprising an ATP-binding N-terminal domain (NTD) and a C-terminal domain (CTD) that hosts the Sph binding site, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>. The CTD folds as a two-layer β-sandwich with three extended interstrand loops packing across one face to generate the Sph binding site as a J-shaped cavity, termed the “J-channel”. One of the three “lipid binding loops”, LBL-1, consists of two reverse-paired helices (α7 and α8) that may gate substrate entry and product egress by a hinged motion.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Residues in LBL-1 and in the second loop, LBL-2, define much of the contact surface for the polar headgroup and central region of the lipid. The third loop, LBL-3, folds with an additional helix (α9), running antiparallel along α8, and provides enclosure for the lipid tail. To date, SK1 cocrystal structures have been acquired with three inhibitors bound in the J-channel, namely with SKi (<b>10</b>; also known as SKI-II),<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> with Amgen-23 (<b>3</b>),<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and most recently with PF-543 (<b>1</b>).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> We have used the latter structure as a starting point to explore differences in the foot of the J-channel of SK1 and SK2. Here we report our results from a ligand-based structure–activity relationship (SAR) study that highlights key determinants for switching between SK1-selective and SK2-selective inhibition.</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/medium/jm-2019-00162z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of SK1 is shown with bound PF-543 (<b>1</b>; orange surface) (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V24">4V24</a>).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> PF-543 occupies the substrate Sph binding site, formed by the packing of three lipid binding loops (LBL-1 to LBL-3) against a β-sandwich core. The nucleotide binding site is shown by superimposition of Mg-ADP (green sphere/rose surface) from its separate cocrystal structure (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VZD">3VZD</a>) with SK1.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00162&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60345" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60345" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Design Rationale for Ligand Selectivity Switching</h3><div class="NLM_p">Of the 20 or so residues that contribute to the J-channel in SK1, SK2 differs at only three points in the direct hydrophobic contact surface of the binding site, namely in Ile174, Met272, and Phe288 of SK1, corresponding respectively to Val304, Leu517, and Cys533 in SK2 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, orange). Phe288 stoppers the toe of the SK1 J-channel, and its substitution by Cys533 in SK2 may result in a longer J-channel and potentially also confer greater surface plasticity in that region of SK2 due to loosened packing against adjacent hydrophobic residues. Ile174 and Met272 contribute to the throat of the J-channel and, in the SK1/PF-543 cocrystal structure, are seen to form part of the flanking surface on either side of the inhibitor’s <i>p</i>-xylylene subunit; their replacement by Val and Leu may make this region of the J-channel slightly wider in SK2 than in SK1. Ile174 additionally contributes surface on one edge of the PF-543 terminal subunit, with contact distances of 3.6 and 3.4 Å between its Cδ methyl carbon and the PF-543 phenyl <i>ortho</i> and <i>meta</i> carbons, respectively. A leucine (Leu261; <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, yellow), that is packed against Ile174 in SK1, also contributes to the contact surface around the edge of the PF-543 terminal phenyl and, although conserved in SK2 (as Leu506), may differ in its conformational profile due to the replacement of the adjacent Ile174 in SK1 by Val304 in SK2. Together, these considerations suggest that the J-channel toe might be expanded in SK2 on a contact surface mapping to the <i>para</i>-position of the terminal phenyl of SK1-bound PF-543 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, green arrow).</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/medium/jm-2019-00162z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. J-Channel surface detail (mesh) from the PF-543/SK1 cocrystal (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V24">4V24</a>),<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> highlighting key isoform residue differences that likely impact on the J-channel structure of SK2. SK1 residue numbering is shown; cognate SK2 residues, where different, are in parentheses (residue color notation, see text).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00162&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In principle, an expanded surface in SK2 at the J-channel toe might contribute to reduced affinity for PF-543 and hence, at least in part, to the established SK1-over-SK2 selectivity of this inhibitor (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>). However, SK2 also differs from SK1 in several other residues that, while not contributing directly to the ligand contact surface, are likely to indirectly affect the J-channel structure. Thus, a set of residues in LBL-3 of SK1 (Val294, Met298, Met312, Tyr314, Tyr318; <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, green) differs in SK2 (as Ile539, Ala543, Phe557, Leu559, and Gln563, respectively). Inspection of the SK1/PF-543 cocrystal structure suggests that these differences may impact on the conformation of a conserved leucine (Leu302 in SK1; <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, magenta), which contributes to the contact surface for the sulfonyl group of PF-543. We hypothesized that the cognate residue (Leu547) in SK2 might be driven inward to narrow the J-channel at that point. If so, surface encroachment in the J-channel heel of SK2 might then interdict comfortable accommodation of the sulfonyl oxygens of PF-543 and also contribute to the observed SK1 selectivity of this inhibitor.</div><div class="NLM_p last">Two further residue differences, Ala175 and Ala339 in SK1 (corresponding to Ser305 and Thr584 in SK2), might also potentially be relevant to isoform discrimination by ligands targeting the J-channel. These residues (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, cyan) lie proximal to the 2-(hydroxymethyl)pyrrolidine “headgroup” of PF-543, and their variation in SK2 might affect a network of polar interactions that engages the PF-543 headgroup or/and slightly reposition LBL-1 with respect to the β-sandwich core, which could then impact on the surface of a notch in the J-channel that accommodates the PF-543 methyl group (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). However, it is known<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> that the hydroxyl group of SK1-bound PF-543 precisely maps to the position of the Sph-3-OH and, given that Sph serves as a substrate for <i>both</i> SK1 and SK2, it is likely that the headgroup hydrogen bonding features in SK2 should also support the binding of the PF-543 2-(hydroxymethyl)pyrrolidine subunit. Thus, in seeking to identify determinants for SK2-selective inhibition, we focused attention on a series of PF-543 analogues that retained the 2-(hydroxymethyl)pyrrolidine headgroup but embodied alterations to the tail targeted to the enclosed J-channel foot, predicted by our analysis to offer scope for isoform-discriminating interactions with ligands. Accordingly, we prepared a concise compound test set to evaluate whether SK2 inhibitory activity might be enhanced by alleviating steric demand in the sulfonyl linker and/or by deletion of the PF-543 methyl group. We also sought to test the hypothesis that optimization of ligand fit to the J-channel toe in SK2 might confer selectivity over SK1.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Synthesis of Probe Compound Set</h3><div class="NLM_p">To assess the contribution of the methyl group to the SK1 selectivity of PF-543, we prepared the normethyl analogue (<b>18</b>; <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) for evaluation. The compound was prepared from <i>m</i>-methoxybenzyl bromide (<b>11</b>) by reaction with sodium benzenesulfonate followed by boron tribromide mediated cleavage of the aryl methyl ether in <b>12</b> to afford phenol <b>14</b>. The latter was then alkylated with 4-(bromomethyl)benzaldehyde and the resulting aldehyde (<b>16</b>) subjected to reductive amination with (<i>R</i>)-(−)-prolinol.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/medium/jm-2019-00162z_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0011.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Probe Compounds <b>18</b> and <b>19</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00162&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaSO<sub>2</sub>Ph, Aliquat 336, 85 °C (47%); (b) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C (77%); (c) phenylsulfonyl chloride K<sub>2</sub>CO<sub>3</sub>/MeCN (21%); (d) 4-(bromomethyl)benzaldehyde, K<sub>2</sub>CO<sub>3</sub>, MeCN, 60 °C; (e) (<i>R</i>)-2-(hydroxymethyl)pyrrolidine, NaBH(OAc)<sub>3</sub>, DCE.</p></p></figure><div class="NLM_p">A collection of compounds was then prepared in order to evaluate the contribution of the −SO<sub>2</sub>–CH<sub>2</sub>– tail linker to inhibitory performance and selectivity. Analogues were designed to test the impact of replacing the PF-543 sulfonyl group by methylene, but we also included an isosteric sulfonate (<b>19</b>) to probe the impact of subtle changes in ligand bond angle preferences. Sulfonate <b>19</b> was prepared by initial sulfonylation of resorcinol (<b>13</b>) followed by alkylation of the resulting phenol (<b>15</b>) with 4-(bromomethyl)benzaldehyde and reductive amination with (<i>R</i>)-(−)-prolinol, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.</div><div class="NLM_p">The ethylene-linked analogue (<b>23</b>, <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) was prepared to assess the impact of reducing steric demand in the locus occupied by the PF-543 sulfonyl group. For reasons of synthetic convenience, this and other sulfonyl deletion analogues were prepared for comparative evaluation against <b>18</b> without the methyl group in place on the central arene ring. Synthesis of <b>23</b> was undertaken from acetylene <b>20</b>, prepared by ambient temperature Sonogashira coupling of 3-iodophenol<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> with phenylacetylene. The acetylene was hydrogenated to afford phenol <b>21</b>, which was alkylated with 4-(bromomethyl)benzaldehyde to afford <b>22</b>. Reductive amination of the latter with (<i>R</i>)-(−)-prolinol afforded <b>23</b>.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/medium/jm-2019-00162z_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0012.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Probe Compound <b>23</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00162&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) H<sub>2</sub>, Pd/C, EtOH (95%); (b) 4-(bromomethyl)benzaldehyde, K<sub>2</sub>CO<sub>3</sub>, MeCN, 20 °C, 16 h (87%); (c) (<i>R</i>)-2-(hydroxymethyl)pyrrolidine, NaBH(OAc)<sub>3</sub>, DCE (82%).</p></p></figure><div class="NLM_p">An ether-linked variant (<b>49</b>) of <b>23</b> was prepared according to <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Thus, resorcinol (<b>13</b>) was alkylated with benzyl bromide and the resulting phenol (<b>25</b>) transformed into <b>49</b> by the two-step alkylation/reductive amination procedure applied in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a> for compounds <b>18</b>, <b>19</b>, and <b>23</b>. A subset of six halogenated analogues (<b>50</b>–<b>55</b>, <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>) was then expanded to facilitate systematic exploration of the space in the J-channel foot. Two further analogues were included in the ether-linked test set to explore the impact of steric demand in the critical toe region of the J-channel, namely methyl ether <b>56</b> and nitrile <b>57</b>, with bent and linear two-atom extensions from the <i>para</i>-position of the tail arene. The sulfide counterpart (<b>58</b>) of the ether-linked parent (<b>49</b>) was prepared in a similar manner starting from benzenethiol (<b>24</b>). The <i>para</i>-fluorophenyl and <i>para</i>-chlorophenyl analogues (<b>59</b> and <b>60</b>) of this latter compound were made by a similar strategy. Sulfides <b>58</b>–<b>60</b> were included to test the impact of incorporating a heteroatom in the linker with greater steric demand and differing bond angle preferences, which might impact on positioning of the ligand’s terminal <i>para</i>-site in the critical J-channel toe region.</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/medium/jm-2019-00162z_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0013.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Probe Compounds <b>49</b>–<b>60</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00162&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>25</b>–<b>33</b>, (substituted)benzyl bromide (or 4-chlorobenzyl chloride in the case of <b>31</b>), K<sub>2</sub>CO<sub>3</sub>, acetone, 65 °C, 5 h; (b) <b>34</b>–<b>36</b>, (substituted)benzyl bromide (or 4-chlorobenzyl chloride in the case of <b>36</b>), K<sub>2</sub>CO<sub>3</sub>, MeCN, 20 °C, 16 h; (c) <b>37</b>–<b>45</b>, NaH, DMF, then 4-(bromomethyl)benzaldehyde, 16 h, 20 °C; (d) <b>46</b>–<b>48</b>, 4-(bromomethyl)benzaldehyde, K<sub>2</sub>CO<sub>3</sub>, MeCN, 20 °C, 16 h; (e) (<i>R</i>)-2-(hydroxymethyl)pyrrolidine, NaBH(OAc)<sub>3</sub>, THF (for <b>49</b>–<b>57</b>) or DCE (for <b>48</b>–<b>60</b>).</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> SK Inhibitory Performance and Selectivity of Probe Compound Set</h3><div class="NLM_p">Compounds were evaluated for inhibition of purified SK1 and SK2 using a radiometric assay, as detailed in our earlier work.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> In brief, the procedure uses [γ-<sup>32</sup>P]ATP and measures incorporation of the radiolabeled phosphate into the S1P product. SK1 and SK2 were assayed, respectively, at 3 and 10 μM Sph substrate concentration. These concentrations correspond to the <i>K</i><sub>m</sub> values of SK1<a onclick="showRef(event, 'ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44">(42−44)</a> and SK2<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and, therefore, allow direct comparison of the sensitivity of the two enzymes at 50% saturation with Sph. Assays were performed with ATP at 250 μM concentration, well above the <i>K</i><sub>m</sub> value for the nucleotide, to ensure saturation with ATP. Activity data are summarized in <a class="ref internalNav" href="#cht2" aria-label="Chart 2">Chart 2</a>.</div><figure id="cht2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/medium/jm-2019-00162z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. SK1 and SK2 Inhibitory Activity for Probe Compound Set Derived from PF-543 (<b>1</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00162&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>SK1 activity was assayed using 3 μM Sph and 250 μM ATP. SK2 activity was assayed using 10 μM Sph and 250 μM ATP. Data are reported as IC<sub>50</sub> values (or % enzyme inhibition) vs control determined in triplicate assays. NE: no inhibitory effect at maximal test concentration of 3 μM. SI denotes selectivity index as IC<sub>50</sub> (SK1)/IC<sub>50</sub> (SK2).</p></p></figure><div class="NLM_p">We have previously obtained<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> an IC<sub>50</sub> of 28 nM for inhibition of SK1 by PF-543 in our assay, considerably higher than the <i>K</i><sub>i</sub> value of 3.6 nM reported by Schnute et al.,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> with the caveat that the latter determination was performed under conditions where ATP was not saturating and therefore subject to two-substrate kinetics. As reported, however, PF-543 was highly selective for inhibition of SK1, giving only 33% inhibition of SK2 at 5 μM and 72% at 50 μM.</div><div class="NLM_p">Our analysis (vide supra) suggested that the most likely explanation for the SK1-over-SK2 selectivity of PF-543 is due to surface encroachment in the SK2 J-channel heel targeted by the inhibitor’s sulfonyl group (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, red arrow). However, at the outset of our studies, we could not eliminate the possibility that structural differences in the subpocket that accommodates the PF-543 methyl group (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, “notch”) might also be a contributory factor. We therefore evaluated the normethyl analogue (<b>18</b>) of PF-543. This compound showed a modest (5-fold) loss in SK1 inhibitory potency compared to PF-543, consistent with a slight reduction in favorable surface contact with that isoform. However, the gain in SK2 inhibition that might have been expected for relief of an unfavorable surface compression against the methyl was not observed. Indeed, only slight inhibition of SK2 (16%) was detectable at the maximal test concentration of 3 μM in our current studies, suggesting that the PF-543 methyl group is not a strong determinant of selectivity. During the course of our studies, Schnute et al. disclosed<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> further details of their development of PF-543, including comparative activity data for normethyl analogue <b>18</b> using a different assay system. In this study, the methyl group was also shown to contribute only marginally to the strong SK1-selectivity of PF-543; its deletion led to a change in selectivity by less than a factor of 2.</div><div class="NLM_p">Interestingly, the sulfonate analogue (<b>19</b>) was 13-fold more potent against SK1 than its counterpart (<b>18</b>) with the sulfonylmethylene linker. A corresponding increase in inhibitory potency was also seen against SK2, with a quantifiable IC<sub>50</sub> of 902 nM determined. Replacement of the sulfonyl group in <b>18</b> with a second methylene in <b>23</b> led to a modest 5.5-fold improvement in potency against SK1 but a pronounced enhancement in potency against SK2 so that the compound was almost equipotent against both isoforms (IC<sub>50</sub> 26 and 35 nM for SK1 and SK2, respectively). Taken together, these results suggest that the heel of the SK1 J-channel might be a tight fit for the sulfonylmethylene linker in PF-543 and <b>18</b> and supported our hypothesis that in SK2 the J-channel heel may be tighter still, encroaching sufficiently on the sulfonyl oxygens so as to be a key determinant for isoform discrimination. Thus, in SK2, higher compression is postulated along a trajectory (axis-1 in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) between the headgroup and sulfonyl oxygens of the ligand, with the headgroup locked in place by a highly organized network of polar interactions involving features that normally serve to position the substrate for phosphorylation. These “headlock” features include a structural water and an aspartic acid on helix-α7 (Asp178 in SK1, conserved as Asp308 in SK2) that have been shown to form three tight hydrogen bonds with charge stabilization to the hydroxypyrrolidinium subunit of PF-543 in its SK1 cocrystal structure.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/medium/jm-2019-00162z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Key compression axes postulated to influence ligand binding to the J-channels of SK1 and SK2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00162&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The methyleneoxy-linked analogue (<b>49</b>) also exhibited near equipotent inhibitory activity against the two isoforms, but with a marginal increase in overall potency relative to the ethylene-linked compound (<b>23</b>). Thus, <b>49</b> exhibited IC<sub>50</sub> values of 14 and 16 nM against SK1 and SK2, respectively. However, replacement of the oxygen by a larger sulfur atom in compound <b>58</b> caused a 10-fold loss in potency against SK1 with only a slight loss (<2-fold) against SK2, thereby resulting in a compound with reversed selectivity (albeit modest) in favor of SK2 (IC<sub>50</sub> values of 137 and 26 nM against SK1 and SK2, respectively). This was an important finding because it supported our second hypothesis, namely that the J-channel toe is likely expanded in SK2 or/and exhibits greater plasticity. Thus, compression along an axis linking the large sulfur atom and <i>para</i> position of the phenyl ring in <b>58</b> (axis-2 in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) might be less severe in SK2 than in SK1. Indeed, analysis of our PF-543/SK1 cocrystal structure<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) had suggested a remarkably close fit for the phenylsulfonylmethylene tail unit of PF-543 in the SK1 J-channel, with the <i>para</i>-CH packed against Phe288 and the methylene of the linker wedged against helix-α9. Conceivably, alleviation of compression between these two points (and associated ligand strain) might contribute to the enhanced inhibitory potency of sulfonate <b>19</b> over the sulfonylmethylene-linked analogue (<b>18</b>).</div><div class="NLM_p">We next sought to exploit the hypothesized tighter compression axis between toe and heel in SK1 (axis-2 in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) still further by installation of a substituent in the terminal phenyl ring of <b>49</b> and <b>58</b>, with a particular focus on the <i>para</i>-position to see whether compounds with even greater selectivity for SK2 could be achieved. Given the potential differences in J-channel surface allied to the replacement of Ile174 in SK1 by Val304 in SK2, however, we also wished to examine the impact of substitution at the <i>ortho</i>- and <i>meta</i>-positions. For that reason, we evaluated fluorides <b>50</b>–<b>52</b> and chlorides <b>53</b>–<b>55</b> derived from methyleneoxy-linked parent <b>49</b>. The standout feature with this compound set was indeed a pronounced loss in SK1 inhibitory potency for the <i>para</i>-fluoro and <i>para</i>-chloro analogues (<b>52</b> and <b>55</b>), which showed ca. 12-fold and 295-fold increases in IC<sub>50</sub> relative to <b>49</b>, respectively. Some loss in potency against SK2 was also observed for these compounds (≤3-fold relative to parent <b>49</b>), but SK1 was preferentially penalized, leading to highly selective, nanomolar-potent SK2 inhibition in the case of chloride <b>55</b> (see concentration response curves in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Curiously the <i>para</i>-fluoro analogue (<b>52</b>; SK2 IC<sub>50</sub> 49 nM) showed equivalent or even rather more loss in SK2 potency relative to parent <b>49</b> (SK2 IC<sub>50</sub> 16 nM) than its chloride counterpart (<b>55</b>; SK2 IC<sub>50</sub> 41 nM). This outcome may reflect a requirement for some induced fit to accommodate the halogen in SK2. Thus, the cost associated with side chain perturbation caused by binding of the ligand might be offset by greater surface contact for the chloride over the fluoride.</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/medium/jm-2019-00162z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Selected SK1 and SK2 concentration response curves for PF-543-derived J-channel probes, highlighting the reversal of behavior from SK1-selective inhibition (left) to SK2-selective inhibition (right) with ligand features that induce compression along axis-1 and axis-2 of <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, respectively (assay conditions: see legend of <a class="ref internalNav" href="#cht2" aria-label="Chart 2">Chart 2</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00162&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the case of the methylenesulfanyl-linked analogue (<b>58</b>), the effects of <i>para</i>-fluoro and <i>para</i>-chloro substitution (<b>59</b>/<b>60</b>) broadly mirror those seen in the methyleneoxy-linked series (<b>52</b>/<b>55</b>), where inhibition of SK1 but not SK2 is significantly penalized (<a class="ref internalNav" href="#cht2" aria-label="Chart 2">Chart 2</a>). Although differences in the size and bond angle preferences of the sulfide and ether linkages may subtly modulate terminal halogen fit to the J-channel toe and ligand strain, in both cases the presence of the larger chlorine atom afforded greatest isoform discrimination, with selectivity for inhibition of SK2 over SK1 in the range of 75-fold to 100-fold for <b>60</b> and <b>55</b>, respectively. Introduction of bulkier or/and more polar <i>para</i>-substituents may be counterproductive for SK2 inhibitory performance however. Thus, in the methyleneoxy-linked series, introduction of a methoxy group (compound <b>56</b>, SK2 IC<sub>50</sub> 119 nM) led to a 7-fold loss in SK2 inhibitory potency relative to parent <b>49</b> and a linear nitrile extension (compound <b>57</b>, SK2 IC<sub>50</sub> 1.12 μM) caused a 70-fold loss in activity. While this fall off in inhibitory potency may reflect a limit to the capacity of the SK2 J-channel toe, changes in dipole and lipophilicity of the terminal subunit may also be factor in the activity fall off. Thus, a nitrile group is sometimes exploited as a bioisostere for the halogen in (hetero)aromatic chlorides, conferring a significant reduction in lipophilicity and, therefore, increased lipophilic ligand efficiency.<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45,46)</a></div><div class="NLM_p last">In contrast to substitution at the <i>para</i>-position, the SK1-inhibitory activity of <b>49</b> is more tolerant of halogenation at the <i>ortho</i>- and <i>meta</i>-positions on the terminal arene (<a class="ref internalNav" href="#cht2" aria-label="Chart 2">Chart 2</a>, compounds <b>50</b>, <b>51</b>, <b>53</b>, and <b>54</b>). Here, only modest activity loss (ca. 3-fold) is observed (<b>50</b>/<b>53</b>/<b>54</b>), while <i>meta</i>-fluorination even marginally enhances activity (<b>51</b>, SK1 IC<sub>50</sub> 9 nM) relative to parent <b>49</b> (SK1 IC<sub>50</sub> 14 nM). Interestingly SK2 is less tolerant of substitutions at the <i>ortho</i>- and <i>meta</i>-positions, particularly at the latter site, where fluorination (<b>51</b>, SK2 IC<sub>50</sub> 143 nM) and chlorination (<b>54</b>, SK2 IC<sub>50</sub> 412 nM) produce respectively 9-fold and 26-fold activity loss versus parent <b>49</b> (SK2 IC<sub>50</sub> 16 nM). These results suggest that the SK2 J-channel foot, while extended compared to SK1, is tighter in width, at least between certain points.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Structural Inferences for the SK2 J-Channel</h3><div class="NLM_p">Crystal structures of SK1 have only recently emerged (since 2013), while no structures are currently available for SK2. To facilitate qualitative rationalization of the isoform selectivity profiles of the ligands, we constructed an homology model for SK2 based on the crystal structure (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V24">4V24</a>) of the large SK1 splice variant (SK1b, sometimes also called SK1c) with bound PF-543 that we had recently determined at 1.8 Å resolution.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> In brief, an initial model was generated using the default automated routines of the SWISS-MODEL server<a onclick="showRef(event, 'ref47 ref48 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref47 ref48 ref49 ref50">(47−50)</a> and this was refined using the Small Molecule Drug Discovery software suite from Schrödinger, LLC. In particular, LBL-2 was remodelled from the structure of the corresponding loop in the <i>Enterococcus faecalis</i> diacylglycerol kinase family protein, as defined in the crystal structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WER">4WER</a> (DOI: 10.2210/pdb4wer/pdb). The rationale for this adjustment was that the C-terminal end of LBL-2 in SK2 (524-RFDDGL-529) has sequence features that are more closely related to prokaryotic diacylglycerol kinases than to SK1 (Supporting Information, Figure S1, in Adams et al.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a>).</div><div class="NLM_p">Our activity data for the normethyl analogue (<b>18</b>) of PF-543 suggested that the central ring methyl group in PF-543 is not a key SK2-discriminating feature and determinant of the high SK1-inhibitory selectivity exhibited by PF-543. Nevertheless, we did find that energy minimization of our ligand probe set docked into the SK2 model, as illustrated for <b>60</b> in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A, tended to result in contraction of the J-channel notch that hosts the PF-543 methyl. This notch is formed at the interface between helices-α8 and -α9 of the two flap-like LBL-1 and LBL-3 loops, respectively (cf. <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). As such, size and surface contouring of the notch may be sensitive to subtle changes in the seating of the two helices as well as to accessible conformational volumes of local residues. Indeed, inspection of an overlay of all protein chains from the currently available crystal structures revealed significant differences in the notch surface even across different SK1 structures, thus suggesting a degree of plasticity in this region of the J-channel (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B,C). A particularly important residue in this regard is Leu299 in SK1, which is located on helix-α9 and conserved in SK2 as Leu544 (marked in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). This residue exhibits some conformational variance across SK1 crystal structures and would expand the notch region in the SK2 model illustrated in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> to accommodate the PF-543 methyl group with only modest movement.</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/medium/jm-2019-00162z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0007.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Comparison of modeled binding mode for SK2-selective inhibitor <b>60</b> with SK1 cocrystal structures of PF-543 (<b>1</b>) and SKi (<b>10</b>). (A) <b>60</b> (blue stick) docked into SK2 model (red mesh), highlighting key contact residues (cyan stick) and expanded SK2 J-channel toe surface. (B) PF-543 (<b>1</b>; orange stick) is shown from its cocrystal structure (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V24">4V24</a>) with SK1 (green mesh) and the SK2 model surface (red mesh) overlaid from (A); SK1 contact residues are shown (light-orange stick) and the constrained SK1 J-channel toe surface is evident. (C) As (B), but showing cocrystal structure (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VZD">3VZD</a>) of SKi (<b>10</b>, magenta stick) with SK1 (blue mesh and pink stick key contact residues) superimposed onto the SK2 model (red mesh) from (A); the heel region adjacent to SK1 Leu302 is consistently less compressed in SK1 structures (relative to the SK2 model), while the notch surface exhibits some plasticity. (D) Overlay of (A–C) minus the J-channel surface; the chlorine atom of <b>60</b> is accommodated in SK2 between Cys533 and Leu506, with rotation of the latter possible while the cognate SK1 residue (Leu261) is constrained by the packing of adjacent residues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00162&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although the notch region exhibits significant plasticity, inspection of the SK1 J-channel across different crystal structures revealed that the protein surface is quite tightly defined (irrespective of ligand occupancy), both around the J-channel heel that contacts the PF-543 sulfonyl group and around the toe that interfaces with the end of the PF-543 terminal phenyl subunit. Our data indicate that sulfonyl replacement by methylene in compounds <b>23</b> and <b>49</b> enhances SK1 inhibitory potency compared to the sulfonylmethylene-linked parent (<b>18</b>), which suggests that the sulfonylmethylene linker is already a little oversized for an optimal fit of the tail of the ligand to the SK1 J-channel. Thus, only a modest additional contraction in the SK2 J-channel at this point could generate a strongly unfavorable compressive effect for compounds such as PF-543 and its normethyl analogue (<b>18</b>) to account for their SK1 selectivity. The SK2 model supported the proposal that the SK2 J-channel may be contracted in the heel region, in particular due to inward movement of Leu547 (corresponding to Leu302 in SK1), <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A. However, the model also suggested that the basis for such movement may be a consequence, at least in part, of differences in the LBL-2/LBL-3 interfaces of the isoforms and not merely due to local residue differences immediately surrounding the leucine, as we had first conceived (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). In particular, Leu547 is located on helix-α9 in LBL-3, and the C-terminal end of this helix engages the hairpin-like tip of LBL-2 (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>a). The model suggested that residue differences in LBL-2 might promote an inward movement at the C-terminus of helix-α9, thereby exerting leverage on the J-channel heel through Leu547. As the key heel compression contact is against the Cβ atom of Leu547, rather than the end of the side chain, the leverage cannot be alleviated by side chain rotation. However, compounds with reduced steric demand in the heel (<b>23</b> and <b>49</b>) can be accommodated in both SK1 and SK2 (illustrated for <b>49</b> in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B,C).</div><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/medium/jm-2019-00162z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0008.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. J-Channel heel is a key determinant of isoform discrimination by SK inhibitors. (A) LBL-2 and LBL-3 are shown from the cocrystal structure (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V24">4V24</a>) of PF-543 (orange stick) with SK1 (green ribbon); the corresponding elements from our SK2 homology model (red ribbon) are overlaid, illustrating inward movement in LBL-3 leading to heel compression in SK2 by Leu547. (B) Potent unselective inhibitor <b>49</b> (blue stick) is shown modeled into the SK2 J-channel (red mesh); the J-channel heel surface is driven significantly inward relative to SK1 so that the presence of a sulfonyl group in the ligand (<b>49</b> → <b>19</b>, 56-fold activity loss) is poorly tolerated by SK2. (C) Inhibitor <b>49</b> (magenta stick) is again shown, here modeled into the SK1 J-channel (green mesh); the SK1 J-channel heel surface exhibits less compression and accommodates a sterically more demanding sulfonyl containing linker more readily (<b>49</b> → <b>19</b>, no activity loss; <b>23</b> → <b>18</b>, 5-fold activity loss). (D) Overlay of (B) and (C) minus the J-channel surface.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00162&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The model also suggested that the strong SK2 selectivity of the <i>para</i>-halo derivatives of <b>49</b>/<b>58</b> is indeed likely due to J-channel toe surface expansion but that this may not be solely due to the single amino acid substitution of Phe288 in SK1 by Cys533 in SK2 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Indeed, in the absence of halogen substituents on the ligand, the energy minimized SK2 model complexes showed little apparent expansion in the toe surface compared to SK1, as illustrated for <b>49</b> docked to SK2 and SK1 (parts B and C of <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>, respectively). The key to accommodation of the <i>para</i>-halo atom appears to be perturbation in the conformation of an adjacent leucine (Leu506 in SK2, conserved in SK1 as Leu261) that packs against the cysteine. The combination of Cys533 and Leu506 generates the toe surface in SK2 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>), with movement of the latter predicted to allow expansion to accommodate the chlorine of <b>55</b>/<b>60</b>. The leucine additionally packs against two other nonconserved residues, Val304 (Ile174 in SK1) and Ile508 (Leu263 in SK1), and our model suggests that loosened packing with these residues and the cysteine may confer greater plasticity in the toe of the SK2 J-channel than in SK1. Thus, ligand binding in SK2 may involve an element of induced fit in the J-channel toe, potentially with an associated energy cost that is more or less offset depending on the effectiveness of surface contact between the ligand and the expanded toe. In contrast, the toe of the SK1 J-channel is likely to be more rigid and introduction of <i>para</i>-substitution in the ligand is predicted to generate an unfavorable compression between the J-channel toe and helix-α9, as illustrated in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a> for chloride <b>60</b>. Despite the enhanced plasticity and capacity indicated for the SK2 J-channel toe, our results nevertheless indicate significant limitations on the size of the <i>para</i>-substituent that can be accommodated in SK2. Thus, the axis of the <i>para</i>-substituent is predicted to orientate directly at the Cβ atom of Ile508 presented from the SK2 CTD β-sandwich core, <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A. In the case of chloride <b>60</b>, a distance of ca. 4.3 Å is predicted between Ile508 Cβ and the chlorine atom, and this spatial constraint likely contributes to the sharp drop in inhibitory potency against SK2 seen with the introduction of a <i>para</i>-cyano group in <b>57</b>.</div><figure id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/medium/jm-2019-00162z_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0009.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. J-Channel toe is a second key determinant for isoform discrimination by SK inhibitors. A comparison of modeled binding modes for the SK2-selective inhibitor (<b>60</b>) is shown here, with the SK2-docked inhibitor (cyan stick) superimposed onto the SK1-docked inhibitor (magenta stick). With reduced plasticity in the SK1 J-channel toe (pink mesh), the sulfur atom of <b>60</b> is predicted to be tightly wedged against the backbone of helix-α9 (pink ribbon). This generates an unfavorable compression axis (black arrow, corresponding to “axis-2” of <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) that preferentially penalizes binding to SK1. In SK2, the greater plasticity of the J-channel toe (cyan mesh) is predicted to allow accommodation of <b>60</b> with less compression.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00162&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">During the course of our work, Childress et al.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> described a series of pyrrolidine carboximidamide SK inhibitors with a spectrum of SK1 and SK2 inhibitory selectivity. The highest SK2 selectivity was seen with compound <b>9</b>, which is notable for its extended tail structure. With the guanidinium headgroup engaging key acidic residues in the mouth of the J-channel, the aminothiazole subunit in <b>9</b> would be expected to overlay the middle arene subunit of our ligands, while the oxadiazole ring of <b>9</b> would lie in plane and partially map onto the <i>p</i>-xylylene subunit (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>B,C). However, an intriguing feature with such a binding mode is that the rod like biphenyl tail of <b>9</b> could only be accommodated if there is a significant expansion in the toe of the J-channel, and this on the other side of Cys533 to that occupied by the chlorine in <b>55</b>/<b>60</b>. There are two key residue substitutions that may make this possible for SK2 but not readily achievable for SK1: one is the replacement of SK1 Phe288 by Cys533 in SK2, the second is the exchange of SK1Met312 for Phe557 in SK2. In the absence of compound <b>9</b> the latter residue, which is surface exposed on LBL-3, is predicted to fold inward toward the adjacent cysteine (in partial surrogacy for the Phe288 residue of SK1). Rotation of these two side chains alone (Cys533/Phe557) was sufficient to open an extended pocket in our model and accommodate the terminal phenyl group of <b>9</b> with a reasonably relaxed biphenyl torsion (37°) and favorable packing interactions against Cys533, Phe557, and other aromatic residues (Tyr, His). This postulated binding mode for <b>9</b>, in effect, amounts to tunnelling between LBL-2 and LBL-3 in SK2. In SK1 the more rigid J-channel toe is stoppered by Phe288, for which a rotation analogous to that required of Cys533 in SK2 is sterically precluded. The suggested binding mode for ligand <b>9</b> would also avoid encroachment on the Leu547 heel compression point in SK2 that we propose biases inhibitor selectivity toward SK1. Binding of compound <b>9</b> to SK1 would require much more extensive perturbation to the protein structure and packing of the LBL-3 return leg.</div><figure id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/medium/jm-2019-00162z_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0010.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Plasticity in the J-channel toe of SK2 may be exploited to develop SK2-selective inhibitors. (A) Compound <b>60</b> (blue stick) docked into the SK2 model (red mesh), highlighting key contact residues (cyan stick) and two predicted trajectories for possible toe expansion (arrows). Small groups may be accommodated between Cys533 and Leu506 (trajectory-1, hollow arrow). This is the predicted expansion for binding of <b>55</b>/<b>60</b>, where the fit of the Cl atom is likely made possible largely by rotation in Leu506. Larger groups may be accommodated between Cys533 and Phe557 (trajectory-2, filled arrow) upon rotation of these side chains. (B) VT-20dd (<b>9</b>, green stick) docked into the SK2 model (gray mesh), highlighting key contact residues (orange stick). Here the ligand is predicted to exploit the second toe expansion trajectory. (C) Overlay of (A) and (B) showing the SK2 J-channel surface for docked <b>60</b> (red mesh) and illustrating the two key residue rotations in Cys533 and Phe557 required for trajectory-2 expansion (cyan stick → orange stick positions). (D) ABC294640 (<b>4</b>, orange stick) docked into SK2 (gray mesh). In this model, the trajectory-1 expansion is made possible chiefly by rotation of Cys533 rather than Leu506, but the space generated by the expansion is underused by the Cl atom.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00162&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although our analysis suggests that outward rotation of Phe557 might allow tunnelling of substantially extended ligand tail groups in SK2 (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>C), the preferred orientation of the Phe557 side chain (in the absence of such ligand extensions) is predicted to lie inward toward Cys533 to maximize surface contact with adjacent hydrophobic residues. In this tightly packed inward orientation, the end of the Phe557 side chain is predicted to come into close contact with the <i>meta</i>-position of the terminal phenyl ring of our PF-543-derived ligands series. This might contribute to the poor tolerance by SK2 of <i>meta</i>-halogenation, as seen with <b>51</b> and <b>54</b> (vide supra). In SK1, the cognate residue (Met312, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) is more flexible and exhibits less reach compared to Phe557 in SK2, which is consistent with the greater tolerance toward <i>meta</i>-halogenation in <b>51</b> and <b>54</b>. A suitable tail extension to enable tunnelling in SK2 (“trajectory-2” in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>) may require a large group to provoke the necessary rotation in Phe557 and compensate for the loss of packing interactions between this residue and adjacent side chains. While potentially interesting for future investigation, our objective here was to achieve selectivity control with conservative changes in the parent ligand structure, thereby keeping molecular weight within druglike bounds.</div><div class="NLM_p last">We also docked ABC294640 (<b>4</b>) into our SK2 model for comparison (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>D). In this case, we found that the pyridyl group closely overlays the <i>p</i>-xylylene subunit of our ligands while the adamantyl group sits well in the J-channel bend, partly overlaying the middle arene of our compounds but also the tail linker (and again without encroaching severely on the Leu547 heel compression point). The plane of the terminal chlorophenyl group was slightly rotated relative to <b>55</b>/<b>60</b>, but the chlorine atom occupied a similar position to that proposed for the chlorine in our SK2-selective compound, <b>55</b>.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78183" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78183" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Growing interest in the therapeutic potential of targets within the sphingolipid signaling pathway is fueling efforts to develop isoform-selective SK inhibitors across a range of chemotypes.<a onclick="showRef(event, 'ref51 ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref51 ref52 ref53">(51−53)</a> PF-543 has attracted significant attention as a nanomolar-potent SK1 selective inhibitor. However, a structural basis for the compound’s SK1-over-SK2 selectivity has not been described until now, despite the recent disclosure of activity data for additional analogues.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Moreover, a lack of discriminating nanomolar-potent SK2 selective inhibitors as signaling pathway probes has hindered thorough exploration of the pharmacological potential of SK2 as a distinct target to date. From a clinical perspective, the most advanced compound remains the micromolar-potent, SK2-selective inhibitor, ABC294640 (<b>4</b>). However, the biological activity of this compound is complicated because it is a modulator of dihydroceramide desaturase and induces the proteasomal degradation of SK1.<a onclick="showRef(event, 'ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33">(31−33)</a></div><div class="NLM_p last">To develop a qualitative structural rationale for the design of isoform-selective inhibitors, we mapped SK2 sequence differences onto our recently determined<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> SK1/PF-543 cocrystal structure. That analysis (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) suggested a focus on the heel and toe of the J-channel, which we then probed with a concise set of PF-543 analogues modified in the tail linker and terminal phenyl ring (<a class="ref internalNav" href="#cht2" aria-label="Chart 2">Chart 2</a>). Our studies indicate that the phenyl group of PF-543, which is tightly fitted to the toe of the ligand-binding J-channel, constrains placement of the sulfonyl oxygens of the ligand into a region of surface encroachment in the J-channel heel of SK2. Deleting the sulfonyl oxygens by installation of replacement linkers for the PF-543 sulfonylmethylene group endows the ligand with dual SK1/SK2 inhibitory activity (<b>23</b>, <b>49</b>, <b>58</b>). In contrast to the heel, our work suggests that the surface of the J-channel toe in SK2 may be expanded and exhibit greater plasticity compared to SK1. We have shown that this difference may be exploited with a suitably positioned halogenated terminal arene in the ligand to undermine inhibition of SK1. Coupled with replacement of the PF-543 sulfonylmethylene linker, this strategy allows full reversal in the SK isoform selectivity profile to be engineered, with up to 100-fold selectivity for SK2 over SK1 achieved in our series with <i>p</i>-chlorophenyl terminal ligand subunits. Comparative analysis of another recently disclosed SK2 selective inhibitor (<b>9</b>)<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> suggests an additional tail trajectory where ligand extensions may be accommodated through plasticity in SK2 that does not exist in SK1. Taken together, we suggest that these studies now provide a blueprint for rational design of isoform-selective SK inhibitors and the development of suitable tool compounds for further exploring the pharmacological potential of SK2 as a therapeutic target.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52836" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52836" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> SK1 and SK2 Assays</h3><div class="NLM_p last">Sphingosine kinase assays employed purified SK1 or purified SK2 (40–180 ng/mL) and were performed using the <i>K</i><sub>m</sub> concentrations of Sph (3 and 10 μM, respectively) and 250 μM [γ-<sup>32</sup>P]ATP (0.75 kBq/nmol) for 30 min at 30 °C in a buffer containing 20 mM Tris (pH 7.4), 1 mM EDTA, 1 mM Na<sub>3</sub>VO<sub>4</sub>, 40 mM β-glycerophosphate, 1 mM NaF, 0.007% (v/v) β-mercaptoethanol, 20% (v/v) glycerol, 10 μg/mL aprotinin, 10 μg/mL soybean trypsin inhibitor, 1 mM PMSF, and 0.5 mM 4-deoxypyridoxine (and 400 mM KCl in the case of SK2 assays). Sph was presented in Triton X-100 (final concentration, 0.063% w/v) for SK1, whereas fatty acid free bovine serum albumin (final concentration, 0.2 mg/mL) was used in SK2 assays. Inhibitors were dissolved and diluted in DMSO (5% v/v final in assay). <sup>32</sup>P-Sphingosine 1-phosphate was extracted with 500 μL of 1-butanol, followed by a phase-split using 1 mL of 2 M KCl and two washes of the lower (aqueous) phase, using 2 M KCl, to remove unreacted [γ-<sup>32</sup>P]ATP before harvesting the upper (organic) phase and quantification by Cerenkov counting.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Synthetic Chemistry General Methods</h3><div class="NLM_p">Solvents and reagents were procured from commercial suppliers (Acros, Geel, Belgium; Alfa Aesar, Heysham, United Kingdom; Apollo Scientific, Stockport, United Kingdom; Fisher Scientific, Loughborough, United Kingdom; Fluorochem, Hadfield, United Kingdom; Sigma-Aldrich, Gillingham, United Kingdom) and used as supplied without further purification unless otherwise stated. “Light petroleum” refers to the fraction boiling between 40 and 60 °C. Analytical thin layer chromatography was carried out using aluminum backed plates coated with Merck Kieselgel 60 GF254 (no. 05554). Developed plates were visualized under ultraviolet light (254 and 366 nm) and/or by alkaline potassium permanganate dip. Preparative chromatography was performed (a) in conventional glass columns under flash column chromatography conditions (silica gel of 40–63 μm particle size from Fisher Scientific) or (b) using SP4 Biotage MPLC apparatus with silica gel of 40–63 μm particle size (Fisher Scientific) in 10 or 50 g cartridges depending on the scale of material to be processed, or (c) using Strata SI-1 cartridges (Phenomenex). Fully characterized compounds were chromatographically homogeneous. <sup>1</sup>H NMR spectra were recorded at 400 MHz on JEOL Lambda Delta 400, Bruker AMX-400, and Bruker AVIII-400 spectrometers. <sup>13</sup>C NMR spectra were recorded at 101 MHz on the same instruments. Chemical shifts are recorded in parts per million (δ in ppm) and are referenced against solvent signals (δ<sub>C</sub> 77.16 for chloroform and δ<sub>C</sub> 39.52 for methyl sulfoxide) for <sup>13</sup>C spectra and solvent residual resonances (δ<sub>H</sub> 7.26 for chloroform and δ<sub>H</sub> 2.50 methyl sulfoxide) for <sup>1</sup>H spectra.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a><sup>1</sup>H and <sup>13</sup>C chemical shift values are accurate to ±0.01 and ±0.1 ppm, respectively. <i>J</i> values are given in Hz. Multiplicity designations used are as follows: s, d, t, q, sept, and m for singlet, doublet, triplet, quartet, septet, and multiplet (respectively); br denotes an exchange-broadened signal. <sup>13</sup>C signal assignments, taken from distortionless enhancement by polarization transfer (DEPT) experiments are listed in parentheses. High-resolution mass spectroscopy (HRMS) was carried out under electrospray ionization (ESI) in a Fourier transform analyzer by an Exactive ThermoFisher Scientific instrument. All compounds subjected to enzyme assay evaluation were ≥95% pure as determined by HPLC analysis. HPLC method (A): YMC hydrosphere C<sub>18</sub> 5 μm/12 nm (150 mm × 4.5 mm) column under isocratic elution [0.1% CF<sub>3</sub>CO<sub>2</sub>H in 35/65 water/MeCN] at 0.7 mL/min and 40 °C with detection at λ 230 nm. HPLC method (B): Poroshell 120 C<sub>18</sub> 2.7 μm (75 mm × 4.6 mm) column under gradient elution from 95% water (5 mM NH<sub>4</sub>OAc) and 5% MeCN (5 mM NH<sub>4</sub>OAc) to 100% MeCN (5 mM NH<sub>4</sub>OAc) at 1 mL/min and 40 °C with detection at λ 214 nm.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 1-Methoxy-3-((phenylsulfonyl)methyl)benzene (<b>12</b>)</h4><div class="NLM_p last">A mixture of <b>11</b> (7.58 g, 37.7 mmol), sodium benzene sulfinate (NaSO<sub>2</sub>Ph, 6.75 g, 41.1 mmol), and Aliquat 336 (0.28 g, 0.70 mmol) was stirred at 85 °C for 18 h. The reaction mixture was diluted with hot EtOAc (120 mL), stirred at ambient temperature for 1 h, and the resulting slurry filtered through Celite to afford a filtrate that was concentrated in vacuo. The residue was subjected to flash column chromatography (light petroleum/EtOAc gradient 4:1 to 1:1) to afford <b>12</b> (4.61 g, 47%) as a white powder. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.71 (s, 3H), 4.28 (s, 2H), 6.61 (t, <i>J</i> = 2.2 Hz, 1H), 6.64 (ddd, <i>J</i> = 7.4, 1.6, 1.0 Hz, 1H), 6.85 (ddd, <i>J</i> = 8.3, 2.6, 1.0 Hz, 1H), 7.16 (t, <i>J</i> = 7.9 Hz, 1H), 7.44–7.48 (m, 2H), 7.58–7.63 (m, 1H), 7.64–7.67 (m, 2H).</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 3-((Phenylsulfonyl)methyl)phenol (<b>14</b>)</h4><div class="NLM_p last">To a solution of <b>12</b> (1.31 g, 5.00 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (30 mL) at −78 °C under N<sub>2</sub> was added dropwise BBr<sub>3</sub> (1 M in CH<sub>2</sub>Cl<sub>2</sub>; 5.50 mL, 5.50 mmol). The mixture was allowed to come to ambient temperature over 2 h and then cooled to 0 °C and quenched with saturated NaHCO<sub>3</sub> (40 mL). The separated aq phase was backextracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 30 mL). The combined organics were washed with brine (2 × 15 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and filtered. The filtrate was evaporated and the resulting residue subjected to flash column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH gradient 99.5:0.5 to 99:1) to afford <b>14</b> (958 mg, 77%) as a white powder. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.26 (s, 2H), 4.88 (s, 1H), 6.58 (ddd, <i>J</i> = 7.6, 1.6, 0.9 Hz, 1H), 6.66 (1 H, app t, <i>J</i> 2.0), 6.79 (ddd, <i>J</i> = 8.2, 2.6, 0.9 Hz, 1H), 7.10 (t, <i>J</i> = 7.9 Hz, 1H), 7.44–7.49 (m, 2H), 7.59–7.63 (m, 1H), 7.65–7.68 (m, 2H).</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 3-Hydroxyphenyl Benzenesulfonate (<b>15</b>)</h4><div class="NLM_p last">A mixture of resorcinol (500 mg, 4.54 mmol), K<sub>2</sub>CO<sub>3</sub> (1.88 g, 13.6 mmol), and phenylsulfonyl chloride (637 μL, 4.99 mmol) in MeCN (6 mL) was stirred at ambient temperature for 16 h. The mixture was partitioned between Et<sub>2</sub>O and water, and the separated organic phase then washed with saturated K<sub>2</sub>CO<sub>3</sub> solution and extracted with 1 M NaOH (aq). The aqueous extract was acidified with 3 M HCl (aq) and backextracted with Et<sub>2</sub>O. The organic phase was dried (MgSO<sub>4</sub>) and evaporated to afford <b>15</b> (244 mg, 21%) as a beige solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 6.37–6.47 (m, 2H), 6.69 (dd, <i>J</i> = 8.1, 1.5 Hz, 1H), 7.11–7.15 (m, 1H), 7.65–7.69 (m, 2H), 7.81 (t, <i>J</i> = 7.5 Hz, 1H), 7.86 (d, <i>J</i> = 7.6 Hz, 2H), 9.87 (br s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 106.2, 109.0, 112.1, 114.5, 128.1, 128.1, 129.7, 134.9, 149.8, 158.5.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 4-((3-((Phenylsulfonyl)methyl)phenoxy)methyl)benzaldehyde (<b>16</b>)</h4><div class="NLM_p last">A stirred mixture of <b>14</b> (283 mg, 1.14 mmol), 4-(bromomethyl)benzaldehyde (239 mg, 1.20 mmol), and K<sub>2</sub>CO<sub>3</sub> (440 mg, 3.19 mmol) in MeCN (8.0 mL) was heated at 60 °C for 3 h. The mixture was filtered through Celite to afford a filtrate that was concentrated in vacuo. The residue was partitioned between EtOAc (50 mL) and water (20 mL). The organic phase was washed with brine (15 mL), dried (MgSO<sub>4</sub>), concentrated, and processed by flash column chromatography (CH<sub>2</sub>Cl<sub>2</sub> to 0.5% MeOH/CH<sub>2</sub>Cl<sub>2</sub> gradient elution) to afford <b>16</b> (338 mg, 81%) as a white powder. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.28 (s, 2H),5.07 (s, 2H), 6.65 (ddd, <i>J</i> = 7.5, 1.6, 0.9 Hz, 1H), 6.78 (dd, <i>J</i> = 2.5, 1.6 Hz, 1H), 6.92 (ddd, <i>J</i> = 8.3, 2.6, 1.0 Hz, 1H), 7.16 (dd, <i>J</i> = 8.3, 7.6 Hz, 1H), 7.43–7.48 (m, 2H), 7.55–7.58 (m, 2H), 7.58–7.63 (m, 1H), 7.63–7.67 (m, 2H), 7.89–7.92 (m, 2H), 10.03 (s, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 62.8 (CH<sub>2</sub>), 69.2 (CH<sub>2</sub>), 115.6 (CH), 117.0 (CH), 123.9 (CH), 127.5 (2 × CH), 128.6 (2 × CH), 128.9 (2 × CH), 129.6 (C), 129.7 (CH), 133.1 (CH), 130.0 (2 × CH), 136.1 (C), 138.0 (C), 143.6 (C), 158.4 (C), 191.8 (CO).</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 3-((4-Formylbenzyl)oxy)phenyl Benzenesulfonate (<b>17</b>)</h4><div class="NLM_p last">Following the procedure for <b>16</b>, phenol <b>15</b> (150 mg, 0.568 mmol) afforded <b>17</b> (196 mg, 88%) as a colorless solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 5.16 (s, 2H), 6.62 (ddd, <i>J</i> = 8.1, 2.2, 0.8 Hz, 1H), 6.69–6.70 (m, 1H), 6.99 (ddd, <i>J</i> = 8.4, 2.5, 0.8 Hz, 1H), 7.27–7.31 (m, 1H), 7.60 (d, <i>J</i> = 8.1 Hz, 2H), 7.66 (dd, <i>J</i> = 8.2, 7.5 Hz, 2H), 7.77–7.84 (m, 1H), 7.86 (dd, <i>J</i> = 8.2, 1.3 Hz, 2H), 7.93 (d, <i>J</i> = 8.1 Hz, 2H), 10.02 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 68.9, 108.9, 114.1, 114.3, 127.8, 128.2, 129.7, 129.7, 130.5, 134.2, 135.0, 135.7, 143.3, 149.8, 158.8, 192.8.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> (<i>R</i>)-(1-(4-((3-((Phenylsulfonyl)methyl)phenoxy)methyl)benzyl)pyrrolidin-2-yl)methanol (<b>18</b>)</h4><div class="NLM_p last">To a solution of <b>16</b> (96 mg, 0.262 mmol) and (<i>R</i>)-(−)-2-pyrrolidinemethanol (28 μL, 0.287 mmol) in 1,2-dichloroethane (2 mL) was added NaBH(OAc)<sub>3</sub> (83 mg, 0.393 mmol). The mixture was stirred at ambient temperature for 16 h. A further portion of NaBH(OAc)<sub>3</sub> (28 mg, 0.13 mmol) was added and stirring continued for 18 h until complete consumption of <b>16</b> was observed by TLC analysis (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 9:1). The mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> (30 mL) and washed with saturated NaHCO<sub>3</sub> solution (10 mL). The organic phase was dried (MgSO<sub>4</sub>), evaporated, and the resulting residue subjected to flash column chromatography (gradient elution, 1–5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to afford <b>18</b> (84 mg, 71%) as a white powder. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.65–1.75 (m, 2H), 1.80–1.88 (m, 1H), 1.88–1.99 (m, 1H), 2.30 (q, <i>J</i> = 8.4 Hz, 1H), 2.40–3.00 (br s, 1H), 2.72–2.78 (m, 1H), 2.96–3.01 (m, 1H), 3.38 (d, <i>J</i> = 13.0 Hz, 1H), 3.44 (dd, <i>J</i> = 10.8, 2.2 Hz, 1H), 3.66 (dd, <i>J</i> = 10.8, 3.5 Hz, 1H), 3.98 (d, <i>J</i> = 13.0 Hz, 1H), 4.28 (s, 2H), 4.94 (s, 2H), 6.64 (dt, <i>J</i> = 7.6, 1.2 Hz, 1H), 6.73 (dd, <i>J</i> = 2.5, 1.7 Hz, 1H), 6.92 (ddd, <i>J</i> = 8.3, 2.6, 1.0 Hz, 1H), 7.15 (dd, <i>J</i> = 8.3, 7.6 Hz, 1H), 7.29–7.37 (m, 4H), 7.43–7.48 (m, 2H), 7.58–7.63 (m, 1H), 7.63–7.66 (m, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 23.5 (CH<sub>2</sub>), 27.8 (CH<sub>2</sub>), 54.5 (CH<sub>2</sub>), 58.3 (CH<sub>2</sub>), 61.8 (CH<sub>2</sub>), 62.9 (CH<sub>2</sub>), 64.4 (CH), 69.9 (CH<sub>2</sub>), 115.7 (CH), 117.0 (CH), 123.4 (CH), 127.6 (2 × CH), 128.7 (2 × CH), 128.9 (2 × CH), 128.9 (2 × CH), 129.5 (C), 129.6 (CH), 133.7 (CH), 135.5 (C), 138.0 (C), 139.3 (C), 158.8 (C). ESI-HRMS [M + H]<sup>+</sup> calcd for C<sub>26</sub>H<sub>30</sub>NO<sub>4</sub>S<sup>+</sup> 452.1890, found 452.1904. HPLC: method (A) <i>t</i><sub>R</sub> 3.89 min (99.5%).</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (<i>R</i>)-3-((4-((2-(Hydroxymethyl)pyrrolidin-1-yl)methyl)benzyl)oxy)phenyl Benzenesulfonate (<b>19</b>)</h4><div class="NLM_p last">Following the procedure for <b>18</b>, aldehyde <b>17</b> (100 mg, 0.271 mmol) afforded <b>19</b> (40 mg, 33%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.52–1.65 (m, 3H), 1.79–1.88 (m, 1H), 2.10–2.16 (m, 1H), 2.52–2.59 (m, 1H), 2.73–2.78 (m, 1H), 3.26–3.31 (br m, 1H), 3.33 (d, <i>J</i> = 13.3 Hz, 1H), 3.45 (br dd, <i>J</i> = 10.3 and 3.9 Hz, 1H), 4.04 (d, <i>J</i> = 13.3 Hz, 1H), 4.38 (br s, 1H), 4.98 (s, 2H), 6.59 (ddd, <i>J</i> = 8.2, 2.2, and 0.7 Hz, 1H), 6.66 (t, <i>J</i> = 2.3 Hz, 1H), 6.96 (ddd, <i>J</i> = 8.4, 2.4, and 0.7 Hz, 1H), 7.27 (t, <i>J</i> = 8.3 Hz, 1H), 7.31 (app s, 4H), 7.64–7.69 (m, 2H), 7.80–7.84 (m, 1H), 7.84–7.87 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 22.5, 28.0, 54.0, 58.4, 64.2, 64.8, 69.5, 108.8, 114.0, 127.6, 128.2, 128.6, 129.7, 130.4, 134.3, 134.6, 135.0, 139.9, 148.8, 149.8, 159.2. ESI-HRMS [M + H]<sup>+</sup> calcd for C<sub>25</sub>H<sub>28</sub>NO<sub>5</sub>S<sup>+</sup> 454.1683, found 454.1681. HPLC: method (B) <i>t</i><sub>R</sub> 6.64 min (96.7%).</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 3-(Phenylethynyl)phenol (<b>20</b>)</h4><div class="NLM_p last">A flask was charged under Ar with 3-iodophenol (1.51 g, 6.86 mmol), copper(I) iodide (140 mg, 734 μmol), tetrakis(triphenylphosphine)palladium(0) (382 mg, 332 μmol), anhydrous THF (30 mL), triethylamine (24 mL), and phenylacetylene (2.80 g, 27.4 mmol). The mixture was stirred at ambient temperature for 48 h and concentrated in vacuo, and the resulting residue partitioned between CHCl<sub>3</sub> (100 mL) and 1 M HCl (aq) (200 mL). The organic phase was dried (MgSO<sub>4</sub>) and evaporated. The residual oil was processed by flash column chromatography (1:2:8 Et<sub>2</sub>O/CH<sub>2</sub>Cl<sub>2</sub>/light petroleum) followed by crystallization (CH<sub>2</sub>Cl<sub>2</sub>/light petroleum) to afford <b>20</b> (759 mg, 57%) as off-white plates. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.77 (br s, 1H), 6.83 (ddd, <i>J</i> = 8.1, 2.6, and 1.0 Hz, 1H), 7.01 (dd, <i>J</i> = 2.4 and 1.4 Hz, 1H), 7.13 (dt, <i>J</i> = 7.6 and 1.2 Hz, 1H), 7.23 (t, <i>J</i> = 7.9 Hz, 1H), 7.31–7.38 (m, 3H), 7.50–7.55 (m, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 89.1 (C), 89.6 (C), 115.9 (CH), 118.4 (CH), 123.3 (C), 124.6 (CH), 124.7 (C), 128.5 (3 × CH), 129.8 (CH), 131.8 (2 × CH), 155.4 (C).</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 3-Phenethylphenol (<b>21</b>)</h4><div class="NLM_p last">A solution of <b>20</b> (400 mg, 2.06 mmol) in EtOH (40 mL) was hydrogenated using an H-Cube (ThalesNano) fitted with a 10% Pd/C cartridge under full H<sub>2</sub> mode at 30 °C with a flow rate of 0.7 mL/min. The hydrogenated product solution was evaporated to <b>21</b> (390 mg, 95%) as a colorless oil that solidified to a crystalline solid on standing. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.86–2.95 (m, 4H), 4.68 (br s, 1H), 6.67–6.69 (m, 2H), 6.78 (app d, <i>J</i> = 7.5 Hz, 1H), 7.14–7.23 (m, 4H), 7.27–7.32 (m, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 37.75 (CH<sub>2</sub>), 37.80 (CH<sub>2</sub>), 113.0 (CH), 115.6 (CH), 121.2 (CH), 126.1 (CH), 128.5 (2 × CH), 128.6 (2 × CH), 129.7 (CH), 141.8 (C), 143.9 (C), 155.5 (C).</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 4-((3-Phenethylphenoxy)methyl)benzaldehyde (<b>22</b>)</h4><div class="NLM_p last">A mixture of 4-(bromomethyl)benzaldehyde (301 mg, 1.51 mmol), <b>21</b> (337 mg, 1.70 mmol), and K<sub>2</sub>CO<sub>3</sub> (707 mg, 5.12 mmol) in MeCN (10 mL) was stirred at ambient temperature for 16 h. The mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> (25 mL), filtered through Celite, and the filtrate evaporated to dryness. The residual oil was processed chromatographically (20 g Strata SI-1 cartridge; 1:39:60 Et<sub>2</sub>O/CH<sub>2</sub>Cl<sub>2</sub>/light petroleum) to afford <b>22</b> (417 mg, 87%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.86–2.96 (m, 4H), 5.12 (s, 2H), 6.79–6.84 (m, 3H), 7.16–7.23 (m, 4H), 7.26–7.31 (m, 2H), 7.59–7.62 (AA′BB′ m, 2H), 7.89–7.92 (AA′BB′ m, 2H), 10.03 (s, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 37.8 (CH<sub>2</sub>), 38.0 (CH<sub>2</sub>), 69.2 (CH<sub>2</sub>), 112.2 (CH), 115.3 (CH), 121.7 (CH), 126.1 (CH), 127.6 (2 × CH), 128.45 (2 × CH), 128.55 (2 × CH), 129.5 (CH), 130.1 (2 × CH), 136.0 (C), 141.7 (C), 143.7 (C), 144.3 (C), 158.5 (C), 192.0 (CH).</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (<i>R</i>)-(1-(4-((3-Phenethylphenoxy)methyl)benzyl)pyrrolidin-2-yl)methanol (<b>23</b>)</h4><div class="NLM_p last">Following the procedure for <b>18</b>, aldehyde <b>22</b> (417 mg, 1.32 mmol) afforded <b>23</b> (432 mg, 82%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.66–1.76 (m, 2H), 1.81–2.00 (m, 2H), 2.30 (td, <i>J</i> = 9.3 and 7.5 Hz, 1H), 2.50–3.00 (br s, 1H), 2.73–2.78 (m, 1H), 2.88–2.96 (m, 4H), 2.97–3.02 (m, 1H), 3.39 (d, <i>J</i> = 13.1 Hz, 1H), 3.45 (dd, <i>J</i> = 10.8 and 1.9 Hz, 1H), 3.68 (dd, <i>J</i> = 10.8 and 3.5 Hz, 1H), 3.99 (d, <i>J</i> = 13.1 Hz, 1H), 5.02 (s, 2H), 6.80–6.84 (m, 3H), 7.19–7.23 (m, 4H), 7.28–7.41 (m, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 23.6 (CH<sub>2</sub>), 27.9 (CH<sub>2</sub>), 37.9 (CH<sub>2</sub>), 38.1 (CH<sub>2</sub>), 54.5 (CH<sub>2</sub>), 58.3 (CH<sub>2</sub>), 61.9 (CH<sub>2</sub>), 64.4 (CH), 69.8 (CH<sub>2</sub>), 112.3 (CH), 115.3 (CH), 121.2 (CH), 126.0 (CH), 127.7 (2 × CH), 128.4 (2 × CH), 128.5 (2 × CH), 129.0 (2 × CH), 129.4 (CH), 136.0 (C), 139.2 (C), 141.8 (C), 143.5 (C), 159.0 (C). ESI-HRMS [M + H]<sup>+</sup> calcd for C<sub>27</sub>H<sub>32</sub>NO<sub>2</sub><sup>+</sup> 402.2428, found 402.2434. HPLC: method (A) <i>t</i><sub>R</sub> 4.73 min (>99%).</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 3-(Benzyloxy)phenol (<b>25</b>)</h4><div class="NLM_p last">A heavy-walled sealable reaction flask was charged with resorcinol (2.20 g, 20.0 mmol), K<sub>2</sub>CO<sub>3</sub> (2.80 g, 20.3 mmol), acetone (30 mL), and a magnetic stir bar. Benzyl bromide (1.72 g, 10.1 mmol) was added and the flask closed under argon. The mixture was then heated at 65–70 °C. After 5 h, the mixture was returned to ambient temperature and filtered through Celite, washing well with acetone. The filtrate was evaporated to afford a residue that was partitioned between CHCl<sub>3</sub> (100 mL) and water (100 mL). The organic phase was separated and the aqueous layer extracted with CHCl<sub>3</sub> (25 mL). The combined organic phase was dried (MgSO<sub>4</sub>) and evaporated to give a residue that was processed by flash column chromatography (25% Et<sub>2</sub>O/light petroleum). Fractions containing the target material were evaporated to afford <b>25</b> (1.11 g, 55%) as a colorless oil that solidified to a crystalline solid on standing. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.67 (br s, 1H), 5.04 (s, 2H), 6.44 (ddd, <i>J</i> = 8.0, 2.4 and 0.9, 1H), 6.49 (t, <i>J</i> = 2.3, 1H), 6.58 (ddd, <i>J</i> = 8.3, 2.4 and 0.8, 1H), 7.14 (t, <i>J =</i> 8.1, 1H), 7.30–7.45 (m, 5H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 70.2 (CH<sub>2</sub>), 102.6 (CH), 107.6 (CH), 108.3 (CH), 127.6 (2 × CH), 128.1 (CH), 128.7 (2 × CH), 130.3 (CH), 136.9 (C), 156.7 (C), 160.1 (C).</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 3-((2-Fluorobenzyl)oxy)phenol (<b>26</b>)</h4><div class="NLM_p last">Following the procedure for <b>25</b>, 2-fluorobenzyl bromide (1.91 g, 10.1 mmol) afforded <b>26</b> (1.17 g, 53%) as a pale-yellow oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 4.86 (br s, 1H), 5.11 (s, 2H), 6.45 (ddd, <i>J</i> = 8.0, 2.4, and 0.8 Hz, 1H), 6.50 (t, <i>J</i> = 2.3 Hz, 1H), 6.59 (ddd, <i>J</i> = 8.3, 2.4, and 0.8 Hz, 1H), 7.06–7.19 (m, 3H), 7.32 (tdd, <i>J</i> = 7.8, 5.6, and 2.1 Hz, 1H), 7.47–7.53 (m, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 63.9 (d, <i>J</i> = 4.5 Hz, CH<sub>2</sub>), 102.6 (CH), 107.5 (CH), 108.5 (CH), 115.4 (d, <i>J</i> = 21.1 Hz, CH), 124.0 (d, <i>J</i> = 14.3 Hz, C), 124.4 (d, <i>J</i> = 3.6 Hz, CH), 129.8 (d, <i>J</i> = 2.9 Hz, CH), 129.9 (d, <i>J</i> = 1.3 Hz, CH), 130.4 (CH), 156.6 (C), 159.9 (C), 160.6 (d, <i>J</i> = 247.1 Hz, C). <sup>19</sup>F NMR (282 MHz, CDCl<sub>3</sub>) δ −118.5.</div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 3-((3-Fluorobenzyl)oxy)phenol (<b>27</b>)</h4><div class="NLM_p last">Following the procedure for <b>25</b>, 3-fluorobenzyl bromide (1.91 g, 10.1 mmol) afforded <b>27</b> (1.27 g, 58%) as a pale-yellow oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 5.03 (s, 2H), 5.07 (br s, 1H), 6.44–6.49 (m, 2H), 6.57 (ddd, <i>J</i> = 8.3, 2.3, and 0.9 Hz, 1H), 6.98–7.05 (m, 1H), 7.12–7.20 (m, 3H), 7.34 (td, <i>J</i> = 7.9 and 5.8 Hz, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 69.3 (CH<sub>2</sub>), 102.6 (CH), 107.6 (CH), 108.5 (CH), 114.3 (d, <i>J</i> = 22.0 Hz, CH), 114.9 (d, <i>J</i> = 21.1 Hz, CH), 122.9 (CH), 130.2 (d, <i>J</i> = 8.2 Hz, CH), 130.4 (CH), 139.5 (d, <i>J</i> = 7.3 Hz, C), 159.8 (C), 161.4 (C), 163.1 (d, <i>J</i> = 246.1 Hz, C). <sup>19</sup>F NMR (282 MHz, CDCl<sub>3</sub>) δ −112.6.</div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 3-((4-Fluorobenzyl)oxy)phenol (<b>28</b>)</h4><div class="NLM_p last">Following the procedure for <b>25</b>, 4-fluorobenzyl bromide (1.83 g, 9.67 mmol) afforded <b>28</b> (803 mg, 38%) as a colorless crystalline solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.98 (br s, 1H), 4.99 (s, 2H), 6.45 (ddd, <i>J</i> = 7.9, 2.3 and 0.8,1H), 6.48 (t, <i>J</i> = 2.2, 1H), 6.56 (ddd, <i>J</i> = 8.3, 2.3 and 0.9,1H), 7.03–7.11 (m, 2H), 7.14 (t, <i>J =</i> 8.1, 1H), 7.36–7.43 (m, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 69.5 (CH<sub>2</sub>), 102.7 (CH), 107.4 (CH), 108.4 (CH), 115.6 (d, <i>J</i> = 21.4, CH), 129.5 (d, <i>J</i> = 8.2, CH), 130.3 (CH), 132.7 (d, <i>J</i> = 3.0, C), 156.9 (C), 160.0 (C), 162.6 (d, <i>J</i> = 246, C). <sup>19</sup>F NMR (282 MHz, CDCl<sub>3</sub>) δ −114.2.</div></div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 3-((2-Chlorobenzyl)oxy)phenol (<b>29</b>)</h4><div class="NLM_p last">Following the procedure for <b>25</b>, 2-chlorobenzyl bromide (2.01 g, 9.79 mmol) afforded <b>29</b> (1.24 g, 54%) as a pale-yellow oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 4.72 (br s, 1H), 5.11 (s, 2H), 6.42 (dd, <i>J</i> = 8.0 and 2.3 Hz, 1H), 6.47 (t, <i>J</i> = 2.3 Hz, 1H), 6.55 (dd, <i>J</i> = 8.2 and 2.3 Hz, 1H), 7.12 (t, <i>J =</i> 8.1, 1H), 7.19–7.29 (m, 2H), 7.32–7.39 (m, 1H), 7.48–7.54 (m, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 67.3 (CH<sub>2</sub>), 102.7 (CH), 107.5 (CH), 108.6 (CH), 127.0 (CH), 129.0 (CH), 129.1 (CH), 129.4 (CH), 130.4 (CH), 132.7 (C), 134.5 (C), 156.7 (C), 159.8 (C).</div></div><div id="sec4_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 3-((3-Chlorobenzyl)oxy)phenol (<b>30</b>)</h4><div class="NLM_p last">Following the procedure for <b>25</b>, 3-chlorobenzyl bromide (2.01 g, 9.77 mmol) afforded <b>30</b> (1.12 g, 49%) as a pale-yellow oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 4.90 (br s, 1H), 5.01 (s, 2H), 6.44–6.48 (m, 2H), 6.55 (ddd, <i>J</i> = 8.3, 2.2, and 1.1 Hz, 1H), 7.11–7.18 (m, 1H), 7.28–7.40 (m, 3H), 7.32–7.39 (m, 1H), 7.42–7.44 (m, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 69.3 (CH<sub>2</sub>), 102.6 (CH), 107.5 (CH), 108.6 (CH), 125.5 (CH), 127.5 (CH), 128.2 (CH), 129.9 (CH), 130.4 (CH), 134.5 (C), 138.9 (C), 156.6 (C), 159.8 (C).</div></div><div id="sec4_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 3-((4-Chlorobenzyl)oxy)phenol (<b>31</b>)</h4><div class="NLM_p last">Following the procedure for <b>25</b>, 4-chlorobenzyl chloride (1.62 g, 10.1 mmol) afforded <b>31</b> (1.14 g, 48%) as a colorless crystalline solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.99 (s, 2H), 5.12 (br s, 1H), 6.43–6.48 (m, 2H), 6.56 (dd, <i>J</i> = 8.1 and 2.2, 1H), 7.14 (t, <i>J =</i> 8.1, 1H), 7.30–7.40 (tight AA′BB′ m, 4H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 69.5 (CH<sub>2</sub>), 102.8 (CH), 107.6 (CH), 108.5 (CH), 128.9 (4 × CH), 130.4 (CH), 133.9 (C), 135.5 (C), 156.8 (C), 160.1 (C).</div></div><div id="sec4_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 3-((4-Methoxybenzyl)oxy)phenol (<b>32</b>)</h4><div class="NLM_p last">Following the procedure for <b>25</b>, 4-methoxybenzyl chloride (1.57 g, 10.0 mmol) afforded <b>32</b> (736 mg, 32%) as a white powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 3.82 (s, 3H), 4.67 (br s, 1H), 4.96 (s, 2H), 6.43 (1 H, ddd, <i>J</i> = 8.0, 2.4 and 0.8, 1H), 6.47 (t, <i>J</i> = 2.3, 1H), 6.57 (ddd, <i>J</i> = 8.3, 2.4 and 0.8, 1H), 6.89–6.94 (AA′BB′ m, 2H), 7.13 (t, <i>J</i> = 8.2, 1H), 7.33–7.37 (AA′BB′ m, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 55.5 (CH<sub>3</sub>), 70.0 (CH<sub>2</sub>), 102.6 (CH), 107.5 (CH), 108.1 (CH), 114.2 (2 × CH), 129.1 (C), 129.4 (2 × CH), 130.3 (CH), 156.8 (C), 159.4 (C), 160.3 (C).</div></div><div id="sec4_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 4-((3-Hydroxyphenoxy)methyl)benzonitrile (<b>33</b>)</h4><div class="NLM_p last">Following the procedure for <b>25</b>, 4-cyanobenzyl bromide (1.96 g, 9.98 mmol) afforded <b>33</b> (1.05 g, 47%) as an off-white powder. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.90 (br s, 1H), 5.10 (s, 2H), 6.45–6.48 (m, 2H), 6.53 (ddd, <i>J</i> = 8.3, 2.3 and 1.0, 1H), 7.12–7.17 (m, 1H), 7.52–7.55 (AA′BB′ m, 2H), 7.66–7.69 (AA′BB′ m, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 69.1 (CH<sub>2</sub>), 102.7 (CH), 107.4 (CH), 108.8 (CH), 111.9 (C), 118.8 (C), 127.7 (2 × CH), 130.5 (CH), 132.6 (2 × CH), 142.7 (C), 157.1 (C), 159.8 (C).</div></div><div id="sec4_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 3-(Benzylthio)phenol (<b>34</b>)</h4><div class="NLM_p last">A mixture of 3-mercaptophenol (621 mg, 4.92 mmol), benzyl bromide (888 mg, 5.19 mmol), and K<sub>2</sub>CO<sub>3</sub> (2.05 g, 14.8 mmol) in acetonitrile (10 mL) was stirred under Ar at ambient temperature. After 2 d the reaction mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> (25 mL) and filtered through Celite, washing well with CH<sub>2</sub>Cl<sub>2</sub>. The filtrate was evaporated and the residue processed chromatographically (20 g Strata SI-1 cartridge; 1:3:8 Et<sub>2</sub>O/CH<sub>2</sub>Cl<sub>2</sub>/light petroleum) to afford <b>34</b> (720 mg, 68%) as a colorless solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.12 (s, 2H), 4.90 (br s, 1H), 6.64 (ddd, <i>J</i> = 8.1, 2.5, and 0.9 Hz, 1H), 6.78 (t, <i>J</i> = 2.1 Hz, 1H), 6.88 (ddd, <i>J</i> = 7.8, 1.7, and 0.9 Hz, 1H), 7.13 (t, <i>J</i> = 7.9 Hz, 1H), 7.22–7.33 (m, 5H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 38.6 (CH<sub>2</sub>), 113.5 (CH), 116.1 (CH), 121.7 (CH), 127.4 (CH), 128.6 (2 × CH), 128.9 (2 × CH), 130.0 (CH), 137.2 (C), 138.1 (C), 155.8 (C)</div></div><div id="sec4_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 3-((4-Fluorobenzyl)thio)phenol (<b>35</b>)</h4><div class="NLM_p last">Following the procedure for <b>34</b>, 3-mercaptophenol (500 μL, 4.91 mmol) was alkylated with 4-fluorobenzyl bromide (930 mg, 4.92 mmol) to afford <b>35</b> (818 mg, 71%) as a colorless solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.08 (s, 2H), 4.68 (br s, 1H), 6.65 (ddd, <i>J</i> 8.1, 2.5, and 0.9 Hz, 1H), 6.77 (ddd, <i>J</i> = 2.5, 1.7, and 0.3 Hz, 1H), 6.86 (ddd, <i>J</i> = 7.8, 1.7, and 0.9 Hz, 1H), 6.94–7.00 (m, 2H), 7.13 (td, <i>J</i> = 7.9 and 0.3 Hz, 1H), 7.23–7.28 (m, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 38.1 (CH<sub>2</sub>), 113.7 (CH), 115.5 (d, <i>J</i> = 21.5 Hz, 2 × CH), 116.4 (CH), 122.1 (CH), 130.1 (CH), 130.5 (d, <i>J</i> = 8.1 Hz, 2 × CH), 133.1 (d, <i>J</i> = 3.2 Hz, C), 137.8 (C), 155.7 (C), 162.1 (d, <i>J</i> = 245.7 Hz, C). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −115.3.</div></div><div id="sec4_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 3-((4-Chlorobenzyl)thio)phenol (<b>36</b>)</h4><div class="NLM_p last">Following the procedure for <b>34</b>, 3-mercaptophenol (500 μL, 4.91 mmol) was alkylated with 4-chlorobenzyl chloride (823 mg, 5.11 mmol) to afford <b>36</b> (969 mg, 79%) as a colorless solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.06 (s, 2H), 4.72 (br s, 1H), 6.65 (ddd, <i>J</i> = 8.1, 2.5, and 0.9 Hz, 1H), 6.76 (app t, <i>J</i> = 2.1 Hz, 1H), 6.86 (ddd, <i>J</i> = 7.8, 1.7, and 0.9 Hz, 1H), 7.13 (app t, <i>J</i> = 7.9 Hz, 1H), 7.21–7.27 (m, 4H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 38.2 (CH<sub>2</sub>), 113.8 (CH), 116.4 (CH), 122.2 (CH), 128.8 (2 × CH), 130.1 (CH), 130.2 (2 × CH), 133.1 (C), 135.9 (C), 137.5 (C), 155.7 (C).</div></div><div id="sec4_2_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 4-((3-(Benzyloxy)phenoxy)methyl)benzaldehyde (<b>37</b>)</h4><div class="NLM_p last">To a solution of <b>25</b> (328 mg, 1.64 mmol) in anhydrous DMF (6 mL) under argon was added NaH (60% w/w in mineral oil; 83.0 mg, 2.08 mmol). The mixture was sonicated for 2 min to aid dispersal of the hydride reagent and then stirred at ambient temperature for 15 min prior to addition of 4-(bromomethyl)benzaldehyde (365 mg, 1.83 mmol). After a further 16 h, the mixture was evaporated to dryness (65 °C/15 mbar). The resulting residue was taken up in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) and filtered through Celite, washing well with CHCl<sub>3</sub>. The filtrate was evaporated to dryness and pumped to remove residual DMF. Chromatographic processing of the residue (20 g Strata SI-1 cartridge; 1:49.5:49.5 Et<sub>2</sub>O/CH<sub>2</sub>Cl<sub>2</sub>/light petroleum) affords <b>37</b> (461 mg, 88%) as a colorless solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 5.06 (s, 2H), 5.13 (s, 2H), 6.59–6.66 (m, 3H), 7.19–7.24 (m, 1H), 7.31–7.46 (m, 5H), 7.57–7.62 (AA′BB′ m, 2H), 7.89–7.92 (AA′BB′ m, 2H), 10.03 (s, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 69.0 (CH<sub>2</sub>), 69.9 (CH<sub>2</sub>), 102.2 (CH), 107.3 (CH), 107.5 (CH), 127.3 (2 × CH), 127.4 (2 × CH), 127.9 (CH), 128.5 (2 × CH), 129.8 (2 × CH), 130.0 (CH), 135.8 (C), 136.8 (C), 143.8 (C), 159.5 (C), 160.0 (C), 191.7 (CH).</div></div><div id="sec4_2_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 4-((3-((2-Fluorobenzyl)oxy)phenoxy)methyl)benzaldehyde (<b>38</b>)</h4><div class="NLM_p last">Following the procedure for <b>37</b>, phenol <b>26</b> (333 mg, 1.53 mmol) was alkylated to give <b>38</b> (317 mg, 62%) as a colorless solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 5.12 (s, 2H), 5.14 (s, 2H), 6.58–6.66 (m, 3H), 7.08 (ddd, <i>J</i> = 9.9, 8.4, and 1.3 Hz, 1H), 7.16 (td, <i>J</i> = 7.5 and 1.2, 1H), 7.18–7.24 (m, 1H), 7.28–7.36 (m, 1H), 7.47–7.52 (m, 1H), 7.57–7.61 (AA′BB′ m, 2H), 7.88–7.92 (AA′BB′ m, 2H), 10.03 (s, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 63.8 (d, <i>J</i> = 4.5 Hz, CH<sub>2</sub>), 69.3 (CH<sub>2</sub>), 102.3 (CH), 107.6 (CH), 107.7 (CH), 115.4 (d, <i>J</i> = 21.0 Hz, CH), 124.1 (d, <i>J</i> = 14.3 Hz, C), 124.3 (d, <i>J</i> = 3.7 Hz, CH), 127.5 (2 × CH), 129.77 (CH), 129.84 (d, <i>J</i> = 4.1, CH), 130.1 (2 × CH), 130.2 (CH), 136.0 (C), 144.0 (C), 159.7 (C), 159.9 (C), 160.5 (d, <i>J</i> = 246.9 Hz, C), 191.9 (CH). <sup>19</sup>F NMR (282 MHz, CDCl<sub>3</sub>) δ – 118.6.</div></div><div id="sec4_2_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 4-((3-((3-Fluorobenzyl)oxy)phenoxy)methyl)benzaldehyde (<b>39</b>)</h4><div class="NLM_p last">Following the procedure for <b>37</b>, phenol <b>27</b> (325 mg, 1.49 mmol) was alkylated to give <b>39</b> (322 mg, 64%) as a colorless solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 5.04 (s, 2H), 5.13 (s, 2H), 6.59–6.62 (m, 3H), 7.99–7.04 (m, 1H), 7.13–7.23 (m, 3H), 7.34 (td, <i>J</i> = 7.9 and 5.8 Hz, 1H), 7.57–7.61 (AA′BB′ m, 2H), 7.89–7.92 (AA′BB′ m, 2H), 10.03 (s, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 69.3 (d, <i>J</i> = 2.0 Hz, CH<sub>2</sub>), 69.4 (CH<sub>2</sub>), 102.6 (CH), 107.7 (CH), 107.8 (CH), 114.3 (d, <i>J</i> = 22.1 Hz, CH), 114.9 (d, <i>J</i> = 21.2 Hz, CH), 122.8 (d, <i>J</i> = 2.9 Hz, CH), 127.5 (2 × CH), 130.1 (2 × CH), 130.20 (d, <i>J</i> = 8.1, CH), 130.1 (CH), 136.1 (C), 139.7 (d, <i>J</i> = 7.3 Hz, C), 144.0 (C), 159.8 (C), 159.9 (C), 163.1 (d, <i>J</i> = 246.2 Hz, C), 191.8 (CH). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ – 112.6.</div></div><div id="sec4_2_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 4-((3-((4-Fluorobenzyl)oxy)phenoxy)methyl)benzaldehyde (<b>40</b>)</h4><div class="NLM_p last">Following the procedure for <b>37</b>, phenol <b>28</b> (325 mg, 1.49 mmol) was alkylated to give <b>40</b> (388 mg, 77%) as a colorless solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 5.00 (s, 2H), 5.13 (s, 2H), 6.58–6.63 (m, 3H), 7.03–7.11 (m, 2H), 7.17–7.24 (m, 1H), 7.36–7.43 (m, 2H), 7.56–7.62 (AA′BB′ m, 2H), 7.88–7.92 (AA′BB′ m, 2H), 10.02 (s, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 69.1 (CH<sub>2</sub>), 69.2 (CH<sub>2</sub>), 102.3 (CH), 107.4 (CH), 107.6 (CH), 115.4 (d, <i>J</i> = 21.0 Hz, 2 × CH), 127.4 (2 × CH), 129.3 (d, <i>J</i> = 7.7 Hz, 2 × CH), 129.9 (2 × CH), 130.1 (CH), 132.6 (d, <i>J</i> = 3.3 Hz, C), 135.9 (C), 143.8 (C), 159.6 (C), 159.9 (C), 162.4 (d, <i>J</i> = 247 Hz, C), 191.7 (CH). <sup>19</sup>F NMR (282 MHz, CDCl<sub>3</sub>) δ −113.9.</div></div><div id="sec4_2_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 4-((3-((2-Chlorobenzyl)oxy)phenoxy)methyl)benzaldehyde (<b>41</b>)</h4><div class="NLM_p last">Following the procedure for <b>37</b>, phenol <b>29</b> (352 mg, 1.50 mmol) was alkylated to give <b>41</b> (374 mg, 71%) as a colorless solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 5.14 (s, 2H), 5.15 (s, 2H), 6.59–6.66 (m, 3H), 7.19–7.32 (m, 3H), 7.31–7.43 (m, 1H), 7.53–7.56 (m, 1H), 7.57–7.61 (AA′BB′ m, 2H), 7.88–7.92 (AA′BB′ m, 2H), 10.03 (s, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 67.2 (CH<sub>2</sub>), 69.3 (CH<sub>2</sub>), 102.3 (CH), 107.6 (CH), 107.8 (CH), 127.0 (CH), 127.5 (2 × CH), 128.9 (CH), 129.1 (CH), 129.4 (CH), 130.1 (2 × CH), 130.2 (CH), 132.6 (C), 134.6 (C), 136.0 (C), 144.0 (C), 159.7 (C), 159.9 (C), 191.9 (CH).</div></div><div id="sec4_2_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 4-((3-((3-Chlorobenzyl)oxy)phenoxy)methyl)benzaldehyde (<b>42</b>)</h4><div class="NLM_p last">Following the procedure for <b>37</b>, phenol <b>30</b> (348 mg, 1.48 mmol) was alkylated to give <b>42</b> (286 mg, 55%) as a colorless solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 5.02 (s, 2H), 5.13 (s, 2H), 6.58–6.62 (m, 3H), 7.17–7.23 (m, 1H), 7.27–7.34 (m, 3H), 7.41–7.44 (m, 1H), 7.57–7.61 (AA′BB′ m, 2H), 7.88–7.92 (AA′BB′ m, 2H), 10.03 (s, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 69.1 (CH<sub>2</sub>), 69.2 (CH<sub>2</sub>), 102.3 (CH), 107.6 (2 × CH), 125.4 (CH), 127.39 (CH), 127.44 (2 × CH), 128.1 (CH), 129.9 (CH), 130.0 (2 × CH), 130.2 (CH), 134.5 (C), 136.0 (C), 139.0 (C), 143.9 (C), 159.6 (C), 159.8 (C), 191.8 (CH).</div></div><div id="sec4_2_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 4-((3-((4-Chlorobenzyl)oxy)phenoxy)methyl)benzaldehyde (<b>43</b>)</h4><div class="NLM_p last">Following the procedure for <b>37</b>, phenol <b>31</b> (331 mg, 1.41 mmol) was alkylated to give <b>43</b> (476 mg, 96%) as a colorless solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 5.01 (s, 2H), 5.13 (s, 2H), 6.58–6.61 (m, 3H), 7.17–7.23 (m, 1H), 7.35 (app s, 4H), 7.56–7.61 (AA′BB′ m, 2H), 7.88–7.92 (AA′BB′ m, 2H), 10.03 (s, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 69.18 (CH<sub>2</sub>), 69.20 (CH<sub>2</sub>), 102.3 (CH), 107.5 (CH), 107.6 (CH), 127.4 (2 × CH), 128.74 (2 × CH), 128.78 (2 × CH), 130.0 (2 × CH), 130.1 (CH), 133.7 (C), 135.4 (C), 135.9 (C), 143.9 (C), 159.6 (C), 159.8 (C), 191.8 (CH).</div></div><div id="sec4_2_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 4-((3-((4-Methoxybenzyl)oxy)phenoxy)methyl)benzaldehyde (<b>44</b>)</h4><div class="NLM_p last">Following the procedure for <b>37</b>, phenol <b>32</b> (250 mg, 1.09 mmol) was alkylated to give <b>44</b> (256 mg, 68%) as a colorless solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 3.82 (s, 3H), 4.97 (s, 2H), 5.13 (s, 2H), 6.56–6.64 (m, 3H), 6.89–6.94 (AA′BB′ m, 2H), 7.17–7.22 (m, 1H), 7.31–7.37 (AA′BB′ m, 2H), 7.56–7.61 (AA′BB′ m, 2H), 7.88–7.92 (AA′BB′ m, 2H), 10.02 (s, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 55.4 (CH<sub>3</sub>), 69.3 (CH<sub>2</sub>), 70 (CH<sub>2</sub>), 102.4 (CH), 107.4 (CH), 107.8 (CH), 114.2 (2 × CH), 127.6 (2 × CH), 129.0 (C), 129.4 (2 × CH), 130.2 (3 × CH), 136.1 (C), 144.1 (C), 159.6 (C), 159.7 (C), 160.3 (C), 192.0 (CH).</div></div><div id="sec4_2_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 4-((3-((4-Formylbenzyl)oxy)phenoxy)methyl)benzonitrile (<b>45</b>)</h4><div class="NLM_p last">Following the procedure for <b>37</b>, phenol <b>33</b> (357 mg, 1.59 mmol) was alkylated to give <b>45</b> (520 mg, 95%) as a colorless solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 5.01 (s, 2H), 5.13 (s, 2H), 6.57–6.30 (m, 3H), 7.17–7.25 (m, 1H), 7.51–7.55 (AA′BB′ m, 2H), 7.56–7.61 (AA′BB′ m, 2H), 7.65–7.69 (AA′BB′ m, 2H), 7.88–7.92 (AA′BB′ m, 2H), 10.02 (s, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 68.9 (CH<sub>2</sub>), 69.2 (CH<sub>2</sub>), 102.3 (CH), 107.5 (CH), 107.7 (CH), 111.6 (C), 118.7 (C), 127.4 (2 × CH), 127.5 (2 × CH), 130.0 (2 × CH), 130.2 (CH), 132.3 (2 × CH), 135.9 (C), 142.3 (C), 143.8 (C), 159.4 (C), 159.6 (C), 191.8 (CH).</div></div><div id="sec4_2_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 4-((3-(Benzylthio)phenoxy)methyl)benzaldehyde (<b>46</b>)</h4><div class="NLM_p last">Following the procedure for <b>22</b>, 4-(bromomethyl)benzaldehyde (301 mg, 1.51 mmol) and phenol <b>34</b> (336 mg, 1.55 mmol) gave <b>46</b> (401 mg, 79%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.11 (s, 2H), 5.07 (s, 2H), 6.78 (ddd, <i>J</i> = 8.3, 2.5, and 0.8 Hz, 1H), 6.89 (app t, <i>J</i> = 2.1 Hz, 1H), 6.94 (ddd, <i>J</i> = 7.7, 1.6, and 0.9 Hz, 1H), 7.18 (t, <i>J</i> = 8.0 Hz, 1H), 7.22–7.31 (m, 5H), 7.55–7.58 (AA′BB′ m, 2H), 7.89–7.91 (AA′BB′ m, 2H), 10.03 (s, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 38.9 (CH<sub>2</sub>), 69.3 (CH<sub>2</sub>), 113.1 (CH), 115.8 (CH), 122.4 (CH), 127.4 (CH), 127.6 (2 × CH), 128.7 (2 × CH), 129.0 (2 × CH), 129.9 (CH), 130.2 (2 × CH), 136.1 (C), 137.4 (C), 138.2 (C), 143.9 (C), 158.6 (C), 191.9 (CH).</div></div><div id="sec4_2_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 4-((3-((4-Fluorobenzyl)thio)phenoxy)methyl)benzaldehyde (<b>47</b>)</h4><div class="NLM_p last">Following the procedure for <b>22</b>, 4-(bromomethyl)benzaldehyde (301 mg, 1.51 mmol) and phenol <b>35</b> (398 mg, 1.70 mmol) gave <b>47</b> (495 mg, 93%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.07 (s, 2H), 5.09 (s, 2H), 6.79 (ddd, <i>J</i> = 8.3, 2.5, and 0.8 Hz, 1H), 6.88 (app t, <i>J</i> = 2.1 Hz, 1H), 6.92 (ddd, <i>J</i> = 7.7, 1.7, and 0.9 Hz, 1H), 6.93–6.99 (m, 2H), 7.19 (t, <i>J</i> = 8.0 Hz, 1H), 7.21–7.26 (m, 2H), 7.55–7.58 (AA′BB′ m, 2H), 7.89–7.92 (AA′BB′ m, 2H), 10.03 (s, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 38.1 (CH<sub>2</sub>), 69.3 (CH<sub>2</sub>), 113.1 (CH), 115.4 (d, <i>J</i> = 21.5 Hz, 2 × CH), 116.0 (CH), 122.6 (CH), 127.5 (2 × CH), 129.9 (CH), 130.1 (2 × CH), 130.4 (d, <i>J</i> = 8.1 Hz, 2 × CH), 133.1 (d, <i>J</i> = 3.2 Hz, C), 136.1 (C), 137.7 (C), 158.6 (C), 162.1 (d, <i>J</i> = 245.8 Hz, C), 191.9 (CH). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ – 115.2.</div></div><div id="sec4_2_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 4-((3-((4-Chlorobenzyl)thio)phenoxy)methyl)benzaldehyde (<b>48</b>)</h4><div class="NLM_p last">Following the procedure for <b>22</b>, 4-(bromomethyl)benzaldehyde (300 mg, 1.51 mmol) and phenol <b>36</b> (423 mg, 1.69 mmol) gave <b>48</b> (468 mg, 84%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.05 (s, 2H), 5.07 (s, 2H), 6.79 (ddd, <i>J</i> = 8.3, 2.5, and 0.8 Hz, 1H), 6.86 (app t, <i>J</i> = 2.1 Hz, 1H), 6.92 (ddd, <i>J</i> = 7.7, 1.6, and 0.9 Hz, 1H), 7.15–7.26 (m, 5H), 7.55–7.58 (AA′BB′ m, 2H), 7.89–7.91 (AA′BB′ m, 2H), 10.03 (s, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 38.1 (CH<sub>2</sub>), 69.2 (CH<sub>2</sub>), 113.2 (CH), 116.1 (CH), 122.7 (CH), 127.5 (2 × CH), 128.7 (2 × CH), 129.9 (CH), 130.0 (2 × CH), 130.2 (2 × CH), 133.0 (C), 136.0 (C), 136.1 (C), 137.4 (C), 143.7 (C), 158.6 (C), 191.8 (CH).</div></div><div id="sec4_2_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (<i>R</i>)-(1-(4-((3-(Benzyloxy)phenoxy)methyl)benzyl)pyrrolidin-2-yl)methanol (<b>49</b>)</h4><div class="NLM_p last">To a stirred solution of <b>37</b> (254 mg, 797 μmol) and (<i>R</i>)-prolinol (170 mg, 1.68 mmol) in anhydrous THF (15 mL) under argon was added NaBH(OAc)<sub>3</sub> (347 mg, 1.64 mol). The mixture was sonicated, at ambient temperature for 3 h. A further portion of NaBH(OAc)<sub>3</sub> (214 mg, 1.01 mmol) was then added, and sonication of the turbid mixture continued for 40 min. The mixture was stirred for 12 h, then diluted with 2 M NaOH (aq) (40 mL), vortexing thoroughly, and extracted with CHCl<sub>3</sub> (250 mL). The extract was dried (MgSO<sub>4</sub>), evaporated, and the residue processed chromatographically (20 g Strata SI-1 cartridge; 2.5% MeOH/CHCl<sub>3</sub>). Target material eluted first, with <i>N</i>-acetylprolinol<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> overlapping in tail fractions. Fractions containing clean target material were combined and evaporated to afford <b>49</b> (225 mg, 70%) as a colorless oil that became an amorphous solid on standing. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.66–1.75 (m, 2H), 1.83–2.00 (m, 2H), 2.30 (td, <i>J</i> = 9.3 and 7.5 Hz, 1H), 2.50–3.00 (br s, 1H), 2.72–2.77 (m, 1H), 2.97–3.01 (m, 1H), 3.38 (d, <i>J</i> = 13.1 Hz, 1H), 3.44 (dd, <i>J</i> = 10.8 and 2.1 Hz, 1H), 3.67 (dd, <i>J</i> = 10.7 and 3.5 Hz, 1H), 3.98 (d, <i>J</i> = 13.1 Hz, 1H), 5.02 (s, 2H), 5.05 (s, 2H), 6.59–6.62 (m, 2H), 6.64 (t, <i>J</i> = 2.2 Hz, 1H), 7.17–7.21 (m, 1H), 7.31–7.35 (m, 3H), 7.37–7.45 (m, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 23.5 (CH<sub>2</sub>), 27.9 (CH<sub>2</sub>), 54.5 (CH<sub>2</sub>), 58.4 (CH<sub>2</sub>), 62.1 (CH<sub>2</sub>), 64.5 (CH), 69.9 (CH<sub>2</sub>), 70.1 (CH<sub>2</sub>), 102.4 (CH), 107.5 (2 × CH), 127.5 (2 × CH), 127.6 (2 × CH), 128.0 (CH), 128.6 (2 × CH), 128.9 (2 × CH), 130.0 (CH), 135.8 (C), 137.1 (C), 139.2 (C), 160.2 (2 × C). ESI-HRMS [M + H]<sup>+</sup> calcd for C<sub>26</sub>H<sub>30</sub>NO<sub>3</sub><sup>+</sup> 404.2220, found 404.2203. HPLC: method (A) <i>t</i><sub>R</sub> 4.56 min (97.7%). [Tail fractions from the chromatographic isolation of the product were combined separately to afford a second batch (76.5 mg) of <b>53</b> contaminated with 12 mol % <i>N</i>-acetylprolinol, giving a total target material recovery of 93%.]</div></div><div id="sec4_2_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> (<i>R</i>)-(1-(4-((3-((2-Fluorobenzyl)oxy)phenoxy)methyl)benzyl)pyrrolidin-2-yl)methanol (<b>50</b>)</h4><div class="NLM_p last">Following the procedure for <b>49</b>, aldehyde <b>38</b> (261 mg, 776 μmol) afforded <b>50</b> (226 mg, 69%) as a colorless oil that became an amorphous solid on standing. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.65–1.76 (m, 2H), 1.80–1.99 (m, 2H), 2.30 (td, <i>J</i> = 9.2 and 7.6 Hz, 1H), 2.50–3.00 (br s, 1H), 2.72–2.77 (m, 1H), 2.96–3.01 (m, 1H), 3.38 (d, <i>J</i> = 13.1 Hz, 1H), 3.44 (dd, <i>J</i> = 10.8 and 2.1 Hz, 1H), 3.67 (dd, <i>J</i> = 10.8 and 3.5 Hz, 1H), 3.98 (d, <i>J</i> = 13.1 Hz, 1H), 5.03 (s, 2H), 5.12 (s, 2H), 6.60–6.63 (m, 2H), 6.65 (t, <i>J</i> = 2.3 Hz, 1H), 7.09 (ddd, <i>J</i> = 9.9, 8.4, and 1.3 Hz, 1H), 7.16 (td, <i>J</i> = 7.5 and 1.2, 1H), 7.20 (t, <i>J</i> = 8.2, 1H), 7.21–7.23 (m, 3H), 7.37–7.40 (AA′BB′ m, 2H), 7.48–7.53 (m, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 23.5 (CH<sub>2</sub>), 27.9 (CH<sub>2</sub>), 54.5 (CH<sub>2</sub>), 58.4 (CH<sub>2</sub>), 62.0 (CH<sub>2</sub>), 63.8 (d, <i>J</i> = 4.4 Hz, CH<sub>2</sub>), 64.5 (CH), 70.0 (CH<sub>2</sub>), 102.4 (CH), 107.5 (CH), 107.8 (CH), 115.4 (d, <i>J</i> = 21.2 Hz, CH), 124.27 (d, <i>J</i> = ca.14 Hz, C), 124.30 (d, <i>J</i> = 3.6 Hz, CH), 127.7 (2 × CH), 129.0 (2 × CH), 129.7 (d, <i>J</i> = 8.7 Hz, CH), 129.8 (d, <i>J</i> = 4.1 Hz, CH), 130.0 (CH), 135.8 (C), 139.3 (C), 159.9 (C), 160.2 (C), 160.5 (d, <i>J</i> = 246.9 Hz, C). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ – 118.6. ESI-HRMS [M + H]<sup>+</sup> calcd for C<sub>26</sub>H<sub>29</sub>FNO<sub>3</sub><sup>+</sup> 422.2126, found 422.2106. HPLC: method (A) <i>t</i><sub>R</sub> 4.62 min (97.0%).</div></div><div id="sec4_2_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> (<i>R</i>)-(1-(4-((3-((3-Fluorobenzyl)oxy)phenoxy)methyl)benzyl)pyrrolidin-2-yl)methanol (<b>51</b>)</h4><div class="NLM_p last">Following the procedure for <b>49</b>, aldehyde <b>39</b> (258 mg, 768 μmol) afforded <b>51</b> (185 mg, 57%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.64–1.76 (m, 2H), 1.80–1.99 (m, 2H), 2.30 (td, <i>J</i> = 9.3 and 7.5 Hz, 1H), 2.40–2.90 (br s, 1H), 2.72–2.77 (m, 1H), 2.96–3.01 (m, 1H), 3.38 (d, <i>J</i> = 13.1 Hz, 1H), 3.44 (dd, <i>J</i> = 10.7 and 1.8 Hz, 1H), 3.67 (dd, <i>J</i> = 10.8 and 3.5 Hz, 1H), 3.98 (d, <i>J</i> = 13.1 Hz, 1H), 5.02 (s, 2H), 5.04 (s, 2H), 6.57–6.63 (m, 3H), 6.98–7.04 (m, 1H), 7.13–7.21 (m, 3H), 7.30–7.40 (m, 5H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 23.5 (CH<sub>2</sub>), 27.9 (CH<sub>2</sub>), 54.6 (CH<sub>2</sub>), 58.4 (CH<sub>2</sub>), 62.1 (CH<sub>2</sub>), 64.5 (CH), 69.3 (CH<sub>2</sub>), 70.0 (CH<sub>2</sub>), 102.5 (CH), 107.5 (CH), 107.8 (CH), 114.3 (d, <i>J</i> = 21.9 Hz, CH), 114.8 (d, <i>J</i> = 21.2 Hz, CH), 122.8 (d, <i>J</i> = 2.9 Hz, CH), 127.7 (2 × CH), 129.0 (2 × CH), 130.1 (CH), 130.2 (d, <i>J</i> = 8.2 Hz, CH), 135.8 (C), 139.3 (C), 139.8 (d, <i>J</i> = 7.3 Hz, C), 159.9 (C), 160.2 (C), 163.1 (d, <i>J</i> = 246.1 Hz, C). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −112.7. ESI-HRMS [M + H]<sup>+</sup> calcd for C<sub>26</sub>H<sub>29</sub>FNO<sub>3</sub><sup>+</sup> 422.2126 found 422.2106. HPLC: method (A) <i>t</i><sub>R</sub> 4.67 min (>99%).</div></div><div id="sec4_2_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> (<i>R</i>)-(1-(4-((3-((4-Fluorobenzyl)oxy)phenoxy)methyl)benzyl)pyrrolidin-2-yl)methanol (<b>52</b>)</h4><div class="NLM_p last">Following the procedure for <b>49</b>, aldehyde <b>40</b> (263 mg, 783 μmol) afforded <b>52</b> (239 mg, 73%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.66–1.75 (m, 2H), 1.80–1.99 (m, 2H), 2.30 (td, <i>J</i> = 9.3 and 7.5 Hz, 1H), 2.50–3.00 (br s, 1H), 2.72–2.77 (m, 1H), 2.96–3.01 (m, 1H), 3.38 (d, <i>J</i> = 13.1 Hz, 1H), 3.44 (dd, <i>J</i> = 10.8 and 2.1 Hz, 1H), 3.67 (dd, <i>J</i> = 10.8 and 3.5 Hz, 1H), 3.98 (d, <i>J</i> = 13.1 Hz, 1H), 5.00 (s, 2H), 5.02 (s, 2H), 6.57–6.62 (m, 3H), 7.04–7.10 (m, 2H), 7.17–7.22 (m, 1H), 7.30–7.34 (AA′BB′ m, 2H), 7.37–7.42 (m, 4H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 23.5 (CH<sub>2</sub>), 27.9 (CH<sub>2</sub>), 54.5 (CH<sub>2</sub>), 58.4 (CH<sub>2</sub>), 62.1 (CH<sub>2</sub>), 64.5 (CH), 69.4 (CH<sub>2</sub>), 70 (CH<sub>2</sub>), 102.5 (CH), 107.5 (CH), 107.6 (CH), 115.5 (d, <i>J</i> = 21.5 Hz, 2 × CH), 127.6 (2 × CH), 129.0 (2 × CH), 129.3 (d, <i>J</i> = 8.2 Hz, 2 × CH), 130.0 (CH), 132.9 (d, <i>J</i> = 2.9 Hz, C), 135.8 (C), 139.3 (C), 160.0 (C), 160.2 (C), 162.5 (d, <i>J</i> = 246.1 Hz, C). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −114.27. ESI-HRMS [M + H]<sup>+</sup> calcd for C<sub>26</sub>H<sub>29</sub>FNO<sub>3</sub><sup>+</sup> 422.2126, found 422.2105. HPLC: method (A) <i>t</i><sub>R</sub> 4.56 min (>99%).</div></div><div id="sec4_2_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> (<i>R</i>)-(1-(4-((3-((2-Chlorobenzyl)oxy)phenoxy)methyl)benzyl)pyrrolidin-2-yl)methanol (<b>53</b>)</h4><div class="NLM_p last">Following the procedure for <b>49</b>, aldehyde <b>41</b> (270 mg, 765 μmol) afforded <b>53</b> (196 mg, 58%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.64–1.76 (m, 2H), 1.80–1.99 (m, 2H), 2.29 (td, <i>J</i> = 9.3 and 7.6 Hz, 1H), 2.50–3.00 (br s, 1H), 2.72–2.77 (m, 1H), 2.96–3.01 (m, 1H), 3.37 (d, <i>J</i> = 13.1 Hz, 1H), 3.44 (dd, <i>J</i> = 10.7 and 1.7 Hz, 1H), 3.67 (dd, <i>J</i> = 10.7 and 3.5 Hz, 1H), 3.98 (d, <i>J</i> = 13.1 Hz, 1H), 5.03 (s, 2H), 5.15 (s, 2H), 6.60–6.32 (m, 2H), 6.65 (t, <i>J</i> = 2.2 Hz, 1H), 7.18–7.22 (m, 1H), 7.24–7.29 (m, 2H), 7.30–7.33 (AA′BB′ m, 2H), 7.37–7.41 (m overlapping AA′BB′ m, 3H), 7.54–7.57 (m, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 23.5 (CH<sub>2</sub>), 27.9 (CH<sub>2</sub>), 54.5 (CH<sub>2</sub>), 58.4 (CH<sub>2</sub>), 62.0 (CH<sub>2</sub>), 64.5 (CH), 67.3 (CH<sub>2</sub>), 70.0 (CH<sub>2</sub>), 102.5 (CH), 107.6 (CH), 107.7 (CH), 127.0 (CH), 127.7 (2 × CH), 128.9 (CH), 128.96 (2 × CH), 128.99 (CH), 129.4 (CH), 130.0 (CH), 132.6 (C), 134.8 (C), 135.8 (C), 139.3 (C), 159.9 (C), 160.2 (C). ESI-HRMS [M + H]<sup>+</sup> calcd for C<sub>26</sub>H<sub>29</sub>ClNO<sub>3</sub><sup>+</sup> 438.1831, found 438.1830. HPLC: method (A) <i>t</i><sub>R</sub> 5.00 min (>99%).</div></div><div id="sec4_2_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> (<i>R</i>)-(1-(4-((3-((3-Chlorobenzyl)oxy)phenoxy)methyl)benzyl)pyrrolidin-2-yl)methanol (<b>54</b>)</h4><div class="NLM_p last">Following the procedure for <b>49</b>, aldehyde <b>42</b> (253 mg, 718 μmol) afforded <b>54</b> (158 mg, 50%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.63–1.77 (m, 2H), 1.79–2.01 (m, 2H), 2.30 (td, <i>J</i> = 9.2 and 7.5 Hz, 1H), 2.50–3.00 (br s, 1H), 2.71–2.78 (m, 1H), 2.95–3.02 (m, 1H), 3.38 (d, <i>J</i> = 13.1 Hz, 1H), 3.44 (dd, <i>J</i> = 10.8 and 1.9 Hz, 1H), 3.67 (dd, <i>J</i> = 10.7 and 3.5 Hz, 1H), 3.98 (d, <i>J</i> = 13.1 Hz, 1H), 5.01 (s, 2H), 5.02 (s, 2H), 6.56–6.63 (m, 3H), 7.17–7.22 (m, 1H), 7.28–7.34 (m, 5H), 7.36–7.40 (AA′BB′ m, 2H), 7.42–7.44 (m, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 23.6 (CH<sub>2</sub>), 27.9 (CH<sub>2</sub>), 54.6 (CH<sub>2</sub>), 58.4 (CH<sub>2</sub>), 62.0 (CH<sub>2</sub>), 64.5 (CH), 69.3 (CH<sub>2</sub>), 70.0 (CH<sub>2</sub>), 102.5 (CH), 107.5 (CH), 107.8 (CH), 125.4 (CH), 127.5 (CH), 127.7 (2 × CH), 128.2 (CH), 129.0 (2 × CH), 129.9 (CH), 130.1 (CH), 134.6 (C), 135.8 (C), 139.2 (C), 139.4 (C), 159.9 (C), 160.2 (C). ESI-HRMS [M + H]<sup>+</sup> calcd for C<sub>26</sub>H<sub>29</sub>ClNO<sub>3</sub><sup>+</sup> 438.1831, found 438.1808. HPLC: method (A) <i>t</i><sub>R</sub> 5.03 min (>99%).</div></div><div id="sec4_2_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> (<i>R</i>)-(1-(4-((3-((4-Chlorobenzyl)oxy)phenoxy)methyl)benzyl)pyrrolidin-2-yl)methanol (<b>55</b>)</h4><div class="NLM_p last">Following the procedure for <b>49</b>, aldehyde <b>43</b> (267 mg, 757 μmol) afforded <b>55</b> (286 mg, 86%) as a colorless oil that became an amorphous solid on standing. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.66–1.74 (m, 2H), 1.81–2.00 (m, 2H), 2.30 (td, <i>J</i> = 9.3 and 7.5 Hz, 1H), 2.60–2.95 (br s, 1H), 2.72–2.77 (m, 1H), 2.97–3.01 (m, 1H), 3.38 (d, <i>J</i> = 13.1 Hz, 1H), 3.45 (dd, <i>J</i> = 10.8 and 2.0 Hz, 1H), 3.67 (dd, <i>J</i> = 10.7 and 3.5 Hz, 1H), 3.98 (d, <i>J</i> = 13.1 Hz, 1H), 5.00 (s, 2H), 5.02 (s, 2H), 6.58 (dd, <i>J</i> = 8.2, 2.3, and 0.9 Hz, 1H), 6.60–6.63 (m, 2H), 7.17–7.22 (m, 1H), 7.30–7.41 (m, 8H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 23.5 (CH<sub>2</sub>), 27.8 (CH<sub>2</sub>), 54.5 (CH<sub>2</sub>), 58.3 (CH<sub>2</sub>), 61.9 (CH<sub>2</sub>), 64.4 (CH), 69.2 (CH<sub>2</sub>), 69.9 (CH<sub>2</sub>), 102.3 (CH), 107.4 (CH), 107.6 (CH), 127.7 (2 × CH), 128.78 (2 × CH), 128.82 (2 × CH), 129.0 (2 × CH), 130.0 (CH), 133.8 (C), 135.5 (C), 135.7 (C), 139.3 (C), 159.8 (C), 160.1 (C). ESI-HRMS [M + H]<sup>+</sup> calcd for C<sub>26</sub>H<sub>29</sub>ClNO<sub>3</sub><sup>+</sup> 438.1831, found 438.1808. HPLC: method (A) <i>t</i><sub>R</sub> 5.15 min (97.8%).</div></div><div id="sec4_2_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> (<i>R</i>)-(1-(4-((3-((4-Methoxybenzyl)oxy)phenoxy)methyl)benzyl)pyrrolidin-2-yl)methanol (<b>56</b>)</h4><div class="NLM_p last">Following the procedure for <b>49</b>, aldehyde <b>44</b> (256 mg, 735 μmol) afforded <b>56</b> (266 mg, 84%) as a colorless oil that became an amorphous solid on standing. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.65–1.75 (m, 2H), 1.79–2.01 (m, 2H), 2.30 (td, <i>J</i> = 9.2 and 7.6 Hz, 1H), 2.50–3.00 (br s, 1H), 2.71–2.77 (m, 1H), 2.95–3.02 (m, 1H), 3.38 (d, <i>J</i> = 13.1 Hz, 1H), 3.44 (dd, <i>J</i> = 10.8 and 2.1 Hz, 1H), 3.67 (dd, <i>J</i> = 10.8 and 3.5 Hz, 1H), 3.82 (s, 3H), 3.98 (d, <i>J</i> = 13.1 Hz, 1H), 4.96 (s, 2H), 5.02 (s, 2H), 6.58–6.64 (m, 3H), 6.90–6.94 (AA′BB′ m, 2H), 7.19 (t, <i>J</i> = 8.2 Hz, 1H), 7.31–7.40 (m, 6H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 23.5 (CH<sub>2</sub>), 27.8 (CH<sub>2</sub>), 54.5 (CH<sub>2</sub>), 55.4 (CH<sub>3</sub>), 58.3 (CH<sub>2</sub>), 61.9 (CH<sub>2</sub>), 64.4 (CH), 69.86 (CH<sub>2</sub>), 69.88 (CH<sub>2</sub>), 102.3 (CH), 107.4 (CH), 107.5 (CH), 114.1 (2 × CH), 127.7 (2 × CH), 128.97 (2 × CH), 129.01 (C), 129.3 (2 × CH), 130.0 (CH), 135.8 (C), 139.2 (C), 159.5 (C), 160.1 (C), 160.2 (C). ESI-HRMS [M + H]<sup>+</sup> calcd for C<sub>27</sub>H<sub>32</sub>NO<sub>4</sub><sup>+</sup> 434.2326, found 434.2304. HPLC: method (A) <i>t</i><sub>R</sub> 4.61 min (97.5%).</div></div><div id="sec4_2_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> (<i>R</i>)-4-((3-((4-((2-(Hydroxymethyl)pyrrolidin-1-yl)methyl)benzyl)oxy)phenoxy)methyl)benzonitrile (<b>57</b>)</h4><div class="NLM_p last">Following the procedure for <b>49</b>, aldehyde <b>45</b> (264 mg, 768 μmol) afforded <b>57</b> (124 mg, 38%) as a colorless oil that became an amorphous solid on standing. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.65–1.76 (m, 2H), 1.80–1.99 (m, 2H), 2.30 (td, <i>J</i> = 9.3 and 7.5 Hz, 1H), 2.50–3.00 (br s, 1H), 2.72–2.77 (m, 1H), 2.96–3.01 (m, 1H), 3.38 (d, <i>J</i> = 13.1 Hz, 1H), 3.43 (dd, <i>J</i> = 10.8 and 2.0 Hz, 1H), 3.66 (dd, <i>J</i> = 10.8 and 3.5 Hz, 1H), 3.97 (d, <i>J</i> = 13.1 Hz, 1H), 5.02 (s, 2H), 5.10 (s, 2H), 6.56 (ddd, <i>J</i> = 8.2, 2.4, and 0.8 Hz, 1H), 6.60 (t, <i>J</i> = 2.2 Hz, 1H), 6.62 (ddd, <i>J</i> = 8.2, 2.4, and 0.8 Hz, 1H), 7.18–7.22 (m, 1H), 7.31–7.39 (tight AA′BB′ m, 4H), 7.52–7.54 (AA′BB′ m, 2H), 7.66–7.69 (AA′BB′ m, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 23.5 (CH<sub>2</sub>), 27.8 (CH<sub>2</sub>), 54.5 (CH<sub>2</sub>), 58.4 (CH<sub>2</sub>), 62.0 (CH<sub>2</sub>), 64.4 (CH), 69.0 (CH<sub>2</sub>), 70.0 (CH<sub>2</sub>), 102.5 (CH), 107.4 (CH), 107.9 (CH), 111.7 (C), 118.6 (C), 127.55 (2 × CH), 127.58 (2 × CH), 128.9 (2 × CH), 130.1 (CH), 132.4 (2 × CH), 135.6 (C), 139.4 (C), 142.5 (C), 159.5 (C), 160.2 (C). ESI-HRMS [M + H]<sup>+</sup> calcd for C<sub>27</sub>H<sub>29</sub>N<sub>2</sub>O<sub>3</sub><sup>+</sup> 429.2173, found 429.2152. HPLC: method (A) <i>t</i><sub>R</sub> 4.25 min (99.8%).</div></div><div id="sec4_2_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> (<i>R</i>)-(1-(4-((3-(Benzylthio)phenoxy)methyl)benzyl)pyrrolidin-2-yl)methanol (<b>58</b>)</h4><div class="NLM_p last">Following the procedure for <b>18</b>, aldehyde <b>46</b> (401 mg, 1.20 mmol) afforded <b>58</b> (477 mg, 95%) as a colorless oil that solidified on standing. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.65–1.76 (m, 2H), 1.81–2.00 (m, 2H), 2.30 (td, <i>J</i> = 9.3 and 7.5 Hz, 1H), 2.50–3.00 (br s, 1H), 2.72–2.77 (m, 1H), 2.96–3.01 (m, 1H), 3.38 (d, <i>J</i> = 13.1 Hz, 1H), 3.45 (dd, <i>J</i> = 10.8 and 1.8 Hz, 1H), 3.67 (dd, <i>J</i> = 10.7 and 3.5 Hz, 1H), 3.98 (d, <i>J</i> = 13.1 Hz, 1H), 4.11 (s, 2H), 4.97 (s, 2H), 6.80 (dd, <i>J</i> = 8.3, 2.3, and 0.7 Hz, 1H), 6.91–6.93 (m, 2H), 7.17 (app t, <i>J</i> = 8.2 Hz, 1H), 7.22–7.38 (m, 9H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 23.6 (CH<sub>2</sub>), 27.9 (CH<sub>2</sub>), 38.9 (CH<sub>2</sub>), 54.6 (CH<sub>2</sub>), 58.3 (CH<sub>2</sub>), 61.9 (CH<sub>2</sub>), 64.4 (CH), 69.9 (CH<sub>2</sub>), 113.1 (CH), 115.8 (CH), 122.1 (CH), 127.3 (CH), 127.7 (2 × CH), 128.6 (2 × CH), 128.9 (2 × CH), 129.0 (2 × CH), 129.8 (CH), 135.6 (C), 137.4 (C), 137.9 (C), 139.4 (C), 159.0 (C). ESI-HRMS [M + H]<sup>+</sup> calcd for C<sub>26</sub>H<sub>30</sub>NO<sub>2</sub>S<sup>+</sup> 420.1992, found 420.1995. HPLC: method (A) <i>t</i><sub>R</sub> 4.61 min (>99%).</div></div><div id="sec4_2_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> (<i>R</i>)-(1-(4-((3-((4-Fluorobenzyl)thio)phenoxy)methyl)benzyl)pyrrolidin-2-yl)methanol (<b>59</b>)</h4><div class="NLM_p last">Following the procedure for <b>18</b>, aldehyde <b>47</b> (487 mg, 1.38 mmol) afforded <b>59</b> (471 mg, 78%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.65–1.73 (m, 2H), 1.80–1.99 (m, 2H), 2.29 (td, <i>J</i> = 9.3 and 7.5 Hz, 1H), 2.60–2.85 (br m, 1H), 2.71–2.77 (m, 1H), 2.95–3.01 (m, 1H), 3.37 (d, <i>J</i> = 13.1 Hz, 1H), 3.44 (dd, <i>J</i> = 10.8 and 1.8 Hz, 1H), 3.66 (dd, <i>J</i> = 10.7 and 3.5 Hz, 1H), 3.97 (d, <i>J</i> = 13.1 Hz, 1H), 4.07 (s, 2H), 4.98 (s, 2H), 6.80 (ddd, <i>J</i> = 8.3, 2.3, and 1.1 Hz, 1H), 6.88–6.91 (m, 2H), 6.93–6.99 (m, 2H), 7.15–7.19 (m, 1H), 7.21–7.25 (m, 2H), 7.31–7.37 (tight AA′BB′ m, 4H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 23.6 (CH<sub>2</sub>), 27.9 (CH<sub>2</sub>), 38.3 (CH<sub>2</sub>), 54.6 (CH<sub>2</sub>), 58.4 (CH<sub>2</sub>), 62.0 (CH<sub>2</sub>), 64.5 (CH), 70.0 (CH<sub>2</sub>), 113.4 (CH), 115.4 (d, <i>J</i> = 21.5 Hz, 2 × CH), 116.3 (CH), 122.5 (CH), 127.7 (2 × CH), 129.0 (2 × CH), 129.8 (CH), 130.5 (d, <i>J</i> = 8.1 Hz, 2 × CH), 133.3 (d, <i>J</i> = 2.9 Hz, C), 135.7 (C), 137.5 (C), 139.5 (C), 159.1 (C), 162.2 (d, <i>J</i> = 245.5 Hz, C). <sup>19</sup>F NMR (282 MHz, CDCl<sub>3</sub>) δ −115.2. ESI-HRMS [M + H]<sup>+</sup> calcd for C<sub>26</sub>H<sub>29</sub>FNO<sub>2</sub>S<sup>+</sup> 438.1898, found 438.1891. HPLC: method (A) <i>t</i><sub>R</sub> 4.94 min (95.4%).</div></div><div id="sec4_2_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> (<i>R</i>)-(1-(4-((3-((4-Chlorobenzyl)thio)phenoxy)methyl)benzyl)pyrrolidin-2-yl)methanol (<b>60</b>)</h4><div class="NLM_p last">Following the procedure for <b>18</b>, aldehyde <b>48</b> (100 mg, 0.260 mmol) afforded <b>60</b> (62 mg, 53%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.66–1.74 (m, 2H), 1.80–1.99 (m, 2H), 2.29 (td, <i>J</i> = 9.3 and 7.5 Hz, 1H), 2.50–2.85 (br m, 1H), 2.72–2.77 (m, 1H), 2.95–3.00 (m, 1H), 3.38 (d, <i>J</i> = 13.1 Hz, 1H), 3.44 (dd, <i>J</i> = 10.8 and 2.2 Hz, 1H), 3.67 (dd, <i>J</i> = 10.8 and 3.5 Hz, 1H), 3.98 (d, <i>J</i> = 13.1 Hz, 1H), 4.05 (s, 2H), 4.98 (s, 2H), 6.81 (ddd, <i>J</i> = 8.3, 2.4, and 1.1 Hz, 1H), 6.88–6.91 (m, 2H), 7.15–7.22 (m, 3H), 7.23–7.26 (m, 2H), 7.31–7.37 (tight AA′BB′ m, 4H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 23.6 (CH<sub>2</sub>), 27.9 (CH<sub>2</sub>), 38.4 (CH<sub>2</sub>), 54.6 (CH<sub>2</sub>), 58.4 (CH<sub>2</sub>), 62.0 (CH<sub>2</sub>), 64.51 (CH), 70.0 (CH<sub>2</sub>), 113.5 (CH), 116.4 (CH), 122.6 (CH), 127.7 (2 × CH), 128.7 (2 × CH), 129.0 (2 × CH), 129.9 (CH), 130.2 (2 × CH), 133.1 (C), 135.7 (C), 136.2 (C), 137.2 (C), 139.5 (C), 159.2 (C). ESI-HRMS [M + H]<sup>+</sup> calcd for C<sub>26</sub>H<sub>29</sub>ClNO<sub>2</sub>S<sup>+</sup> 454.1602, found 454.1603. HPLC: method (A) <i>t</i><sub>R</sub> 5.27 min (98.8%).</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Molecular Modeling</h3><div class="NLM_p">An SK2 homology model was constructed in order to provide a qualitative understanding of ligand selectivity determinants. The preliminary model was generated through the SWISS-MODEL server<a onclick="showRef(event, 'ref47 ref48 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref47 ref48 ref49 ref50">(47−50)</a> by submission of the SK2 sequence and specification of the SK1/PF-543 cocrystal structure (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V24">4V24</a> chain A, 1.8 Å resolution)<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> as a template. In SK1 a regulatory “R-loop” (41 residues) is interposed between strands β9/β10 of the CTD and makes no contact with the three lipid binding loops that pack to form the J-channel on the opposite face of the CTD core β-sandwich (see Supporting Information, Figure S1 in Adams et al.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> for SK1/SK2 sequence alignment and definition of loops). The R-loop in SK2 is substantially longer (156 residues) and, in the absence of a suitable template, no attempt was made to model it. Thus, the core of this loop sequence (SK2 residues 345–488 inclusive) was deleted. The implicit assumption, that the R-loop does not directly impact on the structure of the J-channel heel and toe regions, was deemed reasonable based on the known disposition of the R-loop in SK1 crystal structures. The length of the lipid binding loops is identical for SK1 and SK2, and the loops exhibit a high degree of sequence conservation: LBL-1 (34 residues), 62% identity; LBL-2 (21 residues), 43% identity; LBL-3 (28 residues), 61% identity. Very close structural homology observed between the SK2 model output from the SWISS-MODEL server and the SK1 template was therefore fully reasonable.</div><div class="NLM_p">The model was refined using the protein preparation and refinement tools in the Small Molecule Drug Discovery (SMDD) software suite from Schrödinger, LLC. Ramachandran plot analysis of the crude model (lacking the R-loop) identified 4 residues (Ser209, Ala523, Thr578, Pro579) with outlier φ and ψ angle combinations. These were considered sufficiently remote from the J-channel to have little bearing on the quality of the model as starting point for refinement. Hydration from the template protein (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V24">4V24</a>) was merged into the model together with a J-channel ligand, SKi (<b>10</b>), from its cocrystal structure (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VZC">3VZC</a>, chain A) aligned to the crude model. The latter was selected as a suitable J-channel ligand for refinement work because it inhibits both SK1 and SK2 with little discrimination and because the structure of the SK1 J-channel is conserved when bound by PF-543 or SKi. The hydroxymethyl group of PF-543 mimics the 3-OH of Sph substrate in engaging Asp308 on helix-α7. In its absence, as with bound SKi, the position of the hydroxyl is occupied by a surrogate water, defined as W2 in Supporting Information, Figure S3 of Adams et al.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> A water was therefore inserted into the W2 position of the crude model with SKi. The model was manually inspected and waters imported from the <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V24">4V24</a> template that were sterically interdicted were deleted or moved to take account of side chain conformations.</div><div class="NLM_p">The C-terminal end of the less strongly conserved LBL-2 was remodelled with a template taken from residues 209-PEAQVD<u class="uu">DG</u>KLHL-220 in the crystal structure (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WER">4WER</a>) of a prokaryotic diacylglycerol kinase family protein. These residues correspond to 521-PHARFD<u class="uu">DG</u>LVHL-532 in SK2 and 276-PMGRCA<u class="uu">AG</u>VMHL-287 in SK1. In the <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WER">4WER</a> structure, the residues in this sequence form a well-defined lariat which is highly conserved across related crystal structures (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BON">2BON</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2JGR">2JGR</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P1R">2P1R</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QV7">2QV7</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QVL">2QVL</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3S40">3S40</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3T5P">3T5P</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WRR">4WRR</a>). In several of these, the lariat hosts a noncatalytic metal ion by coordination to an aspartate in a <u class="uu">DG</u> motif that is conserved in all the structures and also in SK2 but not in SK1. Where present, the metal ion is also coordinated by a conserved aspartate on one of two long crossed β-strands that form the key interdomain connection. This latter residue (Asp281) is also conserved in SK2 but not conserved in SK1, where the cognate residue is Asn151. When the metal ion is absent, a structural water molecule acts as a surrogate through hydrogen bonded interactions, as is the case in the <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WER">4WER</a> crystal structure. The metal ion may have a regulatory role in the prokaryotic enzymes.<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56,57)</a> At present, there is no evidence to support a role for noncatalytic metal ion regulatory control over SK2, and we therefore modeled the SK2 lariat on the metal-free structure of <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WER">4WER</a>.</div><div class="NLM_p last">To refine the model, preparation was undertaken with the SMDD protein preparation wizard using default optimization and restrained minimization routines. Full OPLS3 force field protein minimization was then undertaken in iterations, initially with SK1-templated Cartesian constraints on selected residues lining the interdomain cleft, at the interdomain tip interface of LBL-1 and at the hinge of LBL-3. The constraints were defined to restrain interdomain movement and to mimic a helix-capping interaction seen in SK1 crystal structures from Arg291 on LBL-3/helix-α9 (conserved as Arg541 in SK2) to the backbone at the C-terminal end of LBL-1/helix-α8. The constraints were progressively removed following the initial minimization with the remodelled LBL-2 loop structure and omitted altogether in the final minimization. Ramachandran plot analysis of the minimsed model identified no residues with outlier φ and ψ angle combinations. Standard precision (Glide SP) docking routines within SMDD were employed for ligand docking using grids generated with SKi as the binding site identifier. Docked structures were then processed with the SMDD Prime refine protein–ligand complex utility using local optimization settings within an 8 Å radius of the ligand. In the case of VT20dd (<b>9</b>), initial ligand docking was undertaken with the smaller analogue, (protonated) (<i>S</i>)-2-((3-(4-((4-(3-(trifluoromethyl)phenyl)thiazol-2-yl)amino)phenyl)-1,2,4-oxadiazol-5-yl)methyl)pyrrolidine-1-carboximidamide (compound <b>20l</b> in Childress et al.),<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> to define a binding mode for the core and polar headgroup of this SK inhibitor chemotype. The ligand in the resulting model was then rebuilt using the SMDD build tools and subjected to the SMDD Prime refine protein–ligand complex routine.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i65"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00162" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22625" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22625" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00162" class="ext-link">10.1021/acs.jmedchem.9b00162</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Reference NMR spectra for key compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_008.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings with SK1 and SK2 inhibition data (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Related to <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a> and <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>, homology model of SK2 with compound <b>60</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_002.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Related to <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>, homology model of SK2 with compound <b>49</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_003.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Related to <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>, docking model of SK1 (based on crystal structure PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V24">4V24</a>) with compound <b>49</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_004.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Related to <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>, docking model of SK1 (based on crystal structure PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V24">4V24</a>) with compound <b>60</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_005.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Related to <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>, homology model of SK2 with compound <b>9</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_006.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Related to <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>, homology model of SK2 with compound <b>10</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_007.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_001.csv">jm9b00162_si_001.csv (1.16 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_002.pdb">jm9b00162_si_002.pdb (413.83 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_003.pdb">jm9b00162_si_003.pdb (413.83 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_004.pdb">jm9b00162_si_004.pdb (471.38 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_005.pdb">jm9b00162_si_005.pdb (471.41 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_006.pdb">jm9b00162_si_006.pdb (414.46 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_007.pdb">jm9b00162_si_007.pdb (413.07 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_008.pdf">jm9b00162_si_008.pdf (2.4 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00162" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08042" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08042" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan Pyne</span> - <span class="hlFld-Affiliation affiliation">Strathclyde
Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6608-9584" title="Orcid link">http://orcid.org/0000-0002-6608-9584</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#21525452404f0f51584f44615255534055490f40420f544a"><span class="__cf_email__" data-cfemail="fe8d8b8d9f90d08e87909bbe8d8a8c9f8a96d09f9dd08b95">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David
R. Adams</span> - <span class="hlFld-Affiliation affiliation">School
of Engineering & Physical Sciences, Heriot-Watt University, Edinburgh EH14 4AS, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7154-7332" title="Orcid link">http://orcid.org/0000-0002-7154-7332</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Salha Tawati</span> - <span class="hlFld-Affiliation affiliation">Strathclyde
Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giacomo Berretta</span> - <span class="hlFld-Affiliation affiliation">Strathclyde
Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paula Lopez Rivas</span> - <span class="hlFld-Affiliation affiliation">Strathclyde
Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jessica Baiget</span> - <span class="hlFld-Affiliation affiliation">Strathclyde
Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhong Jiang</span> - <span class="hlFld-Affiliation affiliation">School
of Engineering & Physical Sciences, Heriot-Watt University, Edinburgh EH14 4AS, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aisha Alsfouk</span> - <span class="hlFld-Affiliation affiliation">Strathclyde
Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simon P. Mackay</span> - <span class="hlFld-Affiliation affiliation">Strathclyde
Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8000-6557" title="Orcid link">http://orcid.org/0000-0001-8000-6557</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nigel J. Pyne</span> - <span class="hlFld-Affiliation affiliation">Strathclyde
Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, U.K.</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e5272-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i67">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35730" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35730" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research is part funded by the MSD Scottish Life Sciences fund. As part of an ongoing contribution to Scottish life sciences, Merck Sharp & Dohme Limited (MSD), a global healthcare leader, has given substantial monetary funding to the Scottish Funding Council (SFC) for distribution via the Scottish Universities Life Science Alliance (SULSA) to develop and deliver a high-quality drug discovery research and training program. All aspects of the program have been geared toward attaining the highest value in terms of scientific discovery, training and impact. The opinions expressed in this research are those of the authors and do not represent those of MSD, nor its Affiliates. S.T. also thanks the Libyan Government for a sponsored Ph.D. studentship.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">Cer</td><td class="NLM_def"><p class="first last">ceramide</p></td></tr><tr><td class="NLM_term">CTD</td><td class="NLM_def"><p class="first last">C-terminal domain</p></td></tr><tr><td class="NLM_term">HDAC1/2</td><td class="NLM_def"><p class="first last">histone deacetylases 1/2</p></td></tr><tr><td class="NLM_term">LBL</td><td class="NLM_def"><p class="first last">lipid binding loop</p></td></tr><tr><td class="NLM_term">NTD</td><td class="NLM_def"><p class="first last">N-terminal domain</p></td></tr><tr><td class="NLM_term">R-loop</td><td class="NLM_def"><p class="first last">regulatory loop</p></td></tr><tr><td class="NLM_term">S1P</td><td class="NLM_def"><p class="first last">sphingosine 1-phosphate</p></td></tr><tr><td class="NLM_term">SK1</td><td class="NLM_def"><p class="first last">sphingosine kinase 1</p></td></tr><tr><td class="NLM_term">SK2</td><td class="NLM_def"><p class="first last">sphingosine kinase 2</p></td></tr><tr><td class="NLM_term">Sph</td><td class="NLM_def"><p class="first last">sphingosine.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i69">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83821" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83821" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 57 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garris, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaho, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hla, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, M. H.</span></span> <span> </span><span class="NLM_article-title">Sphingosine-1-phosphate receptor 1 signalling in T cells: trafficking and beyond</span>. <i>Immunology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>142</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">353</span>, <span class="refDoi"> DOI: 10.1111/imm.12272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1111%2Fimm.12272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=24597601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVajurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2014&pages=347-353&author=C.+S.+Garrisauthor=V.+A.+Blahoauthor=T.+Hlaauthor=M.+H.+Han&title=Sphingosine-1-phosphate+receptor+1+signalling+in+T+cells%3A+trafficking+and+beyond&doi=10.1111%2Fimm.12272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine-1-phosphate receptor 1 signalling in T cells: trafficking and beyond</span></div><div class="casAuthors">Garris, Christopher S.; Blaho, Victoria A.; Hla, Timothy; Han, May H.</div><div class="citationInfo"><span class="NLM_cas:title">Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-353</span>CODEN:
                <span class="NLM_cas:coden">IMMUAM</span>;
        ISSN:<span class="NLM_cas:issn">0019-2805</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Summary : Sphingosine-1-phosphate (S1P) is a lipid second messenger that signals via five G protein-coupled receptors (S1P1-5).  S1P receptor (S1PR) signalling is assocd. with a wide variety of physiol. processes including lymphocyte biol., their recirculation and detn. of T-cell phenotypes.  The effect of FTY720 (Fingolimod, Gilenya®) to regulate lymphocyte egress and to ameliorate paralysis in exptl. autoimmune encephalomyelitis, an animal model of multiple sclerosis led to the use of FTY720 as a first-line oral agent for treatment of relapsing-remitting multiple sclerosis.  However, a significant body of research suggests that S1P signalling may participate in diverse immune regulatory functions other than lymphocyte trafficking.  This review article discusses the current knowledge of S1P signalling in the fate and function of T regulatory, T helper type 17 and memory T cells in health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWhywoNwN3wLVg90H21EOLACvtfcHk0lgKYulsanDEAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVajurY%253D&md5=175ea21ef7460bf57496b971322938e2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1111%2Fimm.12272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fimm.12272%26sid%3Dliteratum%253Aachs%26aulast%3DGarris%26aufirst%3DC.%2BS.%26aulast%3DBlaho%26aufirst%3DV.%2BA.%26aulast%3DHla%26aufirst%3DT.%26aulast%3DHan%26aufirst%3DM.%2BH.%26atitle%3DSphingosine-1-phosphate%2520receptor%25201%2520signalling%2520in%2520T%2520cells%253A%2520trafficking%2520and%2520beyond%26jtitle%3DImmunology%26date%3D2014%26volume%3D142%26spage%3D347%26epage%3D353%26doi%3D10.1111%2Fimm.12272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hait, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allegood, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maceyka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strub, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harikumar, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marmorstein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kordula, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milstien, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiegel, S.</span></span> <span> </span><span class="NLM_article-title">Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>325</i></span>,  <span class="NLM_fpage">1254</span>– <span class="NLM_lpage">1257</span>, <span class="refDoi"> DOI: 10.1126/science.1176709</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1126%2Fscience.1176709" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=19729656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVOmsrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2009&pages=1254-1257&author=N.+C.+Haitauthor=J.+Allegoodauthor=M.+Maceykaauthor=G.+M.+Strubauthor=K.+B.+Harikumarauthor=S.+K.+Singhauthor=C.+Luoauthor=R.+Marmorsteinauthor=T.+Kordulaauthor=S.+Milstienauthor=S.+Spiegel&title=Regulation+of+histone+acetylation+in+the+nucleus+by+sphingosine-1-phosphate&doi=10.1126%2Fscience.1176709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate</span></div><div class="casAuthors">Hait, Nitai C.; Allegood, Jeremy; Maceyka, Michael; Strub, Graham M.; Harikumar, Kuzhuvelil B.; Singh, Sandeep K.; Luo, Cheng; Marmorstein, Ronen; Kordula, Tomasz; Milstien, Sheldon; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">5945</span>),
    <span class="NLM_cas:pages">1254-1257</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The pleiotropic lipid mediator sphingosine-1-phosphate (S1P) can act intracellularly independently of its cell surface receptors through unknown mechanisms.  Sphingosine kinase 2 (SphK2), one of the isoenzymes that generates S1P, was assocd. with histone H3 and produced S1P that regulated histone acetylation.  S1P specifically bound to the histone deacetylases HDAC1 and HDAC2 and inhibited their enzymic activity, preventing the removal of acetyl groups from lysine residues within histone tails.  SphK2 assocd. with HDAC1 and HDAC2 in repressor complexes and was selectively enriched at the promoters of the genes encoding the cyclin-dependent kinase inhibitor p21 or the transcriptional regulator c-fos, where it enhanced local histone H3 acetylation and transcription.  Thus, HDACs are direct intracellular targets of S1P and link nuclear S1P to epigenetic regulation of gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgTq77gwEd97Vg90H21EOLACvtfcHk0lgKYulsanDEAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVOmsrjJ&md5=41b947eb7757066551f714c713cfd1b1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.1176709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1176709%26sid%3Dliteratum%253Aachs%26aulast%3DHait%26aufirst%3DN.%2BC.%26aulast%3DAllegood%26aufirst%3DJ.%26aulast%3DMaceyka%26aufirst%3DM.%26aulast%3DStrub%26aufirst%3DG.%2BM.%26aulast%3DHarikumar%26aufirst%3DK.%2BB.%26aulast%3DSingh%26aufirst%3DS.%2BK.%26aulast%3DLuo%26aufirst%3DC.%26aulast%3DMarmorstein%26aufirst%3DR.%26aulast%3DKordula%26aufirst%3DT.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DRegulation%2520of%2520histone%2520acetylation%2520in%2520the%2520nucleus%2520by%2520sphingosine-1-phosphate%26jtitle%3DScience%26date%3D2009%26volume%3D325%26spage%3D1254%26epage%3D1257%26doi%3D10.1126%2Fscience.1176709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degagne, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandurangan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandhuvula, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eltanawy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshinaga, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nefedov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmedi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saba, J. D.</span></span> <span> </span><span class="NLM_article-title">Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">5368</span>– <span class="NLM_lpage">5384</span>, <span class="refDoi"> DOI: 10.1172/JCI74188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1172%2FJCI74188" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=5368-5384&author=E.+Degagneauthor=A.+Panduranganauthor=P.+Bandhuvulaauthor=A.+Kumarauthor=A.+Eltanawyauthor=M.+Zhangauthor=Y.+Yoshinagaauthor=M.+Nefedovauthor=P.+J.+de+Jongauthor=L.+G.+Fongauthor=S.+G.+Youngauthor=R.+Bittmanauthor=Y.+Ahmediauthor=J.+D.+Saba&title=Sphingosine-1-phosphate+lyase+downregulation+promotes+colon+carcinogenesis+through+STAT3-activated+microRNAs&doi=10.1172%2FJCI74188"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1172%2FJCI74188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI74188%26sid%3Dliteratum%253Aachs%26aulast%3DDegagne%26aufirst%3DE.%26aulast%3DPandurangan%26aufirst%3DA.%26aulast%3DBandhuvula%26aufirst%3DP.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DEltanawy%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DYoshinaga%26aufirst%3DY.%26aulast%3DNefedov%26aufirst%3DM.%26aulast%3Dde%2BJong%26aufirst%3DP.%2BJ.%26aulast%3DFong%26aufirst%3DL.%2BG.%26aulast%3DYoung%26aufirst%3DS.%2BG.%26aulast%3DBittman%26aufirst%3DR.%26aulast%3DAhmedi%26aufirst%3DY.%26aulast%3DSaba%26aufirst%3DJ.%2BD.%26atitle%3DSphingosine-1-phosphate%2520lyase%2520downregulation%2520promotes%2520colon%2520carcinogenesis%2520through%2520STAT3-activated%2520microRNAs%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2014%26volume%3D124%26spage%3D5368%26epage%3D5384%26doi%3D10.1172%2FJCI74188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mandala, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornton, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galve-Roperh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivera, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergstrom, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurtz, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiegel, S.</span></span> <span> </span><span class="NLM_article-title">Molecular cloning and characterization of a lipid phosphohydrolase that degrades sphingosine-1-phosphate and induces cell death</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">7859</span>– <span class="NLM_lpage">7864</span>, <span class="refDoi"> DOI: 10.1073/pnas.120146897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1073%2Fpnas.120146897" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=7859-7864&author=S.+M.+Mandalaauthor=R.+Thorntonauthor=I.+Galve-Roperhauthor=S.+Poultonauthor=C.+Petersonauthor=A.+Oliveraauthor=J.+Bergstromauthor=M.+B.+Kurtzauthor=S.+Spiegel&title=Molecular+cloning+and+characterization+of+a+lipid+phosphohydrolase+that+degrades+sphingosine-1-phosphate+and+induces+cell+death&doi=10.1073%2Fpnas.120146897"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1073%2Fpnas.120146897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.120146897%26sid%3Dliteratum%253Aachs%26aulast%3DMandala%26aufirst%3DS.%2BM.%26aulast%3DThornton%26aufirst%3DR.%26aulast%3DGalve-Roperh%26aufirst%3DI.%26aulast%3DPoulton%26aufirst%3DS.%26aulast%3DPeterson%26aufirst%3DC.%26aulast%3DOlivera%26aufirst%3DA.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DKurtz%26aufirst%3DM.%2BB.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DMolecular%2520cloning%2520and%2520characterization%2520of%2520a%2520lipid%2520phosphohydrolase%2520that%2520degrades%2520sphingosine-1-phosphate%2520and%2520induces%2520cell%2520death%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D7859%26epage%3D7864%26doi%3D10.1073%2Fpnas.120146897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mandala, S. M.</span></span> <span> </span><span class="NLM_article-title">Sphingosine-1-phosphate phosphatases</span>. <i>Prostaglandins Other Lipid Mediators</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">156</span>, <span class="refDoi"> DOI: 10.1016/S0090-6980(01)00111-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1016%2FS0090-6980%2801%2900111-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=11324704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjtVamtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2001&pages=143-156&author=S.+M.+Mandala&title=Sphingosine-1-phosphate+phosphatases&doi=10.1016%2FS0090-6980%2801%2900111-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine-1-phosphate phosphatases</span></div><div class="casAuthors">Mandala, Suzanne M.</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins & Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1-4</span>),
    <span class="NLM_cas:pages">143-156</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with 56 refs.  Sphingosine-1-phosphate is a potent proliferative, survival, and morphogenetic factor, acting as an extracellular ligand for the EDG family of G-protein-coupled receptors and possibly intracellularly through as yet, unidentified targets.  It is produced within most, if not all cells by phosphorylation of sphingosine, and is an abundant serum lipid that is released from activated platelets.  Sphingosine and sphingosine-1-phosphate are in dynamic equil. with each other due to the activities of sphingosine kinase and sphingosine-1-phosphate phosphatase (SPPase).  Several SPPase genes have now been cloned, first from yeast and more recently from mammalian cells.  By sequence homol., these enzymes can be classified as a subset of membrane bound.  Type 2 lipid phosphohydrolases that contain conserved residues within three domains predicted to be at the active site of the enzyme.  Outside of the consensus motif, there is very little homol. between SPPases and the other type 2 lipid phosphohydrolases in the LPP/PAP family.  Type 2 phosphatase activity is Mg+-independent and insensitive to N-ethylmaleimide, and substrate specificity is broad for LPP enzymes, whereas SPPases are highly selective for sphingolipid substrates.  SPPase activity in yeast and mammalian cells regulates intracellular sphingosine-1-phosphate levels, and also alters the levels of sphingosine and ceramide, two other signaling mols. that often oppose the actions of sphingosine-1-phosphate.  Thus, loss of SPPase in yeast results in high sphingosine-1-phosphate levels and cells are more resistant to stress, and in mammalian cells, overexpression of SPPase elevates ceramide levels and provokes apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGkHkEaj8PNLVg90H21EOLACvtfcHk0lipf9jLpxe5Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjtVamtrc%253D&md5=cb97b6a475770c5bb58bb1b93fc1008d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0090-6980%2801%2900111-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0090-6980%252801%252900111-3%26sid%3Dliteratum%253Aachs%26aulast%3DMandala%26aufirst%3DS.%2BM.%26atitle%3DSphingosine-1-phosphate%2520phosphatases%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2001%26volume%3D64%26spage%3D143%26epage%3D156%26doi%3D10.1016%2FS0090-6980%2801%2900111-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gokoh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igarashi, Y.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of a novel human sphingosine-1-phosphate phosphohydrolase, hSPP2</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">1268</span>– <span class="NLM_lpage">1272</span>, <span class="refDoi"> DOI: 10.1074/jbc.M209514200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1074%2Fjbc.M209514200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=1268-1272&author=C.+Ogawaauthor=A.+Kiharaauthor=M.+Gokohauthor=Y.+Igarashi&title=Identification+and+characterization+of+a+novel+human+sphingosine-1-phosphate+phosphohydrolase%2C+hSPP2&doi=10.1074%2Fjbc.M209514200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M209514200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M209514200%26sid%3Dliteratum%253Aachs%26aulast%3DOgawa%26aufirst%3DC.%26aulast%3DKihara%26aufirst%3DA.%26aulast%3DGokoh%26aufirst%3DM.%26aulast%3DIgarashi%26aufirst%3DY.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520a%2520novel%2520human%2520sphingosine-1-phosphate%2520phosphohydrolase%252C%2520hSPP2%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D1268%26epage%3D1272%26doi%3D10.1074%2Fjbc.M209514200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siow, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wattenberg, B.</span></span> <span> </span><span class="NLM_article-title">The compartmentalization and translocation of the sphingosine kinases: mechanisms and functions in cell signaling and sphingolipid metabolism</span>. <i>Crit. Rev. Biochem. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">365</span>– <span class="NLM_lpage">375</span>, <span class="refDoi"> DOI: 10.3109/10409238.2011.580097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.3109%2F10409238.2011.580097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=21864225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1GiurzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=365-375&author=D.+Siowauthor=B.+Wattenberg&title=The+compartmentalization+and+translocation+of+the+sphingosine+kinases%3A+mechanisms+and+functions+in+cell+signaling+and+sphingolipid+metabolism&doi=10.3109%2F10409238.2011.580097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The compartmentalization and translocation of the sphingosine kinases: Mechanisms and functions in cell signaling and sphingolipid metabolism</span></div><div class="casAuthors">Siow, Deanna; Wattenberg, Binks</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">365-375</span>CODEN:
                <span class="NLM_cas:coden">CRBBEJ</span>;
        ISSN:<span class="NLM_cas:issn">1040-9238</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Members of the sphingosine kinase (SK) family of lipid signaling enzymes, comprising SK1 and SK2 in humans, are receiving considerable attention for their roles in a no. of physiol. and pathophysiol. processes.  The SKs are considered signaling enzymes based on their prodn. of the potent lipid second messenger sphingosine-1-phosphate, which is the ligand for a family of five G-protein-linked receptors.  Both SK1 and SK2 are intracellular enzymes and do not possess obvious membrane anchor domains within their primary sequences.  The native substrates (sphingosine and dihydrosphingosine) are lipids, as are the corresponding products, and therefore would have a propensity to be membrane assocd., suggesting that specific membrane localization of the SKs could affect both access to substrate and localized prodn. of product.  Here, we consider the emerging picture of the SKs as enzymes localized to specific intracellular sites, sometimes by agonist-dependent translocation, the mechanism targeting these enzymes to those sites, and the functional consequence of that localization.  Not only is the signaling output of the SKs affected by subcellular localization, but the role of these enzymes as metabolic regulators of sphingolipid metab. may be impacted as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMEbB_RWKQHrVg90H21EOLACvtfcHk0lgb_w-gfQKVDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1GiurzJ&md5=76d7c10a2c50628d2e7934556ee4d994</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3109%2F10409238.2011.580097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10409238.2011.580097%26sid%3Dliteratum%253Aachs%26aulast%3DSiow%26aufirst%3DD.%26aulast%3DWattenberg%26aufirst%3DB.%26atitle%3DThe%2520compartmentalization%2520and%2520translocation%2520of%2520the%2520sphingosine%2520kinases%253A%2520mechanisms%2520and%2520functions%2520in%2520cell%2520signaling%2520and%2520sphingolipid%2520metabolism%26jtitle%3DCrit.%2520Rev.%2520Biochem.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D46%26spage%3D365%26epage%3D375%26doi%3D10.3109%2F10409238.2011.580097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obeid, L. M.</span></span> <span> </span><span class="NLM_article-title">Principles of bioactive lipid signalling: lessons from sphingolipids</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">150</span>, <span class="refDoi"> DOI: 10.1038/nrm2329</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1038%2Fnrm2329" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=18216770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFOntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=139-150&author=Y.+A.+Hannunauthor=L.+M.+Obeid&title=Principles+of+bioactive+lipid+signalling%3A+lessons+from+sphingolipids&doi=10.1038%2Fnrm2329"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Principles of bioactive lipid signalling: lessons from sphingolipids</span></div><div class="casAuthors">Hannun, Yusuf A.; Obeid, Lina M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-150</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  It has become increasingly difficult to find an area of cell biol. in which lipids do not have important, if not key, roles as signaling and regulatory mols.  The rapidly expanding field of bioactive lipids is exemplified by many sphingolipids, such as ceramide, sphingosine, sphingosine-1-phosphate (S1P), ceramide-1-phosphate, and lyso-sphingomyelin, which have roles in the regulation of cell growth, death, senescence, adhesion, migration, inflammation, angiogenesis, and intracellular trafficking.  Deciphering the mechanisms of these varied cell functions necessitates an understanding of the complex pathways of sphingolipid metab. and the mechanisms that regulate lipid generation and lipid action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrJi0iM1f277Vg90H21EOLACvtfcHk0lgb_w-gfQKVDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFOntg%253D%253D&md5=0bee4e560d083ef4c43f7d0b591a0997</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrm2329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2329%26sid%3Dliteratum%253Aachs%26aulast%3DHannun%26aufirst%3DY.%2BA.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26atitle%3DPrinciples%2520of%2520bioactive%2520lipid%2520signalling%253A%2520lessons%2520from%2520sphingolipids%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2008%26volume%3D9%26spage%3D139%26epage%3D150%26doi%3D10.1038%2Fnrm2329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollmeyer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symolon, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Momin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munter, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allegood, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaraju, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullards, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merrill, A. H.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy</span>. <i>Biochim. Biophys. Acta, Biomembr</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1758</i></span>,  <span class="NLM_fpage">1864</span>– <span class="NLM_lpage">1884</span>, <span class="refDoi"> DOI: 10.1016/j.bbamem.2006.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1016%2Fj.bbamem.2006.08.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=17052686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12kt7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1758&publication_year=2006&pages=1864-1884&author=W.+Zhengauthor=J.+Kollmeyerauthor=H.+Symolonauthor=A.+Mominauthor=E.+Munterauthor=E.+Wangauthor=S.+Kellyauthor=J.+C.+Allegoodauthor=Y.+Liuauthor=Q.+Pengauthor=H.+Ramarajuauthor=M.+C.+Sullardsauthor=M.+Cabotauthor=A.+H.+Merrill&title=Ceramides+and+other+bioactive+sphingolipid+backbones+in+health+and+disease%3A+lipidomic+analysis%2C+metabolism+and+roles+in+membrane+structure%2C+dynamics%2C+signaling+and+autophagy&doi=10.1016%2Fj.bbamem.2006.08.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Ceramides and other bioactive sphingolipid backbones in health and disease: Lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy</span></div><div class="casAuthors">Zheng, Wenjing; Kollmeyer, Jessica; Symolon, Holly; Momin, Amin; Munter, Elizabeth; Wang, Elaine; Kelly, Samuel; Allegood, Jeremy C.; Liu, Ying; Peng, Qiong; Ramaraju, Harsha; Sullards, M. Cameron; Cabot, Myles; Merrill, Alfred H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1758</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1864-1884</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Sphingolipids are comprised of a backbone sphingoid base that may be phosphorylated, acylated, glycosylated, bridged to various headgroups through phosphodiester linkages, or otherwise modified.  Organisms usually contain large nos. of sphingolipid subspecies and knowledge about the types and amts. is imperative because they influence membrane structure, interactions with the extracellular matrix and neighboring cells, vesicular traffic and the formation of specialized structures such as phagosomes and autophagosomes, as well as participate in intracellular and extracellular signaling.  Fortunately, "sphingolipidomic" anal. is becoming feasible (at least for important subsets such as all of the backbone "signaling" subspecies: ceramides, ceramide 1-phosphates, sphingoid bases, sphingoid base 1-phosphates, inter alia) using mass spectrometry, and these profiles are revealing many surprises, such as that under certain conditions cells contain significant amts. of "unusual" species: N-mono-, di-, and tri-methyl-sphingoid bases (including N,N-dimethylsphingosine); 3-ketodihydroceramides; N-acetyl-sphingoid bases (C2-ceramides); and dihydroceramides, in the latter case, in very high proportions when cells are treated with the anticancer drug fenretinide (4-hydroxyphenylretinamide).  The elevation of DHceramides by fenretinide is befuddling because the 4,5-trans-double bond of ceramide has been thought to be required for biol. activity; however, DHceramides induce autophagy and may be important in the regulation of this important cellular process.  The complexity of the sphingolipidome is hard to imagine, but one hopes that, when partnered with other systems biol. approaches, the causes and consequences of the complexity will explain how these intriguing compds. are involved in almost every aspect of cell behavior and the malfunctions of many diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5aWjQRdjo6bVg90H21EOLACvtfcHk0lgb_w-gfQKVDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12kt7%252FK&md5=db561208dc8f62f2f56efd083035b047</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2006.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2006.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DKollmeyer%26aufirst%3DJ.%26aulast%3DSymolon%26aufirst%3DH.%26aulast%3DMomin%26aufirst%3DA.%26aulast%3DMunter%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DKelly%26aufirst%3DS.%26aulast%3DAllegood%26aufirst%3DJ.%2BC.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DQ.%26aulast%3DRamaraju%26aufirst%3DH.%26aulast%3DSullards%26aufirst%3DM.%2BC.%26aulast%3DCabot%26aufirst%3DM.%26aulast%3DMerrill%26aufirst%3DA.%2BH.%26atitle%3DCeramides%2520and%2520other%2520bioactive%2520sphingolipid%2520backbones%2520in%2520health%2520and%2520disease%253A%2520lipidomic%2520analysis%252C%2520metabolism%2520and%2520roles%2520in%2520membrane%2520structure%252C%2520dynamics%252C%2520signaling%2520and%2520autophagy%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr%26date%3D2006%26volume%3D1758%26spage%3D1864%26epage%3D1884%26doi%3D10.1016%2Fj.bbamem.2006.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steele, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, N. J.</span></span> <span> </span><span class="NLM_article-title">Sphingomyelin-derived lipids differentially regulate the extracellular signal-regulated kinase 2 (ERK-2) and c-Jun N-terminal kinase (JNK) signal cascades in airway smooth muscle</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>237</i></span>,  <span class="NLM_fpage">819</span>– <span class="NLM_lpage">826</span>, <span class="refDoi"> DOI: 10.1111/j.1432-1033.1996.0819p.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1111%2Fj.1432-1033.1996.0819p.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=8647130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADyaK28XivV2jsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=237&publication_year=1996&pages=819-826&author=S.+Pyneauthor=J.+Chapmanauthor=L.+Steeleauthor=N.+J.+Pyne&title=Sphingomyelin-derived+lipids+differentially+regulate+the+extracellular+signal-regulated+kinase+2+%28ERK-2%29+and+c-Jun+N-terminal+kinase+%28JNK%29+signal+cascades+in+airway+smooth+muscle&doi=10.1111%2Fj.1432-1033.1996.0819p.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingomyelin-derived lipids differentially regulate the extracellular signal-regulated kinase 2 (ERK-2) and c-Jun N-terminal kinase (JNK) signal cascades in airway smooth muscle</span></div><div class="casAuthors">Pyne, Susan; Chapman, Joanna; Steele, Leslie; Pyne, Nigel J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">237</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">819-826</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In airway smooth muscle (ASM) cells platelet-derived growth factor stimulates rapid transient sphingosine phosphate formation, the activation of extracellular signal-regulated kinase 2 (ERK-2), the phosphorylation of p70S6K, and a 9-fold increase in DNA synthesis.  In contrast, this growth factor fails to activate c-Jun N-terminal kinase (JNK).  Based upon these findings we have tested whether the sphingomyelin-derived sphingolipids play a role in growth factor signaling by assessing their effect on ERK-2, JNK, and p70S6K.  We demonstrate that sphingosine phosphate induces the activation of ERK-2, is ineffective against JNK, and fails to induce the phosphorylation of p70S6K.  The latter may explain why it is a poor mitogen when added directly to ASM cells.  In contrast, sphingosine and cell-permeable ceramides elicit the prominent tyrosyl phosphorylation and activation of JNK, are poor stimulators of ERK-2, and do not induce the phosphorylation of p70S6K.  Therefore, the specificity of signaling through either ERK-2 or JNK cascades may be detd. by the rapid agonist-dependent interconversion of these sphingomyelin-derived lipids.  This may also provide a dynamic mechanism that enables growth factors and cytokines to elicit pleiotropic cell responses, such as proliferation and cell survival.  For instance, both ceramide and sphingosine will elicit growth arrest via activation of JNK, whereas sphingosine phosphate will potentiate growth-factor-stimulated DNA synthesis, a consequence of the activation of ERK-2.  Furthermore, under certain conditions, sphingosine and ceramide stimulate cAMP formation, a neg. modulator of cell growth, whereas sphingosine phosphate depresses cAMP, thereby enhancing its own growth-promoting properties.  From these studies, it is evident that sphingosine phosphate displays a signaling profile that is consistent with it mediating part of the action of platelet-derived growth factor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpR5KZPpHZjirVg90H21EOLACvtfcHk0lj-b35wsNgfLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivV2jsLg%253D&md5=a06db34ff751f4e4323ce3fcd6e15f45</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1996.0819p.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1996.0819p.x%26sid%3Dliteratum%253Aachs%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DChapman%26aufirst%3DJ.%26aulast%3DSteele%26aufirst%3DL.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26atitle%3DSphingomyelin-derived%2520lipids%2520differentially%2520regulate%2520the%2520extracellular%2520signal-regulated%2520kinase%25202%2520%2528ERK-2%2529%2520and%2520c-Jun%2520N-terminal%2520kinase%2520%2528JNK%2529%2520signal%2520cascades%2520in%2520airway%2520smooth%2520muscle%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1996%26volume%3D237%26spage%3D819%26epage%3D826%26doi%3D10.1111%2Fj.1432-1033.1996.0819p.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuvillier, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirianov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleuser, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanek, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coso, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutkind, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiegel, S.</span></span> <span> </span><span class="NLM_article-title">Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>381</i></span>,  <span class="NLM_fpage">800</span>– <span class="NLM_lpage">803</span>, <span class="refDoi"> DOI: 10.1038/381800a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1038%2F381800a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=8657285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADyaK28XjvVKnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=381&publication_year=1996&pages=800-803&author=O.+Cuvillierauthor=G.+Pirianovauthor=B.+Kleuserauthor=P.+G.+Vanekauthor=O.+A.+Cosoauthor=S.+Gutkindauthor=S.+Spiegel&title=Suppression+of+ceramide-mediated+programmed+cell+death+by+sphingosine-1-phosphate&doi=10.1038%2F381800a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate</span></div><div class="casAuthors">Cuvillier, Olivier; Pirianov, Grisha; Kleuser, Burkhard; Vanek, Philip G.; Coso, Omar A.; Gutkind, J. Silvio; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">381</span>
        (<span class="NLM_cas:issue">6585</span>),
    <span class="NLM_cas:pages">800-803</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Ceramide is an important regulatory participant of programmed cell death (apoptosis) induced by tumor-necrosis factor (TMF)-α and Fas ligand, members of the TNF superfamily.  Conversely, sphingosine and sphingosine-1-phosphate, which are metabolites of ceramide, induce mitogenesis and have been implicated as second messengers in cellular proliferation induced by platelet-derived growth factor and serum.  Here we report that sphingosine-1-phosphate prevents the appearance of the key features of apoptosis, namely intranucleosomal DNA fragmentation and morphol. changes, which result from increased concns. of ceramide.  Furthermore, inhibition of ceramide-mediated apoptosis by activation of protein kinase C results from stimulation of sphingosine kinase and the concomitant increase in intracellular sphingosine-1-phosphate.  Finally sphingosine-1-phosphate not only stimulates the extracellular signal-regulated kinase (ERK) pathway, it counteracts the ceramide-induced activation of stress-activated protein kinase of ceramide and sphingosine-1-phosphate and their regulatory effects on different family members of mitogen-activated protein kinases dets. the fate of the cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3xEuzICMjarVg90H21EOLACvtfcHk0lj-b35wsNgfLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjvVKnsro%253D&md5=50d91e59dc03600594fd0a236ecc2838</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2F381800a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F381800a0%26sid%3Dliteratum%253Aachs%26aulast%3DCuvillier%26aufirst%3DO.%26aulast%3DPirianov%26aufirst%3DG.%26aulast%3DKleuser%26aufirst%3DB.%26aulast%3DVanek%26aufirst%3DP.%2BG.%26aulast%3DCoso%26aufirst%3DO.%2BA.%26aulast%3DGutkind%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DSuppression%2520of%2520ceramide-mediated%2520programmed%2520cell%2520death%2520by%2520sphingosine-1-phosphate%26jtitle%3DNature%26date%3D1996%26volume%3D381%26spage%3D800%26epage%3D803%26doi%3D10.1038%2F381800a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maceyka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiegel, S.</span></span> <span> </span><span class="NLM_article-title">Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>333</i></span>,  <span class="NLM_fpage">195</span>– <span class="NLM_lpage">200</span>, <span class="refDoi"> DOI: 10.1016/j.yexcr.2015.02.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1016%2Fj.yexcr.2015.02.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=25770011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksFWis7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2015&pages=195-200&author=J.+Newtonauthor=S.+Limaauthor=M.+Maceykaauthor=S.+Spiegel&title=Revisiting+the+sphingolipid+rheostat%3A+Evolving+concepts+in+cancer+therapy&doi=10.1016%2Fj.yexcr.2015.02.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Revisiting the sphingolipid rheostat- evolving concepts in cancer therapy</span></div><div class="casAuthors">Newton, Jason; Lima, Santiago; Maceyka, Michael; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">195-200</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  This article discusses about role of sphingolipid metabolites such as ceramide and sphingosine-1-phosphate in cell fate along with effects of targeting sphingosine-1-phosphate metabolic enzymes in modulation of progression and drug resistance of cancer in human.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGeaW9kxBn-LVg90H21EOLACvtfcHk0lj-b35wsNgfLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksFWis7s%253D&md5=0c70739b9f3c002817f82203d832500a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2015.02.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2015.02.025%26sid%3Dliteratum%253Aachs%26aulast%3DNewton%26aufirst%3DJ.%26aulast%3DLima%26aufirst%3DS.%26aulast%3DMaceyka%26aufirst%3DM.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DRevisiting%2520the%2520sphingolipid%2520rheostat%253A%2520Evolving%2520concepts%2520in%2520cancer%2520therapy%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2015%26volume%3D333%26spage%3D195%26epage%3D200%26doi%3D10.1016%2Fj.yexcr.2015.02.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, S.</span>; <span class="NLM_string-name">Adams, D.
R.</span>; <span class="NLM_string-name">Pyne, N.
J.</span></span> <span> </span><span class="NLM_article-title">Sphingosine kinases as druggable targets</span>. In  <i>Handbook of Experimental Pharmacology</i>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Berlin, Heidelberg</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=S.+Pyne&author=D.%0AR.+Adams&author=N.%0AJ.+Pyne&title=Handbook+of+Experimental+Pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPyne%26aufirst%3DS.%26atitle%3DSphingosine%2520kinases%2520as%2520druggable%2520targets%26btitle%3DHandbook%2520of%2520Experimental%2520Pharmacology%26pub%3DSpringer%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, N. J.</span></span> <span> </span><span class="NLM_article-title">Sphingosine 1-phosphate and sphingosine kinases in health and disease: recent advances</span>. <i>Prog. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">106</span>, <span class="refDoi"> DOI: 10.1016/j.plipres.2016.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1016%2Fj.plipres.2016.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=26970273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC28Xks1Cmsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2016&pages=93-106&author=S.+Pyneauthor=D.+R.+Adamsauthor=N.+J.+Pyne&title=Sphingosine+1-phosphate+and+sphingosine+kinases+in+health+and+disease%3A+recent+advances&doi=10.1016%2Fj.plipres.2016.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate and sphingosine kinases in health and disease: Recent advances</span></div><div class="casAuthors">Pyne, Susan; Adams, David R.; Pyne, Nigel J.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Lipid Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">93-106</span>CODEN:
                <span class="NLM_cas:coden">PLIRDW</span>;
        ISSN:<span class="NLM_cas:issn">0163-7827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Sphingosine kinases (isoforms SK1 and SK2) catalyze the formation of a bioactive lipid, sphingosine 1-phosphate (S1P).  S1P is a well-established ligand of a family of five S1P-specific G protein coupled receptors but also has intracellular signalling roles.  There is substantial evidence to support a role for sphingosine kinases and S1P in health and disease.  This review summarizes recent advances in the area in relation to receptor-mediated signalling by S1P and novel intracellular targets of this lipid.  New evidence for a role of each sphingosine kinase isoform in cancer, the cardiovascular system, central nervous system, inflammation and diabetes is discussed.  There is continued research to develop isoform selective SK inhibitors, summarized here.  Anal. of the crystal structure of SK1 with the SK1-selective inhibitor, PF-543, is used to identify residues that could be exploited to improve selectivity in SK inhibitor development for future therapeutic application.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCVKxUdCGqsrVg90H21EOLACvtfcHk0liTisein5BDpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xks1Cmsb8%253D&md5=fdda88832419c066eecb87a07ae3e6ec</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.plipres.2016.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.plipres.2016.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DD.%2BR.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26atitle%3DSphingosine%25201-phosphate%2520and%2520sphingosine%2520kinases%2520in%2520health%2520and%2520disease%253A%2520recent%2520advances%26jtitle%3DProg.%2520Lipid%2520Res.%26date%3D2016%26volume%3D62%26spage%3D93%26epage%3D106%26doi%3D10.1016%2Fj.plipres.2016.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neubauer, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitson, S. M.</span></span> <span> </span><span class="NLM_article-title">Roles, regulation and inhibitors of sphingosine kinase 2</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">5317</span>– <span class="NLM_lpage">5336</span>, <span class="refDoi"> DOI: 10.1111/febs.12314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1111%2Ffebs.12314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=23638983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Wnsr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2013&pages=5317-5336&author=H.+A.+Neubauerauthor=S.+M.+Pitson&title=Roles%2C+regulation+and+inhibitors+of+sphingosine+kinase+2&doi=10.1111%2Ffebs.12314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Roles, regulation and inhibitors of sphingosine kinase 2</span></div><div class="casAuthors">Neubauer, Heidi A.; Pitson, Stuart M.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5317-5336</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The bioactive sphingolipids, ceramide, sphingosine, and sphingosine 1-phosphate (S1P), are important signaling mols. that regulate a diverse array of cellular processes.  Most notably, the balance of the levels of these 3 sphingolipids in cells, termed the 'sphingolipid rheostat', can dictate cell fate, where ceramide and sphingosine enhance apoptosis and S1P promotes cell survival and proliferation.  Sphingosine kinases (SPHKs) catalyze the prodn. of S1P from sphingosine and are therefore central regulators of the sphingolipid rheostat and attractive targets for cancer therapy.  Two SPHKs exist in humans: SPHK1 and SPHK2.  SPHK1 has been extensively studied and there is a large body of evidence to demonstrate its role in promoting cell survival, proliferation, and neoplastic transformation.  SPHK1 is also elevated in many human cancers which appears to contribute to carcinogenesis, chemotherapeutic resistance, and poor patient outcome.  SPHK2, however, has not been as well characterized, and there are contradictions in the key physiol. functions that have been proposed for this isoform.  Despite this, many studies are now emerging that implicate SPHK2 in key roles in a variety of diseases, including the development of a range of solid tumors.  Here, the authors review the literature examg. SPHK2, its physiol. and pathophysiol. functions, current knowledge of its regulation, and recent developments in targeting this complex enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOz9dLgGu0DbVg90H21EOLACvtfcHk0liTisein5BDpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Wnsr%252FL&md5=52f3e71f8ec83879adc80f4edfbb7d35</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Ffebs.12314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.12314%26sid%3Dliteratum%253Aachs%26aulast%3DNeubauer%26aufirst%3DH.%2BA.%26aulast%3DPitson%26aufirst%3DS.%2BM.%26atitle%3DRoles%252C%2520regulation%2520and%2520inhibitors%2520of%2520sphingosine%2520kinase%25202%26jtitle%3DFEBS%2520J.%26date%3D2013%26volume%3D280%26spage%3D5317%26epage%3D5336%26doi%3D10.1111%2Ffebs.12314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baker, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparks, M. A.</span></span> <span> </span><span class="NLM_article-title">Structure and catalytic function of sphingosine kinases: analysis by site-directed mutagenesis and enzyme kinetics</span>. <i>Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1831</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">146</span>, <span class="refDoi"> DOI: 10.1016/j.bbalip.2012.09.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1016%2Fj.bbalip.2012.09.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=23000541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVemt77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1831&publication_year=2013&pages=139-146&author=D.+L.+Bakerauthor=T.+C.+Phamauthor=M.+A.+Sparks&title=Structure+and+catalytic+function+of+sphingosine+kinases%3A+analysis+by+site-directed+mutagenesis+and+enzyme+kinetics&doi=10.1016%2Fj.bbalip.2012.09.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and catalytic function of sphingosine kinases: Analysis by site-directed mutagenesis and enzyme kinetics</span></div><div class="casAuthors">Baker, Daniel L.; Pham, Truc Chi T.; Sparks, Melanie A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1831</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-146</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Sphingosine kinases 1 and 2 (SK1 and SK2, resp.) generate the bioactive lipid mediator, sphingosine 1-phosphate, and as such play a significant role in cell fate and in human health and disease.  Despite significant interest in and examn. of the role played by SK enzymes in disease, comparatively little is currently known about the 3-dimensional structure and catalytic mechanisms of these enzymes.  To date, limited nos. of studies have used site directed mutagenesis and activity detns. to examine the roles of individual SK residues in substrate, calmodulin, and membrane binding, as well as activation via phosphorylation.  Assays are currently available that allow for both single and bisubstrate kinetic anal. of mutant proteins that show normal, lowered, and enhanced activity as compared to wild-type controls.  Addnl. studies will be required to build on this foundation to completely understand SK-mediated substrate binding and phosphoryl group transfer.  A deeper understanding of the SK catalytic mechanism, as well as SK interactions with potential small mol. inhibitors will be invaluable to the future design and identification of SK activity modulators as research tools and potential therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqp18xfXiX-7Vg90H21EOLACvtfcHk0liTisein5BDpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVemt77I&md5=1a003f617cb24cafb2e7d39927b82c07</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2012.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2012.09.006%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DD.%2BL.%26aulast%3DPham%26aufirst%3DT.%2BC.%26aulast%3DSparks%26aufirst%3DM.%2BA.%26atitle%3DStructure%2520and%2520catalytic%2520function%2520of%2520sphingosine%2520kinases%253A%2520analysis%2520by%2520site-directed%2520mutagenesis%2520and%2520enzyme%2520kinetics%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2013%26volume%3D1831%26spage%3D139%26epage%3D146%26doi%3D10.1016%2Fj.bbalip.2012.09.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pitman, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coolen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moretti, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zebol, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finnie, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Don, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebert, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonder, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gliddon, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitson, S. M.</span></span> <span> </span><span class="NLM_article-title">A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">7065</span>– <span class="NLM_lpage">7083</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.3178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.18632%2Foncotarget.3178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=25788259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A280%3ADC%252BC2MnlslKjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=7065-7083&author=M.+R.+Pitmanauthor=J.+A.+Powellauthor=C.+Coolenauthor=P.+A.+Morettiauthor=J.+R.+Zebolauthor=D.+H.+Phamauthor=J.+W.+Finnieauthor=A.+S.+Donauthor=L.+M.+Ebertauthor=C.+S.+Bonderauthor=B.+L.+Gliddonauthor=S.+M.+Pitson&title=A+selective+ATP-competitive+sphingosine+kinase+inhibitor+demonstrates+anti-cancer+properties&doi=10.18632%2Foncotarget.3178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties</span></div><div class="casAuthors">Pitman Melissa R; Powell Jason A; Coolen Carl; Moretti Paul A B; Zebol Julia R; Pham Duyen H; Ebert Lisa M; Bonder Claudine S; Gliddon Briony L; Pitson Stuart M; Powell Jason A; Ebert Lisa M; Bonder Claudine S; Pitson Stuart M; Finnie John W; Finnie John W; Don Anthony S; Bonder Claudine S; Pitson Stuart M</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">7065-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The dynamic balance of cellular sphingolipids, the sphingolipid rheostat, is an important determinant of cell fate, and is commonly deregulated in cancer.  Sphingosine 1-phosphate is a signaling molecule with anti-apoptotic, pro-proliferative and pro-angiogenic effects, while conversely, ceramide and sphingosine are pro-apoptotic.  The sphingosine kinases (SKs) are key regulators of this sphingolipid rheostat, and are attractive targets for anti-cancer therapy.  Here we report a first-in-class ATP-binding site-directed small molecule SK inhibitor, MP-A08, discovered using an approach of structural homology modelling of the ATP-binding site of SK1 and in silico docking with small molecule libraries.  MP-A08 is a highly selective ATP competitive SK inhibitor that targets both SK1 and SK2.  MP-A08 blocks pro-proliferative signalling pathways, induces mitochondrial-associated apoptosis in a SK-dependent manner, and reduces the growth of human lung adenocarcinoma tumours in a mouse xenograft model by both inducing tumour cell apoptosis and inhibiting tumour angiogenesis.  Thus, this selective ATP competitive SK inhibitor provides a promising candidate for potential development as an anti-cancer therapy, and also, due to its different mode of inhibition to other known SK inhibitors, both validates the SKs as targets for anti-cancer therapy, and represents an important experimental tool to study these enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQxJh4Tcj6QZMrRqEXsZufAfW6udTcc2eYYxLXwmQvp5bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnlslKjtQ%253D%253D&md5=c844ddaa55bc0d75a46b916c98c0e1ae</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.3178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.3178%26sid%3Dliteratum%253Aachs%26aulast%3DPitman%26aufirst%3DM.%2BR.%26aulast%3DPowell%26aufirst%3DJ.%2BA.%26aulast%3DCoolen%26aufirst%3DC.%26aulast%3DMoretti%26aufirst%3DP.%2BA.%26aulast%3DZebol%26aufirst%3DJ.%2BR.%26aulast%3DPham%26aufirst%3DD.%2BH.%26aulast%3DFinnie%26aufirst%3DJ.%2BW.%26aulast%3DDon%26aufirst%3DA.%2BS.%26aulast%3DEbert%26aufirst%3DL.%2BM.%26aulast%3DBonder%26aufirst%3DC.%2BS.%26aulast%3DGliddon%26aufirst%3DB.%2BL.%26aulast%3DPitson%26aufirst%3DS.%2BM.%26atitle%3DA%2520selective%2520ATP-competitive%2520sphingosine%2520kinase%2520inhibitor%2520demonstrates%2520anti-cancer%2520properties%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D7065%26epage%3D7083%26doi%3D10.18632%2Foncotarget.3178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schnute, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McReynolds, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasten, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerome, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rains, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrencik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronin, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saabye, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Highkin, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broadus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cukyne, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zawadzke, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterkin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyanar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholten, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendling, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiwara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemirovskiy, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittwer, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagiec, M. M.</span></span> <span> </span><span class="NLM_article-title">Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>444</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1042/BJ20111929</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1042%2FBJ20111929" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=22397330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1Kltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=444&publication_year=2012&pages=79-88&author=M.+E.+Schnuteauthor=M.+D.+McReynoldsauthor=T.+Kastenauthor=M.+Yatesauthor=G.+Jeromeauthor=J.+W.+Rainsauthor=T.+Hallauthor=J.+Chrencikauthor=M.+Krausauthor=C.+N.+Croninauthor=M.+Saabyeauthor=M.+K.+Highkinauthor=R.+Broadusauthor=S.+Ogawaauthor=K.+Cukyneauthor=L.+E.+Zawadzkeauthor=V.+Peterkinauthor=K.+Iyanarauthor=J.+A.+Scholtenauthor=J.+Wendlingauthor=H.+Fujiwaraauthor=O.+Nemirovskiyauthor=A.+J.+Wittwerauthor=M.+M.+Nagiec&title=Modulation+of+cellular+S1P+levels+with+a+novel%2C+potent+and+specific+inhibitor+of+sphingosine+kinase-1&doi=10.1042%2FBJ20111929"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1</span></div><div class="casAuthors">Schnute, Mark E.; McReynolds, Matthew D.; Kasten, Tom; Yates, Matthew; Jerome, Gina; Rains, John W.; Hall, Troii; Chrencik, Jill; Kraus, Michelle; Cronin, Ciaran N.; Saabye, Matthew; Highkin, Maureen K.; Broadus, Richard; Ogawa, Shinji; Cukyne, Kristin; Zawadzke, Laura E.; Peterkin, Vincent; Iyanar, Kaliapan; Scholten, Jeffrey A.; Wendling, Jay; Fujiwara, Hideji; Nemirovskiy, Olga; Wittwer, Arthur J.; Nagiec, Marek M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">444</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-88</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">SphK (sphingosine kinase) is the major source of the bioactive lipid and GPCR (G-protein-coupled receptor) agonist S1P (sphingosine 1-phosphate).  S1P promotes cell growth, survival and migration, and is a key regulator of lymphocyte trafficking.  Inhibition of S1P signalling has been proposed as a strategy for treatment of inflammatory diseases and cancer.  In the present paper we describe the discovery and characterization of PF-543, a novel cell-permeant inhibitor of SphK1.  PF-543 inhibits SphK1 with a Ki of 3.6 nM, is sphingosine-competitive and is more than 100-fold selective for SphK1 over the SphK2 isoform.  In 1483 head and neck carcinoma cells, which are characterized by high levels of SphK1 expression and an unusually high rate of S1P prodn., PF-543 decreased the level of endogenous S1P 10-fold with a proportional increase in the level of sphingosine.  In contrast with past reports that show that the growth of many cancer cell lines is SphK1-dependent, specific inhibition of SphK1 had no effect on the proliferation and survival of 1483 cells, despite a dramatic change in the cellular S1P/sphingosine ratio.  PF-543 was effective as a potent inhibitor of S1P formation in whole blood, indicating that the SphK1 isoform of sphingosine kinase is the major source of S1P in human blood.  PF-543 is the most potent inhibitor of SphK1 described to date and it will be useful for dissecting specific roles of SphK1-driven S1P signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrenMsEAHJOo7Vg90H21EOLACvtfcHk0lgzbfl-15BYUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Kltrw%253D&md5=7615a3b0e28e4f798e30bf27998dbad0</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1042%2FBJ20111929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20111929%26sid%3Dliteratum%253Aachs%26aulast%3DSchnute%26aufirst%3DM.%2BE.%26aulast%3DMcReynolds%26aufirst%3DM.%2BD.%26aulast%3DKasten%26aufirst%3DT.%26aulast%3DYates%26aufirst%3DM.%26aulast%3DJerome%26aufirst%3DG.%26aulast%3DRains%26aufirst%3DJ.%2BW.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DChrencik%26aufirst%3DJ.%26aulast%3DKraus%26aufirst%3DM.%26aulast%3DCronin%26aufirst%3DC.%2BN.%26aulast%3DSaabye%26aufirst%3DM.%26aulast%3DHighkin%26aufirst%3DM.%2BK.%26aulast%3DBroadus%26aufirst%3DR.%26aulast%3DOgawa%26aufirst%3DS.%26aulast%3DCukyne%26aufirst%3DK.%26aulast%3DZawadzke%26aufirst%3DL.%2BE.%26aulast%3DPeterkin%26aufirst%3DV.%26aulast%3DIyanar%26aufirst%3DK.%26aulast%3DScholten%26aufirst%3DJ.%2BA.%26aulast%3DWendling%26aufirst%3DJ.%26aulast%3DFujiwara%26aufirst%3DH.%26aulast%3DNemirovskiy%26aufirst%3DO.%26aulast%3DWittwer%26aufirst%3DA.%2BJ.%26aulast%3DNagiec%26aufirst%3DM.%2BM.%26atitle%3DModulation%2520of%2520cellular%2520S1P%2520levels%2520with%2520a%2520novel%252C%2520potent%2520and%2520specific%2520inhibitor%2520of%2520sphingosine%2520kinase-1%26jtitle%3DBiochem.%2520J.%26date%3D2012%26volume%3D444%26spage%3D79%26epage%3D88%26doi%3D10.1042%2FBJ20111929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kane, J. L.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noson, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asmussen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzgerald, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klaus, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Booker, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel sphingosine kinase-1 inhibitors. Part 2</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">4550</span>– <span class="NLM_lpage">4554</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.06.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1016%2Fj.bmcl.2010.06.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4550-4554&author=Y.+Xiangauthor=B.+Hirthauthor=J.+L.+Kaneauthor=J.+Liaoauthor=K.+D.+Nosonauthor=C.+Yeeauthor=G.+Asmussenauthor=M.+Fitzgeraldauthor=C.+Klausauthor=M.+Booker&title=Discovery+of+novel+sphingosine+kinase-1+inhibitors.+Part+2&doi=10.1016%2Fj.bmcl.2010.06.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.06.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.06.019%26sid%3Dliteratum%253Aachs%26aulast%3DXiang%26aufirst%3DY.%26aulast%3DHirth%26aufirst%3DB.%26aulast%3DKane%26aufirst%3DJ.%2BL.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DNoson%26aufirst%3DK.%2BD.%26aulast%3DYee%26aufirst%3DC.%26aulast%3DAsmussen%26aufirst%3DG.%26aulast%3DFitzgerald%26aufirst%3DM.%26aulast%3DKlaus%26aufirst%3DC.%26aulast%3DBooker%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520novel%2520sphingosine%2520kinase-1%2520inhibitors.%2520Part%25202%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4550%26epage%3D4554%26doi%3D10.1016%2Fj.bmcl.2010.06.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gustin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connors, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardozo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffries, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franks, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wesche, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgenstern, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rex, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coxon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayser, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span> <span> </span><span class="NLM_article-title">Structure guided design of a series of sphingosine kinase (SphK) inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">4608</span>– <span class="NLM_lpage">4616</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.06.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1016%2Fj.bmcl.2013.06.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=23845219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2lsb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4608-4616&author=D.+J.+Gustinauthor=Y.+Liauthor=M.+L.+Brownauthor=X.+Minauthor=M.+J.+Schmittauthor=M.+Wanskaauthor=X.+Wangauthor=R.+Connorsauthor=S.+Johnstoneauthor=M.+Cardozoauthor=A.+C.+Chengauthor=S.+Jeffriesauthor=B.+Franksauthor=S.+Liauthor=S.+Shenauthor=M.+Wongauthor=H.+Wescheauthor=G.+Xuauthor=T.+J.+Carlsonauthor=M.+Plantauthor=K.+Morgensternauthor=K.+Rexauthor=J.+Schmittauthor=A.+Coxonauthor=N.+Walkerauthor=F.+Kayserauthor=Z.+Wang&title=Structure+guided+design+of+a+series+of+sphingosine+kinase+%28SphK%29+inhibitors&doi=10.1016%2Fj.bmcl.2013.06.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Structure guided design of a series of sphingosine kinase (SphK) inhibitors</span></div><div class="casAuthors">Gustin, Darin J.; Li, Yihong; Brown, Matthew L.; Min, Xiaoshan; Schmitt, Mike J.; Wanska, Malgorzata; Wang, Xiaodong; Connors, Richard; Johnstone, Sheere; Cardozo, Mario; Cheng, Alan C.; Jeffries, Shawn; Franks, Brendon; Li, Shyun; Shen, Shanling; Wong, Mariwil; Wesche, Holger; Xu, Guifen; Carlson, Timothy J.; Plant, Matthew; Morgenstern, Kurt; Rex, Karen; Schmitt, Joanna; Coxon, Angela; Walker, Nigel; Kayser, Frank; Wang, Zhulun</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4608-4616</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sphingosine-1-phosphate (S1P) signaling plays a vital role in mitogenesis, cell migration and angiogenesis.  Sphingosine kinases (SphKs) catalyze a key step in sphingomyelin metab. that leads to the prodn. of S1P.  There are two isoforms of SphK and observations made with SphK deficient mice show the two isoforms can compensate for each other's loss.  Thus, inhibition of both isoforms is likely required to block SphK dependent angiogenesis.  A structure based approach was used to design and synthesize a series of SphK inhibitors resulting in the identification of the first potent inhibitors of both isoforms of human SphK.  Addnl., to our knowledge, this series of inhibitors contains the only sufficiently potent inhibitors of murine SphK1 with suitable physico-chem. properties to pharmacol. interrogate the role of SphK1 in rodent models and to reproduce the phenotype of SphK1 (-/-) mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovzWgmT5jALrVg90H21EOLACvtfcHk0ljk3qZNtXS0gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2lsb%252FN&md5=42c7f013299278232f62a9f70bccd08c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.06.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.06.030%26sid%3Dliteratum%253Aachs%26aulast%3DGustin%26aufirst%3DD.%2BJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DM.%2BL.%26aulast%3DMin%26aufirst%3DX.%26aulast%3DSchmitt%26aufirst%3DM.%2BJ.%26aulast%3DWanska%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DConnors%26aufirst%3DR.%26aulast%3DJohnstone%26aufirst%3DS.%26aulast%3DCardozo%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DJeffries%26aufirst%3DS.%26aulast%3DFranks%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DWesche%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DCarlson%26aufirst%3DT.%2BJ.%26aulast%3DPlant%26aufirst%3DM.%26aulast%3DMorgenstern%26aufirst%3DK.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DSchmitt%26aufirst%3DJ.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DWalker%26aufirst%3DN.%26aulast%3DKayser%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3DStructure%2520guided%2520design%2520of%2520a%2520series%2520of%2520sphingosine%2520kinase%2520%2528SphK%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4608%26epage%3D4616%26doi%3D10.1016%2Fj.bmcl.2013.06.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berka, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ning, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogdanov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milburn, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idowu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdulmalik, O. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowhan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellems, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juneja, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Y.</span></span> <span> </span><span class="NLM_article-title">Elevated sphingosine-1-phosphate promotes sickling and sickle cell disease progression</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">2750</span>– <span class="NLM_lpage">2761</span>, <span class="refDoi"> DOI: 10.1172/JCI74604</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1172%2FJCI74604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=24837436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvFahs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=2750-2761&author=Y.+Zhangauthor=V.+Berkaauthor=A.+Songauthor=K.+Sunauthor=W.+Wangauthor=W.+Zhangauthor=C.+Ningauthor=C.+Liauthor=Q.+Zhangauthor=M.+Bogdanovauthor=D.+C.+Alexanderauthor=M.+V.+Milburnauthor=M.+H.+Ahmedauthor=H.+Linauthor=M.+Idowuauthor=J.+Zhangauthor=G.+J.+Katoauthor=O.+Y.+Abdulmalikauthor=W.+Zhangauthor=W.+Dowhanauthor=R.+E.+Kellemsauthor=P.+Zhangauthor=J.+Jinauthor=M.+Safoauthor=A.+L.+Tsaiauthor=H.+S.+Junejaauthor=Y.+Xia&title=Elevated+sphingosine-1-phosphate+promotes+sickling+and+sickle+cell+disease+progression&doi=10.1172%2FJCI74604"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated sphingosine-1-phosphate promotes sickling and sickle cell disease progression</span></div><div class="casAuthors">Zhang, Yujin; Berka, Vladimir; Song, Anren; Sun, Kaiqi; Wang, Wei; Zhang, Weiru; Ning, Chen; Li, Chonghua; Zhang, Qibo; Bogdanov, Mikhail; Alexander, Danny C.; Milburn, Michael V.; Ahmed, Mostafa H.; Lin, Han; Idowu, Modupe; Zhang, Jun; Kato, Gregory J.; Abdulmalik, Osheiza Y.; Zhang, Wenzheng; Dowhan, William; Kellems, Rodney E.; Zhang, Pumin; Jin, Jianping; Safo, Martin; Tsai, Ah-Lim; Juneja, Harinder S.; Xia, Yang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2750-2761</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Sphingosine-1-phosphate (S1P) is a bioactive lipid that regulates multicellular functions through interactions with its receptors on cell surfaces.  S1P is enriched and stored in erythrocytes; however, it is not clear whether alterations in S1P are involved in the prevalent and debilitating hemolytic disorder sickle cell disease (SCD).  Here, using metabolomic screening, we found that S1P is highly elevated in the blood of mice and humans with SCD.  In murine models of SCD, we demonstrated that elevated erythrocyte sphingosine kinase 1 (SPHK1) underlies sickling and disease progression by increasing S1P levels in the blood.  Addnl., we obsd. elevated SPHK1 activity in erythrocytes and increased S1P in blood collected from patients with SCD and demonstrated a direct impact of elevated SPHK1-mediated prodn. of S1P on sickling that was independent of S1P receptor activation in isolated erythrocytes.  Together, our findings provide insights into erythrocyte pathophysiol., revealing that a SPHK1-mediated elevation of S1P contributes to sickling and promotes disease progression, and highlight potential therapeutic opportunities for SCD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3xAA8WICyg7Vg90H21EOLACvtfcHk0ljk3qZNtXS0gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvFahs7s%253D&md5=0cbb85f9b96956110a5578baf0b382a7</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1172%2FJCI74604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI74604%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBerka%26aufirst%3DV.%26aulast%3DSong%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DNing%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DBogdanov%26aufirst%3DM.%26aulast%3DAlexander%26aufirst%3DD.%2BC.%26aulast%3DMilburn%26aufirst%3DM.%2BV.%26aulast%3DAhmed%26aufirst%3DM.%2BH.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DIdowu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DKato%26aufirst%3DG.%2BJ.%26aulast%3DAbdulmalik%26aufirst%3DO.%2BY.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DDowhan%26aufirst%3DW.%26aulast%3DKellems%26aufirst%3DR.%2BE.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DSafo%26aufirst%3DM.%26aulast%3DTsai%26aufirst%3DA.%2BL.%26aulast%3DJuneja%26aufirst%3DH.%2BS.%26aulast%3DXia%26aufirst%3DY.%26atitle%3DElevated%2520sphingosine-1-phosphate%2520promotes%2520sickling%2520and%2520sickle%2520cell%2520disease%2520progression%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2014%26volume%3D124%26spage%3D2750%26epage%3D2761%26doi%3D10.1172%2FJCI74604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, L.</span></span> <span> </span><span class="NLM_article-title">Sphingosine 1-phosphate signaling contributes to cardiac inflammation, dysfunction, and remodeling following myocardial infarction</span>. <i>Am. J. Physiol. Heart Circ. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>310</i></span>,  <span class="NLM_fpage">H250</span>– <span class="NLM_lpage">H261</span>, <span class="refDoi"> DOI: 10.1152/ajpheart.00372.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1152%2Fajpheart.00372.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=26589326" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=310&publication_year=2016&pages=H250-H261&author=F.+Zhangauthor=Y.+Xiaauthor=W.+Yanauthor=H.+Zhangauthor=F.+Zhouauthor=S.+Zhaoauthor=W.+Wangauthor=D.+Zhuauthor=C.+Xinauthor=Y.+Leeauthor=L.+Zhangauthor=Y.+Heauthor=E.+Gaoauthor=L.+Tao&title=Sphingosine+1-phosphate+signaling+contributes+to+cardiac+inflammation%2C+dysfunction%2C+and+remodeling+following+myocardial+infarction&doi=10.1152%2Fajpheart.00372.2015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1152%2Fajpheart.00372.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpheart.00372.2015%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DXin%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DE.%26aulast%3DTao%26aufirst%3DL.%26atitle%3DSphingosine%25201-phosphate%2520signaling%2520contributes%2520to%2520cardiac%2520inflammation%252C%2520dysfunction%252C%2520and%2520remodeling%2520following%2520myocardial%2520infarction%26jtitle%3DAm.%2520J.%2520Physiol.%2520Heart%2520Circ.%2520Physiol.%26date%3D2016%26volume%3D310%26spage%3DH250%26epage%3DH261%26doi%3D10.1152%2Fajpheart.00372.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MacRitchie, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volpert, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Washih, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futerman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, N. J.</span></span> <span> </span><span class="NLM_article-title">Effect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodelling in a hypoxic model of pulmonary arterial hypertension</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">946</span>– <span class="NLM_lpage">955</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2016.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1016%2Fj.cellsig.2016.03.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=27063355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC28XotFamu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2016&pages=946-955&author=N.+MacRitchieauthor=G.+Volpertauthor=M.+Al+Washihauthor=D.+G.+Watsonauthor=A.+H.+Futermanauthor=S.+Kennedyauthor=S.+Pyneauthor=N.+J.+Pyne&title=Effect+of+the+sphingosine+kinase+1+selective+inhibitor%2C+PF-543+on+arterial+and+cardiac+remodelling+in+a+hypoxic+model+of+pulmonary+arterial+hypertension&doi=10.1016%2Fj.cellsig.2016.03.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodelling in a hypoxic model of pulmonary arterial hypertension</span></div><div class="casAuthors">MacRitchie, Neil; Volpert, Giora; Al Washih, Mohammed; Watson, David G.; Futerman, Anthony H.; Kennedy, Simon; Pyne, Susan; Pyne, Nigel J.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">946-955</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Recent studies have demonstrated that the expression of sphingosine kinase 1, the enzyme that catalyzes formation of the bioactive lipid, sphingosine 1-phosphate, is increased in lungs from patients with pulmonary arterial hypertension.  In addn., Sk1-/- mice are protected from hypoxic-induced pulmonary arterial hypertension.  Therefore, we assessed the effect of the sphingosine kinase 1 selective inhibitor, PF-543 and a sphingosine kinase 1/ceramide synthase inhibitor, RB-005 on pulmonary and cardiac remodelling in a mouse hypoxic model of pulmonary arterial hypertension.  Administration of the potent sphingosine kinase 1 inhibitor, PF-543 in a mouse hypoxic model of pulmonary hypertension had no effect on vascular remodelling but reduced right ventricular hypertrophy.  The latter was assocd. with a significant redn. in cardiomyocyte death.  The protection involves a redn. in the expression of p53 (that promotes cardiomyocyte death) and an increase in the expression of anti-oxidant nuclear factor (erythroid-derived 2)-like 2 (Nrf-2).  In contrast, RB-005 lacked effects on right ventricular hypertrophy, suggesting that sphingosine kinase 1 inhibition might be nullified by concurrent inhibition of ceramide synthase.  Therefore, our findings with PF-543 suggest an important role for sphingosine kinase 1 in the development of hypertrophy in pulmonary arterial hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIc5iHVP6GEbVg90H21EOLACvtfcHk0ljjT_JNS5dYyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotFamu70%253D&md5=35db2cab74cf8939b1bca4345e9d285a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2016.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2016.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DMacRitchie%26aufirst%3DN.%26aulast%3DVolpert%26aufirst%3DG.%26aulast%3DAl%2BWashih%26aufirst%3DM.%26aulast%3DWatson%26aufirst%3DD.%2BG.%26aulast%3DFuterman%26aufirst%3DA.%2BH.%26aulast%3DKennedy%26aufirst%3DS.%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26atitle%3DEffect%2520of%2520the%2520sphingosine%2520kinase%25201%2520selective%2520inhibitor%252C%2520PF-543%2520on%2520arterial%2520and%2520cardiac%2520remodelling%2520in%2520a%2520hypoxic%2520model%2520of%2520pulmonary%2520arterial%2520hypertension%26jtitle%3DCell.%2520Signalling%26date%3D2016%26volume%3D28%26spage%3D946%26epage%3D955%26doi%3D10.1016%2Fj.cellsig.2016.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">French, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maines, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beljanski, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upson, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. D.</span></span> <span> </span><span class="NLM_article-title">Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>333</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1124/jpet.109.163444</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1124%2Fjpet.109.163444" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=20061445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFGktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2010&pages=129-139&author=K.+J.+Frenchauthor=Y.+Zhuangauthor=L.+W.+Mainesauthor=P.+Gaoauthor=W.+Wangauthor=V.+Beljanskiauthor=J.+J.+Upsonauthor=C.+L.+Greenauthor=S.+N.+Kellerauthor=C.+D.+Smith&title=Pharmacology+and+antitumor+activity+of+ABC294640%2C+a+selective+inhibitor+of+sphingosine+kinase-2&doi=10.1124%2Fjpet.109.163444"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2</span></div><div class="casAuthors">French, Kevin J.; Zhuang, Yan; Maines, Lynn W.; Gao, Peng; Wang, Wenxue; Beljanski, Vladimir; Upson, John J.; Green, Cecelia L.; Keller, Staci N.; Smith, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">129-139</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Sphingolipid-metabolizing enzymes control the dynamic balance of the cellular levels of important bioactive lipids, including the apoptotic compd. ceramide and the proliferative compd. sphingosine 1-phosphate (S1P).  Many growth factors and inflammatory cytokines promote the cleavage of sphingomyelin and ceramide leading to rapid elevation of S1P levels through the action of sphingosine kinases (SK1 and SK2).  SK1 and SK2 are overexpressed in a variety of human cancers, making these enzymes potential mol. targets for cancer therapy.  We have identified an aryladamantane compd., termed ABC294640 [3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide], that selectively inhibits SK2 activity in vitro, acting as a competitive inhibitor with respect to sphingosine with a Ki of 9.8 μM, and attenuates S1P formation in intact cells.  In tissue culture, ABC294640 suppresses the proliferation of a broad panel of tumor cell lines, and inhibits tumor cell migration concomitant with loss of microfilaments.  In vivo, ABC294640 has excellent oral bioavailability, and demonstrates a plasma clearance half-time of 4.5 h in mice.  Acute and chronic toxicol. studies indicate that ABC294640 induces a transient minor decrease in the hematocrit of rats and mice; however, this normalizes by 28 days of treatment.  No other changes in hematol. parameters, or gross or microscopic tissue pathol., result from treatment with ABC294640.  Oral administration of ABC294640 to mice bearing mammary adenocarcinoma xenografts results in dose-dependent antitumor activity assocd. with depletion of S1P levels in the tumors and progressive tumor cell apoptosis.  Therefore, this newly developed SK2 inhibitor provides an orally available drug candidate for the treatment of cancer and other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsJFYxYhWjhbVg90H21EOLACvtfcHk0ljjT_JNS5dYyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFGktro%253D&md5=63e0792b887d9ad70c76f209e577a693</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.163444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.163444%26sid%3Dliteratum%253Aachs%26aulast%3DFrench%26aufirst%3DK.%2BJ.%26aulast%3DZhuang%26aufirst%3DY.%26aulast%3DMaines%26aufirst%3DL.%2BW.%26aulast%3DGao%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DBeljanski%26aufirst%3DV.%26aulast%3DUpson%26aufirst%3DJ.%2BJ.%26aulast%3DGreen%26aufirst%3DC.%2BL.%26aulast%3DKeller%26aufirst%3DS.%2BN.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26atitle%3DPharmacology%2520and%2520antitumor%2520activity%2520of%2520ABC294640%252C%2520a%2520selective%2520inhibitor%2520of%2520sphingosine%2520kinase-2%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D333%26spage%3D129%26epage%3D139%26doi%3D10.1124%2Fjpet.109.163444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hait, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allegood, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parikh, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellogg, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiegel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span> <span> </span><span class="NLM_article-title">Biological characterization of 3-(2-aminoethyl)-5-[3-(4-butoxylphenyl)propylidene]thiazolidine-2,4-dione (K145) as a selective sphingosine kinase-2 inhibitor and anticancer agent</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e56471</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0056471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1371%2Fjournal.pone.0056471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=23437140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsF2ju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e56471&author=K.+Liuauthor=T.+L.+Guoauthor=N.+C.+Haitauthor=J.+Allegoodauthor=H.+I.+Parikhauthor=W.+Xuauthor=G.+E.+Kelloggauthor=S.+Grantauthor=S.+Spiegelauthor=S.+Zhang&title=Biological+characterization+of+3-%282-aminoethyl%29-5-%5B3-%284-butoxylphenyl%29propylidene%5Dthiazolidine-2%2C4-dione+%28K145%29+as+a+selective+sphingosine+kinase-2+inhibitor+and+anticancer+agent&doi=10.1371%2Fjournal.pone.0056471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Biological characterization of 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) as a selective sphingosine kinase-2 inhibitor and anticancer agent</span></div><div class="casAuthors">Liu, Kai; Guo, Tai L.; Hait, Nitai C.; Allegood, Jeremy; Parikh, Hardik I.; Xu, Wenfang; Kellogg, Glen E.; Grant, Steven; Spiegel, Sarah; Zhang, Shijun</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e56471</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">In our effort to develop selective sphingosine kinase-2 (SphK2) inhibitors as pharmacol. tools, a thiazolidine-2,4-dione analog, 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione(K145), was synthesized and biol. characterized.  Biochem. assay results indicate that K145 is a selective SphK2 inhibitor.  Mol. modeling studies also support this notion.  In vitro studies using human leukemia U937 cells demonstrated that K145 accumulates in U937 cells, suppresses the S1P level, and inhibits SphK2.  K145 also exhibited inhibitory effects on the growth of U937 cells as well as apoptotic effects in U937 cells, and that these effects may be through the inhibition of down-stream ERK and Akt signaling pathways.  K145 also significantly inhibited the growth of U937 tumors in nude mice by both i.p. and oral administration, thus demonstrating its in vivo efficacy as a potential lead anticancer agent.  The antitumor activity of K145 was also confirmed in a syngeneic mouse model by implanting murine breast cancer JC cells in BALB/c mice.  Collectively, these results strongly encourage further optimization of K145 as a novel lead compd. for development of more potent and selective SphK2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXIc2J15Fc-bVg90H21EOLACvtfcHk0lgys4Wd7cFWgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsF2ju7s%253D&md5=bddb4fe0ce70a76f3b2adcdcd1cb9ec8</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0056471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0056471%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DGuo%26aufirst%3DT.%2BL.%26aulast%3DHait%26aufirst%3DN.%2BC.%26aulast%3DAllegood%26aufirst%3DJ.%26aulast%3DParikh%26aufirst%3DH.%2BI.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DKellogg%26aufirst%3DG.%2BE.%26aulast%3DGrant%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26atitle%3DBiological%2520characterization%2520of%25203-%25282-aminoethyl%2529-5-%255B3-%25284-butoxylphenyl%2529propylidene%255Dthiazolidine-2%252C4-dione%2520%2528K145%2529%2520as%2520a%2520selective%2520sphingosine%2520kinase-2%2520inhibitor%2520and%2520anticancer%2520agent%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De56471%26doi%3D10.1371%2Fjournal.pone.0056471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kharel, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raje, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gellett, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomsig, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, W. L.</span></span> <span> </span><span class="NLM_article-title">Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>447</i></span>,  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.1042/BJ20120609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1042%2FBJ20120609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=22747486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlCjsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=447&publication_year=2012&pages=149-157&author=Y.+Kharelauthor=M.+Rajeauthor=M.+Gaoauthor=A.+M.+Gellettauthor=J.+L.+Tomsigauthor=K.+R.+Lynchauthor=W.+L.+Santos&title=Sphingosine+kinase+type+2+inhibition+elevates+circulating+sphingosine+1-phosphate&doi=10.1042%2FBJ20120609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate</span></div><div class="casAuthors">Kharel, Yugesh; Raje, Mithun; Gao, Ming; Gellett, Amanda M.; Tomsig, Jose L.; Lynch, Kevin R.; Santos, Webster L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">447</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">149-157</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">S1P (sphingosine 1-phosphate) is a pleiotropic lipid mediator involved in numerous cellular and physiol. functions.  Of note among these are cell survival and migration, as well as lymphocyte trafficking.  S1P, which exerts its effects via five GPCRs (G-protein-coupled receptors) (S1P1-S1P5), is formed by the action of two SphKs (sphingosine kinases).  Although SphK1 is the more intensively studied isotype, SphK2 is unique in it nuclear localization and has been reported to oppose some of the actions ascribed to SphK1.  Although several scaffolds of SphK1 inhibitors have been described, there is a scarcity of selective SphK2 inhibitors that are necessary to evaluate the downstream effects of inhibition of this isotype.  In the present paper we report a cationic amphiphilic small mol. that is a selective SphK2 inhibitor.  In the course of characterizing this compd. in wild-type and SphK-null mice, we discovered that administration of the inhibitor to wild-type mice resulted in a rapid increase in blood S1P, which is in contrast with our SphK1 inhibitor that drives circulating S1P levels down.  Using a cohort of F2 hybrid mice, we confirmed, compared with wild-type mice, that circulating S1P levels were higher in SphK2-null mice and lower in SphK1-null mice.  Thus both SphK1 and SphK2 inhibitors recapitulate the blood S1P levels obsd. in the corresponding null mice.  Moreover, circulating S1P levels mirror SphK2 inhibitor levels, providing a convenient biomarker of target engagement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKDtUfuqfG5bVg90H21EOLACvtfcHk0lgys4Wd7cFWgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlCjsLrE&md5=dbd6766a0d93b120155a2c0caa69ceda</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1042%2FBJ20120609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20120609%26sid%3Dliteratum%253Aachs%26aulast%3DKharel%26aufirst%3DY.%26aulast%3DRaje%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DGellett%26aufirst%3DA.%2BM.%26aulast%3DTomsig%26aufirst%3DJ.%2BL.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DSantos%26aufirst%3DW.%2BL.%26atitle%3DSphingosine%2520kinase%2520type%25202%2520inhibition%2520elevates%2520circulating%2520sphingosine%25201-phosphate%26jtitle%3DBiochem.%2520J.%26date%3D2012%26volume%3D447%26spage%3D149%26epage%3D157%26doi%3D10.1042%2FBJ20120609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, S.</span></span> <span> </span><span class="NLM_article-title">(<i>R</i>)-FTY720 methyl ether is a specific sphingosine kinase 2 inhibitor: effect on sphingosine kinase 2 expression in HEK 293 cells and actin rearrangement and survival of MCF-7 breast cancer cells</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1590</span>– <span class="NLM_lpage">1595</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2011.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1016%2Fj.cellsig.2011.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=21620961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpslaisbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2011&pages=1590-1595&author=K.+G.+Limauthor=C.+Sunauthor=R.+Bittmanauthor=N.+J.+Pyneauthor=S.+Pyne&title=%28R%29-FTY720+methyl+ether+is+a+specific+sphingosine+kinase+2+inhibitor%3A+effect+on+sphingosine+kinase+2+expression+in+HEK+293+cells+and+actin+rearrangement+and+survival+of+MCF-7+breast+cancer+cells&doi=10.1016%2Fj.cellsig.2011.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">(R)-FTY720 methyl ether is a specific sphingosine kinase 2 inhibitor: Effect on sphingosine kinase 2 expression in HEK 293 cells and actin rearrangement and survival of MCF-7 breast cancer cells</span></div><div class="casAuthors">Lim, Keng Gat; Sun, Chaode; Bittman, Robert; Pyne, Nigel J.; Pyne, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1590-1595</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Sphingosine kinase 2 (SK2) catalyzes the conversion of sphingosine to the bioactive lipid sphingosine 1-phosphate (S1P).  We report here, the stereospecific synthesis of an analog of FTY720 called (R)-FTY720-OMe, which we show is a competitive inhibitor of SK2. (R)-FTY720-OMe failed to inhibit sphingosine kinase 1 activity, thereby demonstrating specificity for SK2.  Prolonged treatment of HEK 293 cells with (R)-FTY720-OMe also induced a redn. in SK2 expression.  In addn., (R)-FTY720-OMe inhibited DNA synthesis and prevented S1P-stimulated rearrangement of actin in MCF-7 breast cancer cells.  These findings demonstrate that SK2 functions as a pro-survival protein and is involved in promoting actin rearrangement into membrane ruffles/lamellipodia in response to S1P in MCF-7 breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlXS4c2DHDxLVg90H21EOLACvtfcHk0lgys4Wd7cFWgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpslaisbw%253D&md5=651d949ee44042ec0c3d975fb2be5cc6</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2011.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2011.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DK.%2BG.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DBittman%26aufirst%3DR.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26aulast%3DPyne%26aufirst%3DS.%26atitle%3D%2528R%2529-FTY720%2520methyl%2520ether%2520is%2520a%2520specific%2520sphingosine%2520kinase%25202%2520inhibitor%253A%2520effect%2520on%2520sphingosine%2520kinase%25202%2520expression%2520in%2520HEK%2520293%2520cells%2520and%2520actin%2520rearrangement%2520and%2520survival%2520of%2520MCF-7%2520breast%2520cancer%2520cells%26jtitle%3DCell.%2520Signalling%26date%3D2011%26volume%3D23%26spage%3D1590%26epage%3D1595%26doi%3D10.1016%2Fj.cellsig.2011.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beljanski, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knaak, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. D.</span></span> <span> </span><span class="NLM_article-title">A novel sphingosine kinase inhibitor induces autophagy in tumor cells</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>333</i></span>,  <span class="NLM_fpage">454</span>– <span class="NLM_lpage">464</span>, <span class="refDoi"> DOI: 10.1124/jpet.109.163337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1124%2Fjpet.109.163337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=20179157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFKhtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2010&pages=454-464&author=V.+Beljanskiauthor=C.+Knaakauthor=C.+D.+Smith&title=A+novel+sphingosine+kinase+inhibitor+induces+autophagy+in+tumor+cells&doi=10.1124%2Fjpet.109.163337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A novel sphingosine kinase inhibitor induces autophagy in tumor cells</span></div><div class="casAuthors">Beljanski, Vladimir; Knaak, Christian; Smith, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">454-464</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The sphingolipids ceramide, sphingosine, and sphingosine 1-phosphate (S1P) regulate cell signaling, proliferation, apoptosis, and autophagy.  Sphingosine kinase-1 and -2 (SK1 and SK2) phosphorylate sphingosine to form S1P, shifting the balanced activity of these lipids toward cell proliferation.  We have previously reported that pharmacol. inhibition of SK activity delays tumor growth in vivo.  The present studies demonstrate that the SK2-selective inhibitor 3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide (ABC294640) induces nonapoptotic cell death that is preceded by microtubule-assocd. protein light chain 3 cleavage, morphol. changes in lysosomes, formation of autophagosomes, and increases in acidic vesicles in A-498 kidney carcinoma cells.  ABC294640 caused similar autophagic responses in PC-3 prostate and MDA-MB-231 breast adenocarcinoma cells.  Simultaneous exposure of A-498 cells to ABC294640 and 3-methyladenine, an inhibitor of autophagy, switched the mechanism of toxicity to apoptosis, but decreased the potency of the SK2 inhibitor, indicating that autophagy is a major mechanism for tumor cell killing by this compd.  Induction of the unfolded protein response by the proteasome inhibitor N-(benzyloxycarbonyl)leucinylleucinylleucinal Z-Leu-Leu-Leu-al (MG-132) or the heat shock protein 90 inhibitor geldanamycin synergistically increased the cytotoxicity of ABC294640 in vitro.  In severe combined immunodeficient mice bearing A-498 xenografts, daily administration of ABC294640 delayed tumor growth and elevated autophagy markers, but did not increase terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling-pos. cells in the tumors.  These data suggest that ABC294640 promotes tumor cell autophagy, which ultimately results in nonapoptotic cell death and a delay of tumor growth in vivo.  Consequently, ABC294640 may effectively complement anticancer drugs that induce tumor cell apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKrohC6YQacrVg90H21EOLACvtfcHk0ljxoL5WqnONCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFKhtb4%253D&md5=5a3545b993705f7a1f16f9d3c9567061</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.163337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.163337%26sid%3Dliteratum%253Aachs%26aulast%3DBeljanski%26aufirst%3DV.%26aulast%3DKnaak%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26atitle%3DA%2520novel%2520sphingosine%2520kinase%2520inhibitor%2520induces%2520autophagy%2520in%2520tumor%2520cells%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D333%26spage%3D454%26epage%3D464%26doi%3D10.1124%2Fjpet.109.163337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fitzpatrick, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frauenhoffer, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">French, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maines, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upson, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donahue, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosher, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. D.</span></span> <span> </span><span class="NLM_article-title">Attenuation of arthritis in rodents by a novel orally-available inhibitor of sphingosine kinase</span>. <i>Inflammopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1007/s10787-010-0060-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1007%2Fs10787-010-0060-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=20936538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFKitr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=75-87&author=L.+R.+Fitzpatrickauthor=C.+Greenauthor=E.+E.+Frauenhofferauthor=K.+J.+Frenchauthor=Y.+Zhuangauthor=L.+W.+Mainesauthor=J.+J.+Upsonauthor=E.+Paulauthor=H.+Donahueauthor=T.+J.+Mosherauthor=C.+D.+Smith&title=Attenuation+of+arthritis+in+rodents+by+a+novel+orally-available+inhibitor+of+sphingosine+kinase&doi=10.1007%2Fs10787-010-0060-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Attenuation of arthritis in rodents by a novel orally-available inhibitor of sphingosine kinase</span></div><div class="casAuthors">Fitzpatrick, Leo R.; Green, Cecelia; Frauenhoffer, Elizabeth E.; French, Kevin J.; Zhuang, Yan; Maines, Lynn W.; Upson, John J.; Paul, Emmanuel; Donahue, Henry; Mosher, Timothy J.; Smith, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">Inflammopharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">75-87</span>CODEN:
                <span class="NLM_cas:coden">IAOAES</span>;
        ISSN:<span class="NLM_cas:issn">0925-4692</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">Pro-inflammatory cytokines like TNF-α activate sphingosine kinase (SK).  Therefore, inhibition of SK is a potential mol. target for the treatment of rheumatoid arthritis.  Aims The primary goal of this study was to assess the efficacy of ABC249640 (a selective SK-2 inhibitor) in two models of rodent arthritis.  A secondary goal was to evaluate the pharmacol. profile of ABC294640, when given in combination with methotrexate.  Methods The efficacy of ABC294640 was detd. by paw diam./vol. measurements, histol. evaluations, and micro-CT analyses.  Results ABC294640 attenuated both collagen-induced arthritis in mice, as well as adjuvant-induced arthritis in rats.  With the adjuvant arthritis model, the prophylactic efficacy profile of ABC294640 was similar to indomethacin.  Of note, ABC294640 reduced the bone and cartilage degrdn., assocd. with adjuvant-induced arthritis.  Rats treated with a suboptimal dose of MTX (50 μg/kg/day) in combination with ABC249640 (100 mg/kg/day) had better anti-arthritis effects in the adjuvant model, than treatment with either agent alone.  Conclusion Our results suggest that ABC249640 is an orally available drug candidate with a good pre-clin. efficacy profile for the prevention and/or treatment of RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9w8QPB1UOarVg90H21EOLACvtfcHk0ljxoL5WqnONCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFKitr0%253D&md5=ec58032108f1cfe6062b836b8e9abadd</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs10787-010-0060-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10787-010-0060-6%26sid%3Dliteratum%253Aachs%26aulast%3DFitzpatrick%26aufirst%3DL.%2BR.%26aulast%3DGreen%26aufirst%3DC.%26aulast%3DFrauenhoffer%26aufirst%3DE.%2BE.%26aulast%3DFrench%26aufirst%3DK.%2BJ.%26aulast%3DZhuang%26aufirst%3DY.%26aulast%3DMaines%26aufirst%3DL.%2BW.%26aulast%3DUpson%26aufirst%3DJ.%2BJ.%26aulast%3DPaul%26aufirst%3DE.%26aulast%3DDonahue%26aufirst%3DH.%26aulast%3DMosher%26aufirst%3DT.%2BJ.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26atitle%3DAttenuation%2520of%2520arthritis%2520in%2520rodents%2520by%2520a%2520novel%2520orally-available%2520inhibitor%2520of%2520sphingosine%2520kinase%26jtitle%3DInflammopharmacology%26date%3D2011%26volume%3D19%26spage%3D75%26epage%3D87%26doi%3D10.1007%2Fs10787-010-0060-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maines, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzpatrick, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. D.</span></span> <span> </span><span class="NLM_article-title">Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn’s disease</span>. <i>Inflammopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1007/s10787-010-0032-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1007%2Fs10787-010-0032-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=20151210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvVOls7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=73-85&author=L.+W.+Mainesauthor=L.+R.+Fitzpatrickauthor=C.+L.+Greenauthor=Y.+Zhuangauthor=C.+D.+Smith&title=Efficacy+of+a+novel+sphingosine+kinase+inhibitor+in+experimental+Crohn%E2%80%99s+disease&doi=10.1007%2Fs10787-010-0032-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn's disease</span></div><div class="casAuthors">Maines, Lynn W.; Fitzpatrick, Leo R.; Green, Cecelia L.; Zhuang, Yan; Smith, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">Inflammopharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">73-85</span>CODEN:
                <span class="NLM_cas:coden">IAOAES</span>;
        ISSN:<span class="NLM_cas:issn">0925-4692</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">Aim: Activation of sphingosine kinase (SK) is a key response to many inflammatory processes.  The present studies test the hypothesis that an orally available SK inhibitor, ABC294640, would be effective in rodent models of Crohn's disease.  Methods: Trinitrobenzene sulfonic acid (TNBS) was administered rectally to mice and rats.  Rats were treated with ABC294640 orally alone or in combination with olsalazine and disease progression was monitored.  Results: For both rodent species, treatment with ABC294640 attenuated disease progression.  Colon samples from the ABC294640-treated animals had improved histol. and cytokine parameters when compared with vehicle-treated animals.  The expression of SK was similarly increased in TNBS-treated animals and in human colon tissue specimens from inflammatory bowel disease patients relative to normal, control patients.  Conclusions: Sphingosine kinase may be a crit. mediator of colonic damage during intestinal inflammation, and pharmacol. inhibitors of this enzyme may prove useful in the treatment of Crohn's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJIlj5tVU_KbVg90H21EOLACvtfcHk0ljxoL5WqnONCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvVOls7w%253D&md5=ec153ee07064f5783412ffd626d664fb</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2Fs10787-010-0032-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10787-010-0032-x%26sid%3Dliteratum%253Aachs%26aulast%3DMaines%26aufirst%3DL.%2BW.%26aulast%3DFitzpatrick%26aufirst%3DL.%2BR.%26aulast%3DGreen%26aufirst%3DC.%2BL.%26aulast%3DZhuang%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26atitle%3DEfficacy%2520of%2520a%2520novel%2520sphingosine%2520kinase%2520inhibitor%2520in%2520experimental%2520Crohn%25E2%2580%2599s%2520disease%26jtitle%3DInflammopharmacology%26date%3D2010%26volume%3D18%26spage%3D73%26epage%3D85%26doi%3D10.1007%2Fs10787-010-0032-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Venant, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahmaniyan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lilly, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrett-Mayer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drake, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraveka, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voelkel-Johnson, C.</span></span> <span> </span><span class="NLM_article-title">The sphingosine kinase 2 inhibitor ABC294640 reduces the growth of prostate cancer cells and results in accumulation of dihydroceramides <i>in vitro</i> and <i>in vivo</i></span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">2744</span>– <span class="NLM_lpage">2752</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-15-0279</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1158%2F1535-7163.MCT-15-0279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=26494858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKlu73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=2744-2752&author=H.+Venantauthor=M.+Rahmaniyanauthor=E.+E.+Jonesauthor=P.+Luauthor=M.+B.+Lillyauthor=E.+Garrett-Mayerauthor=R.+R.+Drakeauthor=J.+M.+Kravekaauthor=C.+D.+Smithauthor=C.+Voelkel-Johnson&title=The+sphingosine+kinase+2+inhibitor+ABC294640+reduces+the+growth+of+prostate+cancer+cells+and+results+in+accumulation+of+dihydroceramides+in+vitro+and+in+vivo&doi=10.1158%2F1535-7163.MCT-15-0279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The Sphingosine Kinase 2 Inhibitor ABC294640 Reduces the Growth of Prostate Cancer Cells and Results in Accumulation of Dihydroceramides In Vitro and In Vivo</span></div><div class="casAuthors">Venant, Heather; Rahmaniyan, Mehrdad; Jones, E. Ellen; Lu, Ping; Lilly, Michael B.; Garrett-Mayer, Elizabeth; Drake, Richard R.; Kraveka, Jacqueline M.; Smith, Charles D.; Voelkel-Johnson, Christina</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2744-2752</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Despite recent advances in the development of novel therapies against castration-resistant prostate cancer, the advanced form of the disease remains a major treatment challenge.  Aberrant sphingolipid signaling through sphingosine kinases and their product, sphingosine-1-phosphate, can promote proliferation, drug resistance, angiogenesis, and inflammation.  The sphingosine kinase 2 inhibitor ABC294640 is undergoing clin. testing in cancer patients, and in this study we investigated the effects this first-in-class inhibitor in castration-resistant prostate cancer.  In vitro, ABC294640 decreased prostate cancer cell viability as well as the expression of c-Myc and the androgen receptor, while lysosomal acidification increased.  ABC294640 also induced a greater than 3-fold increase in dihydroceramides that inversely correlated with inhibition of dihydroceramide desaturase (DEGS) activity.  Expression of sphingosine kinase 2 was dispensable for the ABC294640-mediated increase in dihydroceramides.  In vivo, ABC294640 diminished the growth rate of TRAMP-C2 xenografts in syngeneic hosts and elevated dihydroceramides within tumors as visualized by MALDI imaging mass spectroscopy.  The plasma of ABC294640-treated mice contained significantly higher levels of C16- and C24:1-ceramides (but not dihydro-C16-ceramide) compared with vehicle-treated mice.  In summary, our results suggest that ABC294640 may reduce the proliferative capacity of castration-resistant prostate cancer cells through inhibition of both sphingosine kinase 2 and dihydroceramide desaturase, thereby providing a foundation for future exploration of this small-mol. inhibitor for the treatment of advanced disease.  Mol Cancer Ther; 14(12); 2744-52. 2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjC4kCtmtncrVg90H21EOLACvtfcHk0libaOgJ_BjK7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKlu73P&md5=b129bca65e5178c48b14284c000ade19</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-15-0279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-15-0279%26sid%3Dliteratum%253Aachs%26aulast%3DVenant%26aufirst%3DH.%26aulast%3DRahmaniyan%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DE.%2BE.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DLilly%26aufirst%3DM.%2BB.%26aulast%3DGarrett-Mayer%26aufirst%3DE.%26aulast%3DDrake%26aufirst%3DR.%2BR.%26aulast%3DKraveka%26aufirst%3DJ.%2BM.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26aulast%3DVoelkel-Johnson%26aufirst%3DC.%26atitle%3DThe%2520sphingosine%2520kinase%25202%2520inhibitor%2520ABC294640%2520reduces%2520the%2520growth%2520of%2520prostate%2520cancer%2520cells%2520and%2520results%2520in%2520accumulation%2520of%2520dihydroceramides%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2015%26volume%3D14%26spage%3D2744%26epage%3D2752%26doi%3D10.1158%2F1535-7163.MCT-15-0279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McNaughton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, S.</span></span> <span> </span><span class="NLM_article-title">Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">16663</span>– <span class="NLM_lpage">16675</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.7693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.18632%2Foncotarget.7693" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=16663-16675&author=M.+McNaughtonauthor=M.+Pitmanauthor=S.+M.+Pitsonauthor=N.+J.+Pyneauthor=S.+Pyne&title=Proteasomal+degradation+of+sphingosine+kinase+1+and+inhibition+of+dihydroceramide+desaturase+by+the+sphingosine+kinase+inhibitors%2C+SKi+or+ABC294640%2C+induces+growth+arrest+in+androgen-independent+LNCaP-AI+prostate+cancer+cells&doi=10.18632%2Foncotarget.7693"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.7693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.7693%26sid%3Dliteratum%253Aachs%26aulast%3DMcNaughton%26aufirst%3DM.%26aulast%3DPitman%26aufirst%3DM.%26aulast%3DPitson%26aufirst%3DS.%2BM.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26aulast%3DPyne%26aufirst%3DS.%26atitle%3DProteasomal%2520degradation%2520of%2520sphingosine%2520kinase%25201%2520and%2520inhibition%2520of%2520dihydroceramide%2520desaturase%2520by%2520the%2520sphingosine%2520kinase%2520inhibitors%252C%2520SKi%2520or%2520ABC294640%252C%2520induces%2520growth%2520arrest%2520in%2520androgen-independent%2520LNCaP-AI%2520prostate%2520cancer%2520cells%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D16663%26epage%3D16675%26doi%3D10.18632%2Foncotarget.7693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alsanafi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jubair, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNaughton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merrill, A. H.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, N. J.</span></span> <span> </span><span class="NLM_article-title">Native and polyubiquitinated forms of dihydroceramide desaturase are differentially linked to human embryonic kidney cell survival</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">e00222</span>, <span class="refDoi"> DOI: 10.1128/MCB.00222-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1128%2FMCB.00222-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=30224516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC1MXksVShtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2018&pages=e00222&author=M.+Alsanafiauthor=S.+L.+Kellyauthor=K.+Jubairauthor=M.+McNaughtonauthor=R.+J.+Tateauthor=A.+H.+Merrillauthor=S.+Pyneauthor=N.+J.+Pyne&title=Native+and+polyubiquitinated+forms+of+dihydroceramide+desaturase+are+differentially+linked+to+human+embryonic+kidney+cell+survival&doi=10.1128%2FMCB.00222-18"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Native and polyubiquitinated forms of dihydroceramide desaturase are differentially linked to human embryonic kidney cell survival</span></div><div class="casAuthors">Alsanafi, Mariam; Kelly, Samuel L.; Jubair, Karawan; McNaughton, Melissa; Tate, Rothwelle J.; Merrill, Alfred H. Jr.; Pyne, Susan; Pyne, Nigel J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">e00222-18/1-e00222-18/19</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">1098-5549</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">There is controversy concerning the role of dihydroceramide desaturase (Degs1) in regulating cell survival, with studies showing that it can both promote and protect against apoptosis.  We have therefore investigated the mol. basis for these opposing roles of Degs1.  Treatment of HEK293T cells with the sphingosine kinase inhibitor SKi [2-(p-hydroxyanilino)-4-(p-chlorophenyl)thiazole] or fenretinide, but not the Degs1 inhibitor GT11 {N-[(1R,2S)-2-hydroxy-1-hydroxymethyl-2-(2-tridecyl-1-cyclopropenyl)ethyl- ]octan-amide], induced the polyubiquitination of Degs1 (Mr = 40 to 140 kDa) via a mechanism involving oxidative stress, p38 mitogen-activated protein kinase (MAPK), and Mdm2 (E3 ligase).  The polyubiquitinated forms of Degs1 exhibit "gain of function" and activate prosurvival pathways, p38 MAPK, c-Jun N-terminal kinase (JNK), and X-box protein 1s (XBP-1s).  In contrast, another sphingosine kinase inhibitor, ABC294640 [3-(4- chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide], at concns. of 25 to 50 μM failed to induce formation of the polyubiquitinated forms of Degs1.  In contrast to SKi, ABC294640 (25 μM) promotes apoptosis of HEK293T cells via a Degs1-dependent mechanism that is assocd. with increased de novo synthesis of ceramide.  These findings are the first to demonstrate that the olyubiquitination of Degs1 appears to change its function from proapoptotic to prosurvival.  Thus, polyubiquitination of Degs1 might provide an explanation for the reported opposing functions of this enzyme in cell survival/apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqTkD499q9SrVg90H21EOLACvtfcHk0libaOgJ_BjK7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXksVShtrY%253D&md5=a68b1652855ea7324e7f938efce3114d</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1128%2FMCB.00222-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00222-18%26sid%3Dliteratum%253Aachs%26aulast%3DAlsanafi%26aufirst%3DM.%26aulast%3DKelly%26aufirst%3DS.%2BL.%26aulast%3DJubair%26aufirst%3DK.%26aulast%3DMcNaughton%26aufirst%3DM.%26aulast%3DTate%26aufirst%3DR.%2BJ.%26aulast%3DMerrill%26aufirst%3DA.%2BH.%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26atitle%3DNative%2520and%2520polyubiquitinated%2520forms%2520of%2520dihydroceramide%2520desaturase%2520are%2520differentially%2520linked%2520to%2520human%2520embryonic%2520kidney%2520cell%2520survival%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2018%26volume%3D38%26spage%3De00222%26doi%3D10.1128%2FMCB.00222-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evangelisti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evangelisti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falconi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchionda, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pession, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertaina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locatelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCubrey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beak, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martelli, A. M.</span></span> <span> </span><span class="NLM_article-title">Assessment of the effect of sphingosine kinase inhibitors on apoptosis, unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">7886</span>– <span class="NLM_lpage">7901</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.2318</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.18632%2Foncotarget.2318" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=7886-7901&author=C.+Evangelistiauthor=C.+Evangelistiauthor=G.+Tetiauthor=F.+Chiariniauthor=M.+Falconiauthor=F.+Melchiondaauthor=A.+Pessionauthor=A.+Bertainaauthor=F.+Locatelliauthor=J.+A.+McCubreyauthor=D.+J.+Beakauthor=R.+Bittmanauthor=S.+Pyneauthor=N.+J.+Pyneauthor=A.+M.+Martelli&title=Assessment+of+the+effect+of+sphingosine+kinase+inhibitors+on+apoptosis%2C+unfolded+protein+response+and+autophagy+of+T-cell+acute+lymphoblastic+leukemia+cells%3B+indications+for+novel+therapeutics&doi=10.18632%2Foncotarget.2318"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2318%26sid%3Dliteratum%253Aachs%26aulast%3DEvangelisti%26aufirst%3DC.%26aulast%3DEvangelisti%26aufirst%3DC.%26aulast%3DTeti%26aufirst%3DG.%26aulast%3DChiarini%26aufirst%3DF.%26aulast%3DFalconi%26aufirst%3DM.%26aulast%3DMelchionda%26aufirst%3DF.%26aulast%3DPession%26aufirst%3DA.%26aulast%3DBertaina%26aufirst%3DA.%26aulast%3DLocatelli%26aufirst%3DF.%26aulast%3DMcCubrey%26aufirst%3DJ.%2BA.%26aulast%3DBeak%26aufirst%3DD.%2BJ.%26aulast%3DBittman%26aufirst%3DR.%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26aulast%3DMartelli%26aufirst%3DA.%2BM.%26atitle%3DAssessment%2520of%2520the%2520effect%2520of%2520sphingosine%2520kinase%2520inhibitors%2520on%2520apoptosis%252C%2520unfolded%2520protein%2520response%2520and%2520autophagy%2520of%2520T-cell%2520acute%2520lymphoblastic%2520leukemia%2520cells%253B%2520indications%2520for%2520novel%2520therapeutics%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26spage%3D7886%26epage%3D7901%26doi%3D10.18632%2Foncotarget.2318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schnute, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McReynolds, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrencik, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Highkin, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyanar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerome, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rains, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saabye, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholten, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagiec, M. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent and selective sphingosine kinase 1 inhibitor through the molecular combination of chemotype distinct screening hits</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2562</span>– <span class="NLM_lpage">2572</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00070</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00070" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2562-2572&author=M.+E.+Schnuteauthor=M.+D.+McReynoldsauthor=J.+Carrollauthor=J.+E.+Chrencikauthor=M.+K.+Highkinauthor=K.+Iyanarauthor=G.+Jeromeauthor=J.+W.+Rainsauthor=M.+Saabyeauthor=J.+A.+Scholtenauthor=M.+Yatesauthor=M.+M.+Nagiec&title=Discovery+of+a+potent+and+selective+sphingosine+kinase+1+inhibitor+through+the+molecular+combination+of+chemotype+distinct+screening+hits&doi=10.1021%2Facs.jmedchem.7b00070"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00070%26sid%3Dliteratum%253Aachs%26aulast%3DSchnute%26aufirst%3DM.%2BE.%26aulast%3DMcReynolds%26aufirst%3DM.%2BD.%26aulast%3DCarroll%26aufirst%3DJ.%26aulast%3DChrencik%26aufirst%3DJ.%2BE.%26aulast%3DHighkin%26aufirst%3DM.%2BK.%26aulast%3DIyanar%26aufirst%3DK.%26aulast%3DJerome%26aufirst%3DG.%26aulast%3DRains%26aufirst%3DJ.%2BW.%26aulast%3DSaabye%26aufirst%3DM.%26aulast%3DScholten%26aufirst%3DJ.%2BA.%26aulast%3DYates%26aufirst%3DM.%26aulast%3DNagiec%26aufirst%3DM.%2BM.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520sphingosine%2520kinase%25201%2520inhibitor%2520through%2520the%2520molecular%2520combination%2520of%2520chemotype%2520distinct%2520screening%2520hits%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2562%26epage%3D2572%26doi%3D10.1021%2Facs.jmedchem.7b00070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Childress, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kharel, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bevan, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, W. L.</span></span> <span> </span><span class="NLM_article-title">Transforming sphingosine kinase 1 inhibitors into dual and sphingosine kinase 2 selective inhibitors: design, synthesis, and <i>in vivo</i> activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3933</span>– <span class="NLM_lpage">3957</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00233</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00233" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtVyjsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3933-3957&author=E.+S.+Childressauthor=Y.+Kharelauthor=A.+M.+Brownauthor=D.+R.+Bevanauthor=K.+R.+Lynchauthor=W.+L.+Santos&title=Transforming+sphingosine+kinase+1+inhibitors+into+dual+and+sphingosine+kinase+2+selective+inhibitors%3A+design%2C+synthesis%2C+and+in+vivo+activity&doi=10.1021%2Facs.jmedchem.7b00233"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Transforming Sphingosine Kinase 1 Inhibitors into Dual and Sphingosine Kinase 2 Selective Inhibitors: Design, Synthesis, and in Vivo Activity</span></div><div class="casAuthors">Childress, Elizabeth S.; Kharel, Yugesh; Brown, Anne M.; Bevan, David R.; Lynch, Kevin R.; Santos, Webster L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3933-3957</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) is a pleiotropic signaling mol. that interacts with its five G-protein coupled receptors (S1P1-5) to regulate cell growth and survival and has been implicated in a variety of diseases including cancer and sickle cell disease.  As the key mediators in the synthesis of S1P, sphingosine kinase (SphK) isoforms 1 and 2 have attracted attention as viable targets for pharmaceutical inhibition.  In this article, we describe the design, synthesis, and biol. evaluation of aminothiazole-based guanidine inhibitors of SphK.  Surprisingly, combining features of reported SphK1 inhibitors generated SphK1/2 dual inhibitor I·HCl (SLC4011540) (hSphK1 Ki = 120 nM, hSphK2 Ki = 90 nM) and SphK2 inhibitor II·HCl (SLC4101431) (Ki = 90 nM, 100-fold SphK2 selectivity).  These compds. effectively decrease S1P levels in vitro.  In vivo administration of II·HCl validated that inhibition of SphK2 increases blood S1P levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_Ie74w8OkL7Vg90H21EOLACvtfcHk0ljTl3sfIxmIFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtVyjsbY%253D&md5=29eda95d41546838fa3d500ccaa3c9b7</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00233%26sid%3Dliteratum%253Aachs%26aulast%3DChildress%26aufirst%3DE.%2BS.%26aulast%3DKharel%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DA.%2BM.%26aulast%3DBevan%26aufirst%3DD.%2BR.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DSantos%26aufirst%3DW.%2BL.%26atitle%3DTransforming%2520sphingosine%2520kinase%25201%2520inhibitors%2520into%2520dual%2520and%2520sphingosine%2520kinase%25202%2520selective%2520inhibitors%253A%2520design%252C%2520synthesis%252C%2520and%2520in%2520vivo%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3933%26epage%3D3957%26doi%3D10.1021%2Facs.jmedchem.7b00233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romanow, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meininger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thibault, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, N.</span></span> <span> </span><span class="NLM_article-title">Molecular basis of sphingosine kinase 1 substrate recognition and catalysis</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">798</span>– <span class="NLM_lpage">809</span>, <span class="refDoi"> DOI: 10.1016/j.str.2013.02.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1016%2Fj.str.2013.02.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=23602659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1Cmsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=798-809&author=Z.+Wangauthor=X.+Minauthor=S.+H.+Xiaoauthor=S.+Johnstoneauthor=W.+Romanowauthor=D.+Meiningerauthor=H.+Xuauthor=J.+Liuauthor=J.+Daiauthor=S.+Anauthor=S.+Thibaultauthor=N.+Walker&title=Molecular+basis+of+sphingosine+kinase+1+substrate+recognition+and+catalysis&doi=10.1016%2Fj.str.2013.02.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Basis of Sphingosine Kinase 1 Substrate Recognition and Catalysis</span></div><div class="casAuthors">Wang, Zhulun; Min, Xiaoshan; Xiao, Shou-Hua; Johnstone, Sheree; Romanow, William; Meininger, David; Xu, Haoda; Liu, Jinsong; Dai, Jessica; An, Songzhu; Thibault, Stephen; Walker, Nigel</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">798-809</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Sphingosine kinase 1 (SphK1) is a lipid kinase that catalyzes the conversion of sphingosine to sphingosine-1-phosphate (S1P), which has been shown to play a role in lymphocyte trafficking, angiogenesis, and response to apoptotic stimuli.  As a central enzyme in modulating the S1P levels in cells, SphK1 emerges as an important regulator for diverse cellular functions and a potential target for drug discovery.  Here, the authors present the crystal structures of human SphK1 in the apo form and in complexes with a substrate sphingosine-like lipid, ADP, and an inhibitor at 2.0-2.3 Å resoln.  The SphK1 structures reveal a two-domain architecture in which its catalytic site is located in the cleft between the two domains and a hydrophobic lipid-binding pocket is buried in the C-terminal domain.  Comparative anal. of these structures with mutagenesis and kinetic studies provides insight into how SphK1 recognizes the lipid substrate and catalyzes ATP-dependent phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGhuSYFEdxbrVg90H21EOLACvtfcHk0ljT-6ObITo9SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1Cmsr8%253D&md5=61b387e356ae18e0420be5e543f2187e</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2013.02.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2013.02.025%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DMin%26aufirst%3DX.%26aulast%3DXiao%26aufirst%3DS.%2BH.%26aulast%3DJohnstone%26aufirst%3DS.%26aulast%3DRomanow%26aufirst%3DW.%26aulast%3DMeininger%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DAn%26aufirst%3DS.%26aulast%3DThibault%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DN.%26atitle%3DMolecular%2520basis%2520of%2520sphingosine%2520kinase%25201%2520substrate%2520recognition%2520and%2520catalysis%26jtitle%3DStructure%26date%3D2013%26volume%3D21%26spage%3D798%26epage%3D809%26doi%3D10.1016%2Fj.str.2013.02.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkins, J. M.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of sphingosine kinase 1 with PF-543</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1329</span>– <span class="NLM_lpage">1333</span>, <span class="refDoi"> DOI: 10.1021/ml5004074</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml5004074" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVWnsrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1329-1333&author=J.+Wangauthor=S.+Knappauthor=N.+J.+Pyneauthor=S.+Pyneauthor=J.+M.+Elkins&title=Crystal+Structure+of+sphingosine+kinase+1+with+PF-543&doi=10.1021%2Fml5004074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of Sphingosine Kinase 1 with PF-543</span></div><div class="casAuthors">Wang, Jing; Knapp, Stefan; Pyne, Nigel J.; Pyne, Susan; Elkins, Jonathan M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1329-1333</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The most potent inhibitor of Sphingosine Kinase 1 (SPHK1) so far identified is PF-543.  The crystal structure of SPHK1 in complex with inhibitor PF-543 to 1.8 Å resoln. reveals the inhibitor bound in a bent conformation analogous to that expected of a bound sphingosine substrate but with a rotated head group.  The structural data presented will aid in the design of SPHK1 and SPHK2 inhibitors with improved properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpT23XvIdxU7Vg90H21EOLACvtfcHk0ljT-6ObITo9SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVWnsrrJ&md5=83cc5caeae2d5fa895c5fee4f0b17f73</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fml5004074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml5004074%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26atitle%3DCrystal%2520Structure%2520of%2520sphingosine%2520kinase%25201%2520with%2520PF-543%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1329%26epage%3D1333%26doi%3D10.1021%2Fml5004074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, N. J.</span></span> <span> </span><span class="NLM_article-title">Sphingosine kinases: emerging structure-function insights</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">409</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2016.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1016%2Fj.tibs.2016.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=27021309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsFKisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2016&pages=395-409&author=D.+R.+Adamsauthor=S.+Pyneauthor=N.+J.+Pyne&title=Sphingosine+kinases%3A+emerging+structure-function+insights&doi=10.1016%2Fj.tibs.2016.02.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine Kinases: Emerging Structure-Function Insights</span></div><div class="casAuthors">Adams, David R.; Pyne, Susan; Pyne, Nigel J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">395-409</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Sphingosine kinases (SK1 and SK2) catalyze the conversion of sphingosine into sphingosine 1-phosphate and control fundamental cellular processes, including cell survival, proliferation, differentiation, migration, and immune function.  In this review, we highlight recent breakthroughs in the structural and functional characterization of SK1 and these are contextualised by anal. of crystal structures for closely related prokaryotic lipid kinases.  We identify a putative dimerization interface and propose novel regulatory mechanisms governing structural plasticity induced by phosphorylation and interaction with phospholipids and proteins.  Our anal. suggests that the catalytic function and regulation of the enzymes might be dependent on conformational mobility and it provides a roadmap for future interrogation of SK1 function and its role in physiol. and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcl9A4KqinlbVg90H21EOLACvtfcHk0ljT-6ObITo9SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsFKisbc%253D&md5=c9dc9180d0ca4a945f2c413ed83ce717</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2016.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2016.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DD.%2BR.%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26atitle%3DSphingosine%2520kinases%253A%2520emerging%2520structure-function%2520insights%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2016%26volume%3D41%26spage%3D395%26epage%3D409%26doi%3D10.1016%2Fj.tibs.2016.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cinelli, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pensa, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martasek, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulos, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, R. B.</span></span> <span> </span><span class="NLM_article-title">Phenyl ether- and aniline-containing 2-aminoquinolines as potent and selective inhibitors of neuronal nitric oxide synthase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8694</span>– <span class="NLM_lpage">8712</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01330</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01330" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1GksrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8694-8712&author=M.+A.+Cinelliauthor=H.+Liauthor=A.+V.+Pensaauthor=S.+Kangauthor=L.+J.+Romanauthor=P.+Martasekauthor=T.+L.+Poulosauthor=R.+B.+Silverman&title=Phenyl+ether-+and+aniline-containing+2-aminoquinolines+as+potent+and+selective+inhibitors+of+neuronal+nitric+oxide+synthase&doi=10.1021%2Facs.jmedchem.5b01330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Phenyl Ether- and Aniline-Containing 2-Aminoquinolines as Potent and Selective Inhibitors of Neuronal Nitric Oxide Synthase</span></div><div class="casAuthors">Cinelli, Maris A.; Li, Huiying; Pensa, Anthony V.; Kang, Soosung; Roman, Linda J.; Martasek, Pavel; Poulos, Thomas L.; Silverman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8694-8712</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Excess nitric oxide (NO) produced by neuronal nitric oxide synthase (nNOS) is implicated in neurodegenerative disorders.  As a result, inhibition of nNOS and redn. of NO levels is desirable therapeutically, but many nNOS inhibitors are poorly bioavailable.  Promising members of our previously reported 2-aminoquinoline class of nNOS inhibitors, although orally bioavailable and brain-penetrant, suffer from unfavorable off-target binding to other CNS receptors; and they resemble known promiscuous binders.  Rearranged Ph ether- and aniline-linked 2-aminoquinoline derivs. were therefore designed to (a) disrupt the promiscuous binding pharmacophore and diminish off-target interactions and (b) preserve potency, isoform selectivity, and cell permeability.  A series of these compds. was synthesized and tested against purified nNOS, endothelial NOS (eNOS), and inducible NOS (iNOS) enzymes.  One compd., I, displayed high potency, selectivity, and good human nNOS inhibition, and retained some permeability in a Caco-2 assay.  Most promisingly, CNS receptor counter-screening revealed that this rearranged scaffold significantly reduces off-target binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8il7hgcnYsLVg90H21EOLACvtfcHk0lhrN6CUQXy7VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1GksrbJ&md5=778d070fdb1256326b30080906976cac</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01330%26sid%3Dliteratum%253Aachs%26aulast%3DCinelli%26aufirst%3DM.%2BA.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DPensa%26aufirst%3DA.%2BV.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DRoman%26aufirst%3DL.%2BJ.%26aulast%3DMartasek%26aufirst%3DP.%26aulast%3DPoulos%26aufirst%3DT.%2BL.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DPhenyl%2520ether-%2520and%2520aniline-containing%25202-aminoquinolines%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520neuronal%2520nitric%2520oxide%2520synthase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8694%26epage%3D8712%26doi%3D10.1021%2Facs.jmedchem.5b01330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Byun, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacRitchie, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittman, R.</span></span> <span> </span><span class="NLM_article-title">Novel sphingosine-containing analogues selectively inhibit sphingosine kinase (SK) isozymes, induce SK1 proteasomal degradation and reduce DNA synthesis in human pulmonary arterial smooth muscle cells</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1394</span>– <span class="NLM_lpage">1399</span>, <span class="refDoi"> DOI: 10.1039/c3md00201b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1039%2Fc3md00201b" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1394-1399&author=H.-S.+Byunauthor=S.+Pyneauthor=N.+MacRitchieauthor=N.+J.+Pyneauthor=R.+Bittman&title=Novel+sphingosine-containing+analogues+selectively+inhibit+sphingosine+kinase+%28SK%29+isozymes%2C+induce+SK1+proteasomal+degradation+and+reduce+DNA+synthesis+in+human+pulmonary+arterial+smooth+muscle+cells&doi=10.1039%2Fc3md00201b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1039%2Fc3md00201b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md00201b%26sid%3Dliteratum%253Aachs%26aulast%3DByun%26aufirst%3DH.-S.%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DMacRitchie%26aufirst%3DN.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26aulast%3DBittman%26aufirst%3DR.%26atitle%3DNovel%2520sphingosine-containing%2520analogues%2520selectively%2520inhibit%2520sphingosine%2520kinase%2520%2528SK%2529%2520isozymes%252C%2520induce%2520SK1%2520proteasomal%2520degradation%2520and%2520reduce%2520DNA%2520synthesis%2520in%2520human%2520pulmonary%2520arterial%2520smooth%2520muscle%2520cells%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D1394%26epage%3D1399%26doi%3D10.1039%2Fc3md00201b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edsall, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Brocklyn, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuvillier, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleuser, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiegel, S.</span></span> <span> </span><span class="NLM_article-title">N,N-Dimethylsphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C: modulation of cellular levels of sphingosine 1-phosphate and ceramide</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">12892</span>– <span class="NLM_lpage">12898</span>, <span class="refDoi"> DOI: 10.1021/bi980744d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi980744d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADyaK1cXlsFSkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=12892-12898&author=L.+C.+Edsallauthor=J.+R.+Van+Brocklynauthor=O.+Cuvillierauthor=B.+Kleuserauthor=S.+Spiegel&title=N%2CN-Dimethylsphingosine+is+a+potent+competitive+inhibitor+of+sphingosine+kinase+but+not+of+protein+kinase+C%3A+modulation+of+cellular+levels+of+sphingosine+1-phosphate+and+ceramide&doi=10.1021%2Fbi980744d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">N,N-Dimethylsphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C: Modulation of cellular levels of sphingosine 1-phosphate and ceramide</span></div><div class="casAuthors">Edsall, Lisa C.; Van Brocklyn, James R.; Cuvillier, Olivier; Kleuser, Burkhard; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">12892-12898</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (SPP), a lipid 2nd messenger formed by the action of sphingosine kinase, has been implicated in regulating diverse biol. processes, including growth, survival, and differentiation.  N,N-Dimethylsphingosine (DMS) inhibits sphingosine kinase and has been used to investigate the biol. roles of SPP; however, little is known of the mechanism of inhibition of sphingosine kinase by DMS.  In addn., DMS has been shown to inhibit protein kinase C in vitro.  Here, the authors report that DMS is a competitive inhibitor of sphingosine kinase from U937 monoblastic leukemia cells, Swiss 3T3 fibroblasts, and PC12 pheochromocytoma cells.  DMS decreased basal levels of SPP and prevented increases in SPP in response to physiol. stimuli known to activate sphingosine kinase.  DMS also effectively increased cellular levels of ceramide in a variety of cell types, and resetting of the ceramide/SPP rheostat may account for the pro-apoptotic effects of DMS.  Moreover, DMS, at concns. which effectively inhibited sphingosine kinase, had no effect on protein kinase C activity or its membrane translocation.  Thus, DMS acts as a specific competitive inhibitor of sphingosine kinase in diverse cell types and is a useful tool to elucidate the role of SPP as an intracellular 2nd messenger.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh2GXD98ZdmLVg90H21EOLACvtfcHk0lhrN6CUQXy7VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsFSkt7w%253D&md5=0010b4548f528912b0c8c51493dd53db</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fbi980744d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi980744d%26sid%3Dliteratum%253Aachs%26aulast%3DEdsall%26aufirst%3DL.%2BC.%26aulast%3DVan%2BBrocklyn%26aufirst%3DJ.%2BR.%26aulast%3DCuvillier%26aufirst%3DO.%26aulast%3DKleuser%26aufirst%3DB.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DN%252CN-Dimethylsphingosine%2520is%2520a%2520potent%2520competitive%2520inhibitor%2520of%2520sphingosine%2520kinase%2520but%2520not%2520of%2520protein%2520kinase%2520C%253A%2520modulation%2520of%2520cellular%2520levels%2520of%2520sphingosine%25201-phosphate%2520and%2520ceramide%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26spage%3D12892%26epage%3D12898%26doi%3D10.1021%2Fbi980744d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hengst, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guilford, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conroy, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, J. K.</span></span> <span> </span><span class="NLM_article-title">Enhancement of sphingosine kinase 1 catalytic activity by deletion of 21 amino acids from the COOH-terminus</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>494</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">31</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2009.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1016%2Fj.abb.2009.11.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=494&publication_year=2010&pages=23-31&author=J.+A.+Hengstauthor=J.+M.+Guilfordauthor=E.+J.+Conroyauthor=X.+Wangauthor=J.+K.+Yun&title=Enhancement+of+sphingosine+kinase+1+catalytic+activity+by+deletion+of+21+amino+acids+from+the+COOH-terminus&doi=10.1016%2Fj.abb.2009.11.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2009.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2009.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DHengst%26aufirst%3DJ.%2BA.%26aulast%3DGuilford%26aufirst%3DJ.%2BM.%26aulast%3DConroy%26aufirst%3DE.%2BJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DYun%26aufirst%3DJ.%2BK.%26atitle%3DEnhancement%2520of%2520sphingosine%2520kinase%25201%2520catalytic%2520activity%2520by%2520deletion%2520of%252021%2520amino%2520acids%2520from%2520the%2520COOH-terminus%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2010%26volume%3D494%26spage%3D23%26epage%3D31%26doi%3D10.1016%2Fj.abb.2009.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, N. J.</span></span> <span> </span><span class="NLM_article-title">FTY720 analogues as sphingosine kinase 1 inhibitors: enzyme inhibition kinetics, allosterism, proteasomal degradation, and actin rearrangement in MCF-7 breast cancer cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">18633</span>– <span class="NLM_lpage">18640</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.220756</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1074%2Fjbc.M111.220756" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=18633-18640&author=K.+G.+Limauthor=F.+Tonelliauthor=Z.+Liauthor=X.+Luauthor=R.+Bittmanauthor=S.+Pyneauthor=N.+J.+Pyne&title=FTY720+analogues+as+sphingosine+kinase+1+inhibitors%3A+enzyme+inhibition+kinetics%2C+allosterism%2C+proteasomal+degradation%2C+and+actin+rearrangement+in+MCF-7+breast+cancer+cells&doi=10.1074%2Fjbc.M111.220756"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.220756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.220756%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DK.%2BG.%26aulast%3DTonelli%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DBittman%26aufirst%3DR.%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26atitle%3DFTY720%2520analogues%2520as%2520sphingosine%2520kinase%25201%2520inhibitors%253A%2520enzyme%2520inhibition%2520kinetics%252C%2520allosterism%252C%2520proteasomal%2520degradation%252C%2520and%2520actin%2520rearrangement%2520in%2520MCF-7%2520breast%2520cancer%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D18633%26epage%3D18640%26doi%3D10.1074%2Fjbc.M111.220756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summerhill, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, J. E.</span></span> <span> </span><span class="NLM_article-title">Aromatic chloride to nitrile transformation: medicinal and synthetic chemistry</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">318</span>, <span class="refDoi"> DOI: 10.1039/c0md00135j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1039%2Fc0md00135j" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=309-318&author=L.+H.+Jonesauthor=N.+W.+Summerhillauthor=N.+A.+Swainauthor=J.+E.+Mills&title=Aromatic+chloride+to+nitrile+transformation%3A+medicinal+and+synthetic+chemistry&doi=10.1039%2Fc0md00135j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1039%2Fc0md00135j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0md00135j%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DL.%2BH.%26aulast%3DSummerhill%26aufirst%3DN.%2BW.%26aulast%3DSwain%26aufirst%3DN.%2BA.%26aulast%3DMills%26aufirst%3DJ.%2BE.%26atitle%3DAromatic%2520chloride%2520to%2520nitrile%2520transformation%253A%2520medicinal%2520and%2520synthetic%2520chemistry%26jtitle%3DMedChemComm%26date%3D2010%26volume%3D1%26spage%3D309%26epage%3D318%26doi%3D10.1039%2Fc0md00135j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravikumar, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funk, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shook, B. C.</span></span> <span> </span><span class="NLM_article-title">Nitrile-containing pharmaceuticals: efficacious roles of the nitrile pharmacophore</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">7902</span>– <span class="NLM_lpage">7917</span>, <span class="refDoi"> DOI: 10.1021/jm100762r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100762r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2kurvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7902-7917&author=F.+F.+Flemingauthor=L.+Yaoauthor=P.+C.+Ravikumarauthor=L.+Funkauthor=B.+C.+Shook&title=Nitrile-containing+pharmaceuticals%3A+efficacious+roles+of+the+nitrile+pharmacophore&doi=10.1021%2Fjm100762r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore</span></div><div class="casAuthors">Fleming, Fraser F.; Yao, Lihua; Ravikumar, P. C.; Funk, Lee; Shook, Brian C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7902-7917</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The review is structured according to the nature of the nitrile-bearing substituent.  As the no. of nitrile-contg. drug leads is vast, the review has focused on launched nitrile-contg. pharmaceuticals and currently active clin. candidates.  Most nitrile-contg. pharmaceuticals are aroms. with aliph.-, alkene-, and nitrogen-bearing nitriles being progressively less frequent.  Within each class, the bioactive nitriles are collated according to common structural elements and mode of action.  The hope is that this survey will allow greater deployment of this versatile functionality within drug leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR6kPPdWVuvLVg90H21EOLACvtfcHk0lgm1YM4t9KbPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2kurvP&md5=040bbaebd9e8c9999d195b9a22221fea</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm100762r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100762r%26sid%3Dliteratum%253Aachs%26aulast%3DFleming%26aufirst%3DF.%2BF.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DRavikumar%26aufirst%3DP.%2BC.%26aulast%3DFunk%26aufirst%3DL.%26aulast%3DShook%26aufirst%3DB.%2BC.%26atitle%3DNitrile-containing%2520pharmaceuticals%253A%2520efficacious%2520roles%2520of%2520the%2520nitrile%2520pharmacophore%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7902%26epage%3D7917%26doi%3D10.1021%2Fjm100762r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bordoli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwede, T.</span></span> <span> </span><span class="NLM_article-title">The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling</span>. <i>Bioinformatics</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">195</span>– <span class="NLM_lpage">201</span>, <span class="refDoi"> DOI: 10.1093/bioinformatics/bti770</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1093%2Fbioinformatics%2Fbti770" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=16301204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BD28XovVCltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2006&pages=195-201&author=K.+Arnoldauthor=L.+Bordoliauthor=J.+Koppauthor=T.+Schwede&title=The+SWISS-MODEL+workspace%3A+a+web-based+environment+for+protein+structure+homology+modelling&doi=10.1093%2Fbioinformatics%2Fbti770"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling</span></div><div class="casAuthors">Arnold, Konstantin; Bordoli, Lorenza; Kopp, Juergen; Schwede, Torsten</div><div class="citationInfo"><span class="NLM_cas:title">Bioinformatics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">195-201</span>CODEN:
                <span class="NLM_cas:coden">BOINFP</span>;
        ISSN:<span class="NLM_cas:issn">1367-4803</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Motivation: Homol. models of proteins are of great interest for planning and analyzing biol. expts. when no exptl. three-dimensional structures are available.  Building homol. models requires specialized programs and up-to-date sequence and structural databases.  Integrating all required tools, programs and databases into a single web-based workspace facilitates access to homol. modeling from a computer with web connection without the need of downloading and installing large program packages and databases.  Results: SWISS-MODEL workspace is a web-based integrated service dedicated to protein structure homol. modeling.  It assists and guides the user in building protein homol. models at different levels of complexity.  A personal working environment is provided for each user where several modeling projects can be carried out in parallel.  Protein sequence and structure databases necessary for modeling are accessible from the workspace and are updated in regular intervals.  Tools for template selection, model building and structure quality evaluation can be invoked from within the workspace.  Workflow and usage of the workspace are illustrated by modeling human Cyclin A1 and human Transmembrane Protease 3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDwXLAG5Kz27Vg90H21EOLACvtfcHk0lgm1YM4t9KbPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovVCltw%253D%253D&md5=66fa733d2ad6d2abf7d3d87ae837ebce</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1093%2Fbioinformatics%2Fbti770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbioinformatics%252Fbti770%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DK.%26aulast%3DBordoli%26aufirst%3DL.%26aulast%3DKopp%26aufirst%3DJ.%26aulast%3DSchwede%26aufirst%3DT.%26atitle%3DThe%2520SWISS-MODEL%2520workspace%253A%2520a%2520web-based%2520environment%2520for%2520protein%2520structure%2520homology%2520modelling%26jtitle%3DBioinformatics%26date%3D2006%26volume%3D22%26spage%3D195%26epage%3D201%26doi%3D10.1093%2Fbioinformatics%2Fbti770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kiefer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunzli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bordoli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwede, T.</span></span> <span> </span><span class="NLM_article-title">The SWISS-MODEL Repository and associated resources</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">D387</span>– <span class="NLM_lpage">D392</span>, <span class="refDoi"> DOI: 10.1093/nar/gkn750</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1093%2Fnar%2Fgkn750" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=18931379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFejtb7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=D387-D392&author=F.+Kieferauthor=K.+Arnoldauthor=M.+Kunzliauthor=L.+Bordoliauthor=T.+Schwede&title=The+SWISS-MODEL+Repository+and+associated+resources&doi=10.1093%2Fnar%2Fgkn750"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">The SWISS-MODEL Repository and associated resources</span></div><div class="casAuthors">Kiefer, Florian; Arnold, Konstantin; Kuenzli, Michael; Bordoli, Lorenza; Schwede, Torsten</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">Database Iss</span>),
    <span class="NLM_cas:pages">D387-D392</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">SWISS-MODEL Repository (http://swissmodel.expasy.org/repository/) is a database of 3D protein structure models generated by the SWISS-MODEL homol.-modeling pipeline.  The aim of the SWISS-MODEL Repository is to provide access to an up-to-date collection of annotated 3D protein models generated by automated homol. modeling for all sequences in Swiss-Prot and for relevant models organisms.  Regular updates ensure that target coverage is complete, that models are built using the most recent sequence and template structure databases, and that improvements in the underlying modeling pipeline are fully utilized.  As of Sept. 2008, the database contains 3.4 million entries for 2.7 million different protein sequences from the UniProt database.  SWISS-MODEL Repository allows the users to assess the quality of the models in the database, search for alternative template structures, and to build models interactively via SWISS-MODEL Workspace (http://swissmodel.expasy.org/workspace/).  Annotation of models with functional information and crosslinking with other databases such as the Protein Model Portal (http://www.proteinmodelportal.org) of the PSI Structural Genomics Knowledge Base facilitates the navigation between protein sequence and structure resources.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrceZMva79o97Vg90H21EOLACvtfcHk0lgm1YM4t9KbPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFejtb7P&md5=7142f7db9b36d48c322f8ddfdc2032d5</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkn750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkn750%26sid%3Dliteratum%253Aachs%26aulast%3DKiefer%26aufirst%3DF.%26aulast%3DArnold%26aufirst%3DK.%26aulast%3DKunzli%26aufirst%3DM.%26aulast%3DBordoli%26aufirst%3DL.%26aulast%3DSchwede%26aufirst%3DT.%26atitle%3DThe%2520SWISS-MODEL%2520Repository%2520and%2520associated%2520resources%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2009%26volume%3D37%26spage%3DD387%26epage%3DD392%26doi%3D10.1093%2Fnar%2Fgkn750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guex, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peitsch, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwede, T.</span></span> <span> </span><span class="NLM_article-title">Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: a historical perspective</span>. <i>Electrophoresis</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">S162</span>– <span class="NLM_lpage">S173</span>, <span class="refDoi"> DOI: 10.1002/elps.200900140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1002%2Felps.200900140" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=19517507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A280%3ADC%252BD1Mvis1Ortg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=S162-S173&author=N.+Guexauthor=M.+C.+Peitschauthor=T.+Schwede&title=Automated+comparative+protein+structure+modeling+with+SWISS-MODEL+and+Swiss-PdbViewer%3A+a+historical+perspective&doi=10.1002%2Felps.200900140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: a historical perspective</span></div><div class="casAuthors">Guex Nicolas; Peitsch Manuel C; Schwede Torsten</div><div class="citationInfo"><span class="NLM_cas:title">Electrophoresis</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30 Suppl 1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">S162-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">SWISS-MODEL pioneered the field of automated modeling as the first protein modeling service on the Internet.  In combination with the visualization tool Swiss-PdbViewer, the Internet-based Workspace and the SWISS-MODEL Repository, it provides a fully integrated sequence to structure analysis and modeling platform.  This computational environment is made freely available to the scientific community with the aim to hide the computational complexity of structural bioinformatics and encourage bench scientists to make use of the ever-increasing structural information available.  Indeed, over the last decade, the availability of structural information has significantly increased for many organisms as a direct consequence of the complementary nature of comparative protein modeling and experimental structure determination.  This has a very positive and enabling impact on many different applications in biomedical research as described in this paper.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPUn40ZFOULN-cVm4E2RlLfW6udTcc2eak1y-s2MSwCrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mvis1Ortg%253D%253D&md5=e74c27636b8f333cd344bedff31c97fa</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1002%2Felps.200900140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Felps.200900140%26sid%3Dliteratum%253Aachs%26aulast%3DGuex%26aufirst%3DN.%26aulast%3DPeitsch%26aufirst%3DM.%2BC.%26aulast%3DSchwede%26aufirst%3DT.%26atitle%3DAutomated%2520comparative%2520protein%2520structure%2520modeling%2520with%2520SWISS-MODEL%2520and%2520Swiss-PdbViewer%253A%2520a%2520historical%2520perspective%26jtitle%3DElectrophoresis%26date%3D2009%26volume%3D30%26spage%3DS162%26epage%3DS173%26doi%3D10.1002%2Felps.200900140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biasini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterhouse, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Studer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiefer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo Cassarino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertoni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bordoli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwede, T.</span></span> <span> </span><span class="NLM_article-title">SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">W252</span>– <span class="NLM_lpage">W258</span>, <span class="refDoi"> DOI: 10.1093/nar/gku340</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1093%2Fnar%2Fgku340" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=24782522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFCqs73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=W252-W258&author=M.+Biasiniauthor=S.+Bienertauthor=A.+Waterhouseauthor=K.+Arnoldauthor=G.+Studerauthor=T.+Schmidtauthor=F.+Kieferauthor=T.+Gallo+Cassarinoauthor=M.+Bertoniauthor=L.+Bordoliauthor=T.+Schwede&title=SWISS-MODEL%3A+modelling+protein+tertiary+and+quaternary+structure+using+evolutionary+information&doi=10.1093%2Fnar%2Fgku340"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information</span></div><div class="casAuthors">Biasini, Marco; Bienert, Stefan; Waterhouse, Andrew; Arnold, Konstantin; Studer, Gabriel; Schmidt, Tobias; Kiefer, Florian; Cassarino, Tiziano Gallo; Bertoni, Martino; Bordoli, Lorenza; Schwede, Torsten</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">W1</span>),
    <span class="NLM_cas:pages">W252-W258</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Protein structure homol. modeling has become a routine technique to generate 3D models for proteins when exptl. structures are not available.  Fully automated servers such as SWISS-MODEL with user-friendly web interfaces generate reliable models without the need for complex software packages or downloading large databases.  Here, we describe the latest version of the SWISS-MODEL expert system for protein structure modeling.  The SWISS-MODEL template library provides annotation of quaternary structure and essential ligands and co-factors to allow for building of complete structural models, including their oligomeric structure.  The improved SWISS-MODEL pipeline makes extensive use of model quality estn. for selection of the most suitable templates and provides ests. of the expected accuracy of the resulting models.  The accuracy of the models generated by SWISS-MODEL is continuously evaluated by the CAMEO system.  The new web site allows users to interactively search for templates, cluster them by sequence similarity, structurally compare alternative templates and select the ones to be used for model building.  In cases where multiple alternative template structures are available for a protein of interest, a user-guided template selection step allows building models in different functional states.  SWISS-MODEL is available at http://swissmodel.expasy.org/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpevqhyplQxI7Vg90H21EOLACvtfcHk0lglONZUPuXyjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFCqs73I&md5=51509ba8353b06f286d954ebe7e6673a</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgku340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgku340%26sid%3Dliteratum%253Aachs%26aulast%3DBiasini%26aufirst%3DM.%26aulast%3DBienert%26aufirst%3DS.%26aulast%3DWaterhouse%26aufirst%3DA.%26aulast%3DArnold%26aufirst%3DK.%26aulast%3DStuder%26aufirst%3DG.%26aulast%3DSchmidt%26aufirst%3DT.%26aulast%3DKiefer%26aufirst%3DF.%26aulast%3DGallo%2BCassarino%26aufirst%3DT.%26aulast%3DBertoni%26aufirst%3DM.%26aulast%3DBordoli%26aufirst%3DL.%26aulast%3DSchwede%26aufirst%3DT.%26atitle%3DSWISS-MODEL%253A%2520modelling%2520protein%2520tertiary%2520and%2520quaternary%2520structure%2520using%2520evolutionary%2520information%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2014%26volume%3D42%26spage%3DW252%26epage%3DW258%26doi%3D10.1093%2Fnar%2Fgku340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Congdon, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kharel, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bevan, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, W. L.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship studies and molecular modeling of naphthalene-based sphingosine kinase 2 Inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00304</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00304" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFOmsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=229-234&author=M.+D.+Congdonauthor=Y.+Kharelauthor=A.+M.+Brownauthor=S.+N.+Lewisauthor=D.+R.+Bevanauthor=K.+R.+Lynchauthor=W.+L.+Santos&title=Structure-activity+relationship+studies+and+molecular+modeling+of+naphthalene-based+sphingosine+kinase+2+Inhibitors&doi=10.1021%2Facsmedchemlett.5b00304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship Studies and Molecular Modeling of Naphthalene-Based Sphingosine Kinase 2 Inhibitors</span></div><div class="casAuthors">Congdon, Molly D.; Kharel, Yugesh; Brown, Anne M.; Lewis, Stephanie N.; Bevan, David R.; Lynch, Kevin R.; Santos, Webster L.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">229-234</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The two isoforms of sphingosine kinase (SphK1 and SphK2) are the only enzymes that phosphorylate sphingosine to sphingosine-1-phosphate (S1P), which is a pleiotropic lipid mediator involved in a broad range of cellular processes including migration, proliferation, and inflammation.  SphKs are targets for various diseases such as cancer, fibrosis, and Alzheimer's and sickle cell disease.  Herein, the authors disclose the structure-activity profile of naphthalene-contg. SphK inhibitors, e.g. I, and mol. modeling studies that reveal a key mol. switch that controls SphK selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPGfYUT33eh7Vg90H21EOLACvtfcHk0lglONZUPuXyjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFOmsLw%253D&md5=537066e8604f804f7a73b4275dbd135d</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00304%26sid%3Dliteratum%253Aachs%26aulast%3DCongdon%26aufirst%3DM.%2BD.%26aulast%3DKharel%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DA.%2BM.%26aulast%3DLewis%26aufirst%3DS.%2BN.%26aulast%3DBevan%26aufirst%3DD.%2BR.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DSantos%26aufirst%3DW.%2BL.%26atitle%3DStructure-activity%2520relationship%2520studies%2520and%2520molecular%2520modeling%2520of%2520naphthalene-based%2520sphingosine%2520kinase%25202%2520Inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D229%26epage%3D234%26doi%3D10.1021%2Facsmedchemlett.5b00304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Houck, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kharel, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naimon, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Field, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, T. L.</span></span> <span> </span><span class="NLM_article-title">Structural requirements and docking analysis of amidine-based sphingosine kinase 1 inhibitors containing oxadiazoles</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">487</span>– <span class="NLM_lpage">492</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsFaqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=487-492&author=J.+D.+Houckauthor=T.+K.+Dawsonauthor=A.+J.+Kennedyauthor=Y.+Kharelauthor=N.+D.+Naimonauthor=S.+D.+Fieldauthor=K.+R.+Lynchauthor=T.+L.+Macdonald&title=Structural+requirements+and+docking+analysis+of+amidine-based+sphingosine+kinase+1+inhibitors+containing+oxadiazoles&doi=10.1021%2Facsmedchemlett.6b00002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Requirements and Docking Analysis of Amidine-Based Sphingosine Kinase 1 Inhibitors Containing Oxadiazoles</span></div><div class="casAuthors">Houck, Joseph D.; Dawson, Thomas K.; Kennedy, Andrew J.; Kharel, Yugesh; Naimon, Niels D.; Field, Saundra D.; Lynch, Kevin R.; Macdonald, Timothy L.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">487-492</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) is a potent growth-signaling lipid that has been implicated in cancer progression, inflammation, sickle cell disease, and fibrosis.  Two sphingosine kinases (SphK1 and 2) are the source of S1P; thus, inhibitors of the SphKs have potential as targeted cancer therapies and will help to clarify the roles of S1P and the SphKs in other hyperproliferative diseases.  Recently, we reported a series of amidine-based inhibitors with high selectivity for SphK1 and potency in the nanomolar range.  However, these inhibitors display a short half-life.  With the goal of increasing metabolic stability and maintaining efficacy, we designed an analogous series of mols. contg. oxadiazole moieties.  Generation of a library of mols. resulted in the identification of the most selective inhibitor of SphK1 reported to date (705-fold selectivity over SphK2), and we found that potency and selectivity vary significantly depending on the particular oxadiazole isomer employed.  The best inhibitors were subjected to in silico mol. dynamics docking anal., which revealed key insights into the binding of amidine-based inhibitors by SphK1.  Herein, the design, synthesis, biol. evaluation, and docking anal. of these mols. are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWZdhVUIviRLVg90H21EOLACvtfcHk0lhvRA4PPeEsOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsFaqsLw%253D&md5=1edf9e0138e7ac44d58e6eec51b699f7</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00002%26sid%3Dliteratum%253Aachs%26aulast%3DHouck%26aufirst%3DJ.%2BD.%26aulast%3DDawson%26aufirst%3DT.%2BK.%26aulast%3DKennedy%26aufirst%3DA.%2BJ.%26aulast%3DKharel%26aufirst%3DY.%26aulast%3DNaimon%26aufirst%3DN.%2BD.%26aulast%3DField%26aufirst%3DS.%2BD.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26atitle%3DStructural%2520requirements%2520and%2520docking%2520analysis%2520of%2520amidine-based%2520sphingosine%2520kinase%25201%2520inhibitors%2520containing%2520oxadiazoles%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D487%26epage%3D492%26doi%3D10.1021%2Facsmedchemlett.6b00002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, D.</span></span> <span> </span><span class="NLM_article-title">Assessing the ligand selectivity of sphingosine kinases using molecular dynamics and MM-PBSA binding free energy calculations</span>. <i>Mol. BioSyst.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1174</span>– <span class="NLM_lpage">1182</span>, <span class="refDoi"> DOI: 10.1039/C6MB00067C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1039%2FC6MB00067C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=26927311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC28XivVKgtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=1174-1182&author=L.+Fangauthor=X.+Wangauthor=M.+Xiauthor=T.+Liuauthor=D.+Yin&title=Assessing+the+ligand+selectivity+of+sphingosine+kinases+using+molecular+dynamics+and+MM-PBSA+binding+free+energy+calculations&doi=10.1039%2FC6MB00067C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing the ligand selectivity of sphingosine kinases using molecular dynamics and MM-PBSA binding free energy calculations</span></div><div class="casAuthors">Fang, Liang; Wang, Xiaojian; Xi, Meiyang; Liu, Tianqi; Yin, Dali</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1174-1182</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-2051</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The dynamic balance of sphingolipids plays a crucial role in diverse biol. processes such as mitogenesis, cell migration and angiogenesis.  Sphingosine kinases (SKs) including SK1 and SK2 phosphorylate sphingosine to sphingosine 1-phosphate (S1P), and control the crit. balance.  SK1 overexpression was reported to increase cell survival and proliferation.  Although several SK1 selective inhibitors have been reported, detailed anal. toward their selectivity to understand the mol. mechanism has not been performed to our knowledge.  Herein, the crystal structure of SK1 and a homol. model of SK2 were used to dock five inhibitors (1, 2, 3, 4 and 5).  Protein-ligand complexes were then subjected to a mol. dynamics study and MM-PBSA binding free energy calcns.  By analyzing the binding model of these inhibitors, we found that residues ILE170, PHE188 and THR192 in SK1 significantly contribute a favorable binding energy to the selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9m5X9YBTn7rVg90H21EOLACvtfcHk0lhvRA4PPeEsOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivVKgtLk%253D&md5=03e4c50dc954ff36437c20387374c2b6</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1039%2FC6MB00067C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6MB00067C%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DXi%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DYin%26aufirst%3DD.%26atitle%3DAssessing%2520the%2520ligand%2520selectivity%2520of%2520sphingosine%2520kinases%2520using%2520molecular%2520dynamics%2520and%2520MM-PBSA%2520binding%2520free%2520energy%2520calculations%26jtitle%3DMol.%2520BioSyst.%26date%3D2016%26volume%3D12%26spage%3D1174%26epage%3D1182%26doi%3D10.1039%2FC6MB00067C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gottlieb, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotlyar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nudelman, A.</span></span> <span> </span><span class="NLM_article-title">NMR chemical shifts of common laboratory solvents as trace impurities</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">7512</span>– <span class="NLM_lpage">7515</span>, <span class="refDoi"> DOI: 10.1021/jo971176v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo971176v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADyaK2sXmvVClsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=7512-7515&author=H.+E.+Gottliebauthor=V.+Kotlyarauthor=A.+Nudelman&title=NMR+chemical+shifts+of+common+laboratory+solvents+as+trace+impurities&doi=10.1021%2Fjo971176v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">NMR chemical shifts of common laboratory solvents as trace impurities</span></div><div class="casAuthors">Gottlieb, Hugo E.; Kotlyar, Vadim; Nudelman, Abraham</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7512-7515</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The 1H (300 MHz) and 13C (75 MHz) NMR chem. shifts for >30 common impurities, such as lab. solvents, stabilizers, greases and water, are reported in 7 deuterated NMR solvents.  The temp. dependence of the chem. shift of the proton residual peak (HDO) in D2O is established for the entire liq. range of this sample.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocnoOemocS9LVg90H21EOLACvtfcHk0lhvRA4PPeEsOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmvVClsbo%253D&md5=c297adda99f8c10e9f9b0ab9fe5f55be</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjo971176v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo971176v%26sid%3Dliteratum%253Aachs%26aulast%3DGottlieb%26aufirst%3DH.%2BE.%26aulast%3DKotlyar%26aufirst%3DV.%26aulast%3DNudelman%26aufirst%3DA.%26atitle%3DNMR%2520chemical%2520shifts%2520of%2520common%2520laboratory%2520solvents%2520as%2520trace%2520impurities%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26spage%3D7512%26epage%3D7515%26doi%3D10.1021%2Fjo971176v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathis, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerdes, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitney, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mailman, R. B.</span></span> <span> </span><span class="NLM_article-title">Synthesis and in vitro evaluation of 2,3-dimethoxy-5-(fluoroalkyl)-substituted benzamides: high-affinity ligands for CNS dopamine D2 receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1612</span>– <span class="NLM_lpage">1624</span>, <span class="refDoi"> DOI: 10.1021/jm00109a013</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00109a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=1612-1624&author=J.+E.+Bishopauthor=C.+A.+Mathisauthor=J.+M.+Gerdesauthor=J.+M.+Whitneyauthor=A.+M.+Eatonauthor=R.+B.+Mailman&title=Synthesis+and+in+vitro+evaluation+of+2%2C3-dimethoxy-5-%28fluoroalkyl%29-substituted+benzamides%3A+high-affinity+ligands+for+CNS+dopamine+D2+receptors&doi=10.1021%2Fjm00109a013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm00109a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00109a013%26sid%3Dliteratum%253Aachs%26aulast%3DBishop%26aufirst%3DJ.%2BE.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DGerdes%26aufirst%3DJ.%2BM.%26aulast%3DWhitney%26aufirst%3DJ.%2BM.%26aulast%3DEaton%26aufirst%3DA.%2BM.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520evaluation%2520of%25202%252C3-dimethoxy-5-%2528fluoroalkyl%2529-substituted%2520benzamides%253A%2520high-affinity%2520ligands%2520for%2520CNS%2520dopamine%2520D2%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D1612%26epage%3D1624%26doi%3D10.1021%2Fjm00109a013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bakali, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieslander, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallberg, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordlund, P.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of YegS, a homologue to the mammalian diacylglycerol kinases, reveals a novel regulatory metal binding site</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">19644</span>– <span class="NLM_lpage">19652</span>, <span class="refDoi"> DOI: 10.1074/jbc.M604852200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1074%2Fjbc.M604852200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=19644-19652&author=H.+M.+Bakaliauthor=M.+D.+Hermanauthor=K.+A.+Johnsonauthor=A.+A.+Kellyauthor=A.+Wieslanderauthor=B.+M.+Hallbergauthor=P.+Nordlund&title=Crystal+structure+of+YegS%2C+a+homologue+to+the+mammalian+diacylglycerol+kinases%2C+reveals+a+novel+regulatory+metal+binding+site&doi=10.1074%2Fjbc.M604852200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M604852200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M604852200%26sid%3Dliteratum%253Aachs%26aulast%3DBakali%26aufirst%3DH.%2BM.%26aulast%3DHerman%26aufirst%3DM.%2BD.%26aulast%3DJohnson%26aufirst%3DK.%2BA.%26aulast%3DKelly%26aufirst%3DA.%2BA.%26aulast%3DWieslander%26aufirst%3DA.%26aulast%3DHallberg%26aufirst%3DB.%2BM.%26aulast%3DNordlund%26aufirst%3DP.%26atitle%3DCrystal%2520structure%2520of%2520YegS%252C%2520a%2520homologue%2520to%2520the%2520mammalian%2520diacylglycerol%2520kinases%252C%2520reveals%2520a%2520novel%2520regulatory%2520metal%2520binding%2520site%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D19644%26epage%3D19652%26doi%3D10.1074%2Fjbc.M604852200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boccone, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vattem, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wek, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, J. P.</span></span> <span> </span><span class="NLM_article-title">Site-directed mutagenesis of the active site of diacylglycerol kinase alpha: calcium and phosphatidylserine stimulate enzyme activity via distinct mechanisms</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>375</i></span>,  <span class="NLM_fpage">673</span>– <span class="NLM_lpage">680</span>, <span class="refDoi"> DOI: 10.1042/bj20031052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1042%2Fbj20031052" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=375&publication_year=2003&pages=673-680&author=T.+Abeauthor=X.+Luauthor=Y.+Jiangauthor=C.+E.+Bocconeauthor=S.+Qianauthor=K.+M.+Vattemauthor=R.+C.+Wekauthor=J.+P.+Walsh&title=Site-directed+mutagenesis+of+the+active+site+of+diacylglycerol+kinase+alpha%3A+calcium+and+phosphatidylserine+stimulate+enzyme+activity+via+distinct+mechanisms&doi=10.1042%2Fbj20031052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1042%2Fbj20031052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20031052%26sid%3Dliteratum%253Aachs%26aulast%3DAbe%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DBoccone%26aufirst%3DC.%2BE.%26aulast%3DQian%26aufirst%3DS.%26aulast%3DVattem%26aufirst%3DK.%2BM.%26aulast%3DWek%26aufirst%3DR.%2BC.%26aulast%3DWalsh%26aufirst%3DJ.%2BP.%26atitle%3DSite-directed%2520mutagenesis%2520of%2520the%2520active%2520site%2520of%2520diacylglycerol%2520kinase%2520alpha%253A%2520calcium%2520and%2520phosphatidylserine%2520stimulate%2520enzyme%2520activity%2520via%2520distinct%2520mechanisms%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D375%26spage%3D673%26epage%3D680%26doi%3D10.1042%2Fbj20031052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 12 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Athanasios Papakyriakou, Francesca Cencetti, Elisa Puliti, Laura Morelli, Jacopo Tricomi, Paola Bruni, Federica Compostella, <span class="NLM_string-name hlFld-ContribAuthor">Barbara Richichi</span>. </span><span class="cited-content_cbyCitation_article-title">Glycans Meet Sphingolipids: Structure-Based Design of Glycan Containing Analogues of a Sphingosine Kinase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (5)
                                     , 913-920. <a href="https://doi.org/10.1021/acsmedchemlett.9b00665" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00665</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00665%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DGlycans%252BMeet%252BSphingolipids%25253A%252BStructure-Based%252BDesign%252Bof%252BGlycan%252BContaining%252BAnalogues%252Bof%252Ba%252BSphingosine%252BKinase%252BInhibitor%26aulast%3DPapakyriakou%26aufirst%3DAthanasios%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D30122019%26date%3D30032020%26date%3D01042020%26date%3D30032020%26volume%3D11%26issue%3D5%26spage%3D913%26epage%3D920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christopher D. Sibley, Emily A. Morris, Yugesh Kharel, Anne M. Brown, Tao Huang, David R. Bevan, Kevin R. Lynch, <span class="NLM_string-name hlFld-ContribAuthor">Webster L. Santos</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Small Side Cavity in Sphingosine Kinase 2 that Enhances Inhibitor Potency and Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (3)
                                     , 1178-1198. <a href="https://doi.org/10.1021/acs.jmedchem.9b01508" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01508</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01508%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BSmall%252BSide%252BCavity%252Bin%252BSphingosine%252BKinase%252B2%252Bthat%252BEnhances%252BInhibitor%252BPotency%252Band%252BSelectivity%26aulast%3DSibley%26aufirst%3DChristopher%2BD.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D10092019%26date%3D28012020%26date%3D02012020%26volume%3D63%26issue%3D3%26spage%3D1178%26epage%3D1198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chenjian  Wang</span>, <span class="hlFld-ContribAuthor ">Tianzhen  Xu</span>, <span class="hlFld-ContribAuthor ">Brittany Bolduc  Lachance</span>, <span class="hlFld-ContribAuthor ">Xiqiang  Zhong</span>, <span class="hlFld-ContribAuthor ">Guangjie  Shen</span>, <span class="hlFld-ContribAuthor ">Tao  Xu</span>, <span class="hlFld-ContribAuthor ">Chengxuan  Tang</span>, <span class="hlFld-ContribAuthor ">Xiaofeng  Jia</span>. </span><span class="cited-content_cbyCitation_article-title">Critical roles of sphingosine kinase 1 in the regulation of neuroinflammation and neuronal injury after spinal cord injury. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neuroinflammation</span><span> <strong>2021,</strong> <em>18 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12974-021-02092-4" title="DOI URL">https://doi.org/10.1186/s12974-021-02092-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12974-021-02092-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12974-021-02092-4%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neuroinflammation%26atitle%3DCritical%252Broles%252Bof%252Bsphingosine%252Bkinase%252B1%252Bin%252Bthe%252Bregulation%252Bof%252Bneuroinflammation%252Band%252Bneuronal%252Binjury%252Bafter%252Bspinal%252Bcord%252Binjury%26aulast%3DWang%26aufirst%3DChenjian%26date%3D2021%26date%3D2021%26volume%3D18%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tiandi  Ding</span>, <span class="hlFld-ContribAuthor ">Ying  Zhi</span>, <span class="hlFld-ContribAuthor ">Weilin  Xie</span>, <span class="hlFld-ContribAuthor ">Qingqiang  Yao</span>, <span class="hlFld-ContribAuthor ">Bo  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Rational design of SphK inhibitors using crystal structures aided by computer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>213 </em>, 113164. <a href="https://doi.org/10.1016/j.ejmech.2021.113164" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113164</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113164%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRational%252Bdesign%252Bof%252BSphK%252Binhibitors%252Busing%252Bcrystal%252Bstructures%252Baided%252Bby%252Bcomputer%26aulast%3DDing%26aufirst%3DTiandi%26date%3D2021%26volume%3D213%26spage%3D113164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Molly  Congdon</span>, <span class="hlFld-ContribAuthor ">Russell G.  Fritzemeier</span>, <span class="hlFld-ContribAuthor ">Yugesh  Kharel</span>, <span class="hlFld-ContribAuthor ">Anne M.  Brown</span>, <span class="hlFld-ContribAuthor ">Vlad  Serbulea</span>, <span class="hlFld-ContribAuthor ">David R.  Bevan</span>, <span class="hlFld-ContribAuthor ">Kevin R.  Lynch</span>, <span class="hlFld-ContribAuthor ">Webster L.  Santos</span>. </span><span class="cited-content_cbyCitation_article-title">Probing the substitution pattern of indole-based scaffold reveals potent and selective sphingosine kinase 2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>212 </em>, 113121. <a href="https://doi.org/10.1016/j.ejmech.2020.113121" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113121</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113121%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProbing%252Bthe%252Bsubstitution%252Bpattern%252Bof%252Bindole-based%252Bscaffold%252Breveals%252Bpotent%252Band%252Bselective%252Bsphingosine%252Bkinase%252B2%252Binhibitors%26aulast%3DCongdon%26aufirst%3DMolly%26date%3D2021%26volume%3D212%26spage%3D113121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Li</span>, <span class="hlFld-ContribAuthor ">Christopher D.  Sibley</span>, <span class="hlFld-ContribAuthor ">Yugesh  Kharel</span>, <span class="hlFld-ContribAuthor ">Tao  Huang</span>, <span class="hlFld-ContribAuthor ">Anne M.  Brown</span>, <span class="hlFld-ContribAuthor ">Laura G.  Wonilowicz</span>, <span class="hlFld-ContribAuthor ">David R.  Bevan</span>, <span class="hlFld-ContribAuthor ">Kevin R.  Lynch</span>, <span class="hlFld-ContribAuthor ">Webster L.  Santos</span>. </span><span class="cited-content_cbyCitation_article-title">Lipophilic tail modifications of 2-(hydroxymethyl)pyrrolidine scaffold reveal dual sphingosine kinase 1 and 2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>30 </em>, 115941. <a href="https://doi.org/10.1016/j.bmc.2020.115941" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115941</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115941%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DLipophilic%252Btail%252Bmodifications%252Bof%252B2-%252528hydroxymethyl%252529pyrrolidine%252Bscaffold%252Breveal%252Bdual%252Bsphingosine%252Bkinase%252B1%252Band%252B2%252Binhibitors%26aulast%3DLi%26aufirst%3DHao%26date%3D2021%26volume%3D30%26spage%3D115941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David R.  Adams</span>, <span class="hlFld-ContribAuthor ">Susan  Pyne</span>, <span class="hlFld-ContribAuthor ">Nigel J.  Pyne</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-function analysis of lipid substrates and inhibitors of sphingosine kinases. </span><span class="cited-content_cbyCitation_journal-name">Cellular Signalling</span><span> <strong>2020,</strong> <em>76 </em>, 109806. <a href="https://doi.org/10.1016/j.cellsig.2020.109806" title="DOI URL">https://doi.org/10.1016/j.cellsig.2020.109806</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cellsig.2020.109806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cellsig.2020.109806%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520Signalling%26atitle%3DStructure-function%252Banalysis%252Bof%252Blipid%252Bsubstrates%252Band%252Binhibitors%252Bof%252Bsphingosine%252Bkinases%26aulast%3DAdams%26aufirst%3DDavid%2BR.%26date%3D2020%26volume%3D76%26spage%3D109806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nigel J.  Pyne</span>, <span class="hlFld-ContribAuthor ">Susan  Pyne</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the role of sphingosine 1‐phosphate in cancer. </span><span class="cited-content_cbyCitation_journal-name">FEBS Letters</span><span> <strong>2020,</strong> <em>594 </em>
                                    (22)
                                     , 3583-3601. <a href="https://doi.org/10.1002/1873-3468.13933" title="DOI URL">https://doi.org/10.1002/1873-3468.13933</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/1873-3468.13933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F1873-3468.13933%26sid%3Dliteratum%253Aachs%26jtitle%3DFEBS%2520Letters%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Brole%252Bof%252Bsphingosine%252B1%2525E2%252580%252590phosphate%252Bin%252Bcancer%26aulast%3DPyne%26aufirst%3DNigel%2BJ.%26date%3D2020%26date%3D2020%26volume%3D594%26issue%3D22%26spage%3D3583%26epage%3D3601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sun-Hye  Shin</span>, <span class="hlFld-ContribAuthor ">Hee-Yeon  Kim</span>, <span class="hlFld-ContribAuthor ">Hee-Soo  Yoon</span>, <span class="hlFld-ContribAuthor ">Woo-Jae  Park</span>, <span class="hlFld-ContribAuthor ">David R.  Adams</span>, <span class="hlFld-ContribAuthor ">Nigel J.  Pyne</span>, <span class="hlFld-ContribAuthor ">Susan  Pyne</span>, <span class="hlFld-ContribAuthor ">Joo-Won  Park</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel Selective Sphingosine Kinase 2 Inhibitor, HWG-35D, Ameliorates the Severity of Imiquimod-Induced Psoriasis Model by Blocking Th17 Differentiation of Naïve CD4 T Lymphocytes. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (21)
                                     , 8371. <a href="https://doi.org/10.3390/ijms21218371" title="DOI URL">https://doi.org/10.3390/ijms21218371</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21218371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21218371%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DA%252BNovel%252BSelective%252BSphingosine%252BKinase%252B2%252BInhibitor%25252C%252BHWG-35D%25252C%252BAmeliorates%252Bthe%252BSeverity%252Bof%252BImiquimod-Induced%252BPsoriasis%252BModel%252Bby%252BBlocking%252BTh17%252BDifferentiation%252Bof%252BNa%2525C3%2525AFve%252BCD4%252BT%252BLymphocytes%26aulast%3DShin%26aufirst%3DSun-Hye%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D21%26spage%3D8371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinmiao  Zhang</span>, <span class="hlFld-ContribAuthor ">Maoyu  Zhang</span>, <span class="hlFld-ContribAuthor ">Jinying  Yu</span>, <span class="hlFld-ContribAuthor ">Yanguo  Shang</span>, <span class="hlFld-ContribAuthor ">Kaixuan  Jiang</span>, <span class="hlFld-ContribAuthor ">Yihe  Jia</span>, <span class="hlFld-ContribAuthor ">Jinxin  Wang</span>, <span class="hlFld-ContribAuthor ">Kan  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Investigating the binding mechanism of sphingosine kinase 1/2 inhibitors: Insights into subtype selectivity by homology modeling, molecular dynamics simulation and free energy calculation studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2020,</strong> <em>1208 </em>, 127900. <a href="https://doi.org/10.1016/j.molstruc.2020.127900" title="DOI URL">https://doi.org/10.1016/j.molstruc.2020.127900</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2020.127900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2020.127900%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DInvestigating%252Bthe%252Bbinding%252Bmechanism%252Bof%252Bsphingosine%252Bkinase%252B1%25252F2%252Binhibitors%25253A%252BInsights%252Binto%252Bsubtype%252Bselectivity%252Bby%252Bhomology%252Bmodeling%25252C%252Bmolecular%252Bdynamics%252Bsimulation%252Band%252Bfree%252Benergy%252Bcalculation%252Bstudies%26aulast%3DZhang%26aufirst%3DJinmiao%26date%3D2020%26volume%3D1208%26spage%3D127900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kan  Yang</span>, <span class="hlFld-ContribAuthor ">Kaixuan  Jiang</span>, <span class="hlFld-ContribAuthor ">Zhengwen  Xu</span>, <span class="hlFld-ContribAuthor ">Yali  Song</span>, <span class="hlFld-ContribAuthor ">Jinxin  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting sphingosine kinase 1 for the treatment of pulmonary arterial hypertension. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2019,</strong> <em>11 </em>
                                    (22)
                                     , 2939-2953. <a href="https://doi.org/10.4155/fmc-2019-0130" title="DOI URL">https://doi.org/10.4155/fmc-2019-0130</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2019-0130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2019-0130%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252Bsphingosine%252Bkinase%252B1%252Bfor%252Bthe%252Btreatment%252Bof%252Bpulmonary%252Barterial%252Bhypertension%26aulast%3DYang%26aufirst%3DKan%26date%3D2019%26volume%3D11%26issue%3D22%26spage%3D2939%26epage%3D2953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giovanni  D'Angelo</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Clarke</span>, <span class="hlFld-ContribAuthor ">Liana C.  Silva</span>. </span><span class="cited-content_cbyCitation_article-title">Meeting Report – The 2019 FEBS special meeting on sphingolipid biology: sphingolipids in physiology and pathology. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cell Science</span><span> <strong>2019,</strong> <em>132 </em>
                                    (15)
                                     <a href="https://doi.org/10.1242/jcs.235705" title="DOI URL">https://doi.org/10.1242/jcs.235705</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1242/jcs.235705&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1242%2Fjcs.235705%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cell%2520Science%26atitle%3DMeeting%252BReport%252B%2525E2%252580%252593%252BThe%252B2019%252BFEBS%252Bspecial%252Bmeeting%252Bon%252Bsphingolipid%252Bbiology%25253A%252Bsphingolipids%252Bin%252Bphysiology%252Band%252Bpathology%26aulast%3DD%2527Angelo%26aufirst%3DGiovanni%26date%3D2019%26date%3D2019%26volume%3D132%26issue%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/medium/jm-2019-00162z_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00162&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/medium/jm-2019-00162z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Lipid Substrate (Sph), Product (S1P), and Established Inhibitors for SK1 and SK2</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00162&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label"><sup>a</sup></span>For references see text.</p><p><span class="fn-label"><sup>b</sup></span>This study.</p><p><span class="fn-label"><sup>c</sup></span>No data.</p><p class="last"><span class="fn-label"><sup>d</sup></span>Co-crystal structure available with SK1.</p></p></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/medium/jm-2019-00162z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of SK1 is shown with bound PF-543 (<b>1</b>; orange surface) (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V24">4V24</a>).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> PF-543 occupies the substrate Sph binding site, formed by the packing of three lipid binding loops (LBL-1 to LBL-3) against a β-sandwich core. The nucleotide binding site is shown by superimposition of Mg-ADP (green sphere/rose surface) from its separate cocrystal structure (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VZD">3VZD</a>) with SK1.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00162&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/medium/jm-2019-00162z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. J-Channel surface detail (mesh) from the PF-543/SK1 cocrystal (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V24">4V24</a>),<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> highlighting key isoform residue differences that likely impact on the J-channel structure of SK2. SK1 residue numbering is shown; cognate SK2 residues, where different, are in parentheses (residue color notation, see text).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00162&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/medium/jm-2019-00162z_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0011.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Probe Compounds <b>18</b> and <b>19</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00162&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaSO<sub>2</sub>Ph, Aliquat 336, 85 °C (47%); (b) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C (77%); (c) phenylsulfonyl chloride K<sub>2</sub>CO<sub>3</sub>/MeCN (21%); (d) 4-(bromomethyl)benzaldehyde, K<sub>2</sub>CO<sub>3</sub>, MeCN, 60 °C; (e) (<i>R</i>)-2-(hydroxymethyl)pyrrolidine, NaBH(OAc)<sub>3</sub>, DCE.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/medium/jm-2019-00162z_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0012.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Probe Compound <b>23</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00162&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) H<sub>2</sub>, Pd/C, EtOH (95%); (b) 4-(bromomethyl)benzaldehyde, K<sub>2</sub>CO<sub>3</sub>, MeCN, 20 °C, 16 h (87%); (c) (<i>R</i>)-2-(hydroxymethyl)pyrrolidine, NaBH(OAc)<sub>3</sub>, DCE (82%).</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/medium/jm-2019-00162z_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0013.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Probe Compounds <b>49</b>–<b>60</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00162&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>25</b>–<b>33</b>, (substituted)benzyl bromide (or 4-chlorobenzyl chloride in the case of <b>31</b>), K<sub>2</sub>CO<sub>3</sub>, acetone, 65 °C, 5 h; (b) <b>34</b>–<b>36</b>, (substituted)benzyl bromide (or 4-chlorobenzyl chloride in the case of <b>36</b>), K<sub>2</sub>CO<sub>3</sub>, MeCN, 20 °C, 16 h; (c) <b>37</b>–<b>45</b>, NaH, DMF, then 4-(bromomethyl)benzaldehyde, 16 h, 20 °C; (d) <b>46</b>–<b>48</b>, 4-(bromomethyl)benzaldehyde, K<sub>2</sub>CO<sub>3</sub>, MeCN, 20 °C, 16 h; (e) (<i>R</i>)-2-(hydroxymethyl)pyrrolidine, NaBH(OAc)<sub>3</sub>, THF (for <b>49</b>–<b>57</b>) or DCE (for <b>48</b>–<b>60</b>).</p></p></figure><figure data-id="cht2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/medium/jm-2019-00162z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. SK1 and SK2 Inhibitory Activity for Probe Compound Set Derived from PF-543 (<b>1</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00162&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>SK1 activity was assayed using 3 μM Sph and 250 μM ATP. SK2 activity was assayed using 10 μM Sph and 250 μM ATP. Data are reported as IC<sub>50</sub> values (or % enzyme inhibition) vs control determined in triplicate assays. NE: no inhibitory effect at maximal test concentration of 3 μM. SI denotes selectivity index as IC<sub>50</sub> (SK1)/IC<sub>50</sub> (SK2).</p></p></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/medium/jm-2019-00162z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Key compression axes postulated to influence ligand binding to the J-channels of SK1 and SK2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00162&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/medium/jm-2019-00162z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Selected SK1 and SK2 concentration response curves for PF-543-derived J-channel probes, highlighting the reversal of behavior from SK1-selective inhibition (left) to SK2-selective inhibition (right) with ligand features that induce compression along axis-1 and axis-2 of <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, respectively (assay conditions: see legend of <a class="ref internalNav" href="#cht2" aria-label="Chart 2">Chart 2</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00162&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/medium/jm-2019-00162z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0007.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Comparison of modeled binding mode for SK2-selective inhibitor <b>60</b> with SK1 cocrystal structures of PF-543 (<b>1</b>) and SKi (<b>10</b>). (A) <b>60</b> (blue stick) docked into SK2 model (red mesh), highlighting key contact residues (cyan stick) and expanded SK2 J-channel toe surface. (B) PF-543 (<b>1</b>; orange stick) is shown from its cocrystal structure (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V24">4V24</a>) with SK1 (green mesh) and the SK2 model surface (red mesh) overlaid from (A); SK1 contact residues are shown (light-orange stick) and the constrained SK1 J-channel toe surface is evident. (C) As (B), but showing cocrystal structure (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VZD">3VZD</a>) of SKi (<b>10</b>, magenta stick) with SK1 (blue mesh and pink stick key contact residues) superimposed onto the SK2 model (red mesh) from (A); the heel region adjacent to SK1 Leu302 is consistently less compressed in SK1 structures (relative to the SK2 model), while the notch surface exhibits some plasticity. (D) Overlay of (A–C) minus the J-channel surface; the chlorine atom of <b>60</b> is accommodated in SK2 between Cys533 and Leu506, with rotation of the latter possible while the cognate SK1 residue (Leu261) is constrained by the packing of adjacent residues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00162&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/medium/jm-2019-00162z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0008.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. J-Channel heel is a key determinant of isoform discrimination by SK inhibitors. (A) LBL-2 and LBL-3 are shown from the cocrystal structure (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V24">4V24</a>) of PF-543 (orange stick) with SK1 (green ribbon); the corresponding elements from our SK2 homology model (red ribbon) are overlaid, illustrating inward movement in LBL-3 leading to heel compression in SK2 by Leu547. (B) Potent unselective inhibitor <b>49</b> (blue stick) is shown modeled into the SK2 J-channel (red mesh); the J-channel heel surface is driven significantly inward relative to SK1 so that the presence of a sulfonyl group in the ligand (<b>49</b> → <b>19</b>, 56-fold activity loss) is poorly tolerated by SK2. (C) Inhibitor <b>49</b> (magenta stick) is again shown, here modeled into the SK1 J-channel (green mesh); the SK1 J-channel heel surface exhibits less compression and accommodates a sterically more demanding sulfonyl containing linker more readily (<b>49</b> → <b>19</b>, no activity loss; <b>23</b> → <b>18</b>, 5-fold activity loss). (D) Overlay of (B) and (C) minus the J-channel surface.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00162&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/medium/jm-2019-00162z_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0009.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. J-Channel toe is a second key determinant for isoform discrimination by SK inhibitors. A comparison of modeled binding modes for the SK2-selective inhibitor (<b>60</b>) is shown here, with the SK2-docked inhibitor (cyan stick) superimposed onto the SK1-docked inhibitor (magenta stick). With reduced plasticity in the SK1 J-channel toe (pink mesh), the sulfur atom of <b>60</b> is predicted to be tightly wedged against the backbone of helix-α9 (pink ribbon). This generates an unfavorable compression axis (black arrow, corresponding to “axis-2” of <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) that preferentially penalizes binding to SK1. In SK2, the greater plasticity of the J-channel toe (cyan mesh) is predicted to allow accommodation of <b>60</b> with less compression.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00162&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/medium/jm-2019-00162z_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0010.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Plasticity in the J-channel toe of SK2 may be exploited to develop SK2-selective inhibitors. (A) Compound <b>60</b> (blue stick) docked into the SK2 model (red mesh), highlighting key contact residues (cyan stick) and two predicted trajectories for possible toe expansion (arrows). Small groups may be accommodated between Cys533 and Leu506 (trajectory-1, hollow arrow). This is the predicted expansion for binding of <b>55</b>/<b>60</b>, where the fit of the Cl atom is likely made possible largely by rotation in Leu506. Larger groups may be accommodated between Cys533 and Phe557 (trajectory-2, filled arrow) upon rotation of these side chains. (B) VT-20dd (<b>9</b>, green stick) docked into the SK2 model (gray mesh), highlighting key contact residues (orange stick). Here the ligand is predicted to exploit the second toe expansion trajectory. (C) Overlay of (A) and (B) showing the SK2 J-channel surface for docked <b>60</b> (red mesh) and illustrating the two key residue rotations in Cys533 and Phe557 required for trajectory-2 expansion (cyan stick → orange stick positions). (D) ABC294640 (<b>4</b>, orange stick) docked into SK2 (gray mesh). In this model, the trajectory-1 expansion is made possible chiefly by rotation of Cys533 rather than Leu506, but the space generated by the expansion is underused by the Cl atom.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00162/20190404/images/large/jm-2019-00162z_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00162&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i69">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51376" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51376" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 57 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garris, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaho, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hla, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, M. H.</span></span> <span> </span><span class="NLM_article-title">Sphingosine-1-phosphate receptor 1 signalling in T cells: trafficking and beyond</span>. <i>Immunology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>142</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">353</span>, <span class="refDoi"> DOI: 10.1111/imm.12272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1111%2Fimm.12272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=24597601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVajurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2014&pages=347-353&author=C.+S.+Garrisauthor=V.+A.+Blahoauthor=T.+Hlaauthor=M.+H.+Han&title=Sphingosine-1-phosphate+receptor+1+signalling+in+T+cells%3A+trafficking+and+beyond&doi=10.1111%2Fimm.12272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine-1-phosphate receptor 1 signalling in T cells: trafficking and beyond</span></div><div class="casAuthors">Garris, Christopher S.; Blaho, Victoria A.; Hla, Timothy; Han, May H.</div><div class="citationInfo"><span class="NLM_cas:title">Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-353</span>CODEN:
                <span class="NLM_cas:coden">IMMUAM</span>;
        ISSN:<span class="NLM_cas:issn">0019-2805</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Summary : Sphingosine-1-phosphate (S1P) is a lipid second messenger that signals via five G protein-coupled receptors (S1P1-5).  S1P receptor (S1PR) signalling is assocd. with a wide variety of physiol. processes including lymphocyte biol., their recirculation and detn. of T-cell phenotypes.  The effect of FTY720 (Fingolimod, Gilenya®) to regulate lymphocyte egress and to ameliorate paralysis in exptl. autoimmune encephalomyelitis, an animal model of multiple sclerosis led to the use of FTY720 as a first-line oral agent for treatment of relapsing-remitting multiple sclerosis.  However, a significant body of research suggests that S1P signalling may participate in diverse immune regulatory functions other than lymphocyte trafficking.  This review article discusses the current knowledge of S1P signalling in the fate and function of T regulatory, T helper type 17 and memory T cells in health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWhywoNwN3wLVg90H21EOLACvtfcHk0lgv26drHhZKSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVajurY%253D&md5=175ea21ef7460bf57496b971322938e2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1111%2Fimm.12272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fimm.12272%26sid%3Dliteratum%253Aachs%26aulast%3DGarris%26aufirst%3DC.%2BS.%26aulast%3DBlaho%26aufirst%3DV.%2BA.%26aulast%3DHla%26aufirst%3DT.%26aulast%3DHan%26aufirst%3DM.%2BH.%26atitle%3DSphingosine-1-phosphate%2520receptor%25201%2520signalling%2520in%2520T%2520cells%253A%2520trafficking%2520and%2520beyond%26jtitle%3DImmunology%26date%3D2014%26volume%3D142%26spage%3D347%26epage%3D353%26doi%3D10.1111%2Fimm.12272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hait, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allegood, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maceyka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strub, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harikumar, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marmorstein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kordula, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milstien, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiegel, S.</span></span> <span> </span><span class="NLM_article-title">Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>325</i></span>,  <span class="NLM_fpage">1254</span>– <span class="NLM_lpage">1257</span>, <span class="refDoi"> DOI: 10.1126/science.1176709</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1126%2Fscience.1176709" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=19729656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVOmsrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2009&pages=1254-1257&author=N.+C.+Haitauthor=J.+Allegoodauthor=M.+Maceykaauthor=G.+M.+Strubauthor=K.+B.+Harikumarauthor=S.+K.+Singhauthor=C.+Luoauthor=R.+Marmorsteinauthor=T.+Kordulaauthor=S.+Milstienauthor=S.+Spiegel&title=Regulation+of+histone+acetylation+in+the+nucleus+by+sphingosine-1-phosphate&doi=10.1126%2Fscience.1176709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate</span></div><div class="casAuthors">Hait, Nitai C.; Allegood, Jeremy; Maceyka, Michael; Strub, Graham M.; Harikumar, Kuzhuvelil B.; Singh, Sandeep K.; Luo, Cheng; Marmorstein, Ronen; Kordula, Tomasz; Milstien, Sheldon; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">5945</span>),
    <span class="NLM_cas:pages">1254-1257</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The pleiotropic lipid mediator sphingosine-1-phosphate (S1P) can act intracellularly independently of its cell surface receptors through unknown mechanisms.  Sphingosine kinase 2 (SphK2), one of the isoenzymes that generates S1P, was assocd. with histone H3 and produced S1P that regulated histone acetylation.  S1P specifically bound to the histone deacetylases HDAC1 and HDAC2 and inhibited their enzymic activity, preventing the removal of acetyl groups from lysine residues within histone tails.  SphK2 assocd. with HDAC1 and HDAC2 in repressor complexes and was selectively enriched at the promoters of the genes encoding the cyclin-dependent kinase inhibitor p21 or the transcriptional regulator c-fos, where it enhanced local histone H3 acetylation and transcription.  Thus, HDACs are direct intracellular targets of S1P and link nuclear S1P to epigenetic regulation of gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgTq77gwEd97Vg90H21EOLACvtfcHk0lgv26drHhZKSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVOmsrjJ&md5=41b947eb7757066551f714c713cfd1b1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.1176709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1176709%26sid%3Dliteratum%253Aachs%26aulast%3DHait%26aufirst%3DN.%2BC.%26aulast%3DAllegood%26aufirst%3DJ.%26aulast%3DMaceyka%26aufirst%3DM.%26aulast%3DStrub%26aufirst%3DG.%2BM.%26aulast%3DHarikumar%26aufirst%3DK.%2BB.%26aulast%3DSingh%26aufirst%3DS.%2BK.%26aulast%3DLuo%26aufirst%3DC.%26aulast%3DMarmorstein%26aufirst%3DR.%26aulast%3DKordula%26aufirst%3DT.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DRegulation%2520of%2520histone%2520acetylation%2520in%2520the%2520nucleus%2520by%2520sphingosine-1-phosphate%26jtitle%3DScience%26date%3D2009%26volume%3D325%26spage%3D1254%26epage%3D1257%26doi%3D10.1126%2Fscience.1176709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degagne, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandurangan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandhuvula, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eltanawy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshinaga, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nefedov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmedi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saba, J. D.</span></span> <span> </span><span class="NLM_article-title">Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">5368</span>– <span class="NLM_lpage">5384</span>, <span class="refDoi"> DOI: 10.1172/JCI74188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1172%2FJCI74188" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=5368-5384&author=E.+Degagneauthor=A.+Panduranganauthor=P.+Bandhuvulaauthor=A.+Kumarauthor=A.+Eltanawyauthor=M.+Zhangauthor=Y.+Yoshinagaauthor=M.+Nefedovauthor=P.+J.+de+Jongauthor=L.+G.+Fongauthor=S.+G.+Youngauthor=R.+Bittmanauthor=Y.+Ahmediauthor=J.+D.+Saba&title=Sphingosine-1-phosphate+lyase+downregulation+promotes+colon+carcinogenesis+through+STAT3-activated+microRNAs&doi=10.1172%2FJCI74188"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1172%2FJCI74188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI74188%26sid%3Dliteratum%253Aachs%26aulast%3DDegagne%26aufirst%3DE.%26aulast%3DPandurangan%26aufirst%3DA.%26aulast%3DBandhuvula%26aufirst%3DP.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DEltanawy%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DYoshinaga%26aufirst%3DY.%26aulast%3DNefedov%26aufirst%3DM.%26aulast%3Dde%2BJong%26aufirst%3DP.%2BJ.%26aulast%3DFong%26aufirst%3DL.%2BG.%26aulast%3DYoung%26aufirst%3DS.%2BG.%26aulast%3DBittman%26aufirst%3DR.%26aulast%3DAhmedi%26aufirst%3DY.%26aulast%3DSaba%26aufirst%3DJ.%2BD.%26atitle%3DSphingosine-1-phosphate%2520lyase%2520downregulation%2520promotes%2520colon%2520carcinogenesis%2520through%2520STAT3-activated%2520microRNAs%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2014%26volume%3D124%26spage%3D5368%26epage%3D5384%26doi%3D10.1172%2FJCI74188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mandala, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornton, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galve-Roperh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivera, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergstrom, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurtz, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiegel, S.</span></span> <span> </span><span class="NLM_article-title">Molecular cloning and characterization of a lipid phosphohydrolase that degrades sphingosine-1-phosphate and induces cell death</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">7859</span>– <span class="NLM_lpage">7864</span>, <span class="refDoi"> DOI: 10.1073/pnas.120146897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1073%2Fpnas.120146897" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=7859-7864&author=S.+M.+Mandalaauthor=R.+Thorntonauthor=I.+Galve-Roperhauthor=S.+Poultonauthor=C.+Petersonauthor=A.+Oliveraauthor=J.+Bergstromauthor=M.+B.+Kurtzauthor=S.+Spiegel&title=Molecular+cloning+and+characterization+of+a+lipid+phosphohydrolase+that+degrades+sphingosine-1-phosphate+and+induces+cell+death&doi=10.1073%2Fpnas.120146897"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1073%2Fpnas.120146897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.120146897%26sid%3Dliteratum%253Aachs%26aulast%3DMandala%26aufirst%3DS.%2BM.%26aulast%3DThornton%26aufirst%3DR.%26aulast%3DGalve-Roperh%26aufirst%3DI.%26aulast%3DPoulton%26aufirst%3DS.%26aulast%3DPeterson%26aufirst%3DC.%26aulast%3DOlivera%26aufirst%3DA.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DKurtz%26aufirst%3DM.%2BB.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DMolecular%2520cloning%2520and%2520characterization%2520of%2520a%2520lipid%2520phosphohydrolase%2520that%2520degrades%2520sphingosine-1-phosphate%2520and%2520induces%2520cell%2520death%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D7859%26epage%3D7864%26doi%3D10.1073%2Fpnas.120146897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mandala, S. M.</span></span> <span> </span><span class="NLM_article-title">Sphingosine-1-phosphate phosphatases</span>. <i>Prostaglandins Other Lipid Mediators</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">156</span>, <span class="refDoi"> DOI: 10.1016/S0090-6980(01)00111-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1016%2FS0090-6980%2801%2900111-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=11324704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjtVamtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2001&pages=143-156&author=S.+M.+Mandala&title=Sphingosine-1-phosphate+phosphatases&doi=10.1016%2FS0090-6980%2801%2900111-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine-1-phosphate phosphatases</span></div><div class="casAuthors">Mandala, Suzanne M.</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins & Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1-4</span>),
    <span class="NLM_cas:pages">143-156</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with 56 refs.  Sphingosine-1-phosphate is a potent proliferative, survival, and morphogenetic factor, acting as an extracellular ligand for the EDG family of G-protein-coupled receptors and possibly intracellularly through as yet, unidentified targets.  It is produced within most, if not all cells by phosphorylation of sphingosine, and is an abundant serum lipid that is released from activated platelets.  Sphingosine and sphingosine-1-phosphate are in dynamic equil. with each other due to the activities of sphingosine kinase and sphingosine-1-phosphate phosphatase (SPPase).  Several SPPase genes have now been cloned, first from yeast and more recently from mammalian cells.  By sequence homol., these enzymes can be classified as a subset of membrane bound.  Type 2 lipid phosphohydrolases that contain conserved residues within three domains predicted to be at the active site of the enzyme.  Outside of the consensus motif, there is very little homol. between SPPases and the other type 2 lipid phosphohydrolases in the LPP/PAP family.  Type 2 phosphatase activity is Mg+-independent and insensitive to N-ethylmaleimide, and substrate specificity is broad for LPP enzymes, whereas SPPases are highly selective for sphingolipid substrates.  SPPase activity in yeast and mammalian cells regulates intracellular sphingosine-1-phosphate levels, and also alters the levels of sphingosine and ceramide, two other signaling mols. that often oppose the actions of sphingosine-1-phosphate.  Thus, loss of SPPase in yeast results in high sphingosine-1-phosphate levels and cells are more resistant to stress, and in mammalian cells, overexpression of SPPase elevates ceramide levels and provokes apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGkHkEaj8PNLVg90H21EOLACvtfcHk0lgQupKmUHBTYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjtVamtrc%253D&md5=cb97b6a475770c5bb58bb1b93fc1008d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0090-6980%2801%2900111-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0090-6980%252801%252900111-3%26sid%3Dliteratum%253Aachs%26aulast%3DMandala%26aufirst%3DS.%2BM.%26atitle%3DSphingosine-1-phosphate%2520phosphatases%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2001%26volume%3D64%26spage%3D143%26epage%3D156%26doi%3D10.1016%2FS0090-6980%2801%2900111-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gokoh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igarashi, Y.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of a novel human sphingosine-1-phosphate phosphohydrolase, hSPP2</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">1268</span>– <span class="NLM_lpage">1272</span>, <span class="refDoi"> DOI: 10.1074/jbc.M209514200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1074%2Fjbc.M209514200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=1268-1272&author=C.+Ogawaauthor=A.+Kiharaauthor=M.+Gokohauthor=Y.+Igarashi&title=Identification+and+characterization+of+a+novel+human+sphingosine-1-phosphate+phosphohydrolase%2C+hSPP2&doi=10.1074%2Fjbc.M209514200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M209514200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M209514200%26sid%3Dliteratum%253Aachs%26aulast%3DOgawa%26aufirst%3DC.%26aulast%3DKihara%26aufirst%3DA.%26aulast%3DGokoh%26aufirst%3DM.%26aulast%3DIgarashi%26aufirst%3DY.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520a%2520novel%2520human%2520sphingosine-1-phosphate%2520phosphohydrolase%252C%2520hSPP2%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D1268%26epage%3D1272%26doi%3D10.1074%2Fjbc.M209514200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siow, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wattenberg, B.</span></span> <span> </span><span class="NLM_article-title">The compartmentalization and translocation of the sphingosine kinases: mechanisms and functions in cell signaling and sphingolipid metabolism</span>. <i>Crit. Rev. Biochem. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">365</span>– <span class="NLM_lpage">375</span>, <span class="refDoi"> DOI: 10.3109/10409238.2011.580097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.3109%2F10409238.2011.580097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=21864225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1GiurzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=365-375&author=D.+Siowauthor=B.+Wattenberg&title=The+compartmentalization+and+translocation+of+the+sphingosine+kinases%3A+mechanisms+and+functions+in+cell+signaling+and+sphingolipid+metabolism&doi=10.3109%2F10409238.2011.580097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The compartmentalization and translocation of the sphingosine kinases: Mechanisms and functions in cell signaling and sphingolipid metabolism</span></div><div class="casAuthors">Siow, Deanna; Wattenberg, Binks</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">365-375</span>CODEN:
                <span class="NLM_cas:coden">CRBBEJ</span>;
        ISSN:<span class="NLM_cas:issn">1040-9238</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Members of the sphingosine kinase (SK) family of lipid signaling enzymes, comprising SK1 and SK2 in humans, are receiving considerable attention for their roles in a no. of physiol. and pathophysiol. processes.  The SKs are considered signaling enzymes based on their prodn. of the potent lipid second messenger sphingosine-1-phosphate, which is the ligand for a family of five G-protein-linked receptors.  Both SK1 and SK2 are intracellular enzymes and do not possess obvious membrane anchor domains within their primary sequences.  The native substrates (sphingosine and dihydrosphingosine) are lipids, as are the corresponding products, and therefore would have a propensity to be membrane assocd., suggesting that specific membrane localization of the SKs could affect both access to substrate and localized prodn. of product.  Here, we consider the emerging picture of the SKs as enzymes localized to specific intracellular sites, sometimes by agonist-dependent translocation, the mechanism targeting these enzymes to those sites, and the functional consequence of that localization.  Not only is the signaling output of the SKs affected by subcellular localization, but the role of these enzymes as metabolic regulators of sphingolipid metab. may be impacted as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMEbB_RWKQHrVg90H21EOLACvtfcHk0lgEEDhk6DYp-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1GiurzJ&md5=76d7c10a2c50628d2e7934556ee4d994</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3109%2F10409238.2011.580097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10409238.2011.580097%26sid%3Dliteratum%253Aachs%26aulast%3DSiow%26aufirst%3DD.%26aulast%3DWattenberg%26aufirst%3DB.%26atitle%3DThe%2520compartmentalization%2520and%2520translocation%2520of%2520the%2520sphingosine%2520kinases%253A%2520mechanisms%2520and%2520functions%2520in%2520cell%2520signaling%2520and%2520sphingolipid%2520metabolism%26jtitle%3DCrit.%2520Rev.%2520Biochem.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D46%26spage%3D365%26epage%3D375%26doi%3D10.3109%2F10409238.2011.580097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obeid, L. M.</span></span> <span> </span><span class="NLM_article-title">Principles of bioactive lipid signalling: lessons from sphingolipids</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">150</span>, <span class="refDoi"> DOI: 10.1038/nrm2329</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1038%2Fnrm2329" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=18216770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFOntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=139-150&author=Y.+A.+Hannunauthor=L.+M.+Obeid&title=Principles+of+bioactive+lipid+signalling%3A+lessons+from+sphingolipids&doi=10.1038%2Fnrm2329"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Principles of bioactive lipid signalling: lessons from sphingolipids</span></div><div class="casAuthors">Hannun, Yusuf A.; Obeid, Lina M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-150</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  It has become increasingly difficult to find an area of cell biol. in which lipids do not have important, if not key, roles as signaling and regulatory mols.  The rapidly expanding field of bioactive lipids is exemplified by many sphingolipids, such as ceramide, sphingosine, sphingosine-1-phosphate (S1P), ceramide-1-phosphate, and lyso-sphingomyelin, which have roles in the regulation of cell growth, death, senescence, adhesion, migration, inflammation, angiogenesis, and intracellular trafficking.  Deciphering the mechanisms of these varied cell functions necessitates an understanding of the complex pathways of sphingolipid metab. and the mechanisms that regulate lipid generation and lipid action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrJi0iM1f277Vg90H21EOLACvtfcHk0lgEEDhk6DYp-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFOntg%253D%253D&md5=0bee4e560d083ef4c43f7d0b591a0997</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrm2329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2329%26sid%3Dliteratum%253Aachs%26aulast%3DHannun%26aufirst%3DY.%2BA.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26atitle%3DPrinciples%2520of%2520bioactive%2520lipid%2520signalling%253A%2520lessons%2520from%2520sphingolipids%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2008%26volume%3D9%26spage%3D139%26epage%3D150%26doi%3D10.1038%2Fnrm2329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollmeyer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symolon, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Momin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munter, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allegood, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaraju, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullards, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merrill, A. H.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy</span>. <i>Biochim. Biophys. Acta, Biomembr</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1758</i></span>,  <span class="NLM_fpage">1864</span>– <span class="NLM_lpage">1884</span>, <span class="refDoi"> DOI: 10.1016/j.bbamem.2006.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1016%2Fj.bbamem.2006.08.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=17052686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12kt7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1758&publication_year=2006&pages=1864-1884&author=W.+Zhengauthor=J.+Kollmeyerauthor=H.+Symolonauthor=A.+Mominauthor=E.+Munterauthor=E.+Wangauthor=S.+Kellyauthor=J.+C.+Allegoodauthor=Y.+Liuauthor=Q.+Pengauthor=H.+Ramarajuauthor=M.+C.+Sullardsauthor=M.+Cabotauthor=A.+H.+Merrill&title=Ceramides+and+other+bioactive+sphingolipid+backbones+in+health+and+disease%3A+lipidomic+analysis%2C+metabolism+and+roles+in+membrane+structure%2C+dynamics%2C+signaling+and+autophagy&doi=10.1016%2Fj.bbamem.2006.08.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Ceramides and other bioactive sphingolipid backbones in health and disease: Lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy</span></div><div class="casAuthors">Zheng, Wenjing; Kollmeyer, Jessica; Symolon, Holly; Momin, Amin; Munter, Elizabeth; Wang, Elaine; Kelly, Samuel; Allegood, Jeremy C.; Liu, Ying; Peng, Qiong; Ramaraju, Harsha; Sullards, M. Cameron; Cabot, Myles; Merrill, Alfred H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1758</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1864-1884</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Sphingolipids are comprised of a backbone sphingoid base that may be phosphorylated, acylated, glycosylated, bridged to various headgroups through phosphodiester linkages, or otherwise modified.  Organisms usually contain large nos. of sphingolipid subspecies and knowledge about the types and amts. is imperative because they influence membrane structure, interactions with the extracellular matrix and neighboring cells, vesicular traffic and the formation of specialized structures such as phagosomes and autophagosomes, as well as participate in intracellular and extracellular signaling.  Fortunately, "sphingolipidomic" anal. is becoming feasible (at least for important subsets such as all of the backbone "signaling" subspecies: ceramides, ceramide 1-phosphates, sphingoid bases, sphingoid base 1-phosphates, inter alia) using mass spectrometry, and these profiles are revealing many surprises, such as that under certain conditions cells contain significant amts. of "unusual" species: N-mono-, di-, and tri-methyl-sphingoid bases (including N,N-dimethylsphingosine); 3-ketodihydroceramides; N-acetyl-sphingoid bases (C2-ceramides); and dihydroceramides, in the latter case, in very high proportions when cells are treated with the anticancer drug fenretinide (4-hydroxyphenylretinamide).  The elevation of DHceramides by fenretinide is befuddling because the 4,5-trans-double bond of ceramide has been thought to be required for biol. activity; however, DHceramides induce autophagy and may be important in the regulation of this important cellular process.  The complexity of the sphingolipidome is hard to imagine, but one hopes that, when partnered with other systems biol. approaches, the causes and consequences of the complexity will explain how these intriguing compds. are involved in almost every aspect of cell behavior and the malfunctions of many diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5aWjQRdjo6bVg90H21EOLACvtfcHk0lgEEDhk6DYp-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12kt7%252FK&md5=db561208dc8f62f2f56efd083035b047</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2006.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2006.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DKollmeyer%26aufirst%3DJ.%26aulast%3DSymolon%26aufirst%3DH.%26aulast%3DMomin%26aufirst%3DA.%26aulast%3DMunter%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DKelly%26aufirst%3DS.%26aulast%3DAllegood%26aufirst%3DJ.%2BC.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DQ.%26aulast%3DRamaraju%26aufirst%3DH.%26aulast%3DSullards%26aufirst%3DM.%2BC.%26aulast%3DCabot%26aufirst%3DM.%26aulast%3DMerrill%26aufirst%3DA.%2BH.%26atitle%3DCeramides%2520and%2520other%2520bioactive%2520sphingolipid%2520backbones%2520in%2520health%2520and%2520disease%253A%2520lipidomic%2520analysis%252C%2520metabolism%2520and%2520roles%2520in%2520membrane%2520structure%252C%2520dynamics%252C%2520signaling%2520and%2520autophagy%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr%26date%3D2006%26volume%3D1758%26spage%3D1864%26epage%3D1884%26doi%3D10.1016%2Fj.bbamem.2006.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steele, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, N. J.</span></span> <span> </span><span class="NLM_article-title">Sphingomyelin-derived lipids differentially regulate the extracellular signal-regulated kinase 2 (ERK-2) and c-Jun N-terminal kinase (JNK) signal cascades in airway smooth muscle</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>237</i></span>,  <span class="NLM_fpage">819</span>– <span class="NLM_lpage">826</span>, <span class="refDoi"> DOI: 10.1111/j.1432-1033.1996.0819p.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1111%2Fj.1432-1033.1996.0819p.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=8647130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADyaK28XivV2jsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=237&publication_year=1996&pages=819-826&author=S.+Pyneauthor=J.+Chapmanauthor=L.+Steeleauthor=N.+J.+Pyne&title=Sphingomyelin-derived+lipids+differentially+regulate+the+extracellular+signal-regulated+kinase+2+%28ERK-2%29+and+c-Jun+N-terminal+kinase+%28JNK%29+signal+cascades+in+airway+smooth+muscle&doi=10.1111%2Fj.1432-1033.1996.0819p.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingomyelin-derived lipids differentially regulate the extracellular signal-regulated kinase 2 (ERK-2) and c-Jun N-terminal kinase (JNK) signal cascades in airway smooth muscle</span></div><div class="casAuthors">Pyne, Susan; Chapman, Joanna; Steele, Leslie; Pyne, Nigel J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">237</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">819-826</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In airway smooth muscle (ASM) cells platelet-derived growth factor stimulates rapid transient sphingosine phosphate formation, the activation of extracellular signal-regulated kinase 2 (ERK-2), the phosphorylation of p70S6K, and a 9-fold increase in DNA synthesis.  In contrast, this growth factor fails to activate c-Jun N-terminal kinase (JNK).  Based upon these findings we have tested whether the sphingomyelin-derived sphingolipids play a role in growth factor signaling by assessing their effect on ERK-2, JNK, and p70S6K.  We demonstrate that sphingosine phosphate induces the activation of ERK-2, is ineffective against JNK, and fails to induce the phosphorylation of p70S6K.  The latter may explain why it is a poor mitogen when added directly to ASM cells.  In contrast, sphingosine and cell-permeable ceramides elicit the prominent tyrosyl phosphorylation and activation of JNK, are poor stimulators of ERK-2, and do not induce the phosphorylation of p70S6K.  Therefore, the specificity of signaling through either ERK-2 or JNK cascades may be detd. by the rapid agonist-dependent interconversion of these sphingomyelin-derived lipids.  This may also provide a dynamic mechanism that enables growth factors and cytokines to elicit pleiotropic cell responses, such as proliferation and cell survival.  For instance, both ceramide and sphingosine will elicit growth arrest via activation of JNK, whereas sphingosine phosphate will potentiate growth-factor-stimulated DNA synthesis, a consequence of the activation of ERK-2.  Furthermore, under certain conditions, sphingosine and ceramide stimulate cAMP formation, a neg. modulator of cell growth, whereas sphingosine phosphate depresses cAMP, thereby enhancing its own growth-promoting properties.  From these studies, it is evident that sphingosine phosphate displays a signaling profile that is consistent with it mediating part of the action of platelet-derived growth factor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpR5KZPpHZjirVg90H21EOLACvtfcHk0lhFPrwHArJ6ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivV2jsLg%253D&md5=a06db34ff751f4e4323ce3fcd6e15f45</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1996.0819p.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1996.0819p.x%26sid%3Dliteratum%253Aachs%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DChapman%26aufirst%3DJ.%26aulast%3DSteele%26aufirst%3DL.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26atitle%3DSphingomyelin-derived%2520lipids%2520differentially%2520regulate%2520the%2520extracellular%2520signal-regulated%2520kinase%25202%2520%2528ERK-2%2529%2520and%2520c-Jun%2520N-terminal%2520kinase%2520%2528JNK%2529%2520signal%2520cascades%2520in%2520airway%2520smooth%2520muscle%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1996%26volume%3D237%26spage%3D819%26epage%3D826%26doi%3D10.1111%2Fj.1432-1033.1996.0819p.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuvillier, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirianov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleuser, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanek, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coso, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutkind, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiegel, S.</span></span> <span> </span><span class="NLM_article-title">Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>381</i></span>,  <span class="NLM_fpage">800</span>– <span class="NLM_lpage">803</span>, <span class="refDoi"> DOI: 10.1038/381800a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1038%2F381800a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=8657285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADyaK28XjvVKnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=381&publication_year=1996&pages=800-803&author=O.+Cuvillierauthor=G.+Pirianovauthor=B.+Kleuserauthor=P.+G.+Vanekauthor=O.+A.+Cosoauthor=S.+Gutkindauthor=S.+Spiegel&title=Suppression+of+ceramide-mediated+programmed+cell+death+by+sphingosine-1-phosphate&doi=10.1038%2F381800a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate</span></div><div class="casAuthors">Cuvillier, Olivier; Pirianov, Grisha; Kleuser, Burkhard; Vanek, Philip G.; Coso, Omar A.; Gutkind, J. Silvio; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">381</span>
        (<span class="NLM_cas:issue">6585</span>),
    <span class="NLM_cas:pages">800-803</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Ceramide is an important regulatory participant of programmed cell death (apoptosis) induced by tumor-necrosis factor (TMF)-α and Fas ligand, members of the TNF superfamily.  Conversely, sphingosine and sphingosine-1-phosphate, which are metabolites of ceramide, induce mitogenesis and have been implicated as second messengers in cellular proliferation induced by platelet-derived growth factor and serum.  Here we report that sphingosine-1-phosphate prevents the appearance of the key features of apoptosis, namely intranucleosomal DNA fragmentation and morphol. changes, which result from increased concns. of ceramide.  Furthermore, inhibition of ceramide-mediated apoptosis by activation of protein kinase C results from stimulation of sphingosine kinase and the concomitant increase in intracellular sphingosine-1-phosphate.  Finally sphingosine-1-phosphate not only stimulates the extracellular signal-regulated kinase (ERK) pathway, it counteracts the ceramide-induced activation of stress-activated protein kinase of ceramide and sphingosine-1-phosphate and their regulatory effects on different family members of mitogen-activated protein kinases dets. the fate of the cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3xEuzICMjarVg90H21EOLACvtfcHk0lhFPrwHArJ6ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjvVKnsro%253D&md5=50d91e59dc03600594fd0a236ecc2838</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2F381800a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F381800a0%26sid%3Dliteratum%253Aachs%26aulast%3DCuvillier%26aufirst%3DO.%26aulast%3DPirianov%26aufirst%3DG.%26aulast%3DKleuser%26aufirst%3DB.%26aulast%3DVanek%26aufirst%3DP.%2BG.%26aulast%3DCoso%26aufirst%3DO.%2BA.%26aulast%3DGutkind%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DSuppression%2520of%2520ceramide-mediated%2520programmed%2520cell%2520death%2520by%2520sphingosine-1-phosphate%26jtitle%3DNature%26date%3D1996%26volume%3D381%26spage%3D800%26epage%3D803%26doi%3D10.1038%2F381800a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maceyka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiegel, S.</span></span> <span> </span><span class="NLM_article-title">Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>333</i></span>,  <span class="NLM_fpage">195</span>– <span class="NLM_lpage">200</span>, <span class="refDoi"> DOI: 10.1016/j.yexcr.2015.02.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1016%2Fj.yexcr.2015.02.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=25770011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksFWis7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2015&pages=195-200&author=J.+Newtonauthor=S.+Limaauthor=M.+Maceykaauthor=S.+Spiegel&title=Revisiting+the+sphingolipid+rheostat%3A+Evolving+concepts+in+cancer+therapy&doi=10.1016%2Fj.yexcr.2015.02.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Revisiting the sphingolipid rheostat- evolving concepts in cancer therapy</span></div><div class="casAuthors">Newton, Jason; Lima, Santiago; Maceyka, Michael; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">195-200</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  This article discusses about role of sphingolipid metabolites such as ceramide and sphingosine-1-phosphate in cell fate along with effects of targeting sphingosine-1-phosphate metabolic enzymes in modulation of progression and drug resistance of cancer in human.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGeaW9kxBn-LVg90H21EOLACvtfcHk0lhFPrwHArJ6ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksFWis7s%253D&md5=0c70739b9f3c002817f82203d832500a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2015.02.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2015.02.025%26sid%3Dliteratum%253Aachs%26aulast%3DNewton%26aufirst%3DJ.%26aulast%3DLima%26aufirst%3DS.%26aulast%3DMaceyka%26aufirst%3DM.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DRevisiting%2520the%2520sphingolipid%2520rheostat%253A%2520Evolving%2520concepts%2520in%2520cancer%2520therapy%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2015%26volume%3D333%26spage%3D195%26epage%3D200%26doi%3D10.1016%2Fj.yexcr.2015.02.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, S.</span>; <span class="NLM_string-name">Adams, D.
R.</span>; <span class="NLM_string-name">Pyne, N.
J.</span></span> <span> </span><span class="NLM_article-title">Sphingosine kinases as druggable targets</span>. In  <i>Handbook of Experimental Pharmacology</i>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Berlin, Heidelberg</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=S.+Pyne&author=D.%0AR.+Adams&author=N.%0AJ.+Pyne&title=Handbook+of+Experimental+Pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPyne%26aufirst%3DS.%26atitle%3DSphingosine%2520kinases%2520as%2520druggable%2520targets%26btitle%3DHandbook%2520of%2520Experimental%2520Pharmacology%26pub%3DSpringer%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, N. J.</span></span> <span> </span><span class="NLM_article-title">Sphingosine 1-phosphate and sphingosine kinases in health and disease: recent advances</span>. <i>Prog. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">106</span>, <span class="refDoi"> DOI: 10.1016/j.plipres.2016.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1016%2Fj.plipres.2016.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=26970273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC28Xks1Cmsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2016&pages=93-106&author=S.+Pyneauthor=D.+R.+Adamsauthor=N.+J.+Pyne&title=Sphingosine+1-phosphate+and+sphingosine+kinases+in+health+and+disease%3A+recent+advances&doi=10.1016%2Fj.plipres.2016.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate and sphingosine kinases in health and disease: Recent advances</span></div><div class="casAuthors">Pyne, Susan; Adams, David R.; Pyne, Nigel J.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Lipid Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">93-106</span>CODEN:
                <span class="NLM_cas:coden">PLIRDW</span>;
        ISSN:<span class="NLM_cas:issn">0163-7827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Sphingosine kinases (isoforms SK1 and SK2) catalyze the formation of a bioactive lipid, sphingosine 1-phosphate (S1P).  S1P is a well-established ligand of a family of five S1P-specific G protein coupled receptors but also has intracellular signalling roles.  There is substantial evidence to support a role for sphingosine kinases and S1P in health and disease.  This review summarizes recent advances in the area in relation to receptor-mediated signalling by S1P and novel intracellular targets of this lipid.  New evidence for a role of each sphingosine kinase isoform in cancer, the cardiovascular system, central nervous system, inflammation and diabetes is discussed.  There is continued research to develop isoform selective SK inhibitors, summarized here.  Anal. of the crystal structure of SK1 with the SK1-selective inhibitor, PF-543, is used to identify residues that could be exploited to improve selectivity in SK inhibitor development for future therapeutic application.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCVKxUdCGqsrVg90H21EOLACvtfcHk0lgK7336g2Pb6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xks1Cmsb8%253D&md5=fdda88832419c066eecb87a07ae3e6ec</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.plipres.2016.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.plipres.2016.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DD.%2BR.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26atitle%3DSphingosine%25201-phosphate%2520and%2520sphingosine%2520kinases%2520in%2520health%2520and%2520disease%253A%2520recent%2520advances%26jtitle%3DProg.%2520Lipid%2520Res.%26date%3D2016%26volume%3D62%26spage%3D93%26epage%3D106%26doi%3D10.1016%2Fj.plipres.2016.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neubauer, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitson, S. M.</span></span> <span> </span><span class="NLM_article-title">Roles, regulation and inhibitors of sphingosine kinase 2</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">5317</span>– <span class="NLM_lpage">5336</span>, <span class="refDoi"> DOI: 10.1111/febs.12314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1111%2Ffebs.12314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=23638983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Wnsr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2013&pages=5317-5336&author=H.+A.+Neubauerauthor=S.+M.+Pitson&title=Roles%2C+regulation+and+inhibitors+of+sphingosine+kinase+2&doi=10.1111%2Ffebs.12314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Roles, regulation and inhibitors of sphingosine kinase 2</span></div><div class="casAuthors">Neubauer, Heidi A.; Pitson, Stuart M.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5317-5336</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The bioactive sphingolipids, ceramide, sphingosine, and sphingosine 1-phosphate (S1P), are important signaling mols. that regulate a diverse array of cellular processes.  Most notably, the balance of the levels of these 3 sphingolipids in cells, termed the 'sphingolipid rheostat', can dictate cell fate, where ceramide and sphingosine enhance apoptosis and S1P promotes cell survival and proliferation.  Sphingosine kinases (SPHKs) catalyze the prodn. of S1P from sphingosine and are therefore central regulators of the sphingolipid rheostat and attractive targets for cancer therapy.  Two SPHKs exist in humans: SPHK1 and SPHK2.  SPHK1 has been extensively studied and there is a large body of evidence to demonstrate its role in promoting cell survival, proliferation, and neoplastic transformation.  SPHK1 is also elevated in many human cancers which appears to contribute to carcinogenesis, chemotherapeutic resistance, and poor patient outcome.  SPHK2, however, has not been as well characterized, and there are contradictions in the key physiol. functions that have been proposed for this isoform.  Despite this, many studies are now emerging that implicate SPHK2 in key roles in a variety of diseases, including the development of a range of solid tumors.  Here, the authors review the literature examg. SPHK2, its physiol. and pathophysiol. functions, current knowledge of its regulation, and recent developments in targeting this complex enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOz9dLgGu0DbVg90H21EOLACvtfcHk0lgK7336g2Pb6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Wnsr%252FL&md5=52f3e71f8ec83879adc80f4edfbb7d35</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Ffebs.12314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.12314%26sid%3Dliteratum%253Aachs%26aulast%3DNeubauer%26aufirst%3DH.%2BA.%26aulast%3DPitson%26aufirst%3DS.%2BM.%26atitle%3DRoles%252C%2520regulation%2520and%2520inhibitors%2520of%2520sphingosine%2520kinase%25202%26jtitle%3DFEBS%2520J.%26date%3D2013%26volume%3D280%26spage%3D5317%26epage%3D5336%26doi%3D10.1111%2Ffebs.12314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baker, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparks, M. A.</span></span> <span> </span><span class="NLM_article-title">Structure and catalytic function of sphingosine kinases: analysis by site-directed mutagenesis and enzyme kinetics</span>. <i>Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1831</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">146</span>, <span class="refDoi"> DOI: 10.1016/j.bbalip.2012.09.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1016%2Fj.bbalip.2012.09.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=23000541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVemt77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1831&publication_year=2013&pages=139-146&author=D.+L.+Bakerauthor=T.+C.+Phamauthor=M.+A.+Sparks&title=Structure+and+catalytic+function+of+sphingosine+kinases%3A+analysis+by+site-directed+mutagenesis+and+enzyme+kinetics&doi=10.1016%2Fj.bbalip.2012.09.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and catalytic function of sphingosine kinases: Analysis by site-directed mutagenesis and enzyme kinetics</span></div><div class="casAuthors">Baker, Daniel L.; Pham, Truc Chi T.; Sparks, Melanie A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1831</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-146</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Sphingosine kinases 1 and 2 (SK1 and SK2, resp.) generate the bioactive lipid mediator, sphingosine 1-phosphate, and as such play a significant role in cell fate and in human health and disease.  Despite significant interest in and examn. of the role played by SK enzymes in disease, comparatively little is currently known about the 3-dimensional structure and catalytic mechanisms of these enzymes.  To date, limited nos. of studies have used site directed mutagenesis and activity detns. to examine the roles of individual SK residues in substrate, calmodulin, and membrane binding, as well as activation via phosphorylation.  Assays are currently available that allow for both single and bisubstrate kinetic anal. of mutant proteins that show normal, lowered, and enhanced activity as compared to wild-type controls.  Addnl. studies will be required to build on this foundation to completely understand SK-mediated substrate binding and phosphoryl group transfer.  A deeper understanding of the SK catalytic mechanism, as well as SK interactions with potential small mol. inhibitors will be invaluable to the future design and identification of SK activity modulators as research tools and potential therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqp18xfXiX-7Vg90H21EOLACvtfcHk0lgK7336g2Pb6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVemt77I&md5=1a003f617cb24cafb2e7d39927b82c07</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2012.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2012.09.006%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DD.%2BL.%26aulast%3DPham%26aufirst%3DT.%2BC.%26aulast%3DSparks%26aufirst%3DM.%2BA.%26atitle%3DStructure%2520and%2520catalytic%2520function%2520of%2520sphingosine%2520kinases%253A%2520analysis%2520by%2520site-directed%2520mutagenesis%2520and%2520enzyme%2520kinetics%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2013%26volume%3D1831%26spage%3D139%26epage%3D146%26doi%3D10.1016%2Fj.bbalip.2012.09.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pitman, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coolen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moretti, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zebol, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finnie, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Don, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebert, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonder, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gliddon, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitson, S. M.</span></span> <span> </span><span class="NLM_article-title">A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">7065</span>– <span class="NLM_lpage">7083</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.3178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.18632%2Foncotarget.3178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=25788259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A280%3ADC%252BC2MnlslKjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=7065-7083&author=M.+R.+Pitmanauthor=J.+A.+Powellauthor=C.+Coolenauthor=P.+A.+Morettiauthor=J.+R.+Zebolauthor=D.+H.+Phamauthor=J.+W.+Finnieauthor=A.+S.+Donauthor=L.+M.+Ebertauthor=C.+S.+Bonderauthor=B.+L.+Gliddonauthor=S.+M.+Pitson&title=A+selective+ATP-competitive+sphingosine+kinase+inhibitor+demonstrates+anti-cancer+properties&doi=10.18632%2Foncotarget.3178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties</span></div><div class="casAuthors">Pitman Melissa R; Powell Jason A; Coolen Carl; Moretti Paul A B; Zebol Julia R; Pham Duyen H; Ebert Lisa M; Bonder Claudine S; Gliddon Briony L; Pitson Stuart M; Powell Jason A; Ebert Lisa M; Bonder Claudine S; Pitson Stuart M; Finnie John W; Finnie John W; Don Anthony S; Bonder Claudine S; Pitson Stuart M</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">7065-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The dynamic balance of cellular sphingolipids, the sphingolipid rheostat, is an important determinant of cell fate, and is commonly deregulated in cancer.  Sphingosine 1-phosphate is a signaling molecule with anti-apoptotic, pro-proliferative and pro-angiogenic effects, while conversely, ceramide and sphingosine are pro-apoptotic.  The sphingosine kinases (SKs) are key regulators of this sphingolipid rheostat, and are attractive targets for anti-cancer therapy.  Here we report a first-in-class ATP-binding site-directed small molecule SK inhibitor, MP-A08, discovered using an approach of structural homology modelling of the ATP-binding site of SK1 and in silico docking with small molecule libraries.  MP-A08 is a highly selective ATP competitive SK inhibitor that targets both SK1 and SK2.  MP-A08 blocks pro-proliferative signalling pathways, induces mitochondrial-associated apoptosis in a SK-dependent manner, and reduces the growth of human lung adenocarcinoma tumours in a mouse xenograft model by both inducing tumour cell apoptosis and inhibiting tumour angiogenesis.  Thus, this selective ATP competitive SK inhibitor provides a promising candidate for potential development as an anti-cancer therapy, and also, due to its different mode of inhibition to other known SK inhibitors, both validates the SKs as targets for anti-cancer therapy, and represents an important experimental tool to study these enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQxJh4Tcj6QZMrRqEXsZufAfW6udTcc2eaT6BRWBgluv7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnlslKjtQ%253D%253D&md5=c844ddaa55bc0d75a46b916c98c0e1ae</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.3178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.3178%26sid%3Dliteratum%253Aachs%26aulast%3DPitman%26aufirst%3DM.%2BR.%26aulast%3DPowell%26aufirst%3DJ.%2BA.%26aulast%3DCoolen%26aufirst%3DC.%26aulast%3DMoretti%26aufirst%3DP.%2BA.%26aulast%3DZebol%26aufirst%3DJ.%2BR.%26aulast%3DPham%26aufirst%3DD.%2BH.%26aulast%3DFinnie%26aufirst%3DJ.%2BW.%26aulast%3DDon%26aufirst%3DA.%2BS.%26aulast%3DEbert%26aufirst%3DL.%2BM.%26aulast%3DBonder%26aufirst%3DC.%2BS.%26aulast%3DGliddon%26aufirst%3DB.%2BL.%26aulast%3DPitson%26aufirst%3DS.%2BM.%26atitle%3DA%2520selective%2520ATP-competitive%2520sphingosine%2520kinase%2520inhibitor%2520demonstrates%2520anti-cancer%2520properties%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D7065%26epage%3D7083%26doi%3D10.18632%2Foncotarget.3178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schnute, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McReynolds, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasten, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerome, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rains, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrencik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronin, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saabye, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Highkin, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broadus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cukyne, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zawadzke, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterkin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyanar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholten, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendling, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiwara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemirovskiy, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittwer, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagiec, M. M.</span></span> <span> </span><span class="NLM_article-title">Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>444</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1042/BJ20111929</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1042%2FBJ20111929" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=22397330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1Kltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=444&publication_year=2012&pages=79-88&author=M.+E.+Schnuteauthor=M.+D.+McReynoldsauthor=T.+Kastenauthor=M.+Yatesauthor=G.+Jeromeauthor=J.+W.+Rainsauthor=T.+Hallauthor=J.+Chrencikauthor=M.+Krausauthor=C.+N.+Croninauthor=M.+Saabyeauthor=M.+K.+Highkinauthor=R.+Broadusauthor=S.+Ogawaauthor=K.+Cukyneauthor=L.+E.+Zawadzkeauthor=V.+Peterkinauthor=K.+Iyanarauthor=J.+A.+Scholtenauthor=J.+Wendlingauthor=H.+Fujiwaraauthor=O.+Nemirovskiyauthor=A.+J.+Wittwerauthor=M.+M.+Nagiec&title=Modulation+of+cellular+S1P+levels+with+a+novel%2C+potent+and+specific+inhibitor+of+sphingosine+kinase-1&doi=10.1042%2FBJ20111929"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1</span></div><div class="casAuthors">Schnute, Mark E.; McReynolds, Matthew D.; Kasten, Tom; Yates, Matthew; Jerome, Gina; Rains, John W.; Hall, Troii; Chrencik, Jill; Kraus, Michelle; Cronin, Ciaran N.; Saabye, Matthew; Highkin, Maureen K.; Broadus, Richard; Ogawa, Shinji; Cukyne, Kristin; Zawadzke, Laura E.; Peterkin, Vincent; Iyanar, Kaliapan; Scholten, Jeffrey A.; Wendling, Jay; Fujiwara, Hideji; Nemirovskiy, Olga; Wittwer, Arthur J.; Nagiec, Marek M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">444</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-88</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">SphK (sphingosine kinase) is the major source of the bioactive lipid and GPCR (G-protein-coupled receptor) agonist S1P (sphingosine 1-phosphate).  S1P promotes cell growth, survival and migration, and is a key regulator of lymphocyte trafficking.  Inhibition of S1P signalling has been proposed as a strategy for treatment of inflammatory diseases and cancer.  In the present paper we describe the discovery and characterization of PF-543, a novel cell-permeant inhibitor of SphK1.  PF-543 inhibits SphK1 with a Ki of 3.6 nM, is sphingosine-competitive and is more than 100-fold selective for SphK1 over the SphK2 isoform.  In 1483 head and neck carcinoma cells, which are characterized by high levels of SphK1 expression and an unusually high rate of S1P prodn., PF-543 decreased the level of endogenous S1P 10-fold with a proportional increase in the level of sphingosine.  In contrast with past reports that show that the growth of many cancer cell lines is SphK1-dependent, specific inhibition of SphK1 had no effect on the proliferation and survival of 1483 cells, despite a dramatic change in the cellular S1P/sphingosine ratio.  PF-543 was effective as a potent inhibitor of S1P formation in whole blood, indicating that the SphK1 isoform of sphingosine kinase is the major source of S1P in human blood.  PF-543 is the most potent inhibitor of SphK1 described to date and it will be useful for dissecting specific roles of SphK1-driven S1P signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrenMsEAHJOo7Vg90H21EOLACvtfcHk0ljg1F3CrP8ldw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Kltrw%253D&md5=7615a3b0e28e4f798e30bf27998dbad0</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1042%2FBJ20111929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20111929%26sid%3Dliteratum%253Aachs%26aulast%3DSchnute%26aufirst%3DM.%2BE.%26aulast%3DMcReynolds%26aufirst%3DM.%2BD.%26aulast%3DKasten%26aufirst%3DT.%26aulast%3DYates%26aufirst%3DM.%26aulast%3DJerome%26aufirst%3DG.%26aulast%3DRains%26aufirst%3DJ.%2BW.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DChrencik%26aufirst%3DJ.%26aulast%3DKraus%26aufirst%3DM.%26aulast%3DCronin%26aufirst%3DC.%2BN.%26aulast%3DSaabye%26aufirst%3DM.%26aulast%3DHighkin%26aufirst%3DM.%2BK.%26aulast%3DBroadus%26aufirst%3DR.%26aulast%3DOgawa%26aufirst%3DS.%26aulast%3DCukyne%26aufirst%3DK.%26aulast%3DZawadzke%26aufirst%3DL.%2BE.%26aulast%3DPeterkin%26aufirst%3DV.%26aulast%3DIyanar%26aufirst%3DK.%26aulast%3DScholten%26aufirst%3DJ.%2BA.%26aulast%3DWendling%26aufirst%3DJ.%26aulast%3DFujiwara%26aufirst%3DH.%26aulast%3DNemirovskiy%26aufirst%3DO.%26aulast%3DWittwer%26aufirst%3DA.%2BJ.%26aulast%3DNagiec%26aufirst%3DM.%2BM.%26atitle%3DModulation%2520of%2520cellular%2520S1P%2520levels%2520with%2520a%2520novel%252C%2520potent%2520and%2520specific%2520inhibitor%2520of%2520sphingosine%2520kinase-1%26jtitle%3DBiochem.%2520J.%26date%3D2012%26volume%3D444%26spage%3D79%26epage%3D88%26doi%3D10.1042%2FBJ20111929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kane, J. L.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noson, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asmussen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzgerald, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klaus, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Booker, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel sphingosine kinase-1 inhibitors. Part 2</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">4550</span>– <span class="NLM_lpage">4554</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.06.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1016%2Fj.bmcl.2010.06.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4550-4554&author=Y.+Xiangauthor=B.+Hirthauthor=J.+L.+Kaneauthor=J.+Liaoauthor=K.+D.+Nosonauthor=C.+Yeeauthor=G.+Asmussenauthor=M.+Fitzgeraldauthor=C.+Klausauthor=M.+Booker&title=Discovery+of+novel+sphingosine+kinase-1+inhibitors.+Part+2&doi=10.1016%2Fj.bmcl.2010.06.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.06.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.06.019%26sid%3Dliteratum%253Aachs%26aulast%3DXiang%26aufirst%3DY.%26aulast%3DHirth%26aufirst%3DB.%26aulast%3DKane%26aufirst%3DJ.%2BL.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DNoson%26aufirst%3DK.%2BD.%26aulast%3DYee%26aufirst%3DC.%26aulast%3DAsmussen%26aufirst%3DG.%26aulast%3DFitzgerald%26aufirst%3DM.%26aulast%3DKlaus%26aufirst%3DC.%26aulast%3DBooker%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520novel%2520sphingosine%2520kinase-1%2520inhibitors.%2520Part%25202%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4550%26epage%3D4554%26doi%3D10.1016%2Fj.bmcl.2010.06.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gustin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connors, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardozo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffries, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franks, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wesche, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgenstern, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rex, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coxon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayser, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span> <span> </span><span class="NLM_article-title">Structure guided design of a series of sphingosine kinase (SphK) inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">4608</span>– <span class="NLM_lpage">4616</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.06.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1016%2Fj.bmcl.2013.06.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=23845219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2lsb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4608-4616&author=D.+J.+Gustinauthor=Y.+Liauthor=M.+L.+Brownauthor=X.+Minauthor=M.+J.+Schmittauthor=M.+Wanskaauthor=X.+Wangauthor=R.+Connorsauthor=S.+Johnstoneauthor=M.+Cardozoauthor=A.+C.+Chengauthor=S.+Jeffriesauthor=B.+Franksauthor=S.+Liauthor=S.+Shenauthor=M.+Wongauthor=H.+Wescheauthor=G.+Xuauthor=T.+J.+Carlsonauthor=M.+Plantauthor=K.+Morgensternauthor=K.+Rexauthor=J.+Schmittauthor=A.+Coxonauthor=N.+Walkerauthor=F.+Kayserauthor=Z.+Wang&title=Structure+guided+design+of+a+series+of+sphingosine+kinase+%28SphK%29+inhibitors&doi=10.1016%2Fj.bmcl.2013.06.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Structure guided design of a series of sphingosine kinase (SphK) inhibitors</span></div><div class="casAuthors">Gustin, Darin J.; Li, Yihong; Brown, Matthew L.; Min, Xiaoshan; Schmitt, Mike J.; Wanska, Malgorzata; Wang, Xiaodong; Connors, Richard; Johnstone, Sheere; Cardozo, Mario; Cheng, Alan C.; Jeffries, Shawn; Franks, Brendon; Li, Shyun; Shen, Shanling; Wong, Mariwil; Wesche, Holger; Xu, Guifen; Carlson, Timothy J.; Plant, Matthew; Morgenstern, Kurt; Rex, Karen; Schmitt, Joanna; Coxon, Angela; Walker, Nigel; Kayser, Frank; Wang, Zhulun</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4608-4616</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sphingosine-1-phosphate (S1P) signaling plays a vital role in mitogenesis, cell migration and angiogenesis.  Sphingosine kinases (SphKs) catalyze a key step in sphingomyelin metab. that leads to the prodn. of S1P.  There are two isoforms of SphK and observations made with SphK deficient mice show the two isoforms can compensate for each other's loss.  Thus, inhibition of both isoforms is likely required to block SphK dependent angiogenesis.  A structure based approach was used to design and synthesize a series of SphK inhibitors resulting in the identification of the first potent inhibitors of both isoforms of human SphK.  Addnl., to our knowledge, this series of inhibitors contains the only sufficiently potent inhibitors of murine SphK1 with suitable physico-chem. properties to pharmacol. interrogate the role of SphK1 in rodent models and to reproduce the phenotype of SphK1 (-/-) mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovzWgmT5jALrVg90H21EOLACvtfcHk0lh5A2YLkOpnFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2lsb%252FN&md5=42c7f013299278232f62a9f70bccd08c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.06.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.06.030%26sid%3Dliteratum%253Aachs%26aulast%3DGustin%26aufirst%3DD.%2BJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DM.%2BL.%26aulast%3DMin%26aufirst%3DX.%26aulast%3DSchmitt%26aufirst%3DM.%2BJ.%26aulast%3DWanska%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DConnors%26aufirst%3DR.%26aulast%3DJohnstone%26aufirst%3DS.%26aulast%3DCardozo%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DJeffries%26aufirst%3DS.%26aulast%3DFranks%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DWesche%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DCarlson%26aufirst%3DT.%2BJ.%26aulast%3DPlant%26aufirst%3DM.%26aulast%3DMorgenstern%26aufirst%3DK.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DSchmitt%26aufirst%3DJ.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DWalker%26aufirst%3DN.%26aulast%3DKayser%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3DStructure%2520guided%2520design%2520of%2520a%2520series%2520of%2520sphingosine%2520kinase%2520%2528SphK%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4608%26epage%3D4616%26doi%3D10.1016%2Fj.bmcl.2013.06.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berka, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ning, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogdanov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milburn, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idowu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdulmalik, O. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowhan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellems, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juneja, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Y.</span></span> <span> </span><span class="NLM_article-title">Elevated sphingosine-1-phosphate promotes sickling and sickle cell disease progression</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">2750</span>– <span class="NLM_lpage">2761</span>, <span class="refDoi"> DOI: 10.1172/JCI74604</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1172%2FJCI74604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=24837436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvFahs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=2750-2761&author=Y.+Zhangauthor=V.+Berkaauthor=A.+Songauthor=K.+Sunauthor=W.+Wangauthor=W.+Zhangauthor=C.+Ningauthor=C.+Liauthor=Q.+Zhangauthor=M.+Bogdanovauthor=D.+C.+Alexanderauthor=M.+V.+Milburnauthor=M.+H.+Ahmedauthor=H.+Linauthor=M.+Idowuauthor=J.+Zhangauthor=G.+J.+Katoauthor=O.+Y.+Abdulmalikauthor=W.+Zhangauthor=W.+Dowhanauthor=R.+E.+Kellemsauthor=P.+Zhangauthor=J.+Jinauthor=M.+Safoauthor=A.+L.+Tsaiauthor=H.+S.+Junejaauthor=Y.+Xia&title=Elevated+sphingosine-1-phosphate+promotes+sickling+and+sickle+cell+disease+progression&doi=10.1172%2FJCI74604"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated sphingosine-1-phosphate promotes sickling and sickle cell disease progression</span></div><div class="casAuthors">Zhang, Yujin; Berka, Vladimir; Song, Anren; Sun, Kaiqi; Wang, Wei; Zhang, Weiru; Ning, Chen; Li, Chonghua; Zhang, Qibo; Bogdanov, Mikhail; Alexander, Danny C.; Milburn, Michael V.; Ahmed, Mostafa H.; Lin, Han; Idowu, Modupe; Zhang, Jun; Kato, Gregory J.; Abdulmalik, Osheiza Y.; Zhang, Wenzheng; Dowhan, William; Kellems, Rodney E.; Zhang, Pumin; Jin, Jianping; Safo, Martin; Tsai, Ah-Lim; Juneja, Harinder S.; Xia, Yang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2750-2761</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Sphingosine-1-phosphate (S1P) is a bioactive lipid that regulates multicellular functions through interactions with its receptors on cell surfaces.  S1P is enriched and stored in erythrocytes; however, it is not clear whether alterations in S1P are involved in the prevalent and debilitating hemolytic disorder sickle cell disease (SCD).  Here, using metabolomic screening, we found that S1P is highly elevated in the blood of mice and humans with SCD.  In murine models of SCD, we demonstrated that elevated erythrocyte sphingosine kinase 1 (SPHK1) underlies sickling and disease progression by increasing S1P levels in the blood.  Addnl., we obsd. elevated SPHK1 activity in erythrocytes and increased S1P in blood collected from patients with SCD and demonstrated a direct impact of elevated SPHK1-mediated prodn. of S1P on sickling that was independent of S1P receptor activation in isolated erythrocytes.  Together, our findings provide insights into erythrocyte pathophysiol., revealing that a SPHK1-mediated elevation of S1P contributes to sickling and promotes disease progression, and highlight potential therapeutic opportunities for SCD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3xAA8WICyg7Vg90H21EOLACvtfcHk0lh5A2YLkOpnFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvFahs7s%253D&md5=0cbb85f9b96956110a5578baf0b382a7</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1172%2FJCI74604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI74604%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBerka%26aufirst%3DV.%26aulast%3DSong%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DNing%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DBogdanov%26aufirst%3DM.%26aulast%3DAlexander%26aufirst%3DD.%2BC.%26aulast%3DMilburn%26aufirst%3DM.%2BV.%26aulast%3DAhmed%26aufirst%3DM.%2BH.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DIdowu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DKato%26aufirst%3DG.%2BJ.%26aulast%3DAbdulmalik%26aufirst%3DO.%2BY.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DDowhan%26aufirst%3DW.%26aulast%3DKellems%26aufirst%3DR.%2BE.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DSafo%26aufirst%3DM.%26aulast%3DTsai%26aufirst%3DA.%2BL.%26aulast%3DJuneja%26aufirst%3DH.%2BS.%26aulast%3DXia%26aufirst%3DY.%26atitle%3DElevated%2520sphingosine-1-phosphate%2520promotes%2520sickling%2520and%2520sickle%2520cell%2520disease%2520progression%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2014%26volume%3D124%26spage%3D2750%26epage%3D2761%26doi%3D10.1172%2FJCI74604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, L.</span></span> <span> </span><span class="NLM_article-title">Sphingosine 1-phosphate signaling contributes to cardiac inflammation, dysfunction, and remodeling following myocardial infarction</span>. <i>Am. J. Physiol. Heart Circ. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>310</i></span>,  <span class="NLM_fpage">H250</span>– <span class="NLM_lpage">H261</span>, <span class="refDoi"> DOI: 10.1152/ajpheart.00372.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1152%2Fajpheart.00372.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=26589326" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=310&publication_year=2016&pages=H250-H261&author=F.+Zhangauthor=Y.+Xiaauthor=W.+Yanauthor=H.+Zhangauthor=F.+Zhouauthor=S.+Zhaoauthor=W.+Wangauthor=D.+Zhuauthor=C.+Xinauthor=Y.+Leeauthor=L.+Zhangauthor=Y.+Heauthor=E.+Gaoauthor=L.+Tao&title=Sphingosine+1-phosphate+signaling+contributes+to+cardiac+inflammation%2C+dysfunction%2C+and+remodeling+following+myocardial+infarction&doi=10.1152%2Fajpheart.00372.2015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1152%2Fajpheart.00372.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpheart.00372.2015%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DXin%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DE.%26aulast%3DTao%26aufirst%3DL.%26atitle%3DSphingosine%25201-phosphate%2520signaling%2520contributes%2520to%2520cardiac%2520inflammation%252C%2520dysfunction%252C%2520and%2520remodeling%2520following%2520myocardial%2520infarction%26jtitle%3DAm.%2520J.%2520Physiol.%2520Heart%2520Circ.%2520Physiol.%26date%3D2016%26volume%3D310%26spage%3DH250%26epage%3DH261%26doi%3D10.1152%2Fajpheart.00372.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MacRitchie, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volpert, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Washih, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futerman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, N. J.</span></span> <span> </span><span class="NLM_article-title">Effect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodelling in a hypoxic model of pulmonary arterial hypertension</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">946</span>– <span class="NLM_lpage">955</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2016.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1016%2Fj.cellsig.2016.03.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=27063355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC28XotFamu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2016&pages=946-955&author=N.+MacRitchieauthor=G.+Volpertauthor=M.+Al+Washihauthor=D.+G.+Watsonauthor=A.+H.+Futermanauthor=S.+Kennedyauthor=S.+Pyneauthor=N.+J.+Pyne&title=Effect+of+the+sphingosine+kinase+1+selective+inhibitor%2C+PF-543+on+arterial+and+cardiac+remodelling+in+a+hypoxic+model+of+pulmonary+arterial+hypertension&doi=10.1016%2Fj.cellsig.2016.03.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodelling in a hypoxic model of pulmonary arterial hypertension</span></div><div class="casAuthors">MacRitchie, Neil; Volpert, Giora; Al Washih, Mohammed; Watson, David G.; Futerman, Anthony H.; Kennedy, Simon; Pyne, Susan; Pyne, Nigel J.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">946-955</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Recent studies have demonstrated that the expression of sphingosine kinase 1, the enzyme that catalyzes formation of the bioactive lipid, sphingosine 1-phosphate, is increased in lungs from patients with pulmonary arterial hypertension.  In addn., Sk1-/- mice are protected from hypoxic-induced pulmonary arterial hypertension.  Therefore, we assessed the effect of the sphingosine kinase 1 selective inhibitor, PF-543 and a sphingosine kinase 1/ceramide synthase inhibitor, RB-005 on pulmonary and cardiac remodelling in a mouse hypoxic model of pulmonary arterial hypertension.  Administration of the potent sphingosine kinase 1 inhibitor, PF-543 in a mouse hypoxic model of pulmonary hypertension had no effect on vascular remodelling but reduced right ventricular hypertrophy.  The latter was assocd. with a significant redn. in cardiomyocyte death.  The protection involves a redn. in the expression of p53 (that promotes cardiomyocyte death) and an increase in the expression of anti-oxidant nuclear factor (erythroid-derived 2)-like 2 (Nrf-2).  In contrast, RB-005 lacked effects on right ventricular hypertrophy, suggesting that sphingosine kinase 1 inhibition might be nullified by concurrent inhibition of ceramide synthase.  Therefore, our findings with PF-543 suggest an important role for sphingosine kinase 1 in the development of hypertrophy in pulmonary arterial hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIc5iHVP6GEbVg90H21EOLACvtfcHk0ljTku6N241KSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotFamu70%253D&md5=35db2cab74cf8939b1bca4345e9d285a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2016.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2016.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DMacRitchie%26aufirst%3DN.%26aulast%3DVolpert%26aufirst%3DG.%26aulast%3DAl%2BWashih%26aufirst%3DM.%26aulast%3DWatson%26aufirst%3DD.%2BG.%26aulast%3DFuterman%26aufirst%3DA.%2BH.%26aulast%3DKennedy%26aufirst%3DS.%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26atitle%3DEffect%2520of%2520the%2520sphingosine%2520kinase%25201%2520selective%2520inhibitor%252C%2520PF-543%2520on%2520arterial%2520and%2520cardiac%2520remodelling%2520in%2520a%2520hypoxic%2520model%2520of%2520pulmonary%2520arterial%2520hypertension%26jtitle%3DCell.%2520Signalling%26date%3D2016%26volume%3D28%26spage%3D946%26epage%3D955%26doi%3D10.1016%2Fj.cellsig.2016.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">French, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maines, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beljanski, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upson, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. D.</span></span> <span> </span><span class="NLM_article-title">Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>333</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1124/jpet.109.163444</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1124%2Fjpet.109.163444" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=20061445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFGktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2010&pages=129-139&author=K.+J.+Frenchauthor=Y.+Zhuangauthor=L.+W.+Mainesauthor=P.+Gaoauthor=W.+Wangauthor=V.+Beljanskiauthor=J.+J.+Upsonauthor=C.+L.+Greenauthor=S.+N.+Kellerauthor=C.+D.+Smith&title=Pharmacology+and+antitumor+activity+of+ABC294640%2C+a+selective+inhibitor+of+sphingosine+kinase-2&doi=10.1124%2Fjpet.109.163444"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2</span></div><div class="casAuthors">French, Kevin J.; Zhuang, Yan; Maines, Lynn W.; Gao, Peng; Wang, Wenxue; Beljanski, Vladimir; Upson, John J.; Green, Cecelia L.; Keller, Staci N.; Smith, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">129-139</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Sphingolipid-metabolizing enzymes control the dynamic balance of the cellular levels of important bioactive lipids, including the apoptotic compd. ceramide and the proliferative compd. sphingosine 1-phosphate (S1P).  Many growth factors and inflammatory cytokines promote the cleavage of sphingomyelin and ceramide leading to rapid elevation of S1P levels through the action of sphingosine kinases (SK1 and SK2).  SK1 and SK2 are overexpressed in a variety of human cancers, making these enzymes potential mol. targets for cancer therapy.  We have identified an aryladamantane compd., termed ABC294640 [3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide], that selectively inhibits SK2 activity in vitro, acting as a competitive inhibitor with respect to sphingosine with a Ki of 9.8 μM, and attenuates S1P formation in intact cells.  In tissue culture, ABC294640 suppresses the proliferation of a broad panel of tumor cell lines, and inhibits tumor cell migration concomitant with loss of microfilaments.  In vivo, ABC294640 has excellent oral bioavailability, and demonstrates a plasma clearance half-time of 4.5 h in mice.  Acute and chronic toxicol. studies indicate that ABC294640 induces a transient minor decrease in the hematocrit of rats and mice; however, this normalizes by 28 days of treatment.  No other changes in hematol. parameters, or gross or microscopic tissue pathol., result from treatment with ABC294640.  Oral administration of ABC294640 to mice bearing mammary adenocarcinoma xenografts results in dose-dependent antitumor activity assocd. with depletion of S1P levels in the tumors and progressive tumor cell apoptosis.  Therefore, this newly developed SK2 inhibitor provides an orally available drug candidate for the treatment of cancer and other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsJFYxYhWjhbVg90H21EOLACvtfcHk0ljTku6N241KSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFGktro%253D&md5=63e0792b887d9ad70c76f209e577a693</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.163444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.163444%26sid%3Dliteratum%253Aachs%26aulast%3DFrench%26aufirst%3DK.%2BJ.%26aulast%3DZhuang%26aufirst%3DY.%26aulast%3DMaines%26aufirst%3DL.%2BW.%26aulast%3DGao%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DBeljanski%26aufirst%3DV.%26aulast%3DUpson%26aufirst%3DJ.%2BJ.%26aulast%3DGreen%26aufirst%3DC.%2BL.%26aulast%3DKeller%26aufirst%3DS.%2BN.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26atitle%3DPharmacology%2520and%2520antitumor%2520activity%2520of%2520ABC294640%252C%2520a%2520selective%2520inhibitor%2520of%2520sphingosine%2520kinase-2%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D333%26spage%3D129%26epage%3D139%26doi%3D10.1124%2Fjpet.109.163444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hait, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allegood, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parikh, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellogg, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiegel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span> <span> </span><span class="NLM_article-title">Biological characterization of 3-(2-aminoethyl)-5-[3-(4-butoxylphenyl)propylidene]thiazolidine-2,4-dione (K145) as a selective sphingosine kinase-2 inhibitor and anticancer agent</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e56471</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0056471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1371%2Fjournal.pone.0056471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=23437140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsF2ju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e56471&author=K.+Liuauthor=T.+L.+Guoauthor=N.+C.+Haitauthor=J.+Allegoodauthor=H.+I.+Parikhauthor=W.+Xuauthor=G.+E.+Kelloggauthor=S.+Grantauthor=S.+Spiegelauthor=S.+Zhang&title=Biological+characterization+of+3-%282-aminoethyl%29-5-%5B3-%284-butoxylphenyl%29propylidene%5Dthiazolidine-2%2C4-dione+%28K145%29+as+a+selective+sphingosine+kinase-2+inhibitor+and+anticancer+agent&doi=10.1371%2Fjournal.pone.0056471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Biological characterization of 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) as a selective sphingosine kinase-2 inhibitor and anticancer agent</span></div><div class="casAuthors">Liu, Kai; Guo, Tai L.; Hait, Nitai C.; Allegood, Jeremy; Parikh, Hardik I.; Xu, Wenfang; Kellogg, Glen E.; Grant, Steven; Spiegel, Sarah; Zhang, Shijun</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e56471</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">In our effort to develop selective sphingosine kinase-2 (SphK2) inhibitors as pharmacol. tools, a thiazolidine-2,4-dione analog, 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione(K145), was synthesized and biol. characterized.  Biochem. assay results indicate that K145 is a selective SphK2 inhibitor.  Mol. modeling studies also support this notion.  In vitro studies using human leukemia U937 cells demonstrated that K145 accumulates in U937 cells, suppresses the S1P level, and inhibits SphK2.  K145 also exhibited inhibitory effects on the growth of U937 cells as well as apoptotic effects in U937 cells, and that these effects may be through the inhibition of down-stream ERK and Akt signaling pathways.  K145 also significantly inhibited the growth of U937 tumors in nude mice by both i.p. and oral administration, thus demonstrating its in vivo efficacy as a potential lead anticancer agent.  The antitumor activity of K145 was also confirmed in a syngeneic mouse model by implanting murine breast cancer JC cells in BALB/c mice.  Collectively, these results strongly encourage further optimization of K145 as a novel lead compd. for development of more potent and selective SphK2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXIc2J15Fc-bVg90H21EOLACvtfcHk0ljTku6N241KSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsF2ju7s%253D&md5=bddb4fe0ce70a76f3b2adcdcd1cb9ec8</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0056471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0056471%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DGuo%26aufirst%3DT.%2BL.%26aulast%3DHait%26aufirst%3DN.%2BC.%26aulast%3DAllegood%26aufirst%3DJ.%26aulast%3DParikh%26aufirst%3DH.%2BI.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DKellogg%26aufirst%3DG.%2BE.%26aulast%3DGrant%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26atitle%3DBiological%2520characterization%2520of%25203-%25282-aminoethyl%2529-5-%255B3-%25284-butoxylphenyl%2529propylidene%255Dthiazolidine-2%252C4-dione%2520%2528K145%2529%2520as%2520a%2520selective%2520sphingosine%2520kinase-2%2520inhibitor%2520and%2520anticancer%2520agent%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De56471%26doi%3D10.1371%2Fjournal.pone.0056471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kharel, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raje, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gellett, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomsig, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, W. L.</span></span> <span> </span><span class="NLM_article-title">Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>447</i></span>,  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.1042/BJ20120609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1042%2FBJ20120609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=22747486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlCjsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=447&publication_year=2012&pages=149-157&author=Y.+Kharelauthor=M.+Rajeauthor=M.+Gaoauthor=A.+M.+Gellettauthor=J.+L.+Tomsigauthor=K.+R.+Lynchauthor=W.+L.+Santos&title=Sphingosine+kinase+type+2+inhibition+elevates+circulating+sphingosine+1-phosphate&doi=10.1042%2FBJ20120609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate</span></div><div class="casAuthors">Kharel, Yugesh; Raje, Mithun; Gao, Ming; Gellett, Amanda M.; Tomsig, Jose L.; Lynch, Kevin R.; Santos, Webster L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">447</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">149-157</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">S1P (sphingosine 1-phosphate) is a pleiotropic lipid mediator involved in numerous cellular and physiol. functions.  Of note among these are cell survival and migration, as well as lymphocyte trafficking.  S1P, which exerts its effects via five GPCRs (G-protein-coupled receptors) (S1P1-S1P5), is formed by the action of two SphKs (sphingosine kinases).  Although SphK1 is the more intensively studied isotype, SphK2 is unique in it nuclear localization and has been reported to oppose some of the actions ascribed to SphK1.  Although several scaffolds of SphK1 inhibitors have been described, there is a scarcity of selective SphK2 inhibitors that are necessary to evaluate the downstream effects of inhibition of this isotype.  In the present paper we report a cationic amphiphilic small mol. that is a selective SphK2 inhibitor.  In the course of characterizing this compd. in wild-type and SphK-null mice, we discovered that administration of the inhibitor to wild-type mice resulted in a rapid increase in blood S1P, which is in contrast with our SphK1 inhibitor that drives circulating S1P levels down.  Using a cohort of F2 hybrid mice, we confirmed, compared with wild-type mice, that circulating S1P levels were higher in SphK2-null mice and lower in SphK1-null mice.  Thus both SphK1 and SphK2 inhibitors recapitulate the blood S1P levels obsd. in the corresponding null mice.  Moreover, circulating S1P levels mirror SphK2 inhibitor levels, providing a convenient biomarker of target engagement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKDtUfuqfG5bVg90H21EOLACvtfcHk0ljICzSlNhh-xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlCjsLrE&md5=dbd6766a0d93b120155a2c0caa69ceda</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1042%2FBJ20120609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20120609%26sid%3Dliteratum%253Aachs%26aulast%3DKharel%26aufirst%3DY.%26aulast%3DRaje%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DGellett%26aufirst%3DA.%2BM.%26aulast%3DTomsig%26aufirst%3DJ.%2BL.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DSantos%26aufirst%3DW.%2BL.%26atitle%3DSphingosine%2520kinase%2520type%25202%2520inhibition%2520elevates%2520circulating%2520sphingosine%25201-phosphate%26jtitle%3DBiochem.%2520J.%26date%3D2012%26volume%3D447%26spage%3D149%26epage%3D157%26doi%3D10.1042%2FBJ20120609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, S.</span></span> <span> </span><span class="NLM_article-title">(<i>R</i>)-FTY720 methyl ether is a specific sphingosine kinase 2 inhibitor: effect on sphingosine kinase 2 expression in HEK 293 cells and actin rearrangement and survival of MCF-7 breast cancer cells</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1590</span>– <span class="NLM_lpage">1595</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2011.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1016%2Fj.cellsig.2011.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=21620961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpslaisbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2011&pages=1590-1595&author=K.+G.+Limauthor=C.+Sunauthor=R.+Bittmanauthor=N.+J.+Pyneauthor=S.+Pyne&title=%28R%29-FTY720+methyl+ether+is+a+specific+sphingosine+kinase+2+inhibitor%3A+effect+on+sphingosine+kinase+2+expression+in+HEK+293+cells+and+actin+rearrangement+and+survival+of+MCF-7+breast+cancer+cells&doi=10.1016%2Fj.cellsig.2011.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">(R)-FTY720 methyl ether is a specific sphingosine kinase 2 inhibitor: Effect on sphingosine kinase 2 expression in HEK 293 cells and actin rearrangement and survival of MCF-7 breast cancer cells</span></div><div class="casAuthors">Lim, Keng Gat; Sun, Chaode; Bittman, Robert; Pyne, Nigel J.; Pyne, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1590-1595</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Sphingosine kinase 2 (SK2) catalyzes the conversion of sphingosine to the bioactive lipid sphingosine 1-phosphate (S1P).  We report here, the stereospecific synthesis of an analog of FTY720 called (R)-FTY720-OMe, which we show is a competitive inhibitor of SK2. (R)-FTY720-OMe failed to inhibit sphingosine kinase 1 activity, thereby demonstrating specificity for SK2.  Prolonged treatment of HEK 293 cells with (R)-FTY720-OMe also induced a redn. in SK2 expression.  In addn., (R)-FTY720-OMe inhibited DNA synthesis and prevented S1P-stimulated rearrangement of actin in MCF-7 breast cancer cells.  These findings demonstrate that SK2 functions as a pro-survival protein and is involved in promoting actin rearrangement into membrane ruffles/lamellipodia in response to S1P in MCF-7 breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlXS4c2DHDxLVg90H21EOLACvtfcHk0ljICzSlNhh-xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpslaisbw%253D&md5=651d949ee44042ec0c3d975fb2be5cc6</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2011.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2011.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DK.%2BG.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DBittman%26aufirst%3DR.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26aulast%3DPyne%26aufirst%3DS.%26atitle%3D%2528R%2529-FTY720%2520methyl%2520ether%2520is%2520a%2520specific%2520sphingosine%2520kinase%25202%2520inhibitor%253A%2520effect%2520on%2520sphingosine%2520kinase%25202%2520expression%2520in%2520HEK%2520293%2520cells%2520and%2520actin%2520rearrangement%2520and%2520survival%2520of%2520MCF-7%2520breast%2520cancer%2520cells%26jtitle%3DCell.%2520Signalling%26date%3D2011%26volume%3D23%26spage%3D1590%26epage%3D1595%26doi%3D10.1016%2Fj.cellsig.2011.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beljanski, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knaak, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. D.</span></span> <span> </span><span class="NLM_article-title">A novel sphingosine kinase inhibitor induces autophagy in tumor cells</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>333</i></span>,  <span class="NLM_fpage">454</span>– <span class="NLM_lpage">464</span>, <span class="refDoi"> DOI: 10.1124/jpet.109.163337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1124%2Fjpet.109.163337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=20179157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFKhtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2010&pages=454-464&author=V.+Beljanskiauthor=C.+Knaakauthor=C.+D.+Smith&title=A+novel+sphingosine+kinase+inhibitor+induces+autophagy+in+tumor+cells&doi=10.1124%2Fjpet.109.163337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A novel sphingosine kinase inhibitor induces autophagy in tumor cells</span></div><div class="casAuthors">Beljanski, Vladimir; Knaak, Christian; Smith, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">454-464</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The sphingolipids ceramide, sphingosine, and sphingosine 1-phosphate (S1P) regulate cell signaling, proliferation, apoptosis, and autophagy.  Sphingosine kinase-1 and -2 (SK1 and SK2) phosphorylate sphingosine to form S1P, shifting the balanced activity of these lipids toward cell proliferation.  We have previously reported that pharmacol. inhibition of SK activity delays tumor growth in vivo.  The present studies demonstrate that the SK2-selective inhibitor 3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide (ABC294640) induces nonapoptotic cell death that is preceded by microtubule-assocd. protein light chain 3 cleavage, morphol. changes in lysosomes, formation of autophagosomes, and increases in acidic vesicles in A-498 kidney carcinoma cells.  ABC294640 caused similar autophagic responses in PC-3 prostate and MDA-MB-231 breast adenocarcinoma cells.  Simultaneous exposure of A-498 cells to ABC294640 and 3-methyladenine, an inhibitor of autophagy, switched the mechanism of toxicity to apoptosis, but decreased the potency of the SK2 inhibitor, indicating that autophagy is a major mechanism for tumor cell killing by this compd.  Induction of the unfolded protein response by the proteasome inhibitor N-(benzyloxycarbonyl)leucinylleucinylleucinal Z-Leu-Leu-Leu-al (MG-132) or the heat shock protein 90 inhibitor geldanamycin synergistically increased the cytotoxicity of ABC294640 in vitro.  In severe combined immunodeficient mice bearing A-498 xenografts, daily administration of ABC294640 delayed tumor growth and elevated autophagy markers, but did not increase terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling-pos. cells in the tumors.  These data suggest that ABC294640 promotes tumor cell autophagy, which ultimately results in nonapoptotic cell death and a delay of tumor growth in vivo.  Consequently, ABC294640 may effectively complement anticancer drugs that induce tumor cell apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKrohC6YQacrVg90H21EOLACvtfcHk0ljICzSlNhh-xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFKhtb4%253D&md5=5a3545b993705f7a1f16f9d3c9567061</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.163337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.163337%26sid%3Dliteratum%253Aachs%26aulast%3DBeljanski%26aufirst%3DV.%26aulast%3DKnaak%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26atitle%3DA%2520novel%2520sphingosine%2520kinase%2520inhibitor%2520induces%2520autophagy%2520in%2520tumor%2520cells%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D333%26spage%3D454%26epage%3D464%26doi%3D10.1124%2Fjpet.109.163337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fitzpatrick, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frauenhoffer, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">French, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maines, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upson, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donahue, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosher, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. D.</span></span> <span> </span><span class="NLM_article-title">Attenuation of arthritis in rodents by a novel orally-available inhibitor of sphingosine kinase</span>. <i>Inflammopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1007/s10787-010-0060-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1007%2Fs10787-010-0060-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=20936538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFKitr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=75-87&author=L.+R.+Fitzpatrickauthor=C.+Greenauthor=E.+E.+Frauenhofferauthor=K.+J.+Frenchauthor=Y.+Zhuangauthor=L.+W.+Mainesauthor=J.+J.+Upsonauthor=E.+Paulauthor=H.+Donahueauthor=T.+J.+Mosherauthor=C.+D.+Smith&title=Attenuation+of+arthritis+in+rodents+by+a+novel+orally-available+inhibitor+of+sphingosine+kinase&doi=10.1007%2Fs10787-010-0060-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Attenuation of arthritis in rodents by a novel orally-available inhibitor of sphingosine kinase</span></div><div class="casAuthors">Fitzpatrick, Leo R.; Green, Cecelia; Frauenhoffer, Elizabeth E.; French, Kevin J.; Zhuang, Yan; Maines, Lynn W.; Upson, John J.; Paul, Emmanuel; Donahue, Henry; Mosher, Timothy J.; Smith, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">Inflammopharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">75-87</span>CODEN:
                <span class="NLM_cas:coden">IAOAES</span>;
        ISSN:<span class="NLM_cas:issn">0925-4692</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">Pro-inflammatory cytokines like TNF-α activate sphingosine kinase (SK).  Therefore, inhibition of SK is a potential mol. target for the treatment of rheumatoid arthritis.  Aims The primary goal of this study was to assess the efficacy of ABC249640 (a selective SK-2 inhibitor) in two models of rodent arthritis.  A secondary goal was to evaluate the pharmacol. profile of ABC294640, when given in combination with methotrexate.  Methods The efficacy of ABC294640 was detd. by paw diam./vol. measurements, histol. evaluations, and micro-CT analyses.  Results ABC294640 attenuated both collagen-induced arthritis in mice, as well as adjuvant-induced arthritis in rats.  With the adjuvant arthritis model, the prophylactic efficacy profile of ABC294640 was similar to indomethacin.  Of note, ABC294640 reduced the bone and cartilage degrdn., assocd. with adjuvant-induced arthritis.  Rats treated with a suboptimal dose of MTX (50 μg/kg/day) in combination with ABC249640 (100 mg/kg/day) had better anti-arthritis effects in the adjuvant model, than treatment with either agent alone.  Conclusion Our results suggest that ABC249640 is an orally available drug candidate with a good pre-clin. efficacy profile for the prevention and/or treatment of RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9w8QPB1UOarVg90H21EOLACvtfcHk0liB013sPOQM8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFKitr0%253D&md5=ec58032108f1cfe6062b836b8e9abadd</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs10787-010-0060-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10787-010-0060-6%26sid%3Dliteratum%253Aachs%26aulast%3DFitzpatrick%26aufirst%3DL.%2BR.%26aulast%3DGreen%26aufirst%3DC.%26aulast%3DFrauenhoffer%26aufirst%3DE.%2BE.%26aulast%3DFrench%26aufirst%3DK.%2BJ.%26aulast%3DZhuang%26aufirst%3DY.%26aulast%3DMaines%26aufirst%3DL.%2BW.%26aulast%3DUpson%26aufirst%3DJ.%2BJ.%26aulast%3DPaul%26aufirst%3DE.%26aulast%3DDonahue%26aufirst%3DH.%26aulast%3DMosher%26aufirst%3DT.%2BJ.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26atitle%3DAttenuation%2520of%2520arthritis%2520in%2520rodents%2520by%2520a%2520novel%2520orally-available%2520inhibitor%2520of%2520sphingosine%2520kinase%26jtitle%3DInflammopharmacology%26date%3D2011%26volume%3D19%26spage%3D75%26epage%3D87%26doi%3D10.1007%2Fs10787-010-0060-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maines, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzpatrick, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. D.</span></span> <span> </span><span class="NLM_article-title">Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn’s disease</span>. <i>Inflammopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1007/s10787-010-0032-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1007%2Fs10787-010-0032-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=20151210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvVOls7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=73-85&author=L.+W.+Mainesauthor=L.+R.+Fitzpatrickauthor=C.+L.+Greenauthor=Y.+Zhuangauthor=C.+D.+Smith&title=Efficacy+of+a+novel+sphingosine+kinase+inhibitor+in+experimental+Crohn%E2%80%99s+disease&doi=10.1007%2Fs10787-010-0032-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn's disease</span></div><div class="casAuthors">Maines, Lynn W.; Fitzpatrick, Leo R.; Green, Cecelia L.; Zhuang, Yan; Smith, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">Inflammopharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">73-85</span>CODEN:
                <span class="NLM_cas:coden">IAOAES</span>;
        ISSN:<span class="NLM_cas:issn">0925-4692</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">Aim: Activation of sphingosine kinase (SK) is a key response to many inflammatory processes.  The present studies test the hypothesis that an orally available SK inhibitor, ABC294640, would be effective in rodent models of Crohn's disease.  Methods: Trinitrobenzene sulfonic acid (TNBS) was administered rectally to mice and rats.  Rats were treated with ABC294640 orally alone or in combination with olsalazine and disease progression was monitored.  Results: For both rodent species, treatment with ABC294640 attenuated disease progression.  Colon samples from the ABC294640-treated animals had improved histol. and cytokine parameters when compared with vehicle-treated animals.  The expression of SK was similarly increased in TNBS-treated animals and in human colon tissue specimens from inflammatory bowel disease patients relative to normal, control patients.  Conclusions: Sphingosine kinase may be a crit. mediator of colonic damage during intestinal inflammation, and pharmacol. inhibitors of this enzyme may prove useful in the treatment of Crohn's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJIlj5tVU_KbVg90H21EOLACvtfcHk0liB013sPOQM8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvVOls7w%253D&md5=ec153ee07064f5783412ffd626d664fb</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2Fs10787-010-0032-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10787-010-0032-x%26sid%3Dliteratum%253Aachs%26aulast%3DMaines%26aufirst%3DL.%2BW.%26aulast%3DFitzpatrick%26aufirst%3DL.%2BR.%26aulast%3DGreen%26aufirst%3DC.%2BL.%26aulast%3DZhuang%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26atitle%3DEfficacy%2520of%2520a%2520novel%2520sphingosine%2520kinase%2520inhibitor%2520in%2520experimental%2520Crohn%25E2%2580%2599s%2520disease%26jtitle%3DInflammopharmacology%26date%3D2010%26volume%3D18%26spage%3D73%26epage%3D85%26doi%3D10.1007%2Fs10787-010-0032-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Venant, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahmaniyan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lilly, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrett-Mayer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drake, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraveka, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voelkel-Johnson, C.</span></span> <span> </span><span class="NLM_article-title">The sphingosine kinase 2 inhibitor ABC294640 reduces the growth of prostate cancer cells and results in accumulation of dihydroceramides <i>in vitro</i> and <i>in vivo</i></span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">2744</span>– <span class="NLM_lpage">2752</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-15-0279</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1158%2F1535-7163.MCT-15-0279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=26494858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKlu73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=2744-2752&author=H.+Venantauthor=M.+Rahmaniyanauthor=E.+E.+Jonesauthor=P.+Luauthor=M.+B.+Lillyauthor=E.+Garrett-Mayerauthor=R.+R.+Drakeauthor=J.+M.+Kravekaauthor=C.+D.+Smithauthor=C.+Voelkel-Johnson&title=The+sphingosine+kinase+2+inhibitor+ABC294640+reduces+the+growth+of+prostate+cancer+cells+and+results+in+accumulation+of+dihydroceramides+in+vitro+and+in+vivo&doi=10.1158%2F1535-7163.MCT-15-0279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The Sphingosine Kinase 2 Inhibitor ABC294640 Reduces the Growth of Prostate Cancer Cells and Results in Accumulation of Dihydroceramides In Vitro and In Vivo</span></div><div class="casAuthors">Venant, Heather; Rahmaniyan, Mehrdad; Jones, E. Ellen; Lu, Ping; Lilly, Michael B.; Garrett-Mayer, Elizabeth; Drake, Richard R.; Kraveka, Jacqueline M.; Smith, Charles D.; Voelkel-Johnson, Christina</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2744-2752</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Despite recent advances in the development of novel therapies against castration-resistant prostate cancer, the advanced form of the disease remains a major treatment challenge.  Aberrant sphingolipid signaling through sphingosine kinases and their product, sphingosine-1-phosphate, can promote proliferation, drug resistance, angiogenesis, and inflammation.  The sphingosine kinase 2 inhibitor ABC294640 is undergoing clin. testing in cancer patients, and in this study we investigated the effects this first-in-class inhibitor in castration-resistant prostate cancer.  In vitro, ABC294640 decreased prostate cancer cell viability as well as the expression of c-Myc and the androgen receptor, while lysosomal acidification increased.  ABC294640 also induced a greater than 3-fold increase in dihydroceramides that inversely correlated with inhibition of dihydroceramide desaturase (DEGS) activity.  Expression of sphingosine kinase 2 was dispensable for the ABC294640-mediated increase in dihydroceramides.  In vivo, ABC294640 diminished the growth rate of TRAMP-C2 xenografts in syngeneic hosts and elevated dihydroceramides within tumors as visualized by MALDI imaging mass spectroscopy.  The plasma of ABC294640-treated mice contained significantly higher levels of C16- and C24:1-ceramides (but not dihydro-C16-ceramide) compared with vehicle-treated mice.  In summary, our results suggest that ABC294640 may reduce the proliferative capacity of castration-resistant prostate cancer cells through inhibition of both sphingosine kinase 2 and dihydroceramide desaturase, thereby providing a foundation for future exploration of this small-mol. inhibitor for the treatment of advanced disease.  Mol Cancer Ther; 14(12); 2744-52. 2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjC4kCtmtncrVg90H21EOLACvtfcHk0liB013sPOQM8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKlu73P&md5=b129bca65e5178c48b14284c000ade19</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-15-0279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-15-0279%26sid%3Dliteratum%253Aachs%26aulast%3DVenant%26aufirst%3DH.%26aulast%3DRahmaniyan%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DE.%2BE.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DLilly%26aufirst%3DM.%2BB.%26aulast%3DGarrett-Mayer%26aufirst%3DE.%26aulast%3DDrake%26aufirst%3DR.%2BR.%26aulast%3DKraveka%26aufirst%3DJ.%2BM.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26aulast%3DVoelkel-Johnson%26aufirst%3DC.%26atitle%3DThe%2520sphingosine%2520kinase%25202%2520inhibitor%2520ABC294640%2520reduces%2520the%2520growth%2520of%2520prostate%2520cancer%2520cells%2520and%2520results%2520in%2520accumulation%2520of%2520dihydroceramides%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2015%26volume%3D14%26spage%3D2744%26epage%3D2752%26doi%3D10.1158%2F1535-7163.MCT-15-0279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McNaughton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, S.</span></span> <span> </span><span class="NLM_article-title">Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">16663</span>– <span class="NLM_lpage">16675</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.7693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.18632%2Foncotarget.7693" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=16663-16675&author=M.+McNaughtonauthor=M.+Pitmanauthor=S.+M.+Pitsonauthor=N.+J.+Pyneauthor=S.+Pyne&title=Proteasomal+degradation+of+sphingosine+kinase+1+and+inhibition+of+dihydroceramide+desaturase+by+the+sphingosine+kinase+inhibitors%2C+SKi+or+ABC294640%2C+induces+growth+arrest+in+androgen-independent+LNCaP-AI+prostate+cancer+cells&doi=10.18632%2Foncotarget.7693"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.7693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.7693%26sid%3Dliteratum%253Aachs%26aulast%3DMcNaughton%26aufirst%3DM.%26aulast%3DPitman%26aufirst%3DM.%26aulast%3DPitson%26aufirst%3DS.%2BM.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26aulast%3DPyne%26aufirst%3DS.%26atitle%3DProteasomal%2520degradation%2520of%2520sphingosine%2520kinase%25201%2520and%2520inhibition%2520of%2520dihydroceramide%2520desaturase%2520by%2520the%2520sphingosine%2520kinase%2520inhibitors%252C%2520SKi%2520or%2520ABC294640%252C%2520induces%2520growth%2520arrest%2520in%2520androgen-independent%2520LNCaP-AI%2520prostate%2520cancer%2520cells%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D16663%26epage%3D16675%26doi%3D10.18632%2Foncotarget.7693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alsanafi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jubair, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNaughton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merrill, A. H.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, N. J.</span></span> <span> </span><span class="NLM_article-title">Native and polyubiquitinated forms of dihydroceramide desaturase are differentially linked to human embryonic kidney cell survival</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">e00222</span>, <span class="refDoi"> DOI: 10.1128/MCB.00222-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1128%2FMCB.00222-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=30224516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC1MXksVShtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2018&pages=e00222&author=M.+Alsanafiauthor=S.+L.+Kellyauthor=K.+Jubairauthor=M.+McNaughtonauthor=R.+J.+Tateauthor=A.+H.+Merrillauthor=S.+Pyneauthor=N.+J.+Pyne&title=Native+and+polyubiquitinated+forms+of+dihydroceramide+desaturase+are+differentially+linked+to+human+embryonic+kidney+cell+survival&doi=10.1128%2FMCB.00222-18"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Native and polyubiquitinated forms of dihydroceramide desaturase are differentially linked to human embryonic kidney cell survival</span></div><div class="casAuthors">Alsanafi, Mariam; Kelly, Samuel L.; Jubair, Karawan; McNaughton, Melissa; Tate, Rothwelle J.; Merrill, Alfred H. Jr.; Pyne, Susan; Pyne, Nigel J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">e00222-18/1-e00222-18/19</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">1098-5549</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">There is controversy concerning the role of dihydroceramide desaturase (Degs1) in regulating cell survival, with studies showing that it can both promote and protect against apoptosis.  We have therefore investigated the mol. basis for these opposing roles of Degs1.  Treatment of HEK293T cells with the sphingosine kinase inhibitor SKi [2-(p-hydroxyanilino)-4-(p-chlorophenyl)thiazole] or fenretinide, but not the Degs1 inhibitor GT11 {N-[(1R,2S)-2-hydroxy-1-hydroxymethyl-2-(2-tridecyl-1-cyclopropenyl)ethyl- ]octan-amide], induced the polyubiquitination of Degs1 (Mr = 40 to 140 kDa) via a mechanism involving oxidative stress, p38 mitogen-activated protein kinase (MAPK), and Mdm2 (E3 ligase).  The polyubiquitinated forms of Degs1 exhibit "gain of function" and activate prosurvival pathways, p38 MAPK, c-Jun N-terminal kinase (JNK), and X-box protein 1s (XBP-1s).  In contrast, another sphingosine kinase inhibitor, ABC294640 [3-(4- chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide], at concns. of 25 to 50 μM failed to induce formation of the polyubiquitinated forms of Degs1.  In contrast to SKi, ABC294640 (25 μM) promotes apoptosis of HEK293T cells via a Degs1-dependent mechanism that is assocd. with increased de novo synthesis of ceramide.  These findings are the first to demonstrate that the olyubiquitination of Degs1 appears to change its function from proapoptotic to prosurvival.  Thus, polyubiquitination of Degs1 might provide an explanation for the reported opposing functions of this enzyme in cell survival/apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqTkD499q9SrVg90H21EOLACvtfcHk0lgeELvcpB8bGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXksVShtrY%253D&md5=a68b1652855ea7324e7f938efce3114d</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1128%2FMCB.00222-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00222-18%26sid%3Dliteratum%253Aachs%26aulast%3DAlsanafi%26aufirst%3DM.%26aulast%3DKelly%26aufirst%3DS.%2BL.%26aulast%3DJubair%26aufirst%3DK.%26aulast%3DMcNaughton%26aufirst%3DM.%26aulast%3DTate%26aufirst%3DR.%2BJ.%26aulast%3DMerrill%26aufirst%3DA.%2BH.%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26atitle%3DNative%2520and%2520polyubiquitinated%2520forms%2520of%2520dihydroceramide%2520desaturase%2520are%2520differentially%2520linked%2520to%2520human%2520embryonic%2520kidney%2520cell%2520survival%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2018%26volume%3D38%26spage%3De00222%26doi%3D10.1128%2FMCB.00222-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evangelisti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evangelisti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falconi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchionda, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pession, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertaina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locatelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCubrey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beak, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martelli, A. M.</span></span> <span> </span><span class="NLM_article-title">Assessment of the effect of sphingosine kinase inhibitors on apoptosis, unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">7886</span>– <span class="NLM_lpage">7901</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.2318</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.18632%2Foncotarget.2318" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=7886-7901&author=C.+Evangelistiauthor=C.+Evangelistiauthor=G.+Tetiauthor=F.+Chiariniauthor=M.+Falconiauthor=F.+Melchiondaauthor=A.+Pessionauthor=A.+Bertainaauthor=F.+Locatelliauthor=J.+A.+McCubreyauthor=D.+J.+Beakauthor=R.+Bittmanauthor=S.+Pyneauthor=N.+J.+Pyneauthor=A.+M.+Martelli&title=Assessment+of+the+effect+of+sphingosine+kinase+inhibitors+on+apoptosis%2C+unfolded+protein+response+and+autophagy+of+T-cell+acute+lymphoblastic+leukemia+cells%3B+indications+for+novel+therapeutics&doi=10.18632%2Foncotarget.2318"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2318%26sid%3Dliteratum%253Aachs%26aulast%3DEvangelisti%26aufirst%3DC.%26aulast%3DEvangelisti%26aufirst%3DC.%26aulast%3DTeti%26aufirst%3DG.%26aulast%3DChiarini%26aufirst%3DF.%26aulast%3DFalconi%26aufirst%3DM.%26aulast%3DMelchionda%26aufirst%3DF.%26aulast%3DPession%26aufirst%3DA.%26aulast%3DBertaina%26aufirst%3DA.%26aulast%3DLocatelli%26aufirst%3DF.%26aulast%3DMcCubrey%26aufirst%3DJ.%2BA.%26aulast%3DBeak%26aufirst%3DD.%2BJ.%26aulast%3DBittman%26aufirst%3DR.%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26aulast%3DMartelli%26aufirst%3DA.%2BM.%26atitle%3DAssessment%2520of%2520the%2520effect%2520of%2520sphingosine%2520kinase%2520inhibitors%2520on%2520apoptosis%252C%2520unfolded%2520protein%2520response%2520and%2520autophagy%2520of%2520T-cell%2520acute%2520lymphoblastic%2520leukemia%2520cells%253B%2520indications%2520for%2520novel%2520therapeutics%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26spage%3D7886%26epage%3D7901%26doi%3D10.18632%2Foncotarget.2318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schnute, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McReynolds, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrencik, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Highkin, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyanar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerome, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rains, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saabye, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholten, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagiec, M. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent and selective sphingosine kinase 1 inhibitor through the molecular combination of chemotype distinct screening hits</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2562</span>– <span class="NLM_lpage">2572</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00070</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00070" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2562-2572&author=M.+E.+Schnuteauthor=M.+D.+McReynoldsauthor=J.+Carrollauthor=J.+E.+Chrencikauthor=M.+K.+Highkinauthor=K.+Iyanarauthor=G.+Jeromeauthor=J.+W.+Rainsauthor=M.+Saabyeauthor=J.+A.+Scholtenauthor=M.+Yatesauthor=M.+M.+Nagiec&title=Discovery+of+a+potent+and+selective+sphingosine+kinase+1+inhibitor+through+the+molecular+combination+of+chemotype+distinct+screening+hits&doi=10.1021%2Facs.jmedchem.7b00070"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00070%26sid%3Dliteratum%253Aachs%26aulast%3DSchnute%26aufirst%3DM.%2BE.%26aulast%3DMcReynolds%26aufirst%3DM.%2BD.%26aulast%3DCarroll%26aufirst%3DJ.%26aulast%3DChrencik%26aufirst%3DJ.%2BE.%26aulast%3DHighkin%26aufirst%3DM.%2BK.%26aulast%3DIyanar%26aufirst%3DK.%26aulast%3DJerome%26aufirst%3DG.%26aulast%3DRains%26aufirst%3DJ.%2BW.%26aulast%3DSaabye%26aufirst%3DM.%26aulast%3DScholten%26aufirst%3DJ.%2BA.%26aulast%3DYates%26aufirst%3DM.%26aulast%3DNagiec%26aufirst%3DM.%2BM.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520sphingosine%2520kinase%25201%2520inhibitor%2520through%2520the%2520molecular%2520combination%2520of%2520chemotype%2520distinct%2520screening%2520hits%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2562%26epage%3D2572%26doi%3D10.1021%2Facs.jmedchem.7b00070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Childress, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kharel, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bevan, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, W. L.</span></span> <span> </span><span class="NLM_article-title">Transforming sphingosine kinase 1 inhibitors into dual and sphingosine kinase 2 selective inhibitors: design, synthesis, and <i>in vivo</i> activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3933</span>– <span class="NLM_lpage">3957</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00233</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00233" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtVyjsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3933-3957&author=E.+S.+Childressauthor=Y.+Kharelauthor=A.+M.+Brownauthor=D.+R.+Bevanauthor=K.+R.+Lynchauthor=W.+L.+Santos&title=Transforming+sphingosine+kinase+1+inhibitors+into+dual+and+sphingosine+kinase+2+selective+inhibitors%3A+design%2C+synthesis%2C+and+in+vivo+activity&doi=10.1021%2Facs.jmedchem.7b00233"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Transforming Sphingosine Kinase 1 Inhibitors into Dual and Sphingosine Kinase 2 Selective Inhibitors: Design, Synthesis, and in Vivo Activity</span></div><div class="casAuthors">Childress, Elizabeth S.; Kharel, Yugesh; Brown, Anne M.; Bevan, David R.; Lynch, Kevin R.; Santos, Webster L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3933-3957</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) is a pleiotropic signaling mol. that interacts with its five G-protein coupled receptors (S1P1-5) to regulate cell growth and survival and has been implicated in a variety of diseases including cancer and sickle cell disease.  As the key mediators in the synthesis of S1P, sphingosine kinase (SphK) isoforms 1 and 2 have attracted attention as viable targets for pharmaceutical inhibition.  In this article, we describe the design, synthesis, and biol. evaluation of aminothiazole-based guanidine inhibitors of SphK.  Surprisingly, combining features of reported SphK1 inhibitors generated SphK1/2 dual inhibitor I·HCl (SLC4011540) (hSphK1 Ki = 120 nM, hSphK2 Ki = 90 nM) and SphK2 inhibitor II·HCl (SLC4101431) (Ki = 90 nM, 100-fold SphK2 selectivity).  These compds. effectively decrease S1P levels in vitro.  In vivo administration of II·HCl validated that inhibition of SphK2 increases blood S1P levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_Ie74w8OkL7Vg90H21EOLACvtfcHk0lhgCx-HHQ_gaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtVyjsbY%253D&md5=29eda95d41546838fa3d500ccaa3c9b7</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00233%26sid%3Dliteratum%253Aachs%26aulast%3DChildress%26aufirst%3DE.%2BS.%26aulast%3DKharel%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DA.%2BM.%26aulast%3DBevan%26aufirst%3DD.%2BR.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DSantos%26aufirst%3DW.%2BL.%26atitle%3DTransforming%2520sphingosine%2520kinase%25201%2520inhibitors%2520into%2520dual%2520and%2520sphingosine%2520kinase%25202%2520selective%2520inhibitors%253A%2520design%252C%2520synthesis%252C%2520and%2520in%2520vivo%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3933%26epage%3D3957%26doi%3D10.1021%2Facs.jmedchem.7b00233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romanow, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meininger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thibault, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, N.</span></span> <span> </span><span class="NLM_article-title">Molecular basis of sphingosine kinase 1 substrate recognition and catalysis</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">798</span>– <span class="NLM_lpage">809</span>, <span class="refDoi"> DOI: 10.1016/j.str.2013.02.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1016%2Fj.str.2013.02.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=23602659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1Cmsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=798-809&author=Z.+Wangauthor=X.+Minauthor=S.+H.+Xiaoauthor=S.+Johnstoneauthor=W.+Romanowauthor=D.+Meiningerauthor=H.+Xuauthor=J.+Liuauthor=J.+Daiauthor=S.+Anauthor=S.+Thibaultauthor=N.+Walker&title=Molecular+basis+of+sphingosine+kinase+1+substrate+recognition+and+catalysis&doi=10.1016%2Fj.str.2013.02.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Basis of Sphingosine Kinase 1 Substrate Recognition and Catalysis</span></div><div class="casAuthors">Wang, Zhulun; Min, Xiaoshan; Xiao, Shou-Hua; Johnstone, Sheree; Romanow, William; Meininger, David; Xu, Haoda; Liu, Jinsong; Dai, Jessica; An, Songzhu; Thibault, Stephen; Walker, Nigel</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">798-809</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Sphingosine kinase 1 (SphK1) is a lipid kinase that catalyzes the conversion of sphingosine to sphingosine-1-phosphate (S1P), which has been shown to play a role in lymphocyte trafficking, angiogenesis, and response to apoptotic stimuli.  As a central enzyme in modulating the S1P levels in cells, SphK1 emerges as an important regulator for diverse cellular functions and a potential target for drug discovery.  Here, the authors present the crystal structures of human SphK1 in the apo form and in complexes with a substrate sphingosine-like lipid, ADP, and an inhibitor at 2.0-2.3 Å resoln.  The SphK1 structures reveal a two-domain architecture in which its catalytic site is located in the cleft between the two domains and a hydrophobic lipid-binding pocket is buried in the C-terminal domain.  Comparative anal. of these structures with mutagenesis and kinetic studies provides insight into how SphK1 recognizes the lipid substrate and catalyzes ATP-dependent phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGhuSYFEdxbrVg90H21EOLACvtfcHk0lhgCx-HHQ_gaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1Cmsr8%253D&md5=61b387e356ae18e0420be5e543f2187e</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2013.02.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2013.02.025%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DMin%26aufirst%3DX.%26aulast%3DXiao%26aufirst%3DS.%2BH.%26aulast%3DJohnstone%26aufirst%3DS.%26aulast%3DRomanow%26aufirst%3DW.%26aulast%3DMeininger%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DAn%26aufirst%3DS.%26aulast%3DThibault%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DN.%26atitle%3DMolecular%2520basis%2520of%2520sphingosine%2520kinase%25201%2520substrate%2520recognition%2520and%2520catalysis%26jtitle%3DStructure%26date%3D2013%26volume%3D21%26spage%3D798%26epage%3D809%26doi%3D10.1016%2Fj.str.2013.02.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkins, J. M.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of sphingosine kinase 1 with PF-543</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1329</span>– <span class="NLM_lpage">1333</span>, <span class="refDoi"> DOI: 10.1021/ml5004074</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml5004074" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVWnsrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1329-1333&author=J.+Wangauthor=S.+Knappauthor=N.+J.+Pyneauthor=S.+Pyneauthor=J.+M.+Elkins&title=Crystal+Structure+of+sphingosine+kinase+1+with+PF-543&doi=10.1021%2Fml5004074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of Sphingosine Kinase 1 with PF-543</span></div><div class="casAuthors">Wang, Jing; Knapp, Stefan; Pyne, Nigel J.; Pyne, Susan; Elkins, Jonathan M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1329-1333</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The most potent inhibitor of Sphingosine Kinase 1 (SPHK1) so far identified is PF-543.  The crystal structure of SPHK1 in complex with inhibitor PF-543 to 1.8 Å resoln. reveals the inhibitor bound in a bent conformation analogous to that expected of a bound sphingosine substrate but with a rotated head group.  The structural data presented will aid in the design of SPHK1 and SPHK2 inhibitors with improved properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpT23XvIdxU7Vg90H21EOLACvtfcHk0lhgCx-HHQ_gaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVWnsrrJ&md5=83cc5caeae2d5fa895c5fee4f0b17f73</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fml5004074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml5004074%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26atitle%3DCrystal%2520Structure%2520of%2520sphingosine%2520kinase%25201%2520with%2520PF-543%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1329%26epage%3D1333%26doi%3D10.1021%2Fml5004074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, N. J.</span></span> <span> </span><span class="NLM_article-title">Sphingosine kinases: emerging structure-function insights</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">409</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2016.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1016%2Fj.tibs.2016.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=27021309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsFKisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2016&pages=395-409&author=D.+R.+Adamsauthor=S.+Pyneauthor=N.+J.+Pyne&title=Sphingosine+kinases%3A+emerging+structure-function+insights&doi=10.1016%2Fj.tibs.2016.02.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine Kinases: Emerging Structure-Function Insights</span></div><div class="casAuthors">Adams, David R.; Pyne, Susan; Pyne, Nigel J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">395-409</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Sphingosine kinases (SK1 and SK2) catalyze the conversion of sphingosine into sphingosine 1-phosphate and control fundamental cellular processes, including cell survival, proliferation, differentiation, migration, and immune function.  In this review, we highlight recent breakthroughs in the structural and functional characterization of SK1 and these are contextualised by anal. of crystal structures for closely related prokaryotic lipid kinases.  We identify a putative dimerization interface and propose novel regulatory mechanisms governing structural plasticity induced by phosphorylation and interaction with phospholipids and proteins.  Our anal. suggests that the catalytic function and regulation of the enzymes might be dependent on conformational mobility and it provides a roadmap for future interrogation of SK1 function and its role in physiol. and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcl9A4KqinlbVg90H21EOLACvtfcHk0lhT-Q20Vx7zwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsFKisbc%253D&md5=c9dc9180d0ca4a945f2c413ed83ce717</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2016.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2016.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DD.%2BR.%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26atitle%3DSphingosine%2520kinases%253A%2520emerging%2520structure-function%2520insights%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2016%26volume%3D41%26spage%3D395%26epage%3D409%26doi%3D10.1016%2Fj.tibs.2016.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cinelli, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pensa, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martasek, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulos, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, R. B.</span></span> <span> </span><span class="NLM_article-title">Phenyl ether- and aniline-containing 2-aminoquinolines as potent and selective inhibitors of neuronal nitric oxide synthase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8694</span>– <span class="NLM_lpage">8712</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01330</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01330" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1GksrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8694-8712&author=M.+A.+Cinelliauthor=H.+Liauthor=A.+V.+Pensaauthor=S.+Kangauthor=L.+J.+Romanauthor=P.+Martasekauthor=T.+L.+Poulosauthor=R.+B.+Silverman&title=Phenyl+ether-+and+aniline-containing+2-aminoquinolines+as+potent+and+selective+inhibitors+of+neuronal+nitric+oxide+synthase&doi=10.1021%2Facs.jmedchem.5b01330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Phenyl Ether- and Aniline-Containing 2-Aminoquinolines as Potent and Selective Inhibitors of Neuronal Nitric Oxide Synthase</span></div><div class="casAuthors">Cinelli, Maris A.; Li, Huiying; Pensa, Anthony V.; Kang, Soosung; Roman, Linda J.; Martasek, Pavel; Poulos, Thomas L.; Silverman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8694-8712</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Excess nitric oxide (NO) produced by neuronal nitric oxide synthase (nNOS) is implicated in neurodegenerative disorders.  As a result, inhibition of nNOS and redn. of NO levels is desirable therapeutically, but many nNOS inhibitors are poorly bioavailable.  Promising members of our previously reported 2-aminoquinoline class of nNOS inhibitors, although orally bioavailable and brain-penetrant, suffer from unfavorable off-target binding to other CNS receptors; and they resemble known promiscuous binders.  Rearranged Ph ether- and aniline-linked 2-aminoquinoline derivs. were therefore designed to (a) disrupt the promiscuous binding pharmacophore and diminish off-target interactions and (b) preserve potency, isoform selectivity, and cell permeability.  A series of these compds. was synthesized and tested against purified nNOS, endothelial NOS (eNOS), and inducible NOS (iNOS) enzymes.  One compd., I, displayed high potency, selectivity, and good human nNOS inhibition, and retained some permeability in a Caco-2 assay.  Most promisingly, CNS receptor counter-screening revealed that this rearranged scaffold significantly reduces off-target binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8il7hgcnYsLVg90H21EOLACvtfcHk0lhT-Q20Vx7zwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1GksrbJ&md5=778d070fdb1256326b30080906976cac</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01330%26sid%3Dliteratum%253Aachs%26aulast%3DCinelli%26aufirst%3DM.%2BA.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DPensa%26aufirst%3DA.%2BV.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DRoman%26aufirst%3DL.%2BJ.%26aulast%3DMartasek%26aufirst%3DP.%26aulast%3DPoulos%26aufirst%3DT.%2BL.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DPhenyl%2520ether-%2520and%2520aniline-containing%25202-aminoquinolines%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520neuronal%2520nitric%2520oxide%2520synthase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8694%26epage%3D8712%26doi%3D10.1021%2Facs.jmedchem.5b01330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Byun, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacRitchie, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittman, R.</span></span> <span> </span><span class="NLM_article-title">Novel sphingosine-containing analogues selectively inhibit sphingosine kinase (SK) isozymes, induce SK1 proteasomal degradation and reduce DNA synthesis in human pulmonary arterial smooth muscle cells</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1394</span>– <span class="NLM_lpage">1399</span>, <span class="refDoi"> DOI: 10.1039/c3md00201b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1039%2Fc3md00201b" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1394-1399&author=H.-S.+Byunauthor=S.+Pyneauthor=N.+MacRitchieauthor=N.+J.+Pyneauthor=R.+Bittman&title=Novel+sphingosine-containing+analogues+selectively+inhibit+sphingosine+kinase+%28SK%29+isozymes%2C+induce+SK1+proteasomal+degradation+and+reduce+DNA+synthesis+in+human+pulmonary+arterial+smooth+muscle+cells&doi=10.1039%2Fc3md00201b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1039%2Fc3md00201b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md00201b%26sid%3Dliteratum%253Aachs%26aulast%3DByun%26aufirst%3DH.-S.%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DMacRitchie%26aufirst%3DN.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26aulast%3DBittman%26aufirst%3DR.%26atitle%3DNovel%2520sphingosine-containing%2520analogues%2520selectively%2520inhibit%2520sphingosine%2520kinase%2520%2528SK%2529%2520isozymes%252C%2520induce%2520SK1%2520proteasomal%2520degradation%2520and%2520reduce%2520DNA%2520synthesis%2520in%2520human%2520pulmonary%2520arterial%2520smooth%2520muscle%2520cells%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D1394%26epage%3D1399%26doi%3D10.1039%2Fc3md00201b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edsall, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Brocklyn, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuvillier, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleuser, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiegel, S.</span></span> <span> </span><span class="NLM_article-title">N,N-Dimethylsphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C: modulation of cellular levels of sphingosine 1-phosphate and ceramide</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">12892</span>– <span class="NLM_lpage">12898</span>, <span class="refDoi"> DOI: 10.1021/bi980744d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi980744d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADyaK1cXlsFSkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=12892-12898&author=L.+C.+Edsallauthor=J.+R.+Van+Brocklynauthor=O.+Cuvillierauthor=B.+Kleuserauthor=S.+Spiegel&title=N%2CN-Dimethylsphingosine+is+a+potent+competitive+inhibitor+of+sphingosine+kinase+but+not+of+protein+kinase+C%3A+modulation+of+cellular+levels+of+sphingosine+1-phosphate+and+ceramide&doi=10.1021%2Fbi980744d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">N,N-Dimethylsphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C: Modulation of cellular levels of sphingosine 1-phosphate and ceramide</span></div><div class="casAuthors">Edsall, Lisa C.; Van Brocklyn, James R.; Cuvillier, Olivier; Kleuser, Burkhard; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">12892-12898</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (SPP), a lipid 2nd messenger formed by the action of sphingosine kinase, has been implicated in regulating diverse biol. processes, including growth, survival, and differentiation.  N,N-Dimethylsphingosine (DMS) inhibits sphingosine kinase and has been used to investigate the biol. roles of SPP; however, little is known of the mechanism of inhibition of sphingosine kinase by DMS.  In addn., DMS has been shown to inhibit protein kinase C in vitro.  Here, the authors report that DMS is a competitive inhibitor of sphingosine kinase from U937 monoblastic leukemia cells, Swiss 3T3 fibroblasts, and PC12 pheochromocytoma cells.  DMS decreased basal levels of SPP and prevented increases in SPP in response to physiol. stimuli known to activate sphingosine kinase.  DMS also effectively increased cellular levels of ceramide in a variety of cell types, and resetting of the ceramide/SPP rheostat may account for the pro-apoptotic effects of DMS.  Moreover, DMS, at concns. which effectively inhibited sphingosine kinase, had no effect on protein kinase C activity or its membrane translocation.  Thus, DMS acts as a specific competitive inhibitor of sphingosine kinase in diverse cell types and is a useful tool to elucidate the role of SPP as an intracellular 2nd messenger.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh2GXD98ZdmLVg90H21EOLACvtfcHk0ljoCc9_26XzTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsFSkt7w%253D&md5=0010b4548f528912b0c8c51493dd53db</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fbi980744d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi980744d%26sid%3Dliteratum%253Aachs%26aulast%3DEdsall%26aufirst%3DL.%2BC.%26aulast%3DVan%2BBrocklyn%26aufirst%3DJ.%2BR.%26aulast%3DCuvillier%26aufirst%3DO.%26aulast%3DKleuser%26aufirst%3DB.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DN%252CN-Dimethylsphingosine%2520is%2520a%2520potent%2520competitive%2520inhibitor%2520of%2520sphingosine%2520kinase%2520but%2520not%2520of%2520protein%2520kinase%2520C%253A%2520modulation%2520of%2520cellular%2520levels%2520of%2520sphingosine%25201-phosphate%2520and%2520ceramide%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26spage%3D12892%26epage%3D12898%26doi%3D10.1021%2Fbi980744d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hengst, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guilford, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conroy, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, J. K.</span></span> <span> </span><span class="NLM_article-title">Enhancement of sphingosine kinase 1 catalytic activity by deletion of 21 amino acids from the COOH-terminus</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>494</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">31</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2009.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1016%2Fj.abb.2009.11.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=494&publication_year=2010&pages=23-31&author=J.+A.+Hengstauthor=J.+M.+Guilfordauthor=E.+J.+Conroyauthor=X.+Wangauthor=J.+K.+Yun&title=Enhancement+of+sphingosine+kinase+1+catalytic+activity+by+deletion+of+21+amino+acids+from+the+COOH-terminus&doi=10.1016%2Fj.abb.2009.11.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2009.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2009.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DHengst%26aufirst%3DJ.%2BA.%26aulast%3DGuilford%26aufirst%3DJ.%2BM.%26aulast%3DConroy%26aufirst%3DE.%2BJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DYun%26aufirst%3DJ.%2BK.%26atitle%3DEnhancement%2520of%2520sphingosine%2520kinase%25201%2520catalytic%2520activity%2520by%2520deletion%2520of%252021%2520amino%2520acids%2520from%2520the%2520COOH-terminus%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2010%26volume%3D494%26spage%3D23%26epage%3D31%26doi%3D10.1016%2Fj.abb.2009.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, N. J.</span></span> <span> </span><span class="NLM_article-title">FTY720 analogues as sphingosine kinase 1 inhibitors: enzyme inhibition kinetics, allosterism, proteasomal degradation, and actin rearrangement in MCF-7 breast cancer cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">18633</span>– <span class="NLM_lpage">18640</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.220756</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1074%2Fjbc.M111.220756" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=18633-18640&author=K.+G.+Limauthor=F.+Tonelliauthor=Z.+Liauthor=X.+Luauthor=R.+Bittmanauthor=S.+Pyneauthor=N.+J.+Pyne&title=FTY720+analogues+as+sphingosine+kinase+1+inhibitors%3A+enzyme+inhibition+kinetics%2C+allosterism%2C+proteasomal+degradation%2C+and+actin+rearrangement+in+MCF-7+breast+cancer+cells&doi=10.1074%2Fjbc.M111.220756"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.220756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.220756%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DK.%2BG.%26aulast%3DTonelli%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DBittman%26aufirst%3DR.%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26atitle%3DFTY720%2520analogues%2520as%2520sphingosine%2520kinase%25201%2520inhibitors%253A%2520enzyme%2520inhibition%2520kinetics%252C%2520allosterism%252C%2520proteasomal%2520degradation%252C%2520and%2520actin%2520rearrangement%2520in%2520MCF-7%2520breast%2520cancer%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D18633%26epage%3D18640%26doi%3D10.1074%2Fjbc.M111.220756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summerhill, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, J. E.</span></span> <span> </span><span class="NLM_article-title">Aromatic chloride to nitrile transformation: medicinal and synthetic chemistry</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">318</span>, <span class="refDoi"> DOI: 10.1039/c0md00135j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1039%2Fc0md00135j" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=309-318&author=L.+H.+Jonesauthor=N.+W.+Summerhillauthor=N.+A.+Swainauthor=J.+E.+Mills&title=Aromatic+chloride+to+nitrile+transformation%3A+medicinal+and+synthetic+chemistry&doi=10.1039%2Fc0md00135j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1039%2Fc0md00135j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0md00135j%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DL.%2BH.%26aulast%3DSummerhill%26aufirst%3DN.%2BW.%26aulast%3DSwain%26aufirst%3DN.%2BA.%26aulast%3DMills%26aufirst%3DJ.%2BE.%26atitle%3DAromatic%2520chloride%2520to%2520nitrile%2520transformation%253A%2520medicinal%2520and%2520synthetic%2520chemistry%26jtitle%3DMedChemComm%26date%3D2010%26volume%3D1%26spage%3D309%26epage%3D318%26doi%3D10.1039%2Fc0md00135j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravikumar, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funk, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shook, B. C.</span></span> <span> </span><span class="NLM_article-title">Nitrile-containing pharmaceuticals: efficacious roles of the nitrile pharmacophore</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">7902</span>– <span class="NLM_lpage">7917</span>, <span class="refDoi"> DOI: 10.1021/jm100762r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100762r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2kurvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7902-7917&author=F.+F.+Flemingauthor=L.+Yaoauthor=P.+C.+Ravikumarauthor=L.+Funkauthor=B.+C.+Shook&title=Nitrile-containing+pharmaceuticals%3A+efficacious+roles+of+the+nitrile+pharmacophore&doi=10.1021%2Fjm100762r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore</span></div><div class="casAuthors">Fleming, Fraser F.; Yao, Lihua; Ravikumar, P. C.; Funk, Lee; Shook, Brian C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7902-7917</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The review is structured according to the nature of the nitrile-bearing substituent.  As the no. of nitrile-contg. drug leads is vast, the review has focused on launched nitrile-contg. pharmaceuticals and currently active clin. candidates.  Most nitrile-contg. pharmaceuticals are aroms. with aliph.-, alkene-, and nitrogen-bearing nitriles being progressively less frequent.  Within each class, the bioactive nitriles are collated according to common structural elements and mode of action.  The hope is that this survey will allow greater deployment of this versatile functionality within drug leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR6kPPdWVuvLVg90H21EOLACvtfcHk0ljoCc9_26XzTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2kurvP&md5=040bbaebd9e8c9999d195b9a22221fea</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm100762r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100762r%26sid%3Dliteratum%253Aachs%26aulast%3DFleming%26aufirst%3DF.%2BF.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DRavikumar%26aufirst%3DP.%2BC.%26aulast%3DFunk%26aufirst%3DL.%26aulast%3DShook%26aufirst%3DB.%2BC.%26atitle%3DNitrile-containing%2520pharmaceuticals%253A%2520efficacious%2520roles%2520of%2520the%2520nitrile%2520pharmacophore%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7902%26epage%3D7917%26doi%3D10.1021%2Fjm100762r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bordoli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwede, T.</span></span> <span> </span><span class="NLM_article-title">The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling</span>. <i>Bioinformatics</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">195</span>– <span class="NLM_lpage">201</span>, <span class="refDoi"> DOI: 10.1093/bioinformatics/bti770</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1093%2Fbioinformatics%2Fbti770" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=16301204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BD28XovVCltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2006&pages=195-201&author=K.+Arnoldauthor=L.+Bordoliauthor=J.+Koppauthor=T.+Schwede&title=The+SWISS-MODEL+workspace%3A+a+web-based+environment+for+protein+structure+homology+modelling&doi=10.1093%2Fbioinformatics%2Fbti770"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling</span></div><div class="casAuthors">Arnold, Konstantin; Bordoli, Lorenza; Kopp, Juergen; Schwede, Torsten</div><div class="citationInfo"><span class="NLM_cas:title">Bioinformatics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">195-201</span>CODEN:
                <span class="NLM_cas:coden">BOINFP</span>;
        ISSN:<span class="NLM_cas:issn">1367-4803</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Motivation: Homol. models of proteins are of great interest for planning and analyzing biol. expts. when no exptl. three-dimensional structures are available.  Building homol. models requires specialized programs and up-to-date sequence and structural databases.  Integrating all required tools, programs and databases into a single web-based workspace facilitates access to homol. modeling from a computer with web connection without the need of downloading and installing large program packages and databases.  Results: SWISS-MODEL workspace is a web-based integrated service dedicated to protein structure homol. modeling.  It assists and guides the user in building protein homol. models at different levels of complexity.  A personal working environment is provided for each user where several modeling projects can be carried out in parallel.  Protein sequence and structure databases necessary for modeling are accessible from the workspace and are updated in regular intervals.  Tools for template selection, model building and structure quality evaluation can be invoked from within the workspace.  Workflow and usage of the workspace are illustrated by modeling human Cyclin A1 and human Transmembrane Protease 3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDwXLAG5Kz27Vg90H21EOLACvtfcHk0lj3BlcoEK1QNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovVCltw%253D%253D&md5=66fa733d2ad6d2abf7d3d87ae837ebce</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1093%2Fbioinformatics%2Fbti770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbioinformatics%252Fbti770%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DK.%26aulast%3DBordoli%26aufirst%3DL.%26aulast%3DKopp%26aufirst%3DJ.%26aulast%3DSchwede%26aufirst%3DT.%26atitle%3DThe%2520SWISS-MODEL%2520workspace%253A%2520a%2520web-based%2520environment%2520for%2520protein%2520structure%2520homology%2520modelling%26jtitle%3DBioinformatics%26date%3D2006%26volume%3D22%26spage%3D195%26epage%3D201%26doi%3D10.1093%2Fbioinformatics%2Fbti770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kiefer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunzli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bordoli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwede, T.</span></span> <span> </span><span class="NLM_article-title">The SWISS-MODEL Repository and associated resources</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">D387</span>– <span class="NLM_lpage">D392</span>, <span class="refDoi"> DOI: 10.1093/nar/gkn750</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1093%2Fnar%2Fgkn750" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=18931379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFejtb7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=D387-D392&author=F.+Kieferauthor=K.+Arnoldauthor=M.+Kunzliauthor=L.+Bordoliauthor=T.+Schwede&title=The+SWISS-MODEL+Repository+and+associated+resources&doi=10.1093%2Fnar%2Fgkn750"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">The SWISS-MODEL Repository and associated resources</span></div><div class="casAuthors">Kiefer, Florian; Arnold, Konstantin; Kuenzli, Michael; Bordoli, Lorenza; Schwede, Torsten</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">Database Iss</span>),
    <span class="NLM_cas:pages">D387-D392</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">SWISS-MODEL Repository (http://swissmodel.expasy.org/repository/) is a database of 3D protein structure models generated by the SWISS-MODEL homol.-modeling pipeline.  The aim of the SWISS-MODEL Repository is to provide access to an up-to-date collection of annotated 3D protein models generated by automated homol. modeling for all sequences in Swiss-Prot and for relevant models organisms.  Regular updates ensure that target coverage is complete, that models are built using the most recent sequence and template structure databases, and that improvements in the underlying modeling pipeline are fully utilized.  As of Sept. 2008, the database contains 3.4 million entries for 2.7 million different protein sequences from the UniProt database.  SWISS-MODEL Repository allows the users to assess the quality of the models in the database, search for alternative template structures, and to build models interactively via SWISS-MODEL Workspace (http://swissmodel.expasy.org/workspace/).  Annotation of models with functional information and crosslinking with other databases such as the Protein Model Portal (http://www.proteinmodelportal.org) of the PSI Structural Genomics Knowledge Base facilitates the navigation between protein sequence and structure resources.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrceZMva79o97Vg90H21EOLACvtfcHk0lj3BlcoEK1QNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFejtb7P&md5=7142f7db9b36d48c322f8ddfdc2032d5</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkn750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkn750%26sid%3Dliteratum%253Aachs%26aulast%3DKiefer%26aufirst%3DF.%26aulast%3DArnold%26aufirst%3DK.%26aulast%3DKunzli%26aufirst%3DM.%26aulast%3DBordoli%26aufirst%3DL.%26aulast%3DSchwede%26aufirst%3DT.%26atitle%3DThe%2520SWISS-MODEL%2520Repository%2520and%2520associated%2520resources%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2009%26volume%3D37%26spage%3DD387%26epage%3DD392%26doi%3D10.1093%2Fnar%2Fgkn750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guex, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peitsch, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwede, T.</span></span> <span> </span><span class="NLM_article-title">Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: a historical perspective</span>. <i>Electrophoresis</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">S162</span>– <span class="NLM_lpage">S173</span>, <span class="refDoi"> DOI: 10.1002/elps.200900140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1002%2Felps.200900140" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=19517507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A280%3ADC%252BD1Mvis1Ortg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=S162-S173&author=N.+Guexauthor=M.+C.+Peitschauthor=T.+Schwede&title=Automated+comparative+protein+structure+modeling+with+SWISS-MODEL+and+Swiss-PdbViewer%3A+a+historical+perspective&doi=10.1002%2Felps.200900140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: a historical perspective</span></div><div class="casAuthors">Guex Nicolas; Peitsch Manuel C; Schwede Torsten</div><div class="citationInfo"><span class="NLM_cas:title">Electrophoresis</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30 Suppl 1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">S162-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">SWISS-MODEL pioneered the field of automated modeling as the first protein modeling service on the Internet.  In combination with the visualization tool Swiss-PdbViewer, the Internet-based Workspace and the SWISS-MODEL Repository, it provides a fully integrated sequence to structure analysis and modeling platform.  This computational environment is made freely available to the scientific community with the aim to hide the computational complexity of structural bioinformatics and encourage bench scientists to make use of the ever-increasing structural information available.  Indeed, over the last decade, the availability of structural information has significantly increased for many organisms as a direct consequence of the complementary nature of comparative protein modeling and experimental structure determination.  This has a very positive and enabling impact on many different applications in biomedical research as described in this paper.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPUn40ZFOULN-cVm4E2RlLfW6udTcc2eYhZCbJ0Ircg7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mvis1Ortg%253D%253D&md5=e74c27636b8f333cd344bedff31c97fa</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1002%2Felps.200900140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Felps.200900140%26sid%3Dliteratum%253Aachs%26aulast%3DGuex%26aufirst%3DN.%26aulast%3DPeitsch%26aufirst%3DM.%2BC.%26aulast%3DSchwede%26aufirst%3DT.%26atitle%3DAutomated%2520comparative%2520protein%2520structure%2520modeling%2520with%2520SWISS-MODEL%2520and%2520Swiss-PdbViewer%253A%2520a%2520historical%2520perspective%26jtitle%3DElectrophoresis%26date%3D2009%26volume%3D30%26spage%3DS162%26epage%3DS173%26doi%3D10.1002%2Felps.200900140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biasini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterhouse, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Studer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiefer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo Cassarino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertoni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bordoli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwede, T.</span></span> <span> </span><span class="NLM_article-title">SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">W252</span>– <span class="NLM_lpage">W258</span>, <span class="refDoi"> DOI: 10.1093/nar/gku340</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1093%2Fnar%2Fgku340" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=24782522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFCqs73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=W252-W258&author=M.+Biasiniauthor=S.+Bienertauthor=A.+Waterhouseauthor=K.+Arnoldauthor=G.+Studerauthor=T.+Schmidtauthor=F.+Kieferauthor=T.+Gallo+Cassarinoauthor=M.+Bertoniauthor=L.+Bordoliauthor=T.+Schwede&title=SWISS-MODEL%3A+modelling+protein+tertiary+and+quaternary+structure+using+evolutionary+information&doi=10.1093%2Fnar%2Fgku340"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information</span></div><div class="casAuthors">Biasini, Marco; Bienert, Stefan; Waterhouse, Andrew; Arnold, Konstantin; Studer, Gabriel; Schmidt, Tobias; Kiefer, Florian; Cassarino, Tiziano Gallo; Bertoni, Martino; Bordoli, Lorenza; Schwede, Torsten</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">W1</span>),
    <span class="NLM_cas:pages">W252-W258</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Protein structure homol. modeling has become a routine technique to generate 3D models for proteins when exptl. structures are not available.  Fully automated servers such as SWISS-MODEL with user-friendly web interfaces generate reliable models without the need for complex software packages or downloading large databases.  Here, we describe the latest version of the SWISS-MODEL expert system for protein structure modeling.  The SWISS-MODEL template library provides annotation of quaternary structure and essential ligands and co-factors to allow for building of complete structural models, including their oligomeric structure.  The improved SWISS-MODEL pipeline makes extensive use of model quality estn. for selection of the most suitable templates and provides ests. of the expected accuracy of the resulting models.  The accuracy of the models generated by SWISS-MODEL is continuously evaluated by the CAMEO system.  The new web site allows users to interactively search for templates, cluster them by sequence similarity, structurally compare alternative templates and select the ones to be used for model building.  In cases where multiple alternative template structures are available for a protein of interest, a user-guided template selection step allows building models in different functional states.  SWISS-MODEL is available at http://swissmodel.expasy.org/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpevqhyplQxI7Vg90H21EOLACvtfcHk0lg-9kb0DHjaUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFCqs73I&md5=51509ba8353b06f286d954ebe7e6673a</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgku340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgku340%26sid%3Dliteratum%253Aachs%26aulast%3DBiasini%26aufirst%3DM.%26aulast%3DBienert%26aufirst%3DS.%26aulast%3DWaterhouse%26aufirst%3DA.%26aulast%3DArnold%26aufirst%3DK.%26aulast%3DStuder%26aufirst%3DG.%26aulast%3DSchmidt%26aufirst%3DT.%26aulast%3DKiefer%26aufirst%3DF.%26aulast%3DGallo%2BCassarino%26aufirst%3DT.%26aulast%3DBertoni%26aufirst%3DM.%26aulast%3DBordoli%26aufirst%3DL.%26aulast%3DSchwede%26aufirst%3DT.%26atitle%3DSWISS-MODEL%253A%2520modelling%2520protein%2520tertiary%2520and%2520quaternary%2520structure%2520using%2520evolutionary%2520information%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2014%26volume%3D42%26spage%3DW252%26epage%3DW258%26doi%3D10.1093%2Fnar%2Fgku340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Congdon, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kharel, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bevan, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, W. L.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship studies and molecular modeling of naphthalene-based sphingosine kinase 2 Inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00304</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00304" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFOmsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=229-234&author=M.+D.+Congdonauthor=Y.+Kharelauthor=A.+M.+Brownauthor=S.+N.+Lewisauthor=D.+R.+Bevanauthor=K.+R.+Lynchauthor=W.+L.+Santos&title=Structure-activity+relationship+studies+and+molecular+modeling+of+naphthalene-based+sphingosine+kinase+2+Inhibitors&doi=10.1021%2Facsmedchemlett.5b00304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship Studies and Molecular Modeling of Naphthalene-Based Sphingosine Kinase 2 Inhibitors</span></div><div class="casAuthors">Congdon, Molly D.; Kharel, Yugesh; Brown, Anne M.; Lewis, Stephanie N.; Bevan, David R.; Lynch, Kevin R.; Santos, Webster L.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">229-234</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The two isoforms of sphingosine kinase (SphK1 and SphK2) are the only enzymes that phosphorylate sphingosine to sphingosine-1-phosphate (S1P), which is a pleiotropic lipid mediator involved in a broad range of cellular processes including migration, proliferation, and inflammation.  SphKs are targets for various diseases such as cancer, fibrosis, and Alzheimer's and sickle cell disease.  Herein, the authors disclose the structure-activity profile of naphthalene-contg. SphK inhibitors, e.g. I, and mol. modeling studies that reveal a key mol. switch that controls SphK selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPGfYUT33eh7Vg90H21EOLACvtfcHk0lg-9kb0DHjaUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFOmsLw%253D&md5=537066e8604f804f7a73b4275dbd135d</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00304%26sid%3Dliteratum%253Aachs%26aulast%3DCongdon%26aufirst%3DM.%2BD.%26aulast%3DKharel%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DA.%2BM.%26aulast%3DLewis%26aufirst%3DS.%2BN.%26aulast%3DBevan%26aufirst%3DD.%2BR.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DSantos%26aufirst%3DW.%2BL.%26atitle%3DStructure-activity%2520relationship%2520studies%2520and%2520molecular%2520modeling%2520of%2520naphthalene-based%2520sphingosine%2520kinase%25202%2520Inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D229%26epage%3D234%26doi%3D10.1021%2Facsmedchemlett.5b00304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Houck, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kharel, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naimon, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Field, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, T. L.</span></span> <span> </span><span class="NLM_article-title">Structural requirements and docking analysis of amidine-based sphingosine kinase 1 inhibitors containing oxadiazoles</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">487</span>– <span class="NLM_lpage">492</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsFaqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=487-492&author=J.+D.+Houckauthor=T.+K.+Dawsonauthor=A.+J.+Kennedyauthor=Y.+Kharelauthor=N.+D.+Naimonauthor=S.+D.+Fieldauthor=K.+R.+Lynchauthor=T.+L.+Macdonald&title=Structural+requirements+and+docking+analysis+of+amidine-based+sphingosine+kinase+1+inhibitors+containing+oxadiazoles&doi=10.1021%2Facsmedchemlett.6b00002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Requirements and Docking Analysis of Amidine-Based Sphingosine Kinase 1 Inhibitors Containing Oxadiazoles</span></div><div class="casAuthors">Houck, Joseph D.; Dawson, Thomas K.; Kennedy, Andrew J.; Kharel, Yugesh; Naimon, Niels D.; Field, Saundra D.; Lynch, Kevin R.; Macdonald, Timothy L.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">487-492</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) is a potent growth-signaling lipid that has been implicated in cancer progression, inflammation, sickle cell disease, and fibrosis.  Two sphingosine kinases (SphK1 and 2) are the source of S1P; thus, inhibitors of the SphKs have potential as targeted cancer therapies and will help to clarify the roles of S1P and the SphKs in other hyperproliferative diseases.  Recently, we reported a series of amidine-based inhibitors with high selectivity for SphK1 and potency in the nanomolar range.  However, these inhibitors display a short half-life.  With the goal of increasing metabolic stability and maintaining efficacy, we designed an analogous series of mols. contg. oxadiazole moieties.  Generation of a library of mols. resulted in the identification of the most selective inhibitor of SphK1 reported to date (705-fold selectivity over SphK2), and we found that potency and selectivity vary significantly depending on the particular oxadiazole isomer employed.  The best inhibitors were subjected to in silico mol. dynamics docking anal., which revealed key insights into the binding of amidine-based inhibitors by SphK1.  Herein, the design, synthesis, biol. evaluation, and docking anal. of these mols. are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWZdhVUIviRLVg90H21EOLACvtfcHk0lg-9kb0DHjaUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsFaqsLw%253D&md5=1edf9e0138e7ac44d58e6eec51b699f7</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00002%26sid%3Dliteratum%253Aachs%26aulast%3DHouck%26aufirst%3DJ.%2BD.%26aulast%3DDawson%26aufirst%3DT.%2BK.%26aulast%3DKennedy%26aufirst%3DA.%2BJ.%26aulast%3DKharel%26aufirst%3DY.%26aulast%3DNaimon%26aufirst%3DN.%2BD.%26aulast%3DField%26aufirst%3DS.%2BD.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26atitle%3DStructural%2520requirements%2520and%2520docking%2520analysis%2520of%2520amidine-based%2520sphingosine%2520kinase%25201%2520inhibitors%2520containing%2520oxadiazoles%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D487%26epage%3D492%26doi%3D10.1021%2Facsmedchemlett.6b00002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, D.</span></span> <span> </span><span class="NLM_article-title">Assessing the ligand selectivity of sphingosine kinases using molecular dynamics and MM-PBSA binding free energy calculations</span>. <i>Mol. BioSyst.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1174</span>– <span class="NLM_lpage">1182</span>, <span class="refDoi"> DOI: 10.1039/C6MB00067C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1039%2FC6MB00067C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=26927311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADC%252BC28XivVKgtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=1174-1182&author=L.+Fangauthor=X.+Wangauthor=M.+Xiauthor=T.+Liuauthor=D.+Yin&title=Assessing+the+ligand+selectivity+of+sphingosine+kinases+using+molecular+dynamics+and+MM-PBSA+binding+free+energy+calculations&doi=10.1039%2FC6MB00067C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing the ligand selectivity of sphingosine kinases using molecular dynamics and MM-PBSA binding free energy calculations</span></div><div class="casAuthors">Fang, Liang; Wang, Xiaojian; Xi, Meiyang; Liu, Tianqi; Yin, Dali</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1174-1182</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-2051</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The dynamic balance of sphingolipids plays a crucial role in diverse biol. processes such as mitogenesis, cell migration and angiogenesis.  Sphingosine kinases (SKs) including SK1 and SK2 phosphorylate sphingosine to sphingosine 1-phosphate (S1P), and control the crit. balance.  SK1 overexpression was reported to increase cell survival and proliferation.  Although several SK1 selective inhibitors have been reported, detailed anal. toward their selectivity to understand the mol. mechanism has not been performed to our knowledge.  Herein, the crystal structure of SK1 and a homol. model of SK2 were used to dock five inhibitors (1, 2, 3, 4 and 5).  Protein-ligand complexes were then subjected to a mol. dynamics study and MM-PBSA binding free energy calcns.  By analyzing the binding model of these inhibitors, we found that residues ILE170, PHE188 and THR192 in SK1 significantly contribute a favorable binding energy to the selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9m5X9YBTn7rVg90H21EOLACvtfcHk0liAh6-P0ksFgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivVKgtLk%253D&md5=03e4c50dc954ff36437c20387374c2b6</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1039%2FC6MB00067C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6MB00067C%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DXi%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DYin%26aufirst%3DD.%26atitle%3DAssessing%2520the%2520ligand%2520selectivity%2520of%2520sphingosine%2520kinases%2520using%2520molecular%2520dynamics%2520and%2520MM-PBSA%2520binding%2520free%2520energy%2520calculations%26jtitle%3DMol.%2520BioSyst.%26date%3D2016%26volume%3D12%26spage%3D1174%26epage%3D1182%26doi%3D10.1039%2FC6MB00067C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gottlieb, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotlyar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nudelman, A.</span></span> <span> </span><span class="NLM_article-title">NMR chemical shifts of common laboratory solvents as trace impurities</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">7512</span>– <span class="NLM_lpage">7515</span>, <span class="refDoi"> DOI: 10.1021/jo971176v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo971176v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=1%3ACAS%3A528%3ADyaK2sXmvVClsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=7512-7515&author=H.+E.+Gottliebauthor=V.+Kotlyarauthor=A.+Nudelman&title=NMR+chemical+shifts+of+common+laboratory+solvents+as+trace+impurities&doi=10.1021%2Fjo971176v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">NMR chemical shifts of common laboratory solvents as trace impurities</span></div><div class="casAuthors">Gottlieb, Hugo E.; Kotlyar, Vadim; Nudelman, Abraham</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7512-7515</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The 1H (300 MHz) and 13C (75 MHz) NMR chem. shifts for >30 common impurities, such as lab. solvents, stabilizers, greases and water, are reported in 7 deuterated NMR solvents.  The temp. dependence of the chem. shift of the proton residual peak (HDO) in D2O is established for the entire liq. range of this sample.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocnoOemocS9LVg90H21EOLACvtfcHk0liAh6-P0ksFgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmvVClsbo%253D&md5=c297adda99f8c10e9f9b0ab9fe5f55be</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjo971176v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo971176v%26sid%3Dliteratum%253Aachs%26aulast%3DGottlieb%26aufirst%3DH.%2BE.%26aulast%3DKotlyar%26aufirst%3DV.%26aulast%3DNudelman%26aufirst%3DA.%26atitle%3DNMR%2520chemical%2520shifts%2520of%2520common%2520laboratory%2520solvents%2520as%2520trace%2520impurities%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26spage%3D7512%26epage%3D7515%26doi%3D10.1021%2Fjo971176v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathis, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerdes, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitney, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mailman, R. B.</span></span> <span> </span><span class="NLM_article-title">Synthesis and in vitro evaluation of 2,3-dimethoxy-5-(fluoroalkyl)-substituted benzamides: high-affinity ligands for CNS dopamine D2 receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1612</span>– <span class="NLM_lpage">1624</span>, <span class="refDoi"> DOI: 10.1021/jm00109a013</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00109a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=1612-1624&author=J.+E.+Bishopauthor=C.+A.+Mathisauthor=J.+M.+Gerdesauthor=J.+M.+Whitneyauthor=A.+M.+Eatonauthor=R.+B.+Mailman&title=Synthesis+and+in+vitro+evaluation+of+2%2C3-dimethoxy-5-%28fluoroalkyl%29-substituted+benzamides%3A+high-affinity+ligands+for+CNS+dopamine+D2+receptors&doi=10.1021%2Fjm00109a013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm00109a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00109a013%26sid%3Dliteratum%253Aachs%26aulast%3DBishop%26aufirst%3DJ.%2BE.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DGerdes%26aufirst%3DJ.%2BM.%26aulast%3DWhitney%26aufirst%3DJ.%2BM.%26aulast%3DEaton%26aufirst%3DA.%2BM.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520evaluation%2520of%25202%252C3-dimethoxy-5-%2528fluoroalkyl%2529-substituted%2520benzamides%253A%2520high-affinity%2520ligands%2520for%2520CNS%2520dopamine%2520D2%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D1612%26epage%3D1624%26doi%3D10.1021%2Fjm00109a013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bakali, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieslander, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallberg, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordlund, P.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of YegS, a homologue to the mammalian diacylglycerol kinases, reveals a novel regulatory metal binding site</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">19644</span>– <span class="NLM_lpage">19652</span>, <span class="refDoi"> DOI: 10.1074/jbc.M604852200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1074%2Fjbc.M604852200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=19644-19652&author=H.+M.+Bakaliauthor=M.+D.+Hermanauthor=K.+A.+Johnsonauthor=A.+A.+Kellyauthor=A.+Wieslanderauthor=B.+M.+Hallbergauthor=P.+Nordlund&title=Crystal+structure+of+YegS%2C+a+homologue+to+the+mammalian+diacylglycerol+kinases%2C+reveals+a+novel+regulatory+metal+binding+site&doi=10.1074%2Fjbc.M604852200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M604852200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M604852200%26sid%3Dliteratum%253Aachs%26aulast%3DBakali%26aufirst%3DH.%2BM.%26aulast%3DHerman%26aufirst%3DM.%2BD.%26aulast%3DJohnson%26aufirst%3DK.%2BA.%26aulast%3DKelly%26aufirst%3DA.%2BA.%26aulast%3DWieslander%26aufirst%3DA.%26aulast%3DHallberg%26aufirst%3DB.%2BM.%26aulast%3DNordlund%26aufirst%3DP.%26atitle%3DCrystal%2520structure%2520of%2520YegS%252C%2520a%2520homologue%2520to%2520the%2520mammalian%2520diacylglycerol%2520kinases%252C%2520reveals%2520a%2520novel%2520regulatory%2520metal%2520binding%2520site%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D19644%26epage%3D19652%26doi%3D10.1074%2Fjbc.M604852200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boccone, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vattem, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wek, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, J. P.</span></span> <span> </span><span class="NLM_article-title">Site-directed mutagenesis of the active site of diacylglycerol kinase alpha: calcium and phosphatidylserine stimulate enzyme activity via distinct mechanisms</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>375</i></span>,  <span class="NLM_fpage">673</span>– <span class="NLM_lpage">680</span>, <span class="refDoi"> DOI: 10.1042/bj20031052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;key=10.1042%2Fbj20031052" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=375&publication_year=2003&pages=673-680&author=T.+Abeauthor=X.+Luauthor=Y.+Jiangauthor=C.+E.+Bocconeauthor=S.+Qianauthor=K.+M.+Vattemauthor=R.+C.+Wekauthor=J.+P.+Walsh&title=Site-directed+mutagenesis+of+the+active+site+of+diacylglycerol+kinase+alpha%3A+calcium+and+phosphatidylserine+stimulate+enzyme+activity+via+distinct+mechanisms&doi=10.1042%2Fbj20031052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1042%2Fbj20031052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20031052%26sid%3Dliteratum%253Aachs%26aulast%3DAbe%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DBoccone%26aufirst%3DC.%2BE.%26aulast%3DQian%26aufirst%3DS.%26aulast%3DVattem%26aufirst%3DK.%2BM.%26aulast%3DWek%26aufirst%3DR.%2BC.%26aulast%3DWalsh%26aufirst%3DJ.%2BP.%26atitle%3DSite-directed%2520mutagenesis%2520of%2520the%2520active%2520site%2520of%2520diacylglycerol%2520kinase%2520alpha%253A%2520calcium%2520and%2520phosphatidylserine%2520stimulate%2520enzyme%2520activity%2520via%2520distinct%2520mechanisms%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D375%26spage%3D673%26epage%3D680%26doi%3D10.1042%2Fbj20031052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V24" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V24','PDB','4V24'); return false;">PDB: 4V24</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VZD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VZD','PDB','3VZD'); return false;">PDB: 3VZD</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WER" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WER','PDB','4WER'); return false;">PDB: 4WER</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VZC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VZC','PDB','3VZC'); return false;">PDB: 3VZC</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BON" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BON','PDB','2BON'); return false;">PDB: 2BON</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2JGR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2JGR','PDB','2JGR'); return false;">PDB: 2JGR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P1R" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P1R','PDB','2P1R'); return false;">PDB: 2P1R</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QV7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QV7','PDB','2QV7'); return false;">PDB: 2QV7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QVL" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QVL','PDB','2QVL'); return false;">PDB: 2QVL</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3S40" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3S40','PDB','3S40'); return false;">PDB: 3S40</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3T5P" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3T5P','PDB','3T5P'); return false;">PDB: 3T5P</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WRR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WRR','PDB','4WRR'); return false;">PDB: 4WRR</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i65"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00162">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_81225"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00162">10.1021/acs.jmedchem.9b00162</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Reference NMR spectra for key compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_008.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings with SK1 and SK2 inhibition data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_001.csv">CSV</a>)</p></li><li><p class="inline">Related to <a id="rightTab-" class=" internalNav" href="#fig5">Figures <a id="rightTab-" class=" internalNav" href="#fig5">5</a></a>, <a id="rightTab-" class=" internalNav" href="#fig7">7</a> and <a id="rightTab-" class=" internalNav" href="#fig8">8</a>, homology model of SK2 with compound <b>60</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_002.pdb">PDB</a>)</p></li><li><p class="inline">Related to <a id="rightTab-" class=" internalNav" href="#fig6">Figure <a id="rightTab-" class=" internalNav" href="#fig6">6</a></a>, homology model of SK2 with compound <b>49</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_003.pdb">PDB</a>)</p></li><li><p class="inline">Related to <a id="rightTab-" class=" internalNav" href="#fig6">Figure <a id="rightTab-" class=" internalNav" href="#fig6">6</a></a>, docking model of SK1 (based on crystal structure PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V24">4V24</a>) with compound <b>49</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_004.pdb">PDB</a>)</p></li><li><p class="inline">Related to <a id="rightTab-" class=" internalNav" href="#fig7">Figure <a id="rightTab-" class=" internalNav" href="#fig7">7</a></a>, docking model of SK1 (based on crystal structure PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V24">4V24</a>) with compound <b>60</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_005.pdb">PDB</a>)</p></li><li><p class="inline">Related to <a id="rightTab-" class=" internalNav" href="#fig8">Figure <a id="rightTab-" class=" internalNav" href="#fig8">8</a></a>, homology model of SK2 with compound <b>9</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_006.pdb">PDB</a>)</p></li><li><p class="inline">Related to <a id="rightTab-" class=" internalNav" href="#fig8">Figure <a id="rightTab-" class=" internalNav" href="#fig8">8</a></a>, homology model of SK2 with compound <b>10</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_007.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_001.csv">jm9b00162_si_001.csv (1.16 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_002.pdb">jm9b00162_si_002.pdb (413.83 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_003.pdb">jm9b00162_si_003.pdb (413.83 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_004.pdb">jm9b00162_si_004.pdb (471.38 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_005.pdb">jm9b00162_si_005.pdb (471.41 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_006.pdb">jm9b00162_si_006.pdb (414.46 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_007.pdb">jm9b00162_si_007.pdb (413.07 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00162/suppl_file/jm9b00162_si_008.pdf">jm9b00162_si_008.pdf (2.4 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00162&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00162%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-7%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00162" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67994e5d49a22458","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
